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1. Abstract 
Oligonucleotides are significant tools in chemical biology and show wide applications. 
This thesis contains two projects concerning the construction of ligandosides and 
functionalization of oligonucleotides for formylcytosine detection. 
In the first project, a novel metal-base pair based on the pyrazole ligand was 
developed. The synthesis of the pyrazole ligandoside comprised the preparation of a 
protected base building block and a cuprate mediated C-glycosylation as the key step 
(Figure 1-1). The correct β-configuration of the nucleoside was confirmed by X-ray 
crystallography. The ligandoside precursor was incorporated into numerous 
oligonucleotides by automated DNA synthesis (Chapter 4.2). 
 
Figure 1-1 Synthesis of the protected pyrazole nucleoside 13 and the phosphoramidite 15. 
With a homo-pyrazole base pair inserted, duplex stability increased by 9°C after 
incooperation of one copper ion. The chelating performance depends on 
deprotonation of the phenol group of the ligandoside. Up to ten copper ions can be 
coordinated inside the duplex. Compared with the bridging salen base pair, the 
non-bridging pyrazole base pair shows a kinetical preference for complexation 
(Figure 1-2, Chapter 4.3). 
The pyrazole triphosphate is accepted by the Therminator polymerase which extends 
the primer. The unsatisfactory efficiency, however, hinders its application in PCR 
(Chapter 4.4.1). A duplex with five pyrazole-copper pairs was applied as a chiral 
catalyst in a model Diels-Alder reaction, which allowed to reach an ee value of 39% 
(Chapter 4.4.2). The novel ligandoside sheds light on how DNA may be used as a 
catalyst in organic reactions and enlightens further design and optimization of 
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ligandosides. 
 
Figure 1-2 a) and b) CD titration of the duplexes containing 5 or 10 Pz pairs; c) and d) UV titration of 
duplex showing Cu2+ kinetical preference. 
The second project is focused on developing a new fdC sequencing method based on 
an oligonucleotide probe connected to a hydroxylamine linker. The linker was 
selected using a combinational chemistry strategy. The most suitable linker at an n+4 
position of the probe strand was known to react with the fdC in the target strand 
irreversibly. Because the probe and the target strand hybridized to form a duplex, the 
probe reacted with the target fdC with high positional specificity (Figure 1-3, Chapter 
4.2). The reaction is limited to fdC and can tolerant single nucleotides polymorphisms 
in the target. Multiple fdC probes can be applied together. 
Enzymatic digestion and primer extension experiments were performed on the 
cross-linked oligonucleotide towards LC-MS and PCR detection (Chapter 4.3). After 
oxime formation, the duplex can be digested into dinucleotides but they cannot be 
detached. The probe strands hinders the Taq polymerase to pass through the target 
strand. 
1. Abstract 
3 
 
 
Figure 1-3 Schematic representation of the fdC probe and target crosslinking. 
A method for relative fdC quantification was developed using the described probe 
(Figure 1-4 Chapter 4.4). After crosslinking, the fdC probe was ligated to an adapter 
strand, wrapped in nanodroplets and replicated using PCR. The signals were counted 
and compared to a reference amplicon. 10-fold increase of fdC was observed at one 
position in an exon in Tdg-/- mES cells compared to Dnmt TKO cells, and 2-fold 
compared to Tdg+/- cells. The method can be applied to other targets of interest in 
order to track the dynamic change of the epigenetic fdC bases. 
  
Figure 1-4 Schematic representation of the relative fdC quantification method and results. 
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2. Zusammenfassung 
Oligonukleotide sind wichtige Werkzeuge in der chemischen Biologie und erlauben 
breite Anwendungen. Diese Arbeit gliedert sich in zwei Projekte. Den Einbau von 
Metallo-Basen in DNA und die Funktionalisierung von Oligonukleotiden zur 
Detektion von 5-Formylcytosin. 
Im Zuge des ersten Projekts wird ein neues Metall-Basenpaar entwickelt, welches auf 
dem Pyrazolliganden basiert. Die Synthese des Pyrazolliganden erforderte die 
Darstellung eines geschützten Basenbausteins und eine Kuprat-vermittelte 
C-Glykosylierung als Schlüsselschritt (Abb.1-1). Die gewünschte β-Konfiguration des 
Nukleosids wurde durch eine Kristallstrukturanalyse bestätigt. Der Ligandosid- 
Vorläufer wurde in zahlreiche Oligonukleotide mittels automatisierter DNA-Synthese 
eingebaut (Kapitel 4.2). 
Liegt ein Homo-Pyrazol-Einzelbasenpaar in einem Strang vor, so erhöht die Zugabe 
von Cu2+ den Schmelzpunkt des Doppelstrangs um 9°C. Die Komplexierung hängt 
von der Deprotonierung des Phenols im Ligandosid ab. Duplexe mit 10 
Pyrazol-Basenpaaren ermöglichte das Stapeln von bis zu zehn Kupferionen im 
Inneren eines Doppelstranges. Verglichen mit dem überbrückten Salen-Basenpaar, 
zeigte das nicht überbrückten Pyrazole-Basenpaar eine kinetische Präferenz zur 
Komplexierung (Abb.1-2, Kapitel 4.3). 
Die enzymatische DNA-Synthese erfolgt durch die Therminator Polymerase. Diese 
katalysiert die Polymerisation des Pyrazolnukleosid-triphosphats zu Polynukleotiden. 
Die unzureichende Effizienz steht weiteren Anwendungen in der PCR jedoch im 
Wege (Kapitel 4.4.1). Ein Duplexstrang mit fünf Pyrazol-Kupferpaaren wurde als 
chiraler Katalysator in einer Diels-Alder-Reaktion eingesetzt und erreicht einen 
ee-Wert von 39% (Kapitel 4.4.2). Der neue Ligandosid kann als DNA- Katalysator in 
organischen Reaktionen genutzt werden. 
Das zweite Projekt konzentriert sich auf die Entwicklung einer neuen 
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Sequenzierungsmethode für fdC. Diese basiert auf einer Oligonukleotidsonde 
verbunden mit einem Hydroxylamin-Linker. Der Linker wurde durch 
kombinatorische Chemie entwickelt. Der am besten geeignete Linker an einer 
geeigneten Position auf dem Sondenstrang kann mit dem fdC des Zielstrangs 
irreversibel reagieren. Da die Sonde- und der Zielstrang zu einem Duplex 
hybridisieren, reagierte die Sonde mit dem erwünschten fdC mit Positionsspezifität 
(Abb.1-3, Kapitel 4.2). Die Reaktion ist spezifisch für fdC und toleriert 
Einzelnukleotid-Polymorphismus im Zielstrang. Mehrere fdC Sonden können 
gemeinsam angewendet werden. 
Enzymatische Hydrolyse und Primer-Extension-Experimente wurden an den 
vernetzten Oligonukleotiden durchgeführt. Dadurch konnten die Sonde durch 
LC-MS- und PCR-Methoden analysiert werden (Kapitel 4.3). Nach der Oximreaktion 
können die Doppelstränge in Dinukleotide verdaut aber nicht voneinander getrennt 
werden. Durch die kovalente Bindung zwischen den Sondensträngen wird die 
Taq-Polymerase gestoppt. Dies unterbindet die Vervielfältigung. 
Eine relative fdC Quantifizierungsmethode wurde mit dieser Sonde entwickelt 
(Abb.1-4, Kapitel 4.4). Nach der Vernetzung, wurden die fdC Sondestränge mit einem 
Adapterstrang ligiert, in Nanotröpfchen verteilt und repliziert. Die Signale in den 
Tröpfchen wurden gezählt und mit einem Referenzamplicon verglichen. So wurde in 
Tdg knokcout mES Zellen in Vergleich zu einem Dnmt Dreifachknockout die 
zehnfache Menge an fdC beobachtet und im Vergleich zu Tdg+/– Zellen die zweifache 
Menge. Das Verfahren kann auf eine Vielzahl von Zielen angewandet werden.
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3. Introduction  
3.1. Nucleosides and ligandosides 
3.1.1.  Nucleosides and their artificial modifications 
3.1.1.1. Deoxyribonucleic acid 
Nucleic acids are essential material for the storage and transmission of the genetic 
information. Due to their difference in the pentose, nucleic acids are divided into 
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA).  
 
In general, DNA molecules are made up of four types of nucleotides linked together 
by phosphodiester bonds. Each nucleotide in DNA consists of a nitrogenous base, a 
sugar deoxyribose, and a phosphate residue. Two types of bases are found in DNA: 
purines, adenine (A) and guanine (G); and pyrimidines, cytosine (C) and thymine (T). 
Figure 3-1 Double helix structure and chemical structure of DNA. 
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Besides, DNA may contain several additional modified bases, namely 
5-methylcytosine (mdC) and its oxidized derivatives, N6-methyladenine (m6A),1, 2 and 
N4-methylcytosine (m4A),3 which result from the post-replicative modification of 
DNA by DNA methyltransferases. The former, mdC and oxidized derivatives, will be 
discussed in Chapter 3.2. 
The nucleosides are linked by phosphodiester bonds, joining the 5’ carbon of one 
deoxyribose to the 3’ carbon of the next, to form a polynucleotide chain, as depicted 
in Figure 3-1. An oligonucleotide is a short strand of DNA, and a nucleoside refers to 
the nitrogenous base and the pentose. 
Polynucleotides exist as single strand molecule or as double strand structure, in which 
two strands are held together by hydrogen bonds between the bases. The antiparallel 
double helix model was put forward in 1953 by J. D. Watson and F. H. C. Crick based 
X-ray diffraction measurements.4, 5 The hydrogen bonds between A and T, G and C 
inside the double helix are the molecular basis for the biological function of DNA. 
Phosphate backbones with negative charges outside the helix are neutralized by metal 
ions or proteins inside the cell.  
The B-DNA form is the most conventional nucleic acid helix. With a diameter of 2 
nm, it has a major groove and a minor groove. Each base in B-DNA is separated by 
0.34 nm along the length of the double helix; each turn consists of 10.5 bases. A-DNA 
form is a right-handed double helix fairly similar to B-DNA form, but with a shorter, 
more compact helical structure whose base pairs are not perpendicular to the helix 
axis. Z-DNA from is a left-handed double helical structure, deemed as one of three 
biologically active double helical structures along with A- and B-DNA. 
DNA duplexes wind on histones and are packaged in nucleosomes in eukaryotic cell 
nuclei. The superhelix unwinds to replicate itself in S-phase of the cell cycle with the 
help of helicase, single-strand DNA-binding protein, DNA polymerase I/III and DNA 
ligase. The information contained in a section of DNA is transcribed in the form of a 
3. Introduction 
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newly assembled piece of messenger RNA (mRNA). This process is called as 
transcription. Transcription factors are proteins that bind to specific DNA sequences 
and control the rate of transcription. Furthermore, RNA polymerase also plays a role. 
In prokaryotic cells, there is no spatial separation of transcription and translation. In 
eukaryotic cells, mature mRNA finds its way to the ribosome and gets translated into 
polypeptides. The above process is named as the central dogma of molecular biology. 
Figure 3-2 provides a graphical elucidation. 
In the natural information flow, 64 triplet codons are possible in the standard genetic 
lexicon with four bases (A, C, G, T). As the genetic code is degenerate, most natural 
amino acids are encoded by more than one triplet codon. As a result, only 20 
proteinogenic amino acids are encoded by all 64 codons, leaving thousands 
conceivable amino acids behind.  
 
Figure 3-2 Schematic representation of the central dogma of molecular biology. Unusual flows of 
information, i.e. reverse transcription and RNA replication, are not showed. 
 
3.1.1.2. DNA reconstruction: XNA world 
Since the discovery of the molecular structure of DNA, its specific recognition and 
the potential for information storage urged the chemists to broaden the knowledge of 
the DNA structure and to endow them with new outstanding properties. In the past 
decades, modern organic synthesis methods, solid-phase synthesis, and polymerase 
chain reaction (PCR) technology made chemically modified nucleosides and 
oligonucleotides technically feasible. Consequently, a collection of sugar-, phosphate- 
and base- modified nucleic acid mimics have been synthesized and evaluated. These 
synthetic genetic polymers are called “xeno- nucleic acids” (XNA), proposed by P. 
Herdewijn and P. Marliere,6 and as shown in Figure 3-3. As in all other endeavors that 
3.1 Nucleosides and ligandosides 
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to synthesize analogs of natural products, the goal of XNA investigation is to learn 
how DNA and RNA work, and to provide them with new properties. Nowadays, 
“XNA” constantly gain wider applicability in biotechnology, nanotechnology, 
molecular biology, and pharmaceutical sciences.  
 
 
Figure 3-3 Xeno- nucleic acids (XNA) chemical space. The x-, y- and z-axes represent sugar, base and 
backbone modifications, respectively. The figure is adapted from reference.15 
In practice, oligonucleotides with non-canonical nucleotides can be synthesized with 
the solid-phase synthesizer. The concept “solid-phase synthesis”, originally invented 
for peptide synthesis, was put forward in 1963 by R. B. Merrifield.7 It was of such 
importance that Merrifield was awarded the Nobel Price in Chemistry in 1984 for the 
development of the field. In short, the amino acids are immobilized on a solid phase 
and undergo repeated cycles of deprotection-wash-coupling-wash until the sequence 
terminates. The peptide is then cleaved from the solid-phase and purified. 
3. Introduction 
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Figure 3-4 Chemistry for oligonucleotide solid-phase synthesis: a) phosphotriester and b) 
phosphite-triester approach invented by Letsinger et al.; c) phosphoramidite approach synthetic cycle, i) 
coupling, ii) capping and oxidation, iii) deprotection. Gray spheres represent the solid phase. 
Another scientist, R.L. Letsinger, who was also working on the peptide solid phase 
synthesis,8,9 after Merrifield’s publication in 1963, decided to focus on 
oligonucleotide solid phase synthesis.10 Phosphotriester11-13 and phosphite-triester14, 15 
chemistry were invented (Figure 3-4a, b) by him, but both methods suffered from 
serious drawbacks such as low coupling efficiency, moisture sensitivity, and 
undesired 3’-3’ by-products. In early 1980’s, M. H. Caruthers, a former student of 
Letsinger, invented the phosphoramidite approach inspired by the phosphite-triester 
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method.16, 17 The phosphoramidite monomers are more stable and can be activated 
before coupling by adding tetrazole, a weak acid. After coupling, the solid-phase is 
oxidized as in phosphite-triester chemistry. The unreacted strands which are left with 
a free 5’-hydroxy group are capped using a mixture of acetic anhydride and 
N-methylimidazole. In this way, a failed strand’s synthesis is terminated. Deprotection 
the dimethoxytrityl (DMTr) group at 5’ terminus with trichloroactate acid leads the 
cycle into the next round (Figure 3-4c). The synthesis cycle, ingenious, simple and 
feasible, has remained virtually unchanged since then. 
Thanks to the automated solid-phase synthesizer later developed by Caruthers and 
co-workers, oligonucleotides containing canonical nucleotides and chemical modifiers 
became increasingly accessible. Chemical modifications corresponding to the three 
parts of the nucleotide are discussed below. 
 
Modification of the phosphate diester 
As a part of the backbone, the polyanionic sugar-phosphodiester unit force the 
nucleotides into a suitable distance for Watson-Crick pairing. On the same strands, 
Coulombic repulsion between the phosphodiesters warrants that the single strand can 
adopt an extended structure in the buffer system. The stretch-out conformation is 
crucial for the pre-organization process needed for the strand to bind its complement. 
Furthermore, the repeated anionic groups maintain the DNA and RNAs unified 
physicochemical properties. Unlike peptides, the properties of oligonucleotides are 
independent of the nucleobase sequence so that DNA mutations do not change the 
chemical and physical properties of the molecular. Figure 3-5 summarizes the 
reported modified phosphodiester linkage. 
The phosphate diester backbone is the natural substrate of phosphodiesterases. 
Replacing the diester bond will alter the biological stability of the DNA duplex. The 
most common modification is formation of thiophosphate esters or phosphorothioates 
(Figure 3-5b).18, 19 With the oxygen replaced by a sulfur atom, the phosphorothioate is 
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still toleranted by DNA polymerases. It causes only a slight change of the 
thermostability. But the stability toward phosphodiesterase is significantly enhanced.  
 
Figure 3-5 Examples of phosphodiester mimics: a) canonical phosphodiester; b) phosphorothioate, 
boranephosphonate, dimethylene sulfone,20 and phosphoselenoate;21 c) methyl-phosphonate,22 
methylated phosphodiester,23 phosphoramidite,24 and N-cyanoguanidine linkage.25 
In 1990, a novel boranephosphonate nucleotide analog (bpDNA) was first reported by 
the Shaw lab.26, 27 These nucleotides contain a borane moiety, which replaces the 
non-bridging phosphate oxygen, resulting in a hydrolytically stable phosphodiester 
analog. Taking advantage of the reductive BH3 group, M. H. Caruthers and co-worker 
demonstrated that bpDNA was capable of reducing Au3+ and Ag+ in situ.28 While 
boranephosphonate solvolyzed to phosphate diesters, the oligomers generated the 
corresponding silver and gold nanoparticles. Soon afterward, the bpDNA oligomers 
were incorporated into a two-dimensional DNA array. In situ reduction of Ag+ on the 
structure generated a well-defined array of silver nanoparticles.29  
 
Modification of the pentose sugar 
Tremendous efforts have been made to replace the pentose sugar with various 
structures. There were different sugar rings or ring-opening backbone structures.  
Substitution of the 2’ hydroxyl group to fluoro (2’-F) and the hydroxymethyl group 
(2’-OCH3), as depicted in Figure 3-6, are known and have numerous beneficial effect, 
e.g. in antisense,30 siRNA31, 32, CRISPR-Cas933, 34 systems.  
2’-SCF3 substitution allows monitoring nucleotides by 19F-NMR at micromolar 
concentration.35 However, this novel modification exerts a high degree of 
destabilization in a double helix.36 Synthetic methods towards 2’-SeCH3 37 and 2’-N3 
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nucleotides38, 39 were established by the same group. Normal phosphoramidite 
chemistry combined with alternate phosphotriester chemistry enabled azido group 
incorporation. 2-Azide nucleic acids later found its applications in RNA interference 
and oligonucleotide labeling.39, 40  
Apart from 2’ modifications, 4’ modifications, i.e. replacing the oxygen atom with 
CH2,41 NAc,42 S,43, 44 Se,45, 46 (Figure 3-6) were found useful in gene-based therapy 
and crystallography. 
 
Figure 3-6 Examples of pentose sugar mimic: modification at 2’, 4’ and a sugar with an expanded ring. 
The Structure on the left shows the canonical deoxyribose. R1 = F, OMe, SCF3, SeMe, N3. R2 = CH2, 
NAc, S, Se. R3 = OH, F, R4 = F. R5 = H, R6 = H, OH, OMe, F; R5 = OH, F, R6 = H. 
A major consideration for the design is to improve the affinity of the synthetic 
oligonucleotide to the coresponding canonical counter strand. Generally, 
conformational restriction of the sugar-phosphate backbone is a very successful idea 
because this change does not interfere with the specificity of Watson-Crick base 
pairing. Revisiting the structure of the nucleotide (Figure 3-7a and b), there are at least 
three strategies to incorporate covalent conformational constraints: 1) rotation 
restriction around torsion angles γ and δ, e.g. tricyclo-DNA;47 2) backbone restriction 
around torsion angles, e.g. α,β-CNA;48 3) furanose conformation restriction in a 
northern type sugar pucker with 2’,4’-bridge, e.g. locked nucleic acids (LNA).49-53 
Oligonucleotides consisting of only LNA bases have no double helix binding 
capacity.54,55 On the other hand, LNA-containing oligonucleotides adopt 
Watson-Crick base pairing, resulting in thermostable and sequence-specific double 
helix interaction with DNA and RNA.56, 57 The S. Hanessia group combined the first 
and the third strategy in the example of triNA.58 (Figure 3-7b) Although the synthesis 
takes more than 20 steps, triNA stabilizes the double helix even better than LNA. 
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Figure 3-7 Examples of pentose sugar mimic: a) canonical nucleotide with highlighted torsion angles; b) 
conformational restricted and c) flexible backbones modifications.  
Parallel to pentose sugar mimics, acyclic nucleotide mimics obtained the interest of 
the community (Figure 3-7c). Acyclic nucleosides that are based on glycerol,59, 60 
propanediol,61-63 butanediol,64 threninol,65 serinol,66 and unlocked nucleic acid67 have 
been invented in the past two decades. In most cases, DNA double strands containing 
the flexible linker are less thermostable than canonical duplexes, supporting the idea 
that the rigid ribose ring is crucial for duplex preorganization rather than simply 
holding the nucleobases together. 
Among these acyclic nucleoside mimics, peptide nucleic acid (PNA) that is endowed 
with remarkable hybridization properties has attracted considerable attention. PNA is 
an achiral and neutral DNA analog, in which the canonical backbone is substituted by 
N-(2-aminoethyl)-N-(methylenecarbonyl)glycine.68 The amide linkage equips PNA 
with a dual character of a peptide and an oligonucleotide. PNA is chemically stable at 
a broad range of temperatures and pH, and it is not a substrate of protease, peptidase, 
or nuclease.69 The neutral backbone structure leads to a PNA/DNA or PNA/RNA 
interaction which is stronger than homologous DNA or RNA duplexes. However, 
lacking charges on the backbone makes PNA less water soluble and PNA easily 
aggregates.70 The fidelity of PNA-pairing to canonical DNA is very high. 
In a previous report,71 PNA modifiers served as the backbone to study the 
photochemical TpT products. The difference of the photoproducts between PNA and 
phosphate dimer is attributed to the backbone flexibility. 
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Figure 3-8 Schematic representation of compartmentalized self-tagging (CST): a) and b) polymerase 
are compartmentalized with primers and modified nucleotides in emulsions to ensure genotype- 
phenotype linkage; c) CST is based on a positive feedback loop whereby a polymerase tags the plasmid 
containing its gene by extending a biotinylated primer; d) primer extension stabilizes the metastable 
primer-plasmid complex allowing capture; e) selection can be further modulated through stringent 
washing of the streptavidin beads; f) recovered plasmid DNA is amplified and used to start a new round 
of selection or screening. The Figure is adapted from reference.72  
To store and process genetic information in DNA analogues, and to discover 
polymerases that are able to process XNA synthesis, P. Holliger and co-workers 
developed a selection strategy called compartmentalized self-tagging (CST) (Figure 
3-8).72 In CST, a library of mutant polymerases is compartmentalized with 
biotinylated primers and modified nucleotides in water-in-oil emulsions. Primer 
extension stabilizes the metastable primer-plasmid complex allowing capture in 
proportion to its stability. Recovered plasmid DNA is amplified and used to start a 
new round of selection and screening. Among the six XNA modifiers, 
1,5-anhydrohexitol (HNA) yielded rapid adaptation toward HNA polymerase activity 
for both replication from DNA and reversed transcription from RNA. Transcription 
possibilities for flexible nucleic acids (FNA, Figure 3-7c)73 and threose nucleic acids 
(TNA)74 were discovered later. However, the efficiency and fidelity are still 
precarious, and future work must envolve development of other mutant polymerases 
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for successful PCR replication.  
Metal ions can be incorporated into the nucleic acid backbone. For example, altering 
the ribose ring to ferrocene made the metal an integral component of the 
backbone.75,76 Although ferronucleoside derivatives were later found to have 
anticancer activity,77 further benefits of the oligonucleotide are still awaiting 
discovery. 
 
Modification of the base pair 
Four strategies for designing artificial base pairs have been published. As 
demonstrated in Figure 3-9, bases can pair via hydrogen bonds, hydrophobic 
interaction, coordination bonds, and reversible covalent bonds.78 The third pattern will 
be discussed in detail in section 3.1.2.  
 
Figure 3-9 Interaction patterns of artificial base pairs: a) altered hydrogen bonds (Z/P pair), b) 
hydrophobic interactions (F/Q pair), c) nmetal coordination bond (P’/P’ pair), and d) reversible 
covalent bond (To/SII pair). R represents deoxyribose. Hydrogen bonds and bonds formed by 
coordination are shown as hashed bonds. 
Different from the straightforwardly designed and accessible phosphate diester and 
pentose sugar modified bases, artificial hetrocycle base pair patterns are more difficult 
to compose and synthesize. The dilemma in design lies in mimicking the natural 
interaction strength in a limited space inside the DNA duplex. The key step for the 
synthesis is to couple the nucleobase with the deoxyribose sugar moiety. 
Formation of C-glycosides or N-glycosides seems unavoidable, and several methods 
are available.79-81 After the glycosidation, the β-anomer has to be separated from the 
α-anomer. In addition, suitable protecting strategies for the artificial base building 
blocks need be adopted. The protecting groups should tolerate solid-phase synthesis 
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and grant mild and efficient deprotection on the column or in aqueous solution after 
the automated synthesis. 
The essence of mimicking Watson-Crick base pairs is size complementarity. Large 
purines pair (pu) with small pyrimidines (py) baned on hydrogen bonding 
complementarity between donors (D) from one nucleobase and acceptors (A) from the 
other. When three hydrogen bonds bridge the base pair, eight bridging patterns can be 
envisaged. Among them, pyDAA/puADD, i.e. guanine-cytosine, is a canonical base 
pair; patterns with three proton donors and acceptors in a row (pyDDD/puAAA and 
pyAAA/puDDD) are excluded because of overstability,82, 83 but they displayed their 
prowess in constructing tetrameric macrocycles and novel supermolecules.84  
In 1989, S. A. Benner and co-workers pioneered the development of base-pairs with 
five different hydrogen bonding patterns (Figure 3-10a).85-88 Although the nucleosides 
with the pyADD heterocycles undergo slow acid-catalyzed epimerization,89 
iso-guanine (pyAAD) could be incorporated into oligonucleotides opposite 
iso-cytosine (pyDDA) on a DNA template.85, 90 By translation of the (iso-C)AG codon 
opposite to CU(iso-G) anticodon on mRNA, the Benner group succeeded in 
incorporating L-3-iodotyrosine, a non-natural amino acid, into a peptide.91  
Unfortunately, iso-G has a minor tautomeric form that allows it also to pair with T as 
shown in Figure 3-10b. Furthermore, iso-C undergoes deamination during solid-phase 
synthesis.90 Realizing that the iso-canonical pair seems not to be an ideal candidate to 
enlarge the genetic alphabet, Benner and co-workers later replaced iso-C with 
2-thio-T.92 Because of the bulky thione moiety, minor tautomeric iso-G could not pair 
with 2-thio-T efficiently. Thus eliminated the tautomer percentage and increased the 
amplification fidelity. 
At the same time, using T7 RNA polymerase, they incorporated a new base pair “κ/χ”, 
as shown in Figure 3-10a.86, 93, 94 Although the incorporation of the artificial pair is 
less efficient compared to that of the natural base pairs, to our best knowledge, these 
are the earliest examples of artificial base pairs in replication and transcription.  
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Figure 3-10 Examples of alternative hydrogen-bonding base pair mimics with canonical size: a) via 
variant hydrogen bonds from Benner et al., pyrimidines are designated by the prefix “py”, purines by 
the prefix “pu”, follow the prefix is the order, from the major groove to the minor groove, of acceptor 
(A) and donor (D) group, letters, and bonds in red highlight the hydrogen donor; b) thymine/tautomeric 
iso-G pair and 2-thio-T/iso-G pair from Benner et al.; c) via variant hydrogen bonds and shape 
complementarity from Hirao et al. R represents pentose sugar. Hydrogen bonds are shown as hashed 
bonds. 
Watson-Crick base pairs are not the only system that can store and transmit genetic 
information, and certain nucleoside mimics also play a role in the genetic information 
flow.95 Chemical biologists are encouraged to question if other base pair can be 
constructed for the encoding of unnatural amino acids. By expanding the genetic 
alphabet, researchers aim at an enlarged genetic lexicon, increasing the numbers of 
non-natural amino acids that can be incorporated into peptides. These efforts do in 
principle not only provide the accessibility to engineered proteins but also shed light 
on the transcription and translation mechanisms. 
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Figure 3-11 Examples of hydrogen-bonding base pair mimics with extended size: a) xDNA and yDNA 
pair patterns from Kool et at.; b) expanded bases with four hydrogen bridges from Matsuda et al.; c) 
ethynyl trestle DNA from Inouye et al.; d) emissive RNA from Tor et al;. R represents deoxyribose. 
Hydrogen bonds are shown as hashed bonds. 
Slightly after Benner, I. Hirao and co-workers synthesized the base pair y/s (Figure 
3-10c) with two hydrogen bonds in between. In the y/s pair, shape complementarity 
was also a factor in base recognition. A yAG codon in the ras mRNA recognized the 
CUs anticodons in aminoacylated tRNA, thereby, incorporation of an unnatural amino 
acid into the Ras protein was achieved.96 In addition, the nucleoside “s” (Figure 3-10c) 
is a strong fluorophore. The translation process enabled the site-specific fluorescent 
labeling of the RNA molecule.97 However, the y/s base pair exhibited a lower 
transcription efficiency compared to the canonical base pair.  
In 1977, N. J. Leonard brought forward the idea of size-expanded bases.98 25 years 
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later, E. T. Kool and co-workers embellished this concept with hydrogen-bonding 
patterns as in xDNA (xA, xT) and yDNA (yA, yT) (Figure 3-11a).99-101   The 
enlarged xDNA differs from widened yDNA in the extension direction. Both base 
pairs stabilized the canonical duplex but replicated with low efficiency and fidelity.102 
As the same time, A. Matsuda et al. described another size-extended base pair with 
four hydrogen bonds in between (Figure 3-11b). Due to the excessive distance 
between the two ribose units in ImON/ImNO base pair,103 ImON/NaNO and 
ImNO/NaON were put forward as the second generation.104, 105 Together with the 
ethynyl trestle base pairs from M. Inouye group (Figure 3-11c),106  these examples 
imply the possibility to maintain the duplex stability using aggrandized bases, which 
suggests the space between the two phosphate backbone is flexible to some extent. 
The Y. Tor group synthesized two sets of RNA bases derived from hieno[3,4-d]- 
pyrimidine107 and isothiazolo[4,3-d]pyrimidine (Figure 3-11d).108  As fluorescent 
nucleoside analogs retaining Watson-Crick pairing patterns, the new alphabet should 
be useful in nucleotide labeling and detection. 
Although improvements of these analogs with H-bonding patterns continuously 
surprise the community, works of the E. T. Kool group proved that hydrogen bridges 
were not essential for polymerase-mediated base pair synthesis.109-111 Packing and 
hydrophobic interactions, the forces which are prevalent and well-documented in 
protein folding, assist the base pairing inside DNA duplex as well. Unlike to design 
the hydrogen-bonding and electrostatic interaction patterns, to predict the impact of 
aromatic stacking, hydrophobic or CH/π interactions, and shape complementarity is 
more challenging. 
Kool et al. started with difluorotoluene base F, the simplest isosteric mimic of 
thymine (Figure 3-12a).112, 113 Although F is meager in stabilizing the DNA duplex, it 
is a satisfactory counter base for adenine in replication with the Klenow fragment.109 
In respect of adenine, its non-hydrogen-bonding shape mimics Z and Q are better in 
extension efficiency when pairing with thymine or F.114 Q is superior to Z because H3 
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facilitates the minor groove H-bonding interaction.115 This indicates that the minor 
groove interaction of base pairs and the polymerase, besides shape complementarity, 
is also a major factor for extension beyond the artificial base pair. 
Hirao designed a similar hydrophobic base pair Dss/Pn as shown in Figure 3-12b. Pn 
was derived from Pa, a base designed for pairing Kool’s Q base, to prevent Pa/A 
pairing. On the other side, as Q can mispair with thymine, the methyl group of Q was 
replaced by Ds with a thienyl group,116 or Dss with a double-thienyl group. Dss has an 
excitation centered at 385 nm and an emission at 456 nm so that it acts as fluorophore 
and Pn as a quencher.117 When the basepair comes to PCR, the efficiency and fidelity 
are crucial issues because any chance of mispairing will accumulate in the PCR 
process. They achieved amplification of Dss/Pa as a molecular beacon in real-time 
PCR.118 Undoubtedly, the unnatural fluorophore/quencher base pair will be a useful 
tool for sensing, imaging and diagnostic applications.  
Since 1999, F. E Romesberg group has done tremendous work in the realm of the 
hydrophobic base pair (Figure 3-12c). Starting from a homo-base pair PICS/PICS,119 
they substituted the isocarbostyril moiety with various heteroatoms. Homo NICS, 
SICS, and SNICS pairs destabilize the duplex compared to homo ICS; SNICS/SNICS 
extended more efficient than ICS with Klenow fragment.120 Benzenes that contain 
methoxy groups at different positions were subsequently studied. Although the 
methoxy group is a weak hydrogen bond acceptor, ortho-situated methoxy group 
forms hydrogen bonds with the polymerase in the minor groove and promotes the 
replication process.121 A screening assay among a library of artificial nucleotides 
revealed the promising 5SICS/MMO2 pair. 5SICS/MMO2 replicates more efficient 
than the previous but is still slightly inferior to the canonical pairs.122, 123 Replacing of 
the methyl group with fluorine or a fusion ring furnished 5FM and NaM.124 Both pairs, 
5SICS/5FM and 5SICS/NaM, replicate and transcribe efficiently with high 
fidelity.125-128 These experiments indicated that all of the properties required of a 
functional unnatural base pair can be optimized within predominantly hydrophobic 
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Figure 3-12 Examples of hydrophobic base pair mimics: a) F, Z, and Q from Kool et al.; b) Pa, Pn, Ds, 
and Dss from Hirao et al.; c) selected bases from Romesberg et al. R represents deoxyribose. 
nucleobases that bear no homology to the natural nucleobases. In 2014, Romesberg 
and co-workers demonstrated that E. coli can stably maintain a plasmid containing a 
5SICS/NaM pair with only the addition of an exogenously expressed algal nucleotide 
triphosphate transporter and the respective triphosphates.129 The base pair can escape 
the excision in DNA repair pathways which made it the first expanded genetic 
alphabet propagated stably in the organism. 
Recently, T. Carell and co-workers described a salen structure based base pair, as 
shown in Figure 3-13a, the first example of a base pair with a reversible covalent 
bond.130 The covalent pattern is more a linker than a base pair. The To/SII pair is 
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Figure 3-13 Examples of reversible covalent bond base pair mimics: a) To/SII from Carell et al.; b) C* 
from Gates et al. R represents deoxyribose. The hydrogen bond is shown as hashed bond. 
connected with a reversible imine bond, which stabilizes the duplex and facilitates 
replication with the DNA polymerase. A co-crystal structure with Bst Pol I showed 
that SII slightly twisted from the To plane while the C1’-C1’ distance was the same as 
in the canonical base pair. Shortly afterward, K. S. Gates described a simplified 
version, a C*/Ap crosslink containing a similar hydrazone linkage131 based on their 
previous study (Figure 3-13b).132 Both patterns should be beneficial in biochemistry 
and material science as the authors claimed.  
 
3.1.2.  Ligandoside: metal incorporated nucleoside 
3.1.2.1. Metal incorporated canonical base pairs 
Ligandosides are canonical or artificial nucleosides that can chelate metal ions inside 
the DNA duplex. In 1952, S. Katz reported a substantial decrease in the viscosity of 
natural DNA upon addition of HgCl2.133 The author explained the observation by an 
overall decrease size of DNA molecular. Two years later, C. A. Thomas clarified that 
the nucleobases can bind Hg2+ by UV spectroscopy.134 Hence, Katz brought forward 
the model of Hg2+-thymine (1:2) complex, as depicted in Figure 3-14, which was 
proved to be corrected.135 
 
Figure 3-14 Examples of metal incorporated canonical base pairs. R represents pentose sugar. Bonds 
formed by coordination and bonds formed by proton displacement are shown as hashed bonds without 
further differentiation. 
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To form a stable metal-ion-mediated base pair, the nucleosides need to coordinate 
metal ions linearly in a 2:1 or 2:N ratio. In this respect, Ag+ and Hg2+ are chosen 
because they are known to adopt linear coordination geometry but at the same time 
are flexible enough to accommodate more than two ligands. 
The complexation is studied using the measuring the melting temperature of the DNA 
duplex. As the temperature rises, the double helix will get loosen and finally become 
two independent strands. The base with absorbance at around 260 nm will be no 
longer wrapped in a phosphate diester backbone. Therefore, the absorbance of the 
solution will increase. In general, the function of absorbance at 260 nm against the 
temperature is a typical S-shape curve for DNA-DNA duplexes. The maximum of the 
first derivative of this function corresponds to the temperature at which the duplex 
denatures at the maximum rate. This temperature is designated as melting temperature 
(TM). The addition of metal ions leads to an increased melting temperature, which is 
the evidence for complexation. Nevertheless, comparison of TM values across 
literature is difficult. Strand context, buffer system, temperature ramping, etc. affect 
the melting curves to a certain degree. 
Apart from melting temperature measurements, ESI mass spectrometry, and NMR 
spectroscopy study provided further clues for complexation. Circular dichroism 
spectrum is helpful in studying the duplex conformation before and after the 
complexation. Among all, the authentic verification of base pair formation should be 
X-ray diffraction. However, difficulties in crystallization resulted only a few X-ray 
structures reported.136, 137 
The past decade has seen a prosperous development of mismatched natural base pairs 
with metal coordination properties. A. Ono and co-workers applied the T-Hg2+-T pair 
in a hairpin structure for selective detection of Hg2+ ions in aqueous solution.138 Later 
they presented the biophysical data of the T-Hg2+-T139 and C-Ag+-C140 containing 
duplexes (Figure 3-14). Based on these results, the Ono group further studied the 
5’-substituted homo-uracil pair.141 5-bromo-, fluoro-, and cyanide- uracils were 
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synthesized. Although all these modified uracils could chelate Ag+ and Hg2+, melting 
profiles indicated that the duplex stabilizing ability was pH-dependent. The feature 
can be utilized for controlling metal arrangement by precisely placing uracil 
modifications along the strand. A systematic crystallographic study in the HIV-1 RNA 
dimerization initiation site revealed the formation of a C-Au3+-G pair,142 while most 
divalent cations as Mg2+ and Zn2+, bind at Hoogsteen sites. 
 
Figure 3-15 X-ray structure of a) T-Hg2+-T and b) C-Ag+-C inside DNA and RNA duplex. For each 
illustration: schematic representation of the complex; complete crystal structure; top review and side 
review of local omit map. Metal ions are shown as gray spheres. The figure is adapted from 
reference.143, 144  
Recently, Ono et al. presented the X-ray crystal structure of T-Hg2+-T in a DNA 
duplex and C-Ag+-C pair in RNA duplexes (Figure 3-15),143, 144 giving evidence that 
these pairs did not disturb the standard form of the duplex. In the absence of Hg2+, the 
DNA duplex was significantly distorted and adopts an unusual non-helical 
conformation while the RNA duplex was not distorted at all without Ag+ in mismatch 
C-C pair. The results provide the basis for the structure-based design of 
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metal-conjugating nucleic acid nanostructure. 
Acknowledging that the T/T pair prefers Hg2+ to Ag+ and C/C mismatch bind Ag+ 
rather than Hg2+, I. Willner et al. constructed a logic AND and OR gate based on 
metal chelating oligonucleotides.145  
Metal ions not only stabilize mispairs in the DNA duplex but also assist DNA triplex 
formation. T. Ihara demonstrated a CGCAg+ complex stabilized parallel-motif 
triplexes at neutral pH,146 an alternative method to stabilize triplexes parallel to using 
auxiliary molecules and modified nucleosides. 
To check whether DNA polymerase can recognize the mismatched pairs and elongate 
the primer, Urata et al. involved T-Hg2+-T147 and C-Ag+-A148 mismatches in primer 
extension experiments. Meanwhile, in vitro transcription of mercury-intermediated 
U/U pairs (U-Hg2+-U) with T7 RNA polymerase was achieved by Müller et al.149 
These works are promising towards the construction of metal ion-triggered replication 
and transcription system as well as enzymatic preparation of metal-containing DNA 
nanodevices. Conceivably, in the prebiotic era, these base metal coordination bonds 
replaced hydrogen bridges, and the complexes acted as catalysts for initial reactions.  
The binding capability of the canonical nucleobases to metal ions is limited to certain 
combinations. Watson-Crick base pairing may interfere with metal binding in 
sequence-dependent situations. Therefore, an orthogonal metal base pair system will 
have a larger arena in the synthetic biology and nanotechnology realm. 
 
 
3.1.2.2. Metal incorporated artificial base pairs 
Artificial DNA base pairing through metal complexation has attracted great interest in 
the development of functionalized biopolymers and in the expansion of the genetic 
alphabet. Since the pioneering work published in 1999 by M. Shionoya et al., 
numerous novel structures came out. Figure 3-16 summarizes the published artificial 
base metal complexes. 
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The first example, o-phenylenediamine ligandoside (Figure 3-16a), was proposed by 
K. Tanaka and M. Shionoya.150 The complex was believed to be square-planar, but 
evidence from NMR and ESI mass spectrometry is only limited to the nucleoside 
level. Further derivate nucleosides, based on the o-aminophenol151 and catechol,152, 153 
were published without modified oligonucleotide properties. Lack of proper 
protection strategy in solid-phase synthesis impeded incorporation into 
oligonucleotides.  
Apart from the ortho-disubstituted phenyl nucleoside, Shionoya reported the 
homo-hydroxypyridone base pair H/H, as well as homo-pyrimidine nucleotide Py/Py 
with incorporated Cu2+ inside the DNA duplex.154, 155 Surprisingly, three Py 
ligandosides formed a base triplet in a triple-strand DNA, making the complex more 
stable than a duplex with Py-Cu2+-Py. With the H/H pair, arranging five Cu2+ ions 
inside a DNA duplex was feasible, confirmed by UV, CD titration, electron 
paramagnetic resonance (EPR) spectroscopy and ESI mass spectrometry.156 Based on 
the EPR results, the distance between the copper centers were estimated to be slightly 
larger than the base-to-base distance in canonical B-type DNA. To our best 
knowledge, it was the first biological approach of arranging metal ions in solution in a 
predictable and discrete manner. Later, Shionoya and co-workers described that three 
strands containing four hydroxypyridone bases coordinated with a Fe3+ ion formed a 
triplex.157 As DNA arrays of the octahedral transition metal complex were seldom 
investigated; this approach provided an excellent way to construct rows of metal 
centers with magnetic and conductive properties. 
Soon afterward, P. G. Schultz et al. synthesized a hetro- tridentate ligandoside pair 
Dipic/Py (Figure 3-16b).158  Upon Cu2+ addition, the complex was similar to an A/T 
pair in the duplex while other metal ions destabilized the system. The crystal structure 
using X-ray showed the Dipic/Py pair is well-behaved as a Z-DNA like conformation, 
and C1’-C1’ distance here is shorter than in the canonical base pair.136 Later, derivate 
Dipim/Py coordinated with Cu2+ 159 and SPy/SPy with Ag+ 160 displayed a greater 
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stabilization effect. These 3+1 unsymmetrical base pairs were novel systems 
orthogonal to Watson-Crick base pairs. Although the enzymatic incorporation has not 
been realized yet, the unsymmetrical pattern enlightens the future design of 
ligandosides.  
Similar to Shionoya’s monodentate Py/Py pair, in 2007, J. Müller described a 
1,2,4-trizaole based homo-monodentate ligandoside (Figure 3-16c).161  A hairpin 
structure with ligandosides located in the loop was formed when three triazole bases 
were placed continuously. With properly labeled fluorescence and quencher groups, 
the oligonucleotide architecture turned out to be a promising metal ion sensor. Later, 
Müller et al. innovatively combined the Dipic base from the Schultz group with a 
glycol backbone and imidazole with a deoxyribose (Im) backbone.162 Although Ag+ 
increases the stability of the modified duplex the most compared to the other metal 
ions, it is still less stable than a canonical duplex. Another ligandoside based on the 
simplified backbone C3HQ/C3HQ was proposed by E. Meggers, stabilized the duplex 
similar to canonical base pairs upon Cu2+ complexation.163 
The homo Py base pair and the 3+1 unsymmetrical pattern enlightened C. Switzer to 
develop a series of triaza-heterocyclic and pyridine ligandoside pairs (Figure 
3-16d).164, 165 Notably, Pu-2,6-Py/3-Py and Pu-6-bipy/4-Py with Ag+ are as stable as 
G/C and A/T pairs in the DNA context. While hetro 3+1 aza-heterocyclic chelate Ag+ 
preferably, homo 2+2 aza-heterocyclic ligandoside complexed with Ni2+ were 
described by Switzer as well (Figure 3-16e).166, 167 Homo PurP and PyrP pairs are 
even more stable than canonical base pairs when coordinated with Ni2+. The pyridine 
pairs adopted a square-planar geometry and the distance in between approached those 
in G/C and A/T of natural B-DNA helices according to Gaussian simulation, which 
was different from earlier reported homo-bipyridine Bipy and Bp pairs that tended to 
stack with each other along the strand simulated by Insight II.168, 169 
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Figure 3-16 Examples of metal incorporated artificial base pairs: a) homo- bidentate and monodentate 
ligandosides from Shionoya et al.; b) hetro 3+1 ligandosides and derivatives from Schultz et al.; c) 
triazole liganoside and acyclic backbone derivates from Müller et al. and Meggers et al.; d) hetro 
poly-pyridine liganosides and e) homo poly-pyridine liganosides from Switzer et al.; f) multi-Ag+ 
ligandosides from Müller et al. R represents pentose sugar. R’ represents the acyclic backbone. Bonds 
formed by coordination and bonds formed by proton displacement are shown as hashed bonds without 
further differentiation. 
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Incorporation of one metal ion is difficult enough; complexation of two ions in one 
base pair remains more challenging. The Müller group reported Ag+-mediated 
Hoogsteen-type base pairs comprising 1,3-dideaza-2’-deoxyadenosine and thymidine 
(Figure 3-16f).170  Because the N3 nitrogen atom of the adenine was substituted by a 
methine moiety, the basicity of the exocyclic amino group increased so that two Ag+ 
could be incorporated. The complexation was studied by UV, CD titration, dynamic 
light scattering, and mass spectrometry. Another homo-PyrdC pairs from F. Seela 
complexed up to three silver ions.171 These novel complexations allow the 
construction of DNA structures with heavy metal ion loading. Most surprisingly, in 
the latest example, Müller and co-workers reported a highly stable Ag+-mediated 
6FP/6FP base pair in parallel stranded DNA.172 
Regretfully, most of the reported research concerning the non-canonical ligandosides 
only provides biophysical characterization. Until now there are few reports regarding 
their structural information and their potential application in other fields of study.  
 
 
Figure 3-17 Salen ligandoside S/S: a) Reversible formation of the complex in the duplex. Mn+ = Cu2+, 
Mn3+, etc. Bonds formed by coordination and bonds formed by proton displacement are shown as 
hashed bonds without further differentiation. b) Schematic representation of the complex; c) complete 
crystal structure; d) two salicylic aldehyde nucleosides are shown facing each other, and the fully 
assembled salen complex is at the n-5 position in the DNA duplex with the Cu2+ ion in a square planar 
geometry, overlaid with A/T base pair. The figure is adapted from reference.137  
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In 2005, T. Carell et al. reported a homo bridged ligandoside S/S based on the 
N,N’-bis(salicylidene) ethylenediamine (salen) ligand (Figure 3-17a).173, 174  The 
metal-salen complex showed planar geometry, which matched well with 
Watson-Crick base pair. Due to the ethylenediamine linker lying inside the duplex, the 
modified duplex became extremely stable upon metal ion complexation. In the 
absence of ethylenediamine, the S/S pair with Cu2+ stabilized the duplex to the same 
degree as H/H pair (Figure 3-17a) from Shionoya in the same duplex context. The 
salen base pair was versatile in binding a variety of metal ions, e.g. Cu2+, Mn2+, Ni2+, 
Fe2+ and VO2+. As Mn2+ coordinated by a salen ligand is known to be oxidized to 
Mn3+ under aerobic conditions, each resulting Mn3+-mediated salen base pair carries 
one positive charge, compensated by the negative charge on the backbone. The 
continually stacked salen base pairs can arrange ten Cu2+ or Mn3+ ions in a row, 
confirmed by UV titration and ESI mass spectrometry.175 Mixing five S-Cu2+-S with 
five T-Hg2+-T pairs along the strand, Carell and co-workers achieved a mixed metal 
ion stack inside the DNA duplex.176 Hence, Cu2+ and Hg2+ ions are arranged in a 
programmable fashion at the atomic level. 
Carell group later reported that salen ligandoside could be replicated using 
polymerase Bst Pol I and amplified in PCR cycles with KOD DNA polymerase.137 
Co-crystal structures of the salen ligandoside inserted duplex inside Bst Pol I showed 
that the reversible imine bond sat directly inside the polymerase, enabling the efficient 
copy of the inorganic crosslink (Figure 3-17b-d). 
Since the first structure of metal base pair complexation was hypothesized in 1952, 
investigation and development of this concept have caught the attention from the 
chemical and biological communities. The main benefit of the DNA-metal 
complexation is the enhancement of thermal stability. Combined with the canonical 
sequence based design and construction, more complex DNA nano-architectures with 
metal ions spatially arranged can be foreseen. The metal-containing double helices 
and nanostructures are expected to display intriguing chemical and physical properties, 
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e.g. magnetic and electric properties, metal-sequence based information storage 
ability, metal-ligandoside chiral complex catalytic activity. 
 
Based on the structure of nucleotides and the DNA double helix, a collection of 
artificial nucleotides is reviewed above. Generally, modifications of the phosphate 
diester bond and the sugar moiety are mainly designed to interfere with the nucleic 
acid metabolism and sequence-specific labeling due to their specificity and strong 
nucleic acid-binding capacity; reconstructions on base pair patterns are aimed at 
expansion of genetic alphabets and mechanistic insights of the central dogma.177, 178 
Base pair with metal coordination bonds may have more applications in 
nanotechnology and material science. To sum up, originated from the evolved 
canonical, the collection of artificial nucleotides, the “XNA” world, displays the 
desire of man to manipulate the nature. The “XNA” world is a powerful toolkit in the 
broad realm of chemistry and biology. 
In Chapter 4, a metal base pair based on pyrazole structure is introduced. The organic 
synthesis and biophysical properties is discussed as well as the efforts to apply the 
complexes as a chiral catalyst and to involve the ligandoside in DNA replication.
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3.2. Epigenetic cytosine modifications and sequencing 
3.2.1.  Epigenetic bases: discovery and function 
“Epigenetic” is a compound word of “epi-” and “genetic”. “Epi” means an 
information layer above the pure genetic information, Watson-Crick base pairing, 
which is inheritable or transmittable to the next cell or generation. Methylation of 
cytosine in the mammalian genome, as a key epigenetic modification, changes the 
functional state of regulatory regions while do not alter the Watson-Crick base pairing 
of cytosine. 
 
3.2.1.1. 5-Methylcytosine 
Discovery. 5-Methylcytosine (mdC) was first reported as a constituent of nucleic 
acids in 1925.179 Study of the methylation mechanism attracted more and more 
interest in the 1970s.180  
In mammals, cytosine methylation patterns are established by the DNA 
methyltransferase 3 (DNMT3) family of de novo methyltransferases and maintained 
by the maintenance methyltransferase DNMT1.181, 182 DNMT catalyze the covalent 
linkage of the methyl group from the methyl donor S-adenosyl-methionine (SAM) to 
the 5’ position of the cytosine-pyrimidine ring.183, 184 In plants, de novo methylation is 
catalyzed by domains rearranged methyltransferase 2 (DRM2), a homolog of the 
DNMT3, and maintained by different pathways.185 
Abundance. mdC is found almost exclusively in CpG dinucleotide.186, 187 Methylation 
of non-CpG context is common in plants, but rare in most mammalian cell types 
except pluripotent embryonic stem cells (ES cells),188 oocytes,189 and mature 
neurons.190, 191 In total, mdC contributes 3.6~7.1% of the bases in higher plants and 
0.7~3.8% in the vertebrate.192 Global DNA hypomethylation and locus-specific DNA 
hypermethylation have been identified as key features in various cancers.193 
Function. In mammals, mdC participate in various biological processes, including 
genomic imprinting, chromosome X-inactivation, and silencing of repetitive 
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elements.184 In gene promoter and enhancer regions, CpG methylation is associated 
with repressed transcription.194 Proteins with methyl-binding domains, e.g. MeCP2, 
bind to mdC and recruit repressor complexes containing histone deacetylases (HDAC), 
allowing the histones to wrap the DNA more tightly. On the other side, gene body 
methylation is usually correlated with gene expression.195-197  
Fate. Global erasure of mdC is known to occur in development. mdC can be lost 
through deficient maintenance or replication-dependent dilution, namely passive 
demethylation.198 However, passive demethylation cannot explain all cellular 
demethylation events during development or differentiation, many of which seem to 
occur in the absence of DNA replication.199, 200 
In plants, active erasure of mdC is mediated by the DNA glycosylases DEMETER 
(DME)/repressor of silencing (ROS1) and the base excision repair (BER) 
machinery.201 In contrast, mammalian orthologs of DME/ROS1 enzymes have not 
been reported. Several mechanisms of active DNA demethylation have been proposed 
over the last several decades, including a nucleotides excision repair (NER) 
pathway,202 a pathway in which RNA is a key component,203 and a pathway involving 
a demethylase.204  
Although activation-induced deaminase (AID)/APOBEC displays lower activity on 
mdC than C,205 studies support its potential role in mdC deamination.206, 207 Moreover, 
DNMTs have been identified to possess mdC deaminase activity in vitro in the 
absence of SAM.208 
 
3.2.1.2. 5-Hydoxymethylcytosine 
Discovery. 5-Hydroxymethylcytosine (hmdC) was first identified in bacteriophage 
nucleic acids in 1952 and later in animal cells.209, 210 The occurrence of hmdC in 
animal cells was debated until 2009 when two independent laboratories found that 
5-hydroxymethylcytosine (hmdC) indeed existed in the mammalian genome.211, 212 
Their experiments convinced that hmdC was the oxidation product of mdC, mediated 
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by the ten-eleven translocation (TET) enzyme.  
Abundance. N. Heintz et al. found that hmdC constitutes 0.6% of all bases in 
cerebellar Purkinje neurons, the highest level of any mammalian cell type.211  A. Rao 
et al. reported in mES cells hmdC corresponded to 4% of all cytosine species in MspI 
cleavage sites (C^CGG) in ES cells, and 0.032% of all bases.212 Bisulfite- and 
affinity-based sequencing methods (see Chapter 3.2.3.3 and 3.2.3.4) proved that in 
mouse and human ES cells, hmdC was enriched at intragenic, low-CpG-density CpG 
islands (CGIs),213, 214 promoters where genes expressed at medium-to-low levels,215,216 
protein-DNA interaction sites,217 and histone modifications associated enhancers.218  
Concerning the tissues, the percentage of hmdC in the brain is as high as 0.3% to 0.6%, 
increasing with age of the mice.219 In liver, bladder and heart tissues, 0.15-0.17% 
relative to dG are observed while in liver, spleen and testes the level is 0.03-0.06% of 
dG.220 Abundance of hmdC in the cancerous colorectal tissues was significantly 
reduced (0.02–0.06%) compared to that in normal colorectal tissues.221 
Function. Although the biological role of mdC has been well studied, the function of 
hmdC, as well as further oxidized bases, remains elusive. Similar to mdC, hmdC is 
linked to numerous biological processes including embryonic stem cell maintenance 
and differentiation, zygote development and cancer.222 The hmdC located in the gene 
body appears to correlative with increased expression and transcription.223, 224  
Fate. Apart from further oxidation reaction, Song et al. claimed that hmdC was more 
sensitive than mdC to activation-induced deaminase. 5-Hydroxymethyluracil (5hmU), 
the deamination product of hmdC, activates BER pathway-mediated demethylation.225 
In vitro biochemical studies suggest that DNMT3A/3B can remove the 
hydroxymethyl group of hmdC to generate unmodified cytosine under oxidizing 
conditions in the absence of SAM.226 Given that SAM is present at relatively high 
levels in all cell types, the physiological relevance of this reaction remains unclear. 
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3.2.1.3. 5-formylcytosine and 5-carboxycytosine 
Discovery. 5-Formylcytosine (fdC) and 5-carboxycytosine (cadC) were discovered in 
2011 by Y. Zhang et al.,227 G. Xu et al.228 and T. Carell et al.229 fdC and cadC are 
consecutively oxidation products of hmdC, in which Fe(II)- and α-KG-dependent 
TET family of dioxygenases are employed as catalysts. 
Abundance. Quantification by mass spectrometry of DNA digested into nucleosides 
showed that the fdC level in genomic DNA of ES cells was around 0.06-0.6% of 
hmdC. cadC was found 10-fold less abundant than fdC, corresponding to 0.01% of 
hmdC.229 In mammalian brain tissues, fdC was found to be 2-3 and cadC 3-4 orders of 
magnitude lower than hmdC.230 
Based on a PvuRts1I-assisted mapping experiment, fdC in non-CpG context was 
found lower in abundance and more dynamic than those in CpG context. fdC tend to 
distribute at regulatory protein-DNA binding sites, active and poised enhancers,231 and 
actively transcribed gene bodies.232 
Function. The mechanism whether fdC and cadC are merely intermediates in the 
active demethylation pathway, or they interact with genomic readers and carry out 
their functions is still not clear. The formyl group of fdC and carboxyl group of cadC 
provide unique chemical anchors for the protein recognition especially the former is a 
relatively reactive group that can react with various cellular components.  
In wild-type mES cells, 90% of fdC-marked regions reside in hmdC-enriched regions, 
which correspond to ~30% of the hmdC regions, suggesting fdC and cadC define only 
a part of the hydroxymethylome.233 
S. Balasubramanian recently speculated that hmdC and fdC were stable DNA 
modifications rather than demethylation intermediates. They fed the mouse with 
13CD3-SAM to generate labeled mdC and observed that globally labeled hmdC levels 
did not change during the cell cycle. The labeled hmdC remained present in DNA for 
more than five days, and the labeling ratios only decreased in cell proliferation. This 
indicates that hmdC is a stable modification. At the same time, fdC labeling ratio was 
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always lower than that of mdC or hmdC, implying fdC was also a stable DNA 
epigenetic base.234  
Fate. Although thymine-DNA glycosylase (TDG) has no significant mdC or hmdC 
excision activity in vitro, it excises fdC and cadC that properly pair to G in duplex 
DNA.235 Therefore, it is believed that fdC and cadC could be recognized and excised 
by TDG to give abasic sites in vivo that are subsequently converted to cytosines 
through base excision repair (BER).228, 236 Knockdown of the gene encoding TDG led 
to elevated fdC and cadC levels in ES cells228 while overexpression of TDG in 
HEK293 cell line led to fdC and cadC depletion.237 These discoveries confirmed that 
TDG is able to excise fdC and cadC in vivo, completing the pathway for active DNA 
demethylation (Figure 3-18). 
Apart from the TDG/BER pathway, direct decarboxylation of cadC by a putative 
decarboxylase may revert the oxidized bases to unmodified cytosines. However, the 
responsible enzyme waits to be identified.238, 239 
 
Figure 3-18 Pathway for dynamic modification of cytosine: a) biochemically validated pathway for 
cytosine modifications; b) individual reactions in the pathway are shown with all reactants involved. 
SMUG 1, strand-selective monofunctional uracil-DNA glycosylase 1; SAM, S-adenosylmethionine; 
SAH, S-adenosylhomocysteine; α-KG, α-ketoglutarate, PPi, pyrophosphate. 
In short, our growing appreciation for epigenetic cytosine bases implies that these 
oxidized derivatives are more than transitional states, and DNA methylation- 
demethylation cycles are dynamic and intricately regulated. 
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3.2.2. Genome sequencing: methods and significance 
For most of the 20th century, the central problem of genetics was to create genomic 
maps of entire chromosomes. These maps were crucial for researchers to understand 
gene structure, function, and evolution. 
As early as 1983, the first genetic disease, Huntington’s Disease, was mapped.240 In 
1984, US government proposed and funded the Human Genome Project (HGP). HGP 
was an international project for determining the sequence of chemical base pairs 
which make up human DNA, and identifying and mapping all of the genes of the 
human physically and functionally. HGP was undertaken in 1990 and declared 
complete in 2003.  
In short, the target genome is fragmented to construct a library. The fragment is 
cloned into a large-fragment cloning vector, e.g. bacterial artificial chromosome 
(BAC) vectors. The genomic DNA fragments represented in the library are then 
organized into a physical map; individual clones are selected and sequenced.241 
Finally, the clone sequences are assembled to reconstruct the sequence of the genome. 
To sequence short DNA strands, A. Maxam and W. Gilbert developed a sequencing 
method based on nucleobase-specific modification followed by backbone cleavage at 
sites adjacent to the modified nucleotides in the mid-1970s.242 Guanine is methylated 
at N7 position by dimethyl sulfate;243 adenine and guanine are depurinated using 
formic acid after methylation; cytosine and thymine are depyrimidinated using 
hydrazine;244 2M NaCl suppresses the reaction of thymines with hydrazine thus only 
cytosines are hydrolysed. After the cleavage in hot piperidine, the fragment is 
analyzed by PAGE and visualized by autoradiography. The replication ends in four 
parallel reactions indicate the bases at responding positions.  
At the same time, Sanger sequencing, a chain termination method, was invented by F. 
Sanger and colleagues.245,246 Sanger sequencing is based on the selective 
incorporation of chain-terminating dideoxynucleotides (ddNTP) during in vitro DNA 
replication. PAGE assay shows the replication termination in four parallel reactions, 
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each employing a different terminator nucleotide. Later, in 1985, dye-labeled ddNTPs 
were introduced, eliminating the need for radioactive labeling.247,248 All of the four 
dideoxynucleotides were labeled with fluorescent dyes and emitted light at different 
wavelengths. Because of its extreme expediency and high speed, dye-terminator 
sequencing became the prevalent method of automated sequencing. 
However, chain termination sequencing is limited to the single strands of 100 to 1000 
base pairs. It remains challenging to separate longer strands and maintain one base 
pair resolution. Longer strands have to be fragmented to small ones first and 
reassembled after sequencing. Two methods are available here: primer walking 
sequencing,249 using continuous priming of the sequencing reaction; and shotgun 
sequencing,250, 251 using randomly cloned strands.  
In the primer walking sequencing, a primer that matches the beginning of the region 
of interest is used to synthesize a short DNA strand adjacent to the unknown sequence. 
Afer the new short DNA strand is sequenced using Sanger sequencing, the end of this 
strand is used as a new primer for the next part of the long strand sequencing.  
In the shotgun method, multiple overlapping reads for the target are obtained by 
performing several rounds of shotgun fragmentation and sequencing. Assembling the 
overlapped fragments into a continuous sequence can be fulfilled by software. 
Shotgun sequencing generates high redundancy and consumes much computer time, 
but sequencing itself takes less time and minimal cost. Although the primer walking is 
superior in redundancy, it is extravagant to synthesize a great amount of primers. As 
time goes on, programs for sequence assembly become more sophisticated and 
computing power becomes cheaper, shotgun sequencing became the prevalent method 
for large-scale sequencing. 
The International Human Genome Sequencing Consortium published the first draft of 
the human genome in February 2001 with the sequence of the entire genome's 3×109 
base pairs.252 In 2003, researchers completed a high-quality sequence of the entire 
human genome. Apart from the human genome, HGP finished sequencing other 
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organisms, including the mouse genome.253  
Genome sequencing is not an end in itself. For us humans, it improves the 
understanding of inheritance and individuality. Genome sequencing has been critical 
for the identification of the genetic risk factors associated with complex human 
diseases and continues to have an emerging role in therapeutics and personalized 
medicine. For a larger picture, it paves the way towards a comprehensive 
understanding of all the biological functions encoded in the genome and their 
evolution. By studying the similarities and differences between human genes and 
those of other organisms, we discover the functions of particular genes and identify 
the genes that are vital for life.  
 
3.2.3. Genome sequencing of epigenetic bases 
By sequencing the Watson-Crick bases, we answered the question: What are these 
bases? By sequencing the epigenetic bases, we try to answer: how much are precent 
of these bases? Where are they located in the genome? 
The first task is to quantify the level of mdC, hmdC, fdC and cadC at the genomic 
level, i.e. global quantification. The next question need to be reached by sequencing 
with single base resolution, i.e. genome mapping, to learn about the genomic sites that 
contain mdC, hmdC, fdC and cadC together with the corresponding probability.  
 
3.2.3.1. Maxam-Gilbert sequencing based mapping methods for mdC 
Before we encountered other oxidized bases, only mdC has been of interest for 
genome sequencing for a long time.  
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Figure 3-19 Chemical modification methods to discriminate mdC and cytosine: a) derivative 
Maxam-Gilbert sequencing from Zhou et al.;254 b) pre-transformation method from Carell et al..255 
Although the Maxam-Gilbert method is no longer used for conventional sequencing 
of the genome, it found its application in mdC sequencing. The reaction of mdC with 
N2H4 is inefficient so that mdC does not introduce a strand cleavage. Compared with 
the recognition of G on the counter strand, mdC positions can be discriminated among 
C. A modified Maxam-Gilbert method reported by Zhou et al.254 described that 
N-sodio-N-chloro-m-nitrobenzenesulfonamide with iodine preferred to react with 
cytosine rather than mdC and caused cleavage only at cytosine sites. Later it was 
known that N-sodio-N-bromo-m-nitrobenzenesulfonamide reacts with both cytosine 
and mdC but not with glycosylated hmdC thus resulting in more cleavage sites. In this 
way, mdC could be distinguished from cytosine and hmdC (Figure 3-19a). 
Alternatively, cleavage at uracil sites by uracil DNA glycosylase (UDG) after bisulfite 
treatment of cytosine,256 and selective cleavage at fdC and cadC sites by hot alkali,257 
were used but this method was only applied to synthetic oligonucleotides. Given the 
fact that Maxam-Gilbert sequencing is complicated, time-consuming and required 
much input material, it may not be suitable for epigenetic studies at the genomic level. 
M. Münzel et al. described O-allyhydroxylamine method to discriminate dC and mdC 
(Figure 3-19b).255 Cytosine stayed as its amino isomer and was read as dC. 
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Alternativly, it could be shifted with the E-imino isomer which is read as T when it 
was reacted with hydroxylamine. mdC in contract was converted to the Z-imino 
isomer and blocked the polymerase. This method is unable to distinguish mdC and 
hmdC because both bring larger steric strain and stop the polymerase.  
 
3.2.3.2. Global genome quantification 
Tahilinani et al. discovered hmdC using radioactively labeled thin-layer 
chromatography (TLC).212 TLC allows detection of hmdC within particular 
dinucleotide contexts. A similar method, called nearest neighbor analysis, allows 
global quantification of hmdC in specific sequence contexts as well.211 These methods 
are useful techniques because of their sequence specificity detection; on the other 
hand, the inaccuracy is the drawback. 
M. Münzel et al. synthesized isotope labeled mdC and hmdC as intern standards and 
quantified their levels in various tissues from mice of different age groups using 
liquid chromatography–mass spectrometry (LC-MS).219 They concluded that hmdC 
level varied while mdC was stable among these tissues. Since then the LC-MS 
method constitutes the gold standard for the global quantification of epigenetic bases. 
Given the fact that hmdC reacts with sodium bisulfite to yield cytosine 
5-methylenesulphonate, Rao et al. developed an antibody against the mdC 
derivative,223 which allows hmdC global quantification and Next Generation 
Sequencing (NGS) by dot-blot or enzyme-linked immunosorbent assay (ELISA). 
Although the antibody was claimed to be more sensitive and less density-dependent 
than antibodies against mdC,258 it still bore the serious defect of density dependence 
and is less accurate compared to LC-MS. Relative mapping of mdC derivatives within 
samples can be achieved by methylated DNA immunoprecipitation (MeDIP-Seq) and 
chromatin immunoprecipitation (ChIP-Seq), but they are impotent in absolute 
quantification. 
Glucosylation can be applied to assist global and local quantification. hmdC is 
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glucosylated with β-glucosyltransferase (β-GT). Quantification of genomic hmdC 
levels is performed by radioactive UDP-glucose labeling with ß-GT and subsequent 
scintillation counting.259 Glucosylation also alters the activity of certain restriction 
enzymes. Therefore local hmdC levels can be measured by methylation-sensitive 
restriction followed by rtPCR. The method itself is convenient, except it is a 
restriction to the enzymatic cleavage site.260, 261 
Concisely, TLC-, LC-MS-, antibody-, and enzyme- based techniques have been 
developed to determine the total amount of epigenetic bases in the genome. Although 
they vary from quite easy to very sophisticated, these methods provide comparable 
information.  
 
3.2.3.3. Affinity enrichment based mapping methods 
Affinity-enrichment based mapping methods profile the regions that contain 
epigenetic bases. The bases of interest are first attached to a biotin tag. After 
enrichment, the fragments of the genome are ligated to forward and backward strands 
for PCR amplification followed by NGS. In this way, the question “where are these 
bases?” can be solved. 
To connect hmdC to a biotin, He and co-workers transferred azide glucose to the 
hydroxyl group of hmdC using β-glucosyltransferase and UDP-6-N3-Glu. After 
copper-free click chemistry, hmdC was labeled with a biotin for enrichment (Figure 
3-20a).262 Similarly, Rao et al. attached the glucose to hmdC,223 whose hydroxyl 
groups were oxidized to aldehydes with sodium periodate and connected to biotin 
linkers (Figure 3-20b).  
The genome can be first cleaved with hmdC-dependent restriction endonucleases, i.e. 
PvuRts 1I. After hmdC connected to biotin-labeled glucose, amplicons containing 
hmdC are enriched and sequenced. Because of the sensitivity of the endonuclease, 
gDNA fragments are shorter and representative, and sequencing is more 
economical.231 
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Figure 3-20 Pull-down enrichment sequencing methods for a), b) hmdC and c), d), e) fdC. The 
transformation moieties are highlighted in red, biotin highlighted in blue. 
Balasubramanian took advantage of an aldehyde reactive probe (ARP), which was 
first applied by Pfaffeneder et al.,229 to pull-down the fdC containing regions for 
genome-wide fdC mapping (Figure 3-20c).263 Later, He et al. reported a similar fdC 
pulldown method (Figure 3-20d).233 The genome was first treated with glucose and 
β-glucosyltransferase to block the hmdC. Then fdC is reduced to hmdC,264 and 
labeled with the an azide-modified glucose. A biotin linker was clicked on the newly 
generate hmdC, after pull-down and sequencing fdC enriched regions were profiled. 
According to the author, this method reduced the nonspecific DNA capture compared 
to the former. 
fdC can be converted to quinoline derivatives via Friedländer synthesis (Figure 3-20e). 
After biotin labeling, enrichment, disulfide bond cleavage, fdC is read as T during 
PCR amplification. Next Generation Sequencing maps fdC genomic-wide at 
single-base resolution.265 The Friedländer conversion can be compared as the bisulfite 
transformation, but more efficient and precise.  
In pull-down enrichment sequencing strategies, several disadvantages have to be 
considered. First, the base in question may not be labeled or converted completely; 
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the labeling can be unspecific. Some regions of the genome are more reactive, and the 
biotin tag may react with other components in the genome or reaction system as well. 
Besides, 8-oxoG is a good biotin mimic and would bind to streptavidin as well, 
making the methods more doubtful. Second, the enrichment efficiency should be 
questioned and checked. Third, the number of reads should be large enough to reach 
sufficient sequencing depth for high accuracy.  
 
3.2.3.4. Bisulfite sequencing based mapping methods 
Bisulfite sequencing (BS-Seq) is a sequencing method to determine the methylation 
pattern using bisulfite-mediated deamination (Figure 3-21). Bisulfite deamination 
reaction was first reported in 1970.266 The bisulfite anion adds across the C5-6 double 
bond of cytosine at acidic pH, resulting in cytosine losing its aromaticity and undergo 
hydrolysis with the loss of ammonia. The uracil bisulfite adducts re-aromatise to form 
uracil when pH increases. In this way, cytosine is deaminated to uracil, but mdC 
remains intact. In Sanger sequencing, all cytosines in the genome that are converted to 
uracil will read as T, so any remaining bases that are read as C are assumed coming 
from mdC. The conversion requires the single strand DNA because bisulfite is 
inaccessible to C5-6 double bond in the double strand. 267  
Bisulfite sequencing fails to discriminate mdC from hmdC because both resist 
deamination thus are read as C. On the contrary, fdC and cadC are converted to uracil 
and read as T under bisulfite condition, which is similar to cytosine. 
Since the discovery of the epigenetic bases, several methods based on bisulfite 
sequencing have been developed to discriminate cytosine, mdC, hmdC, fdC, and cadC. 
The target base is first converted to its adduct or another oxidation state that generates 
readout different from the original base after bisulfite conversion. Comparing the 
sequencing results before and after chemical treatment gives sequence information of 
the target bases. Fehler! Verweisquelle konnte nicht gefunden werden. summarizes 
these methods. 
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Figure 3-21 Bisulfite sequencing proceeding of cytosine, mdC, and further oxidization bases. Dash 
arrows show potential mechanisms of deformylation and decarboxylation. 
Table 3-1 Summary of bisulfite sequencing and its derivatives for epigenetic bases. C indicates the 
product after the convention. R indicates bisulfite sequencing readout results. Bases under conversions 
are highlighted in red. 
 
 
He et al. reported Tet-assisted bisulfite sequencing (TAB-Seq) for mapping hmdC at 
base resolution.213 In TAB-Seq, hmdC is attached to glucose using β-glucosyltransfer- 
ase to protect hmdC from TET oxidation. TET oxidizes mdC to cadC, which is read 
as T in BS-Seq while sugar protected hmdC is read as C. The difference in the readout 
indicated the hmdC sites.  
Parallel methods for quantitive mapping hmdC and fdC, called as oxBS-Seq,214 
5mC
BS-Seq
R C R C R C R C R C R
C T C T C T C T C T C T
5mC C 5caC T 5mC C 5mC C 5mC C 5mC C
5hmC C 5hmC C 5fC T 5hmC C 5hmC C 5hmC C
5fC T 5caC T 5fC T 5hmC C 5fC-EtONH2 C 5fC T
5caC T 5caC T 5caC T 5caC T 5caC T 5caC-Ar C
5hmC 5fC 5caC
oxBS-Seq redBS-Seq fCAB-Seq CAB-SeqTAB-Seq
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oxidative bisulfite sequencing, and redBS-Seq,268 reductive bisulfite sequencing. 
hmdC is first oxidized to fdC using KRuO4 and read as T in BS-Seq while untreated 
hmdC is read as C. Or fdC is first reduced to hmdC using NaBH4,264 and read as C 
while fdC is read as T in untreated samples. Combined these two methods with 
reduced representation bisulfite sequencing (RRBS),269, 270 which selectively enriches 
for CpG dinucleotides, provides a genomic map of mdC, hmdC, and fdC in mouse 
embryonic stem cells. These experiments revealed that fdC is present at comparable 
levels to hmdC and mdC in certain genomic locations.  
Later, the so-called chemical assisted bisulfite sequencing fCAB-Seq233 for fdC and 
CAB-Seq271 for cadC were reported by He group. fdC will be not deaminated and 
read as C if the aldehyde is blocked by ethyl hydroxylamine. Similarly, cadC will not 
be deaminated and read as C after connected to (4-aminoethyl)-benzylazide and 
clicked with a biotin. Therefore, fdC and cadC are identified. 
Although these BS-Seq variations allow us to distinguish cytosine oxidized bases, 
they share common defects of bisulfite sequencing. First of all, the original BS-Seq 
relies on the conversion of every single unmethylated cytosine residue to uracil and 
every single epigenetic base to the corresponding derivatives. Since bisulfite converts 
single-stranded but not double-stranded DNA, incomplete denaturation or reannealing 
leads to insufficient conversion. The subsequent analysis will incorrectly interpret, 
taken the cytosine, fdC, and cadC as mdC or hmdC for example. Not only the 
cytosine may be left unreacted, but also mdC react with bisulfite though with a lower 
rate than cytosine.272 
The second challenge in BS-Seq is the genomic degradation that takes place 
contemporaneously with the conversion,273 which caused by cytosine 5-methylenesul- 
phonate depyrimidination.274 No degradation can be observed in A, G and T as no 
bisulfite adducts form. Protracted bisulfite incubation produces abasic sites and leads 
to strand scission under basic condition. Therefore, conditions benefiting complete 
conversion, e.g., lengthy incubation time, elevated temperature, high bisulfite 
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concentration, can result in genome degradation up to 90%.273 Given that the starting 
amount of DNA is usually limited, such extensive degradation is problematic. 
Moreover, considering that most proofreading enzymes stall at uracil residues in the 
template strand, non-proofreading Taq polymerase has to be employed for the 
second-strand synthesis and PCR amplification, which may lead to sequencing errors.  
Finally, high sequencing costs are required to provide sufficient sequencing depth for 
each oxidized cytosine due to their low abundance.275 For mapping fdC, the whole 
genome-scale mapping is impossible given the requirement of unusually high 
sequencing coverage. So, only partial or reduced representation of the genome has 
been interrogated, e.g. RRBS. The above limitations above are less disturbing for 
single-copy loci but are significant in genome-wide sequencing.  
 
3.2.3.5. Single molecular mapping methods 
At single molecular level, although discrimination methods of mdC and hmdC with 
peptide276 and oligonucleotides277 were reported, they can hardly be applied in the 
genomic level mapping. The reasons are multiple: the complexity of the genomic 
DNA, the signal amplification, and the detection methods, etc. 
SMRT 
The single molecular real-time (SMRT) sequencing method.278, 279 is designed for 
sequencing mdC and hmdC (Figure 3-22a). In SMRT sequencing, DNA polymerases 
catalyze the incorporation of fluorescently labeled nucleotides into complementary 
nucleic acid strands. The arrival times and durations of the resulting fluorescence 
pulses yield information about polymerase kinetics and allow direct detection of 
modified nucleotides in the DNA template, including mdC and hmdC.  
Nanopore Sequencing 
Nanopore originates from membrane channels that contain a gated pore for nutrients 
and ions to cross. Using nanopores as polymer sensors date back to the early 1990s.280 
Figure 3-22b illustrates the principle of the system. When a single pore is inserted into 
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the support device, a characteristic current appears. Single-stranded nucleic acid 
moves through the nanopore and results in a transient blockade of the ionic current. In 
1996, Kasianowicz et al. first reported the electrophoretic transport of individual 
ssDNA and ssRNA molecules through α-haemolysin.281 
Further developments have shown that DNA molecules can be read at single base 
level using nanopores coupled to processive enzyme.282-284 Latest studies demonstrate 
that the nanopore device can discriminate C, mC, hmC,285-287 as well as fC and caC.288 
Generally, the optimal speed for DNA sequencing is 1,000-50,000 nucleotide (nt)/s. 
Nanopore sequencer based on biological pores, e.g. α-haemolysin and MspA, provide 
a translocation speeds of 2.5-70 nt/s, while the solid-state nanopores, e.g. SiN and 
Al2O3 membranes, detect the bases with a speed of 3,000-50,000 nt/s.289 Recently, a 
viscosity gradient system based on the ionic liquid BminPF6 was reported to slow 
down DNA translocation through monolayer MoS2 nanopores towards an optimal 
time resolution and signal resolution.290  
 
Figure 3-22 Illustration of single molecular sequencing methods: a) Principle of SMRT sequencing. A 
single molecule of DNA template-bound Φ29 DNA polymerase is immobilized on nanophotonic 
structure, which enables detection of individual phospholinked nucleotide substrates as they are 
incorporated into the DNA strand by the polymerase. The figure is adapted from reference.291 b) 
Nanopore support device. U-tube supports a lipid bilayer membrane. Hemolysin subunits are added to 
the cis chamber facing the bilayer, and a voltage is applied positive on the trans side. When a single 
pore inserts into the bilayer, a characteristic current immediately appears. An amplifier and an 
analog/digital converter are connected, stored the signals in a computer. The figure is adapted from 
open source.  
For the interest of time and money, sequencing methods based on NGS, bisulfite 
genome-level sequencing, and single molecular methods can be, but rarely, applied as 
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conventional clinical diagnostic means at this moment. The growing need for cheaper 
and faster genome sequencing prompts the development of new technologies. A direct, 
locus-level detection method for epigenetic bases in the context related to specific 
diseases would be poised to meet this challenge. 
In Chapter 5, this task is attempted to fulfill in a simple way. An oligonucleotide 
probe to react with fdC on the target strand is described. Quantification of the fdC 
content in a specific locus in the genome from Mus musculus embryonic stem cells 
using the probe is discussed.
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4. Part I: Pyrazole Ligandoside 
4.1. Aims of the project and rationale 
The first part of the thesis was aimed in developing a novel metal incorporated base 
pair and to broaden its application. 
In 2012, Wang and co-workers genetically incorporated a metal-binding non-natural 
amino acid pyTyr (1) into green fluorescent protein for studying the electron transfer 
mechanism.292 This work inspired the design of the pyrazole ligandoside (Figure 4-1).  
 
Figure 4-1 Origin of the idea: from pyrazole non-natural amino acid 1 to pyrazole noncanonical 
nucleoside 2. 
Identical to pyTyr 1, 1-(2-hydroxyphenyl)pyrazolate based nucleoside 2 should be able 
to chelate copper ion with one oxygen atom and one nitrogen atom solely. Homo 
pyrazole ligandosides recognize each other with a metal ion in the center that consists 
of two oxygen atoms and two nitrogen atoms.  
Characteristic differences resulted from changing the hydroxyl group to a fluorine 
atom, to a hydrogen, or replacing C with N atom, as shown in Figure 4-2. Although 
attempts were made toward these derivatives and indeed the bone building blocks 
have been obtained. However, the synthesis of the nucleosides failed.  
 
Figure 4-2 Further design of pyrazole-based nucleoside. 
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The synthesis of salen ligandoside inspired the synthesis in this work.173 By first 
introducing a bromine atom at the para-position in the phenol, a cuprate-based 
coupling of the base building blocks with toloyl-protected 1-chlororiboside, Hoffer’s 
α-chloro sugar,293 furnished a mixture of α/β-configured protected nucleosides (Figure 
4-3). The base building blocks could be obtained either by substitution of iodo- and 
fluoro-benzene or azotization and cyclization of aniline, depending on the substrates. In 
the next step, a suitable protecting group was chosen to facilitate the C-C bond 
formation for the base building block and the Hoffer’s α-chloro sugar. 
 
 
Figure 4-3 Retrosynthetic analysis of the pyrazole nucleoside. PG = protecting group. 
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4.2. Synthesis of the ligandoside containing oligonucleotide 
4.2.1. Synthesis of pyrazole ligandoside 
The synthesis of pyrazole ligandoside was started from the commercially available 
reagent 4-bromo-2-methoxyaniline (3) as depicted in Scheme 4-1. 
 
Scheme 4-1 Synthesis of the protected ligand building block 6. a) 1) NaNO2, SnCl2, HCl, 0 ºC, 66%, 2) 
1,1,3,3-tetramethoxypropane, EtOH, HCl, reflux, 85%; b) Et2O-BBr3, DCM, -78 ºC, 68%; c) TIPSOTf, 
DIPEA, DCM, 0 ºC, 99%. TIPS = triisopropylsilyl. 
Diazotization of compound 3 with sodium nitrite gave the diazonium salt (Scheme 
4-2),294 followed by reduction with stannous chloride afforded the corresponding 
substituted phenyl hydrazine hydrochlorides intermediate. 
 
Scheme 4-2 Mechanism of diazonium salt formation and the hydrazine intermediate. 
Without further purification, the hydrazine intermediate went on to cyclize with 
excessive malonaldehyde bis(dimethyl acetal) in ethanol to form the pyrazole ring in 
4.295 Cleavage of the methyl group with Lewis acid borane at -78°C provided the 
desired phenol 5. The demethylation reaction proceeds via a bimolecular mechanism 
involving two Et2O-BBr3 adducts with the formation of phenol and bromomethane.296 
(Scheme 4-4) Low temperature is necessary because of the high energy of the B-O 
bond. 
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After this project was finished, H. Batchu et al. reported that the ortho-hydroxy group 
is accessible by N-phenylpyrazoles using lead(II) acetate as catalyst.297 In a plausible 
mechanism, Pd(II) activates the ortho-H to form a five-membered cyclopalladium 
intermediate. After oxidation and elimination, a C-O bond can be formed. In our case, 
Cu(I) was applied when coupling the base building block with the sugar moiety, thus, 
a similar cyclo intermediate may form with H or OH and the N on the pyrazole rings 
(Scheme 4-3). This explains why the hydroxyl group should be protected before 
coupling to the sugar and why N‑phenylpyrazole and other base building blocks in 
Figure 4-2 failed to generate the desired product when reacted with the sugar. 
 
Scheme 4-3 Proposed mechanism of ortho-hydroxylation of N-phenylpyrazole. 
Subsequent reaction of 5 with triisopropylsilyl triflate provided the key intermediate 6. 
Because the electronic density of phenyl in 1-phenyl-1H-pyrazole is higher than 
2-phenyl-1,3-dioxane in the case of salen base 7, the hydroxyl group here is much 
more acidic. As a result, the reaction rate of 5 is faster than the salen base building 
block 7. 
With the key building block 6 in hand, we started working on the sugar moiety. The 
Hoffer’s α-chloro sugar (8) was synthesized from 2-deoxyribose (9). (Scheme 4-5) 
First, the ribose was methylated at 1’-hydroxyl group (10), followed by 
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4-methylbenzoyl protection giving 11. Then, chloride substitution of the methoxyl 
group furnished the sugar building block 8 after precipitation in anhydrous ether.  
 
Scheme 4-4 Biomolecular mechanism of BBr3-assisted cleavage of methyl ethers. 
 
Scheme 4-5 Synthesis of the protected ligand building block 8. a) AcCl, MeOH, Ag2CO3, rt; b) 
4-methylbenzoyl chloride, pyridine, 45 ºC, 87% for 2 steps; c) AcCl, HCl, AcOH, 0 ºC, 55%. Tol = 
4-methylbenzoyl. 
Due to their insolubility or failure to form a copper complex with the substrates, the 
base building blocks of benzene, pyridine, fluorobenzene and anisole (Figure 4-3) all 
failed to form a C-C bond with the sugar. The Corey-House synthesis was achieved 
with intermediate 6.298, 299 The reaction occurred in three steps (Scheme 4-6a). First, 
bromobenzene was treated with t-butyllithium to convert it into a phenyl lithium 
species. 6 was reluctant to undergo a lithium halogen exchange. In practice, neither n- 
nor s-butyllithium could generate the organic lithium species efficiently. So an 
excessive and sufficiently strong base, tert-butyllithium, was used. Because the 
product t-BuBr can react with t-BuLi, 2 equivalents t-BuLi must be used (Scheme 
4-6b). Second, the phenyl lithium species was treated with copper bromide to create a 
lithium diphenyl cuprate intermediate, called “Gilman reagent” in honor of H. 
Gilman’s contribution to the field.300 In the Gilman reagent, the cuprate and lithium 
ions directly link to the carbon atom, forming an 8-membered ring with two lithium and 
two cuprate ions coordinating between four phenyl groups (Scheme 4-6c),301 thus 
negative charges accumulate on the coordinate carbon atom and make the C-Cu and 
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C-Li more reactive. The reaction has to be conducted in ethyl ether to avoid side 
reactions. Finally, the diphenyl cuprate was reacted with the protected chloride ribose 8 
to furnish the cross-product ligandoside. However, the coupling of the Gilman reagent 
with bromobenzene resulted in the undesired dibenzene by-product (Scheme 4-6b). β- 
and α-conformers are very close to each other on TLC, but they were still separable by 
column chromatography.  
 
 
Scheme 4-6 Mechanism of Corey-House synthesis: a) reaction steps towards nucleotide 12. PhBr 
represents 6. R-Cl represents Hoffer’s α-chloro sugar 8. b) side reaction in the Corey-House synthesis; 
c) structure of 8-membered ring Gilman reagent. 
The yield of 12 depended on several factors: 1) Moisture and oxygen can degrade the 
organolithium intermediate or oxidize the Cu(I) complex. 2) Insufficient reaction time 
and improper temperature control for the second step can leave a certain amount of 
organolithium unreacted. In practice, increasing the temperature rapidly at the final 
step generated the undesired α-conformer product. 3) The hydrochloric acid generated 
from the chloride ribose can destroy the Gilman reagent.  
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Scheme 4-7 Synthesis of the building block 15 and of the nucleoside 16. a) 1) t-BuLi, Et2O, -78 oC; 2) 
CuBr-Me2S, -30 oC; 3) 8, rt, 53%; b) K2CO3, MeOH, rt, 65%; c) DMTr-Cl, DIPEA, DCM, rt, 74%; d) 
P(OCH2CH2CN) (NiPr2)2, diisopropylammonium tetrazolide, DCM, rt, quant.; e) TBAF, THF, rt, 87%. 
 
 
Figure 4-4 Pentose region of the 400 MHz NOESY spectrum of 12 in CDCl3.  
Next, deprotection of 12 to 13 was achieved with potassium carbonate in methanol 
(Scheme 4-7). Appropriate reaction time and concentration must be attained to ensure 
that only the 4-methylbenzoyl but not TIPS group is cleaved. NOESY spectra for both 
conformers were measured to confirm the ligandoside configuration. NOESY allows 
us to correlate nuclei through space smaller than 5Å. From the spectrum of 12 (Figure 
4-4), it can be seen that in the β-ligandoside the 1’-H (5.25 ppm) is correlated with the 
2’-H bottom (2.58 ppm). 2’-H top (2.20 ppm) is coupled with 3’-H (5.61 ppm). 3’-H is 
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further correlated with 4’-H (4.57 ppm) and 5’-H (4.60 ppm). No correlation between 
1’-H and 3’-H can be observed. In contrast, α-conformer shows a correlation peak 
between the 1’-H and the 3’-H. The 3’-H is coupled to 2’-H top; 2’-H bottom correlates 
with the aromatic protons. Based on the data, the configuration of the obtained 
ligandoside is verified. 
Finally, 13 was protected with dimethoxytrityl chloride (DMTr-Cl) at the 5’-hydroxyl 
group to give 14 and 14 was further reacted with the phosphoramidite reagent to 
provide 15, needed for oligonucleotide solid-phase synthesis. 
 
Figure 4-5 X-ray crystal structure of nucleoside 16: a) crystal structure of single molecular; b) 
neighboring interaction in a unit cell. 
Completely deprotected 13 furnished the pyrazole ligandoside 16. Small crystals of 16 
were attained by slow evaporation of the unpolar ethyl acetate solution. As presented in 
Figure 4-5, the result of an X-ray diffraction analysis further proved the 
β-configuration. In the X-ray crystal, the phenyl ring and the pyrazole ring are slightly 
tilted against each other by 23.9°~24.5°. The dihedral angle between two planes is 
narrow which facilitates copper chelating with the nitrogen and oxygen atom. 
Unexpectedly, the nitrogen atom (N2) and the hydroxyl group (O4) of the pyrazole are 
not on the same side. In the unit cell (Figure 4-5b), an interactions between N2 and O2i 
of one adjacent sugar, and O4 and O3ii of another adjacent sugar are observed, which 
could be responsible for the “anti” conformation around the anti anti bond. 
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Next, the UV-Vis spectrum of ligandoside 16 was measured. The highest peak is at 246 
nm; the second highest peak is found at 284 nm, similar to the methylated monomer 19 
(see Chapter 4.3.1.2) resulting from the benzyl-pyrazole bicycle system. As canonical 
bases have an average peak at 260 nm, the molar absorbance of 16 was determined at 
260 nm, to calculate the concentration of the oligonucleotides. 
 
4.2.2. Synthesis of oligonucleotides with ligandoside 
With the ligandoside 15 in hand, solid-phase synthesis of DNA was conducted. The 
coupling yield of 15 was equally good compared to the natural bases even without 
extending the coupling time. Pyrazole base and TIPS protecting group did not interrupt 
the synthesis cycle. 
As stated in the previous report,174 TIPS groups on the DNA strands can be easily 
deprotected during ordinary solid-phase cleavage conditions with a mixture of NH3 aq. 
/ MeNH2 aq. (AMA solution)302 at 65°C for 5 min. For the strand with more than one 
pyrazole base, the cleavage time was extended to 10 min to ensure complete 
deprotection. 
The DMTr-off mode was applied for the solid-phase synthesis so DMTr deprotection 
was not necessary after cleavage from the solid phase, and only one round of HPLC 
purification was executed. Typically, the highest peak referred to the desired product. 
Lyophilization after collecting the corresponding eluate gave the anhydrous powder of 
the oligonucleotide, which was then analysed by MALDI-TOF.  
In the case of insertion of pyrazole and salen ligandosides (ODN 8a/b, 9a/b, and 
10a/b), the DNA containing solid-phase material was first exposed to dichloroacetic 
acid solution to remove the cyclic acetal group, then furthere cleavage was performed 
with AMA solution as described above. Prior to preparative HPLC purification, the 
crude oligonucleotide sample was mixed with 20% acetic acid aq. to avoid formation 
of imines from ammonia and the salen aldehyde group. 
A summary of oligonucleotides prepared in this work is listed in Table 4-1. 
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Table 4-1 Synthesized and purchased oligonucleotides in chapter 4. Bold and red letters X represent 
pyrazole ligandoside (Pz), M represent methylated pyrazole ligandoside (Pm), D represent 
1’,2’-dideoxyribose and S represent salen ligandoside. Found values indicate the mass results measured 
by MALDI-TOF. Mass values of purchased oligonucleotides are not shown. 
Entry 5' ----------- 3' mer calc. found 
 0a CAC ATT AGT GTT GTA 15 / / 
 0b TAC AAC ACT AAT GTG 15 /  / 
 1a CAC ATT AXT GTT GTA 15 4588.8  4585.0 
 1b TAC AAC AXT AAT GTG 15 4606.8  4602.9 
 1c TAC AAC AAT AAT GTG 15 / / 
 1d TAC AAC ACT AAT GTG 15 / / 
 1e TAC AAC AGT AAT GTG 15 / / 
 1f TAC AAC ATT AAT GTG 15 / / 
 2a CAC ATT ADT GTT GTA 15 4430.8  4428.8 
 2b TAC AAC ADT AAT GTG 15 4448.8  4447.3 
 3a CAC ATT AMT GTT GTA 15 4602.8  4597.9 
 3b TAC AAC AMT AAT GTG 15 4620.9  4616.3 
 4a ATG CGA CCX TCC CT  14 4206.7  4208.8 
 4b AGG GAX GGT C 10 3140.6  3139.9 
 5a CAC ATT XXT GTT GTA 15 4613.8  4611.6 
 5b TAC AAC AXX AAT GTG 15 4640.9  4636.1 
 6a GCGCG XXXXX GGCCG 15 4758.9  4757.6 
 6b CGGCC XXXXX CGCGC 15 4678.9  4676.6 
 7a GCGCG XXXXX XXXXX GGCCG 20 6449.2  6452.4 
 7b CGGCC XXXXX XXXXX CGCGC 20 6369.2  6370.8 
 8a CAC STT AXT GTS GTA 15 4572.7  4570.0 
 8b TAC SAC AXT AAS GTG 15 4590.7  4586.8 
 9a CAC STT AMT GTS GTA 15 4586.7  4586.8 
 9b TAC SAC AMT AAS GTG 15 4604.7  4604.2 
 10a CAT GST XGS AXC STX CST GCA 21 6452.9  6450.7 
 10b TGC ASG XAS GXT SCX ASC ATG 21 6501.9  6500.1 
 11a GGA TCG XTC TCC CTA TAG TGA GTC GTA TTA 30 9232.6  9228.5 
 11b Fl-TAA TAC GAC TCA CTA TAG GGA GA 23 / / 
 11c GGA TCG ATC TCC CTA TAG TGA GTC GTA TTA 30 / / 
 11d GGA TCG CTC TCC CTA TAG TGA GTC GTA TTA 30 / / 
 11e GGA TCG GTC TCC CTA TAG TGA GTC GTA TTA 30 / / 
 11f GGA TCG TTC TCC CTA TAG TGA GTC GTA TTA 30 / / 
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4.3. Evaluation of the pyrazole ligandoside 
4.3.1. Oligonucleotides with single-inserted ligandoside 
4.3.1.1.  Complexation properties  
Once the single ligandoside base pair was inserted into two strands (ODN 1a/b), the 
biophysical properties of the duplex were investigated. The denaturing profiles of the 
double strands with and without the present of metal ions in different buffers were 
measured. Before the measurement, the two complementary strands were mixed with 
the respective metal ion in the corresponding buffer. The solution was denatured at 
90°C for 5 min and then slowly cooled down to room temperature for reannealing. The 
modified duplex was formed in the annealing process together with metal ions.  
For the control strands, the Pz/Pz pair were replaced a with G/C pair as in duplex 0a/b. 
Here, the melting temperature is relatively stable in the system with varied pH from 6.0 
to 9.0. Another control experiment duplex 2a/b (Table 4-1) was made with the abasic 
nucleoside mimic, 1’,2’-dideoxyribose was used instead of the G/C pair. This gave a 
less stable duplex with a melting temperature as low as 29°C at pH 9.0.  
 
Figure 4-6 Melting profiles of duplex 1a/b: a) melting curves of 1a/b with and without Cu2+ at pH 9.0; 
b) Plot of melting temperatures of duplex 1a/b with and without Cu2+ at varied pH, compared with 0a/b. 
Data are mean ± SD of three replicates. Condition: 150 mM NaCl, 10 mM Na2HPO4/NaH2PO4 buffer 
pH 6.0 / 7.4 or CHES buffer pH 9.0, 1 μM oligonucleotides, with and without 1 μM Cu2+, the final 
volume of 200 μL. 
In the case of the Pz containing duplex 1a/1b, the melting temperature was around 
43°C in NaH2PO4-Na2HPO4 buffer (pH = 6.0), independent on Cu2+ (Figure 4-6). 
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When the pH was raised to 7.4, the duplex without copper reached 51°C, which was 
higher than when Cu2+ was added (47°C). When the buffer was changed to CHES 
buffer (pH = 9.0), the melting point for duplex without copper decreased to 41°C, while 
a melting temperature of 50°C was detected after adding the Cu2+. This is a little higher 
than the control strands under the same condition, indicating that Cu2+ was probably 
incorporated into the strands in the basic environment. The chelating mechanism will 
be described in 4.3.1.2. 
Compared with the homo-salen base pair, Pz-Cu2+-Pz was less stable. In the same 
sequence context and buffer system but at higher duplex concentration, S-Cu2+-S with 
ethylenediamine resulted in a melting temperature of 55°C. The melting temperature 
of Pz-Cu2+-Pz is close to a methylated salen pair (52°C) or a homo hydroxypyridone 
pair (H-Cu2+-H, 50°C),154 Therefore, the geometry of the Pz-Pz is not the best for  
complexation inside the duplex. 
Figure 4-7 Plot of melting temperatures of duplex 1a/b with varied metal ions, compared with 0a/b. 
Condition: 150 mM NaCl, 10 mM CHES buffer pH 9.0, 1 μM oligonucleotides, with 1 μM metal ion, 
the final volume of 200 μL. Data are mean ± SD of three replicates. 
Apparently, Cu+ exhibits a greater stabilization effect in the basic environment (Figure 
4-7). At pH 9.0, Cu+ stabilized the duplex from 41°C to 52°C while a value of 50°C  
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was formed with Cu2+. No impact on the stability was seen when the pH was raised 
from 6.0 to 7.4.  
Manganese ions stabilized the Pz substituted duplex as well, increasing the melting 
temperature by 5°C in CHES buffer. According to the previous report,303 Mn2+ will be 
oxidized to Mn3+ when chelated inside a salen ligand. Mn2+ is supposed to show a 
similar behavior here, adding one positive charge inside the double helix. 
Scanning other metal ions for thermostability showed no improvement, as illustrated in 
Figure 4-7. Metal ions like Co2+, Ni2+, and Pt2+ ions have only weak chelating effects 
with the pyrazole ligandoside, raising the melting point 2~4°C, while Hg2+, Ag+, Zn2+ 
and Pd2+ ions displayed no measurable interactions. The melting points stayed mostly 
unchanged.  
In a single experiment of denaturing and annealing with Cu2+ and Mn3+, a strong 
hysteresis between the heating and the cooling curves was observed (Figure 4-8a). For 
the copper ion, 50°C was measured for heating, while cooling provided 47°C for 
reverse. In the case of Mn3+ ion, the two values are 46°C and 41°C. This difference 
shows kinetic difference bewteen complex formation and destruction during heating 
and cooling of the duplex. 
Titration experiments with copper and manganese ions were subsequently conducted. 
The experiments were carried out for each ion from 0.0 to 2.0 equivalents in CHES 
buffer (Figure 4-8b, c). Clearly, the complexation is finished after adding the first 
equivalent of Cu2+, and further titration did not stabilize the duplex to a higher degree. 
This result supported the duplex:Cu2+=1:1 stoichiometry. Though titration of 
manganese ion was not as clear as that of copper, 1:1 stoichiometry can be deduced 
from the plot (Figure 4-8d). It can be attributed to the impact of the CHES buffer and 
that excessive Mn3+ ion destabilizes the ligand inserted duplex. 
Calculation of thermodynamic parameters is possible based on the data of the melting 
curves obtained above (Table 4-2). At low pH, Cu2+ incorporation made a greater 
enthalpy change in the annealing process, which decreased from -119.3 kJ/mol to 
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-131.9 kJ/mol. At pH 9.0, ΔH increased from -121.5 kJ/mol to -111.0 kJ/mol. The trend 
is same for the entropy change. At pH 9.0, the loss of the disorder between with and 
without copper became smaller. Cu2+ obviously contributes to ΔH and ΔS term 
particularly at higher pH. 
 
 
Figure 4-8 Metal ion titration experiments of duplex 1a/b: a) denaturing and reannealing curves of 1a/b 
with 1.0 eq. Cu2+ and Mn3+; b) melting curves of titration with Cu2+ from 0.0 to 1.0 eq., step of 0.2 eq.; 
c) melting curves of titration with Mn3+ from 0.0 to 1.0 eq., step of 0.2 eq.; d) Plot of the melting 
temperatures against the metal ions equivalent. Data are mean ± SD of three replicates. Conditions: 
150 mM NaCl, 10 mM CHES buffer pH 9.0, 1 μM oligonucleotide, 0.0-2.0 μM Cu2+/Mn3+, the final 
volume of 200 μL. 
Table 4-2 Thermodynamic data for duplex 1a/b. These values are determined by van’t Hoff plots from 
the melting profiles. 
pH 
 - Cu2+ + Cu2+ 
∆H° ∆S° ∆G°310K ∆H° ∆S° ∆G°310K 
[kcal mol-1] [cal K-1mol-1] [kcal mol-1] [kcal mol-1] [cal K-1mol-1] [kcal mol-1]
6.0  -119.3  -373  -3.7  -131.9  -414  -3.6  
7.4  -128.5  -397  -5.4  -125.9  -390  -4.8  
9.0  -121.5  -388  -1.1  -111.0  -345  -4.0  
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Circular dichroism (CD) spectroscopy was employed to investigate the duplex 
conformation. In general, the CD spectrum of B-form DNA has a positive band near 
270 nm, a negative band near 250 nm and a more intense negative band at 210 nm. A 
typical curve was obtained in the control experiment (Figure 4-9a). As expected, the 
duplex containing the pyrazole ligandoside gave a similar curve as the canonical 
duplex. When copper or manganese ions were added, no apparent changes in duplex 
conformation were observed. The DNA duplexes keep their canonical B-form when 
metal ions are incorporated into the ligandoside pairs. With the temperature rising from 
20°C to 80°C, the spectrum shift is similar to the change in natural duplex denaturing 
process (Figure 4-9b,c,d). It is concluded that the duplex conformation is unchanged 
upon metal ion complexation. 
 
 
Figure 4-9 Circular dichroism spectrum of 1a/b with Cu2+ or Mn3+, compared with 0a/b. a) CD 
spectrum of duplex 1a/b with equal equivalent of Cu2+ at 20 °C; b) overlaid CD spectrum of duplex 
0a/b from 20 °C to 80 °C; c) and d) overlaid CD spectrum of duplex 1a/b with equal equivalent of 
Cu2+ or Mn3+, from 20 °C to 80 °C. Conditions: 150 mM NaCl, 10 mM CHES buffer pH 9.0, 1 μM 
oligonucleotides, 1 μM Cu2+/Mn3+, the final volume of 200 μL. 
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4.3.1.2. Complexation mechanism 
As described above, the thermostability of duplex 1a/b was pH-dependent. To clarify 
this issue, we synthesized methylated pyrazole ligandoside 19 (Scheme 4-8). The 
hydroxyl group was transformed into methoxyl group, deprived of any copper 
chelating ability. The methylated building block 19 provided us therefore with the 
possibility to study the coordination mechanism in the DNA duplex. 
We experienced of that, 4 (Scheme 4-1) cannot form a C-C bond with the 1’-chloro 
ribose 8 (Scheme 4-7). Therefore, it was necessary to synthesize 18 from intermediate 
12. Selective deprotection of the TIPS group followed by deprotonation and 
methylation provided compound 18. Basic deprotection of 18 furnished compound 19 
with excellent yields. 19 is charactized with UV spectroscopy by absortion at the 
maximum wavelength of 249 nm. Succeeding tritylation and convertion of 19 into the 
phosphoramidite gave the building block 21 (Pm) for solid-phase synthesis. 
 
Scheme 4-8 Synthesis of the nucleoside 19 and building block 21. a) TBAF, THF, rt, 83%; b) NaH, 
CH3I, DMF, 0 oC, 76%; c) K2CO3, MeOH, rt, 90%; d) DMTr-Cl, DIPEA, DCM, rt, 75%; e) 
P(OCH2CH2CN)(NiPr2)2, diisopropylammonium tetrazolide, DCM, rt, quant. 
After solid-phase synthesis, strands ODN 3a/b with Pm instead of Pz was obtained. 
The methoxy group cannot be deprotonated, and coordination with metal ions is 
impossible. Indeed, we found that pH effect were now negligible (Figure 4-10). The 
data proves that the hydroxyl group is crucial for the interaction with copper and the 
duplex. A proposed mechanism is depicted in Figure 4-11. 
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Figure 4-10 Plot of melting temperatures of duplex 3a/b with and without Cu2+ at varied pH, compared 
with 0a/b. Condition: 150 mM NaCl, 10 mM Na2HPO4/NaH2PO4 buffer pH 6.0 / 7.4 or CHES buffer 
pH 9.0, 1 μM oligonucleotides, with and without 1 μM Cu2+, the final volume of 200 μL. Data are 
mean ± SD of three replicates. 
 
Figure 4-11 Proposed mechanisms of Pz and Pm coordinating with Cu2+ under basic condition. 
 
4.3.1.3. Complexation orthogonality 
The intention for DNA replication experiment involving the ligandoside prompted us 
to investigate the mismatch profile of pyrazole ligandosides at the biophysical level. 
Single Pz-inserted strand 1a showed a lower melting temperature compared to the 
reference duplex at pH 9.0. This indicated a loose interaction of Pz with cytosine and 
faint interaction with adenine and guanine (Figure 4-12). In this property the pyrazole 
base is similar to a pyrimidine, so it shows more favorable interaction with the purine 
base. However, at pH 9.0, Pz-A pair (39°C) is very close regarding duplex stability to a 
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non-copper homo-Pz pair (41°C), suggesting that in the absence of Cu2+, the spatial 
pattern of Pz-A and Pz-Pz are similar to some extent; the two bases intract with each 
other in the duplex. 
 
Figure 4-12 Plot of melting temperatures of 1a combined with different counter strands containing Pz 
(1b), A (1c), C (1d), G (1e), and T (1f) as the counter base. Conditions: 150 mM NaCl, 1 mM CHES 
buffer pH 9.0, 1 μM oligonucleotide, with and without 1 μM Cu2+, the final volume of 200 μL. Data are 
mean ± SD of three replicates. 
Adding Cu2+ to these mismatched pairs stabilizes the duplex slightly. G-Cu2+-Pz 
becomes the most stable pair (43°C) next to the Pz-Cu2+-Pz pair, implying that some 
Cu2+-mediated interaction between Pz and guanine occurs. 
 
4.3.1.4. Cocrystallization of modified duplex and Bst Pol I 
To investigate how pyrazole bases interact within each other in a DNA duplex, we 
crystallized the modified duplex 4a/b together with polymerase Bst Pol I as a matrix. 
The Pz-Pz base pair was placed outside the protein binding site in the duplex forming 
regime. Cocrystalls were obtained using the hanging-drop vapor diffusion method in 
4-morpholinoethanesulfonic acid (MES) aq. The crystal structure, as shown in Figure 
4-13, shows that within in the duplex two Pz bases are stacked on top of each other 
with the oxygen and the nitrogen atom of the ligand pointing in the same direction. 
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Figure 4-13 Cocrystal structures of duplex 4a/b with Bst Pol I: a) complete crystal structure; b) side 
view of the local omit map; c) top view of local omit map. 
Apparently, without the metal ion, the ligandoside is not arranged in a planar base 
pairing pattern but prefers a stacking interaction similar to the hydrophobic artificial 
base pairs from Leumann, Romesberg, and others.127, 168, 169, 304 The stacking of the Pz 
ligandosides also disrupts the neighboring base pairs. The base pair is no longer 
coplanar but tilts and shifts out of the helix axis with only one inter-base hydrogen 
bond. 
Cocrystal of 4a/b with Cu2+ ions in the matrix of Bst Pol I was not obtained. 
 
4.3.2. Oligonucleotides with multi-inserted ligandosides 
4.3.2.1. Insertion of two ligandosides 
In duplex 5a/5b, two Pz pairs are placed in close proximity. In the absence of a copper 
ion, the TM is 11°C lower than in the canonical strands (38°C vs. 49°C, Figure 4-14). 
When 1 eq. of Cu2+ is incorporated, the curve presents a two-phase S shape; the 
melting point of the first phase is 38°C, which is similar to the value without the metal 
ion. The second phase shows an inflection point at 70°C. Thus, the melting process is 
divided into two parts and Cu2+ is dissociated in the second stage. Melting profiles for 
further addition of Cu2+ display the normal S-shape curves. Both melting points are 
now at 70°C, clearly showing that now all Cu2+ binding sites are occupied.  
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Figure 4-14 Melting profiles of duplex 5a/b: a) melting curves of 5a/b with 0-2 eq. Cu2+, arrows show 
two inflection points; b) plot of melting temperatures of 5a/b with 0-2 eq. Cu2+, compared with 0a/b. 
Data are mean ± SD of three replicates. Conditions: 150 mM NaCl, 10 mM CHES buffer pH 9.0, 1 μM 
oligonucleotides, the final volume of 200 μL.  
The result indicates the presence of two well-defined species in solution. With 1 eq. 
Cu2+ half of the duplexes contain two metal ions while the other duplexes feature no 
metal ion. We concluded that Cu2+ complexes within the Pz ligandoside in a 
cooperative manner. This is in agreement with the observation of the isosbestic points 
at 246 nm in the UV and 256 nm in CD titration experiments (Figure 4-15). The 
isosbestic point is a specific wavelength, where the total absorbance of a sample does 
not change during complexation, indicating that only two species that vary in 
concentration contribute to the absorption, i.e. duplex 5a/b without Cu2+ ion and 5a/b 
with two Cu2+ ions. 
 
Figure 4-15 Overlaid UV (a) and CD (b) spectrum of duplex 5a/b at various concentrations of Cu2+ 
(from 0 to 3 eq., step of 1 eq.). Conditions: 150 mM NaCl, 10 mM CHES buffer pH 9.0, 1 μM 
oligonucleotides, the final volume of 200 μL. 
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4.3.2.2. Insertion of consecutive five and ten ligandosides 
Stacking metal ions in a duplex will provide the complex more property and function in 
constructing nanoobjects and nanocatalysts. Duplex 6a/b with five and 7a/b with ten 
consecutive Pz ligandoside pairs were prepared (Table 4-1). The two duplexes possess 
GC-rich wings at both termini for the interest of the duplexes thermostability; despite 
five consecutive ligandosides these wings stabilize the duplex 6a/b with melting 
temperature of 61°C. After incorporation of copper ions, the melting temperature was 
so high that denaturing experiments were no longer possible. 
CD spectra of copper titration with 7a/b showed a clear transfer from 0 eq. to 5 eq. Cu2+ 
(Figure 4-16). After 5 equivalents Cu2+, further titration did not change the signal at 242 
nm. An isosbestic point at 316 nm is observed in the overlaid titration curves, which is 
a sign for two different species obtained during titration. This result is in accord with 
data obtained for the salen complex175 and with data of Shionoya’s hydroxyl pyridine 
ligandoside. 
 
Figure 4-16 CD spectral changes of the duplex 6a/b with Cu2+ from 0 to 10 eq., step of 1 eq., spectra of 
0 eq. is shown in green and 5 eq. in blue. Inset: plot of circular dichroic changes at 242 nm against the 
ratio of [Cu2+]/[6a/b]. Conditions: 150 mM NaCl, 10 mM CHES buffer pH 9.0, 1 μM oligonucleotide, 
the final volume of 200 μL. 
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Figure 4-17 CD spectral changes of the duplex 7a/b with Cu2+ from 0 to 15 eq., step of 1 eq., spectra of 
0 eq. is shown in green and 10 eq. in blue. Inset: plot of circular dichroic changes at 300 nm against the 
ratio of [Cu2+]/[7a/b]. Conditions: 150 mM NaCl, 10 mM CHES buffer pH 9.0, 1 μM oligonucleotide, 
the final volume of 200 μL. 
For duplex 7a/b, the overlaid CD spectra revealed that the structure of the duplex 
changes significantly upon Cu2+ complexation (Figure 4-17). The ellipticity at 300 nm 
shows a linear decrease which then comes to a constant after titration of 10 equivalents 
Cu2+. An authentic isosbestic point is not present.  
The results may be explained by the structural flexibility. Stacked Pz pairs are able to 
complex up to 10 metal ions, but then join in hand with structural changes of the 
duplex. 
 
4.3.2.3. Insertion of mixed ligandosides: kinetics study 
Modified duplexes displayed more intriguing properties when the pyrazole basepair 
was mixed with salen basepairs. 8a/b contains two salen (S) pairs and one Pz pair. 
Duplex 9a/b has two S and one Pm pair. 
Copper ion titrations of duplexes 8a/b and 9a/b up to 4 equivalents exhibit remarkable 
featured on UV-Vis spectrum. For 8a/b, the absorbances at 235 nm and 360 nm remain 
stable during the first equivalents of copper, then the absorbance increases for the next 
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two equivalents and become stable again after adding the third equivalent of copper 
(Figure 4-18a, b). Because S-Cu2+-S complex has a specific wavelength at 360 nm,174 
and pyrazole pair absorbance is not responsive upon copper complexation at 360 nm, 
the result suggests that the copper ions first incorporate into the pyrazole base pairs and 
then inserting into the salen pairs taken place. 
UV-Vis titration curves of duplex 9a/b additionally support this hypothesis (Figure 
4-18c, d). Because the Pm base pair does not chelate Cu2+, the first two equivalents of 
copper ions must go directly into the salen pairs to form S-Cu2+-S. Accordingly, the 
titration spectra shows a positive slope from 0 to 2 equivalents for the absorbance at 
360 nm, which increases for about 0.04 abs., in accord with the observed increase in 
duplex 8a/b. The curve then flattens out. 
 
 
Figure 4-18 UV titration experiment of duplex 8a/b and 9a/b: a) Overlaid UV spectrum with different 
concentrations of Cu2+ (from 0 to 4 eq.) of the duplex 8a/b; b) Plot of UV absorbance at 360 nm against 
the ration of [Cu2+]/[8a/b]; c) Overlaid UV spectrum with different concentrations of Cu2+ (from 0 to 
4 eq.) of the duplex 9a/b; d) Plot of UV absorbance at 360 nm against the ration of [Cu2+]/[9a/b]. 
Conditions: 150 mM NaCl, 10 mM CHES buffer pH 9.0, 3 μM oligonucleotides, 30 eq. ethylene- 
diamine, the final volume of 200 μL. 
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It is worth emphasizing that the absolute absorbance increases from 0.02 to 0.06, 
which is low in respect of what can be safely detected range. Despite the low signal to 
noise ratio, the general trend in the titration is evident. 
A more complicated case was found in duplex 10a/b. This duplex contains 3 pyrazole 
and 4 salen pairs. The complexation of copper ions was confirmed by CD titration, 
showing incorporation of 7 equivalents of Cu2+ into the duplex (Figure 4-19a, b). 
Overlaid spectrum show two isosbestic points, i.e. at 246 nm and 265 nm. The plot of 
the absorbance at 360 nm shows a plateau at 4 equivalents of Cu2+ followed by a steep 
slope upon addition of the subsequent 4 equivalents. We believe that because of the 
crowded situation and the flexible nature of the complexing unit that not all Cu2+ go 
into the Pz pairs in a stoichiometric manner. The plot of absorbance at 405 nm (Figure 
4-19c, d) presents two different trends of the absorbance changes. The first three 
equivalents of Cu2+ seem to cause rather sharp decrease in the absorbance while the 
following four equivalents yield a slight decrease of absorbance.  
 
Figure 4-19 CD and UV titration experiment of duplex 10a/b: a) Overlaid CD spectrum with different 
concentrations of Cu2+ (from 0 to 10 eq.) of the duplex 10a/b; b) Plot of circular dichroic changes at 
250 nm against the ration of [Cu2+]/[10a/b]; c) Overlaid UV spectrum under the same conditions as in 
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a); d) Plot of UV absorbance at 405 nm against the ratio of [Cu2+]/[10a/b]. Conditions: 150 mM NaCl, 
10 mM CHES buffer pH 9.0, 3 μM oligonucleotides, 30 eq. ethylenediamine, the final volume of 
200 μL. 
It is important to note that the above samples were kept at 4°C and were measured at 
20°C within a short period of time. When the sample stayed at room temperature 
longer than 1 h, the absorbance at 260 nm of duplex 10a/b could rise even with less 
than 1 equivalent Cu2+ ion. This indicates that the copper ions jump from Pz-Pz pair 
to the Sa-Sa pair inside the DNA duplex at higher temperature. The instability is 
meanwhile evidence for the thermodynamic preference for the S-Cu2+-S complex. 
With all this evidence in hand, it is safe to conclude that there is a kinetic preference 
for copper coordination with the pyrazole pair at 4°C compared to the salen base pair. 
This conclusion could be the foundation of making logic gates using bridged and 
non-bridged ligandoside.  
 
4.3.2.4. Insertion of mixed ligandosides: thermodynamic study 
Intriguing results were obtained by ESI-Mass measurement. Although the ESI analysis 
of duplex 1a/b, hybridized with Cu2+, always presented two signals corresponding to 
the two single strands ODN 1a and 1b, desired mass peak of the duplex containing a 
copper ion inside could not be obtained, which suggests that the decomplexation of 
Pz-Cu2+-Pz ↔ Pz-Pz is fast in the gas phase. 
ESI measurement of S/Pz inserted duplex 8a/b and 10a/b were thereafter processed. 
Although 3 equivalents Cu2+ was incubated with duplex 8a/b before ESI-MS 
measurement, the mass result showed signals corresponding to a duplex containing 
only two copper ions (Figure 4-20).  
We reasoned that the ethylenediamine linkage of the salen base pairs make the 
complex so stable that the Cu2+ complex survives during the ionization while 
complexes with the Pz base pair are kinetically less stable. 
Being curious in this unique property and considering the possibility of metal ion 
exchange after the coordination, we designed the following experiment. Duplex 8a/b 
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was first incubated with ethylenediamine and 3 equivalents of Cu2+; then another 2 
equivalents of Mn2+ was added. ESI-Mass gave the main peak corresponding to the 
dsDNA+2Cu2+. Sub-peaks corresponding to dsDNA+Cu2++Mn2+ were discovered 
along with the main peak (Figure 4-21).  
 
Figure 4-20 Experimental ESI-Mass spectrum data compared with calculated molecular weights of 
duplex 8a/b with 2 eq. Cu2+: a) Overall ESI spectrum; b) Peaks corresponding to duplex contains 9 
charges (top) compared with calculation (bottom), C316H375O176N96P28Cu29-, [M-9H+], calc. 1036.1627, 
found 1036.1610; c) Peaks corresponding to duplex contains 10 charges (top) compared with 
calculation (bottom), C316H374O176N96P28Cu210-, [M-10H+], calc. 932.4456, found 932.4459. Conditions: 
150 mM NH4OAc, 30 μM oligonucleotides, 30 eq. ethylenediamine. 
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The manganese ions were added after the reannealing process. The solution was not 
heated before the ESI measurement.  
In contract, the melting profile of duplex 1a/b incubated with 1 eq. Cu2+ and 1 eq. 
Mn2+ shows the same temperature as 1a/b with 1 eq. Cu2+. Thus, it is safe to claim 
that the exchange between S-Cu2+-S + Mn3+ ↔ S-Mn3+-S + Cu2+ can take place but 
only to a small extent, while the exchange of Pz-Cu2+-Pz + Mn3+ ↔ Pz-Mn3+-Pz + 
Cu2+ does not occur. This shows that S-S perfers complexation of Mn3+ while Pz-Pz 
perfers Cu2+. 
 
Figure 4-21 ESI-Mass spectrum and comparison of experimental data with calculated molecular 
weights of duplex 8a/b with 3 eq. Cu2+ and 2 eq. Mn2+: a) Peaks corresponding to 8a/b + 2Cu2+ and 
8a/b + Cu2+ + Mn2+; b) Peaks contain 8 charges (top) compared with calculation (bottom), 
C316H376O176N96P28CuMn8-, [M-8H+], calc. 1165.0610, found 1165.0615. Conditions: 150 mM 
NH4OAc, 30 μM oligonucleotides, 30 eq. ethylenediamine. 
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4.4. Application of the pyrazole ligandoside 
4.4.1. Towards genetic code expansion 
The intention to design ligandosides is to expand the genetic alphabet. Therefore, the 
following paragraphs will focus of ligandoside replication within a DNA template.  
Despite being essential for signaling between cells and for the energy household of 
the cell, high concentrations of copper ions can be toxic to cells. Free copper ions 
generate reactive oxygen species such as superoxide O2―, hydrogen peroxide H2O2, 
and hydroxyl radical •OH, which damage proteins, lipids, and DNA.305-307 
Based on these considerations, primer extension experiments were first executed with 
pyrazole ligandoside in the DNA template. 
 
4.4.1.1. Synthesis of the replication components 
To perform primer extension experiment one needs the following components: primer, 
template, deoxynucleoside triphosphates, DNA polymerase, a respective reaction 
buffer, and, if necessary, other factors. First of all, the pyrazole triphosphate was 
synthesized with a minor modified protocol,308 as shown in Scheme 4-9. Further 
triphosphorylation methods were reviewed by K. Burgess and D. Cook.309 
The one-pot synthesis of triphosphate is achieved by generating first a phosphorylation 
intermediate that reacts selectively with the 5’-hydroxyl groups of the unprotected 
nucleosides. In the case of pyrazole triphosphate, we found that the phenol group does 
not interfere with the process.  
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Scheme 4-9 Synthesis of triphosphate 22: a) Condition: 1) bis-tetrabutylammonium pyrophosphate, 
tributylamine, 2-chloro-1,3,2-benzodioxaphosphorin-4-one 23, DMF; 2) I2, pyridine, H2O, RP-HPLC 
purification, 11%. b) Mechanism of the triphosphate addition. 
 
Figure 4-22 Characterization of triphosphate 22: a) ESI+, C20H35N3O13P3+ [M+H++TEA], calc. 
618.1383, found 618.1380, C26H50N4O13P3+ [M+H++2TEA], calc. 719.2587, found 719.2585; and b) 
ESI- of 22, C14H18N2O13P3- [M-H+], calc. 515.0022, found 515.0017; c) 31P NMR of 22. 
After HPLC purification, the triphosphate product was characterized by 31P-NMR and 
ESI-Mass spectrum. ESI-Mass in the positive charge mode showed two high peaks at 
618.1380 and 719.2585 (Figure 4-22a), which equal to the mass of the triphosphate 
plus one and two molecules of triethylamine (calc. 618.1383 and 719.2587), while 
ESI-Mass in the negative detection mode gave the exact triphosphate molecular weight 
of 515.0017 (calc. 515.0022, Figure 4-22b). 31P-NMR showed two set of peaks, one set 
of peaks at around -11.3 ppm, and a set of the triplet at -23.6 ppm (Figure 4-22c). α- and 
γ- phosphorus atoms were crowded into the low field, leaving the β-phosphorus atom at 
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high field. Thus, we affirmed that the pyrazole triphosphate was obtained. 
As a template, a 30 mer oligonucleotide (ODN 11a) with Pz at the 24th position from 3’ 
terminus was synthesized using solid-phase synthesis (Table 4-1). A 5’-fluorescein- 
labeled 23 mer oligonucleotide was designed as a primer. Certainly, the primer can be 
labeled with radioactive 32P using polynucleotide kinase for direct detection. 
  
4.4.1.2. Replication with pyrazole triphosphate 
With all the three components in hand, primer extension experiments were performed.  
First, a collection of polymerases were screened to find out which allowed the 
incorporation of dPzTP (22) in the 24th position of the primer. Taq, Q5, Pwo, Phusion, 
T4, T7, Φ29, KF (exo-), Bst Pol large fragment, Deep Vent and Therminator were 
tried. In the reaction system, an excessive amount of template (2 μM) and primer (1.5 
μM) as well as 100-fold excess of 22 (200 μM) was employed. Experiment with and 
without Cu2+ (200 μM) at both 37°C and 50°C were performed. 
Deep vent (exo-) polymerase and Therminator polymerase, which belong to B family 
polymerase and which are isolated from archaea, are able to incorporate dPzTP with 
the primer opposite a Pz base on the template. Deep Vent achieved the goal at 50°C in 
24 h, while Therminator DNA Polymerase succeeded in 2 h at 37°C or in 5 min at 
75°C. It found out to be the best polymerase able to incorporate the ligandoside 22. 
Considering the incorporation efficiency and temperature consistency, 75°C was fixed 
as the reaction temperature for all further investigations. 
Therminator polymerase is a mutant variant of the 9oN exo- polymerase 
(Thermococcus species 9oN-7), in which the alanine 485 has been replaced by a 
leucine residue. This provides the polymerase with an enhanced ability to incorporate 
modified substrates, e.g. dideoxynucleotides, ribonucleotides, and acyclic- 
nucleotides.310-313 
Next, we studied the dPzTP incorporation efficiency under different conditions. At 
75°C within 5 min, the incorporation was achieved to a full extend, independent of 
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present of copper or magnesium ions (Figure 4-23). 
 
Figure 4-23 PAGE assay shows dPzTP incorporation and extension. Condition: 2 μM template 11a, 1.5 
μM primer 11b, 200 μM dPzTP 22, 200 μM each dNTP, 1 U Therminator, 1× Thermopol buffer, 10 
mM MgSO4, the final volume of 20 μL. 
The extension towards full length seemed more challenging than the dPzTP 
incorporation. For polymerase Therminator, at 50°C, the yield of full length was less 
than 50%. When the reaction temperature was raised to 60°C with the additive Cu2+ 
(200 μM) or Mg2+ (10 μM), the yield reached a maximum value of 65% in 9 h and then 
further decayed. At 75°C, the reaction could be finished in 2 h with additional Cu2+ and 
Mg2+ (Figure 4-23). The co-enzyme Mg2+ is a requisite for the extension, especially at 
the high temperature. Extension experiments with variable Cu2+ concentration showed 
that 200 μM of copper ions give the best condition.  
Further studies showed that the yield reached 80% in 90 min (Figure 4-24). Due to the 
dissatisfied efficiency, PCR amplification is not practical because the failed synthesis 
will be accumulated exponentially in PCR cycles. 
After PAGE analysis, the corresponding gel band was cut out and the DNA contatining 
material was dissolved and desalted. MALDI-TOF analysisi gave a clear signal (Figure 
4-27), corresponding to the 31 mer without the fluorescein tag but with a Pz base at the 
3’-overhang. We speculated this is due to the lack of a 3’-5’ exonuclease activity of the 
polymerase. We think hat the loss of 5’-fluorescein is happening during work up.  
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Figure 4-24 Time dependent study of dPzTP extension: a) PAGE assay shows the primer extends to full 
length in 2 h at 75°C after dPzTP full incorporated in 5 min at 75°C; b) Plot of the percentage of the 
full-length product by the integration from PAGE assay. Data are mean ± SD of three replicates. 
Condition: 2 μM template 11a, 1.5 μM primer 11b extended with 22, 200 μM each dNTP, 1 U 
Therminator, 1× Thermopol buffer, 10 mM MgSO4, the final volume of 20 μL. 
To study if the Pz base was orthogonal to the natural bases, we added four natural 
triphosphates to Pz-containing template ODN 11a, and reversely, dPzTP to four 
different templates with A/C/G/T at the 24th position (ODN 11c/d/e/f).  
At 75°C for 5 min, all the four natural bases were incorporated into the primer 
complementary to the Pz. However, no 25 mer product was visible showing again that 
elongation was blocked. dPzTP could also be complementarily incorporated opposite 
the natural bases on the template. Extension afterward was not discernible either 
(Figure 4-25), which could be good news for the plasmid replication experiments. 
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Figure 4-25 PAGE assay shows incorporation of dPzTP on 11c/d/e/f with primer 11b and incorporation 
of dATP/dCTP/dGTP/dTTP with template 11a on primer 11b. Condition: 2 μM template, 1.5 μM 
primer 11b, 200 μM dPzTP or dNTP, 1 U Therminator, 1× Thermopol buffer, 10 mM MgSO4, the final 
volume of 20 μL. 
 
 
Figure 4-26 PAGE assay shows incorporation of dPzTP mixed with dNTP extend with template 11a on 
primer 11b. Condition: 2 μM template, 1.5 μM primer 11b, 200 μM dPzTP and dNTP, 1 U Therminator, 
1× Thermopol buffer, 10 mM MgSO4, the final volume of 20 μL. 
In all furture studies we fixed the reaction conditions (75°C, 2 h, 1U Therminator DNA 
polymerase, 200 μM Cu2+ and additive Mg2+) constant and investigate the effect of the 
different ratio of dPzTP and dNTP was investigated (Figure 4-26). The best result were 
obtained of a ratio of 1/1, i.e. 200 μM dPzTP, and 200 μM dNTP. Although the primary 
product was a 31 mer oligonucleotide, the yield was lower than when it was done in 
two separate steps. MALDI-TOF failed to give a signal after analysis of band cut out of 
the the PAGE gel. To solve the problem, we cut the gel and extracted the DNA with 
phenol and chloroform, desalted, and measured again. The spectrum, shown in Figure 
4-27, indicated formation of the same product formed in two steps. 
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Figure 4-27 MALDI-TOF spectrum for a) extended primer in two steps, found 9567.3; b) extended 
primer in one pot, found 9569.5; calc. 9566.7, corresponding to the complementary template strand 
with Pz at 3’-overhang without 5’-fluorescein, listed in c). 
In summary, we showed the possibility to incorporate the dPzTP into a primer 
opposite a templating dPz base using the Therminator polymerase. Even for such a 
powerful polymerase, neither the efficiency nor the fidelity was sufficient to continue 
with PCR experiments.  
 
4.4.2. Towards chiral catalyst 
Ligandosides make it practicable to complex copper ions or other metal ions inside 
the DNA double helix. This promoted us to think of applying the complex as water 
soluble or solid-phase based chiral catalysts. Whether the duplex could transfer its 
helicity to the substrates and whether the metal ion inside the duplex could approach 
the substrates to act as a catalytic center are worthwhile and intriguing questions to 
investigate. 
Previously, two strategies using the nucleic acid structure as a chiral catalyst were 
developed. The first example used a copper ligand with a linker that could suspend 
the ligand outside the natural DNA duplex.314 This strategy was further improved as 
an interstrand linker hanging copper ion outside the duplex or inside the duplex.315, 316 
In the second strategy, a G-quadruplex with a copper ion in the center was 
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employed.317 The complex showed excellent stereoselectivity in a model Diels-Alder 
reaction. The parallel and anti-parallel conformations made a difference on the 
stereoisomerism.  
 
 
Scheme 4-10 Model Diels-Alder reaction for testing the catalytic effect of duplex 6a/b. Condition: 0.5 
mol% 6a/b, 2.5 mol% Cu2+, 50 mM NaCl, 20 mM buffer, 4°C, 24h. 
 
Figure 4-28 Typical HPLC traces of the crude products from Cu2+ catalyzed Diels-Alder reaction. a) 
Cu2+ without duplex 6a/b, negative control, entry 2 in Table 2. b) Cu2+ with duplex 6a/b, entry 1 in 
Table 4-3. Condition: heptane/2-propanol 99:1, 0.5 mL/min, column temperature 40 °C. 
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Here, duplex DNA with pyrazole ligandoside was attempted in the same model 
Diels-Alder reaction with aza-chalcone (24) and cyclopentadiene (25) as reported 
(Scheme 4-10).314 To reach a relatively high concentration of copper ions in the 
system, a duplex catalyst with five continuously stacking pyrazole bases (duplex 6a/b) 
was applied. At high temperature, the Diels-Alder reaction yields the predominantly 
the exo product, while at lower temperature needed to ensure the present of the intact 
DNA complex, the endo isomer turns out to be the primary product. Both the exo and 
endo products contain a pair of enantiomers (Figure 4-28). In the absence of the 
catalyst, acidic environment alone accelerates the reaction.318 
The Cu2+ ion was first coordinated inside the duplex in basic ammonium acetate 
buffer, an evaporable mild alkaline solution, to ensure the complex formation. After 
evaporating to dryness, the residual material was redissolved in the corresponding 
reaction buffer. The reaction mixture was subjected to normal phase chiral HPLC to 
determine the enantiomeric excess. A standard curve was made to calculate the molar 
ratio of the product 26 and starting dienophile 24 (Figure 4-29). 
 
Figure 4-29 Determination of the correction factor. The HPLC ratio of peak area (PA24/PA26) were 
determined with the standard molar ratio (n24/n26) of 1/10, 1/5, 1/2, 1, 2, 5 and 10. The correction factor 
(f = 0.69) was estimated from the fitting curve (R2 = 0.9985). 
The results are summarized in Table 4-3. Both single and double strands with the 
Pz-ligands accelerated the reaction and induced chirality in the presence of Cu2+. 
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Copper counter ions and surrounding pH also plays a role in the catalytic process.  
Table 4-3 Results of the catalytic Diels-Alder reaction with duplex 6a/b. 
entry ligand Cu2+ pH ee endo/exo conv. 
1 ds NO3– 6.5 39 93  97% 
2 ds SO42– 6.5 32 87  52% 
3 ds OTf– 6.5 29 84  46% 
4 ds - 6.5 3 76  19% 
5 - NO3– 6.5 1 87  76% 
6 ss NO3– 6.5 29 93  96% 
7 ds NO3– 7.4 36 86  79% 
8 ds NO3– 9.0 23 80  47% 
As generally believed, the metal ions inside the duplex could hardly access the 
substrate and serve as a catalytic center. The results here prove that the 
liganoside-containing DNA strand can act as a chiral catalyst. Further optimization of 
the ee values is now required as well as studies on the relationship between duplex 
sequence and catalytic effect and expansion of the substrate scope and reactions. In 
case that the ligandoside can also coordinate metal ions like palladium, gold or 
ruthenium this would open up new opportunity for recyclable noble metal chiral 
catalysts. 
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4.5. Summary: Part I 
Concerning the reconstruction of oligonucleotides, this chapter focuses on the 
controlled binding of multiple metal ions inside the DNA duplex. Herein, a 
non-bridged pyrazole ligandoside is designed, synthesized and evaluated.  
The organic synthesis started with 3 to furnish the ligand building block 6. After 
connecting to the ribose derivate 8, deprotection and protection gave the monomer 15 
for solid-phase synthesis. In the solid-phase synthesis, the pyrazole ligandoside 
phosphoramidite coupled as efficiently as canonical nucleosides. 
Among the metal ions that have been tested, Cu2+ and Mn3+ stabilized duplex ODN 
1a/b containing a homo pair of pyrazole ligandoside equal to canonical duplex. The 
system maintains the B-form helix conformation. Pyrazole base showed self- 
recognition behavior orthogonal to natural bases in the present or absent of metal ions. 
A co-crystal structure of duplex ODN 4a/b and Bst Pol I was obtained, suggesting 
that, without metal ions, the pyrazole bases are stacking with each other instead of 
having a planar base pair type interaction. 
When two pyrazole ligandosides were in neighboring places in the duplex, copper 
ions complexed cooperatively. The duplexes ODN 6a/b and 7a/b were capable of 
arranging five and ten Cu2+ ions in the duplex. In the case of duplex ODN 8a/b, UV 
titration and ESI-MS suggests that the Pz-Pz pair perfers to complex Cu2+ even 
relative to the S-S pair. 
With Thermopol polymerase, a pyrazole ligandoside triphosphate is placed opposite a 
dPz in the template and extended to full length. When applied as a catalyst, the 
metal-DNA complexation accelerated the Diels-Alder reaction and reached moderate 
stereoselectivity.  
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5. Part II: Oligonucleotide fdC probe  
5.1. Aims of the project and rationale 
The aim of the second project was to develop a novel squence specific quantification 
method for 5-formyl cytosine. Considering the disadvantages of the previous methods, 
i.e. reduce-bisulfite sequencing, and biotin-enriched sequencing, this method should 
be able to detect fdC content in a given gene position or loci. Sequencing depth can be 
alleviated; detection labor-hour and expense should be saved.  
Detecting epigenetic bases is similar to detecting single nucleotide polymorphisms 
(SNP).319 Most SNP detection strategies take advantage of amplification technologies 
like PCR,320 or isothermal amplification,321 to amplify and quantify the signal with 
probes.  
However, epigenetic bases, i.e. mdC, hmdC, fdC, and cadC are similar to cytosine and 
pair with guanine. So, the discrimination among these bases will be impossible in the 
typical PCR reaction. As stated in Chapter 3.2.3.5, there are peptide276 and 
oligonucleotides277 to discriminate dC, mdC, and hmdC using inter-molecular 
interaction. Since they failed to amplify the sequence, these probes may not be 
suitable for genomic detection. Therefore, a covalent bond between the target strand 
and the probe strand must be established.  
To tackle the problem, one idea was to design a complementary oligonucleotide 
containing a linker with a functional group that can react with fdC on the target strand. 
The reaction should be chemically specific with a favorable reaction rate. The 
hybridization of the probe strand with the target strand ensures a sequence-specific 
detection (Figure 5-1). 
As fdC is found at levels below 0.002% of all cytosines in the genomic DNA, the 
method should be able to either amplify the fdC signal or detect the signal with an 
extremely high sensitivity. PCR, PAGE assay, antibody test are conventional methods 
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for gene sequencing. Taking advantage of these methods could be beneficial for the 
fdC profiling. LC-MS, orbitrap or tridruaplex, is another option.  
 
Figure 5-1 a) Structure organization of eukaryotic DNA, the figure is adapted from the reference;322 b) 
schematic representation of the project workflow.
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5.2. fdC probe strand: evolution and evaluation 
5.2.1. Verso-evolution of probe strands 
According to the previous reports, both hydroxylamine229, 323 (R-ONH2, 27, 28) and 
hydrazine derivatives324 (R-NHNH2, 29) irreversibly reacted with fdC (Figure 5-2). 
1-Pyrenemethylamine325 (30) reaction with fdC for formylcytosine labeling was also 
brought to our attention, but due to the absence of α-effect, the Schiff base will be less 
stable in such an aliphatic system. Additionally, a fluorescein tag containing 
hydrazide group (R-CONHNH2) was applied to react with a ketone for protein 
labeling.326-328 
 
Figure 5-2 Examples of small molecules that acted as fdC probes: aldehyde reactive probe (ARP, 27), 
coumarin-HA (28), 9-(hydrazinylmethyl)acridine (29), 1-pyrenemethylamine (30). 
An orthogonal bioconjugation reaction should be employed to attach the amine linker 
on the probe strand. Apart from the hydroxylamine aldehyde condensation, 
Cu-catalyzed Huisgen cycloaddition, tetrazine trans-cyclooctene and cyclopropene 
Diels-Alder reaction,329-331 acyl trifluoroborate amide formation,332 etc. are all 
conventional reactions for bioconjugates that could be employed.333 The 
trans-cyclooctene reaction shows a high rate, 103~106 M-1s-1, however, the large steric 
hindrance impedes its application. The Huisgen cycloaddition and acyl trifluoroborate 
amide formation have similar reaction rate, 10~20 M-1s-1,332 and the hydroxylamine 
aldehyde condensation is relatively slow with a rate of 10-3~10-1 M-1s-1.334 In this 
thesis, the Huisgen cycloaddition was chosen due to its elegance and robustness. Thus, 
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an azide group was placed on one end of the linker, and an alkynyl modifier was 
placed in the probe strand. 
Therefore, two sets of linkers with hydroxylamine (-ONH2) or hydrazide 
(-CONHNH2) at one end and an azide group at the other end were synthesized. Each 
set of linker consists of alkyl chains with three different lengths, i.e. propyl, butyl, and 
pentyl (Figure 5-3). 
 
Figure 5-3 Structures of aliphatic linkers synthesized in this study. 
Synthesis of the hydroxylamine linker 31-33 started with dibromoalkane (Scheme 
5-1). Substitution with N-hydroxyphthalmide followed by conversion of bromide into 
azide furnished 39. After hydrazine solution treatment the hydroxylamine linkers were 
obtained in overall yields of 52-67%. For the hydrazide linkers 34-36, methyl 
esterification followed by azide substitution gave the ω-azide methyl ester 42. 
Conversion of 42 into the hydrazide was achieved by refluxing in a methanol solution 
of hydrazine. 
 
Scheme 5-1 Synthesis of the hydroxylamine linkers 31-33 and hydrazide linkers 34-36. a) 
N-hydroxyphthalimide, triethylamine, DMF, rt; b) NaN3, DMF, rt; c) N2H4•H2O, DCM, rt, 52-67% 
over three steps; d) H2SO4, MeOH, reflux; e) NaN3, DMF, rt; f) N2H4•H2O, MeOH, reflux, 64-69% for 
three steps. 
Aliphatic linkers with hydrazide were also prepared, but their instability at room 
temperature, at least in our hand, limited their further application. 
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Next, a 13 mer single DNA strand with one fdC and a complementary probe strand 
with alkynyl modifiers were prepared, hybridized and studied. To find the best 
combination of alkyl chain length, reactive moiety on the linker, and position of the 
linker on the probe strand, six linkers (31-33 and 34-36) were first connected to the 
fdC target strand (Table 5-1). 20 equivalents of the linker to ODN 13 was used to 
guarantee a complete conversion. After HPLC purification, six fdC contained 
oligonucleotides with different azide linkers were prepared. They are stable enough to 
survive the concentration and redissolving process. 
 
Table 5-1 Synthesized fdC contained oligonucleotides for duplex model study. Bold and red fdC 
represent uncrosslinked and crosslinked formyl cytosine. Found values indicate the mass results 
measured by MALDI-TOF. (L: linker) 
Entry 5' ----------- 3' mer calc. found 
12a GTA ATG CGC TAG G 13 / / 
12b CCT AGC GCA TTA C 13 / / 
13 GTA ATG fCGC TAG G 13 4040.9  4036.2  
13-L31 GTA ATG fCGC TAG G 13 4139.0  4137.4  
13-L32 GTA ATG fCGC TAG G 13 4153.0  4149.8  
13-L33 GTA ATG fCGC TAG G 13 4167.0  4163.8  
13-L34 GTA ATG fCGC TAG G 13 4166.0  4166.2  
13-L35 GTA ATG fCGC TAG G 13 4180.0  4175.7  
  13-L36 GTA ATG fCGC TAG G 13 4194.0  4190.2  
 
To find out the best anchor position on the probe stand, we placed different 
alkynyl-modifiers on the probe strands. Reported alkynyl modifiers are summarized 
in Figure 5-4. 2’-O-alkyne modifier (43) and 5-ethynyl-2’-deoxycytidine (45) were 
chosen because of their accessibility. 
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Figure 5-4 Summary of published alkynyl nucleoside modifiers. 2'-(O-propargyl) cytidine (43), 
uridin-2-yl carbamate (44),335 5-ethynyl-2’-deoxycytidine (45)336 and 3’-O-Acetyl-5-(2-(4-ethynyl 
phenyl)ethynyl)-2’-deoxycytidine (46).337 
The modifier 43 was placed every four bases in the counter strand for the 
consideration that too crowded alkynyl groups at 2’-OH may disturb the normal 
duplex form. ODN 14-17, each containing three alkynyl modifiers, were mixed with 
the six fdC-linker target strands. A library of 24 duplexes was thereby obtained. If the 
azide and the alkynyl group are in an appropriate position, Huisgen 1,3-dipolar 
cycloaddition will occur. The cross-linked oligonucleotides will show a band in the 
gel electrophoresis that is different from the single strand on a denaturing PAGE. 
 
Table 5-2 Synthetized oligonucleotides containing 2’-O-propargyl bases for duplex model studies. Bold 
and red letters represent the alkyne modifier 37. Found values indicate alkyne cytosine modifiers 39. 
Mass results measured by MALDI-TOF. 
Entry 5' ----------- 3' mer calc. found 
14 CCT AGC GCA TTA C 13 4054.7  4052.6  
15 CCT AGC GCA UTA C 13 4040.7  4037.6  
16 CCU AGC GCA TUA C 13 4026.7  4024.1  
17 CCT AGC GCA TTA C 13 4054.7  4052.0  
16a CCU AGC GCA TTA C 13 3932.7  3930.5  
16b CCT AGC GCA TTA C 13 3946.7  3945.8  
  16c CCT AGC GCA TUA C 13 3932.7  3931.5  
 18 CCT AGC GCA UTA C 13 3916.7 3913.3 
 
Percentages of the duplex formed in 4 hours for each trial are listed in Table 5-3. In 
general, the hydroxylamine linkers (L31-33) gave better crosslink than hydrazide 
linkers (L34-36). As reactions were processed, hydrazide linkers displayed more 
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bands, suggesting unspecific reaction or instability under the reaction conditions. To 
obtain optimal crosslinking condition, freshly prepared CuBr-TBTA solution and 4 h 
reaction time are necessary. The best crosslink yield within duplexes (94%) is 
obtained using ODN 16 and ODN 13-L32, suggesting that a hydroxylamine group 
with a (CH2)4 chain gives the most suitable approaching towards one of the three 
alkynyl groups on the probe strand. In the second round of evolution, ODN 16a-c 
were prepared, each containing one alkynyl group corresponding to ODN 16. This 
time, ODN 16a reacted most efficiently with ODN 13-L32: 93% of the fdC reacted in 
this duplex, similar as ODN 16 and ODN 13-L32. This reuslt was then providing the 
optimal probe strand containing a hydroxylamine group to catch fdC aldehyde group 
on a given target strand.  
A similar strategy, using the alkyne cytosine modifiers 45 (Figure 5-4) in the probe 
strand, was explored next one. In the genome, fdC and other epigenetic cytosine 
modification always appear in CpG sites. If the cytosine opposite the guanine can be 
used to target fdC in this CpG site, one can in principle detect fdC in any sequence 
context with the same probe base (Figure 5-5). 
Probe strand ODN 18 containing modifier 45 was kindly obtained from Dr. Milan 
Dejmek. ODN 18 was mixed with ODN 13-L31/32/33 and CuBr-TBTA under the 
same condition mentioned above. PAGE assays showed however that this linkage 
mode is not optimal. The maximal yield of the duplex was 54% with linker 33, but 
multiple bands appeared. Therefore, this strategy was not investigated any further. 
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Table 5-3 Percentage of the aldoxime mediated duplex formation after 1, 2 and 4 h. Percentages in bold 
indicate the best result in each round; Percentages in red indicate the present of multiple bands.  
1 h 13-L31 13-L32 13-L33 13-L34 13-L35 13-L36 
ODN 14 25% 34% 43% 11% 26% 9% 
ODN 15 17% 51% 39% 12% 16% 5% 
ODN 16 38% 75% 52% 28% 37% 9% 
ODN 17 38% 33% 44% 4% 11% 7% 
 ODN 16a 69% 
 ODN 16b 14% 
 ODN 16c   14%         
2 h 13-L31 13-L32 13-L33 13-L34 13-L35 13-L36 
ODN 14 29% 34% 46% 22% 42% 10% 
ODN 15 24% 55% 40% 14% 21% 5% 
ODN 16 42% 83% 53% 29% 38% 12% 
ODN 17 38% 36% 46% 6% 12% 8% 
 ODN 16a 73% 
 ODN 16b 17% 
 ODN 16c   15%         
4 h 13-L31 13-L32 13-L33 13-L34 13-L35 13-L36 
ODN 14 47% 49% 76% 30% 55% 22% 
ODN 15 52% 88% 74% 22% 49% 18% 
ODN 16 70% 94% 85% 41% 67% 28% 
ODN 17 71% 60% 77% 13% 26% 21% 
 ODN 16a 93% 
 ODN 16b 52% 
 ODN 16c   68%         
 
 
 
Figure 5-5 Schematic representation of probe ODN 18 containing modifier 39, and percentage of the 
aldoxime mediated duplex formation after 1, 2 and 4 h. Percentages in red indicate the present of 
multiple bands. 
 
5.2 fdC probe strand: evolution and evaluation 
97 
 
5.2.2. Evaluation of the probe strand 
5.2.2.1.  Confirmation of the crosslink 
After the best linker had been obtained, we questioned whether this combination of 
the linker and modified position on the probe strand essentially worked. The above 
protocol was done reversely; i.e. the linker was first clicked on to the probe strand, 
and then hybridized with the counter strand containing a fdC. 
Great efforts have been made to click the linker 32 on the deprotected probe strands, 
with and without the hydroxylamine protecting group. It is reported that 1,3-dipolar 
cycloaddition succeeded when using the uridin-2’-yl carbamate alkynyl monomer 44 
in solution.335 In the case of 2’-O-propargyl modifier, “on column” cycloaddition338  
and in solution click labeling339 have been reported. However, in our hand, all the in 
solution reaction gave complicated product mixture according to HPLC analysis.  
 
 
Scheme 5-2 Synthesis of oligonucleotides based probe with linker 32. a) MMTr-Cl, DIPEA, DCM, rt, 
84%; b) CuSO4, sodium ascorbate, 47, DIPEA, MeCN, DMSO, H2O, rt; b) NH3•H2O, 25°C; c) 
CH3COOH aq., 25°C, quant. 
So the solid-phase bound alkyne DNA was first reacted with MMTr protected 
hydroxylamine linker 47, as depicted in Scheme 5-2. After cleavage from the solid 
phase, a sharp peak corresponding to the desired ODN 16d was observed by HPLC 
(Figure 5-6). After treating the product with aqueous acetic acid, a single peak with 
shorter retention time appeared in the HPLC trace, indicating MMTr was deprotected. 
The present of the product ODN 16e with the hydroxylamine linker (R-ONH2 + Na+) 
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was confirmed by MALDI-TOF, as shown in Table 5-4.  
The reason why the peak corresponding to deprotected strands without sodium ion 
was absent is not known, even if no sodium ion was used in the deprotection and 
purification steps. Oligonucleotides with one linker were synthesized smoothly while 
effort towards strand with two linkers failed. 
 
Table 5-4 Synthesized oligonucleotides containing hydroxylamine linker and fdC shifted strand. Bold 
and red letters represent alkyne modifiers. *: contain one sodium ion. 
Entry 5' ----------- 3' mer calc. found 
16a CCU AGC GCA TTA C 13 3932.7  3930.5  
16d CCU-L-MMTr AGC GCA TTA C  13 4335.2  4335.1  
  16e CCU-L-ONH2 AGC GCA TTA C 13 4084.8*  4084.2 
 19 GTA ATfC CGC TAG G 13 4000.9 3999.6 
 
 
Figure 5-6 Typical HPLC trace of crude product: a) ODN 16d (ODN 16a attached MMTr protected 
linker 32) and b) ODN 16e (ODN 16a attached deprotected linker 32). Conditions: buffer A, 0.1 M 
TEAA; buffer B, 0.1 M TEAA in 80% acetonitrile, linear gradient from 0% to 70% B over 45 min. 
Retention time: (a) 34.4 min, (b) 18.5 min. AU = arbitrary unit. 
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Figure 5-7 Kinetic of crosslink formation. Denaturing PAGE assay shows the duplex formation of a) 
ODN 13/16e with catalyst 4-methoxyaniline b) ODN 13/16e without a catalyst, c) ODN 19/16e with 
the catalyst at 25 °C for 24 h and d) quantification of DNA duplex formation along the reaction. Error 
bars represent the standard error of mean calculated from three replicates. Conditions: 2 μM 
oligonucleotides, 100 mM NaCl, 10 mM NaOAc buffer pH 6.0, 4-methoxyaniline as catalyst 10 mM. 
M = 13 mer single strand marker. 
When ODN 16e was mixed with ODN 13, the aldoxime formation was monitored by 
denaturing PAGE assay within 24 hours. It was found that 50% of the single strand 
pairs became indivisible duplexes even without the addition of any catalyst after 24 
hours. In the present of 4-methoxyaniline as the catalyst,229 the reaction yield reached 
95%. In the negative control experiment, ODN 16e and ODN 19, in which fdC was 
shifted from +4 to +5 position, only 17% of aldoxime was formed after 24 hours 
(Table 5-4 and Figure 5-7). These experiments confirm that the ODN 16e has the 
optimum position, proper linker length, and reactivity to form an irreversible covalent 
bond with fdC on the target strand. 
In this reaction, fdC first reacts with the catalyst to form a conjugate. The 
4-methoxyaniline has an electron-withdrawing group on the para-position of aniline. 
W. Michaela et al. studied the catalyst effects of different substituted anilines in their 
model protein-PEG conjugation system and deemed the 1,4-diaminobenzene as the 
best.340 In practice, 1,4-diaminobenzene worked better in our case and completed the 
crosslink reaction in 4 hours (Figure 5-8). 
To further confirm the oxime crosslink formation, MALDI-TOF mass spectrum were 
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measured (Table 5-5 and Figure 5-9). Mass signals corresponding to the duplex of two 
13 mer oligonucleotides were observed (calc. 8084.7, found 8081.9). Signals 
corresponding to the two single strands ODN 13, ODN 16e, and ODN 13/ 
4-methoxyaniline conjugate also appeared. 
 
Figure 5-8 Comparison of aniline catalyst: a) denaturing PAGE assay shows the duplex formation using 
1,4-diaminobenzene as a catalyst; b) quantification of DNA duplex formation along the reaction 
compared with reaction using 4-methoxyniline as a catalyst. Error bars represent the standard error of 
mean calculated from three replicates. Conditions: 2 μM oligonucleotides, 100 mM NaCl, 10 mM 
NaOAc buffer pH 6.0, 1 mM 1,4-diaminobenzene or 10 mM 4-methoxyniline. M = 13 mer single 
strand marker. 
The meling profile of duplex 13/16e was measured to provide additional evidence. 
(Figure 5-10) Because 4-methoxyaniline displays a strong absorbance at 200-300 nm, 
the catalyst was not added in this case. Two inflection points are observed after 24 h 
incubation of duplex 13/16e. One point (44°C) corresponds to the duplex melting 
point measured after reannealing. The other from the crosslinked duplex (79°C) is 
28 °C higher than the canonical duplex 13/12b. It is consistent with our assumption 
that the linkage between the two single strands will stabilize the duplex. It also 
confirms that the catalyst is necessary if complete crosslinking is aimed, in accord 
with PAGE assay (Figure 5-7b). 
To sum up, the above results verify that the probe containing a butyl hydroxylamine 
linker at the n+4 position can react with fdC on the counter target strand efficiently 
and in a sequence-specific manner. 
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Table 5-5 MALDI-TOF results of duplex 13/16e. Bold and red letters represent alkyne modifiers. 
Entry 5' ----------- 3' mer calc. found 
13 GTA ATG fCGC TAG G 13 4040.9  4038.4  
13+cat. GTA ATG fCGC TAG G  13 4146.0 4143.9  
  16e CCU-L-ONH2 AGC GCA TTA C 13 4061.8  4060.5 
   duplex 13/15e  8084.7 8081.9 
 
Figure 5-9 MALDI-TOF mass spectrum of linked duplex 13/16e and single strands: a) overall 
MALDI-TOF spectrum; b) peaks corresponding to ODN 13 and ODN 13 conjugated 4-methoxyaniline; 
c) peaks corresponding to linked duplex 13/16e Conditions: 10 μM oligonucleotides, 100 mM NaCl, 10 
mM NaOAc buffer pH 6.0. 
 
Figure 5-10 Melting curves of duplex 13/16e after reannealing or after 24 h incubation without 
4-methoxyaniline compared with duplex 13/12b. Condition: 1 μM oligonucleotides, 100 mM NaCl, 10 
mM NaOAc buffer pH 6.0, the final volume of 200 μL.  
5. Part II: Oligonucleotide fdC probe   
102 
   
5.2.2.2.  Chemical selectivity 
When turned to the chemical selectivity, it is found that the probe strand does not 
react with DNA templates containing a site-specific mdC, hmdC, or cadC (ODN 12a, 
13a-d, Table 5-6 and Figure 5-11). Because genomic DNA may contain abasic sites 
(apurinic/apyrimidinic, AP sites) with an aldehyde function, a control experiment with 
oligonucleotides ODN 13e containing an AP site was performed. In contrast to 
epigenetic bases, AP sites did react with probe strand with a yield of 90% under the 
same condition. 
 
Table 5-6 Synthesized oligonucleotides for specificity study. Bold letter T indicates mismatch position. 
Bold and red letters represent epigenetic, AP or hydroxylamine modifiers. Fl represents fluorescein tag 
(6-FAM). *: contain one sodium ion. 
Entry 5' ----------- 3' mer calc. found 
12a GTA ATG CGC TAG G 13 /  /  
13a GTA ATG TGC TAG G  13 /  /  
  13b GTA ATG mCGC TAG G 13 4026.7  4021.6 
 13c GTA ATG hmCGC TAG G 13 4042.7 4039.6 
 13d GTA ATG caCGC TAG G 13 4056.7 4054.9 
 13e GTA ATG APGC TAG G 13 3916.4 3919.6 
 16e CCU-L-ONH2 AGC GCA TTA C 13 4084.8* 4082.2 
 16f Fl-CCU-L-ONH2 AGC GCA TTA C 13 4622.3* 4621.2 
 
 
Figure 5-11 Specificity study of probe strand ODN 16e: a) denaturing PAGE assay shows the duplex 
formation of ODN 12a, 13, 13a-e and ODN 16e at 25 °C for 24 h; b) quantification of duple 12a, 13, 
13a-e and 16e formed after 24 h. Error bars represent the standard error of mean calculated from three 
replicates. X indicates modified site in the test strand (T, C, mdC, hmdC, cadC, and abasic site). 
Conditions: 2 μM oligonucleotides, 100 mM NaCl, 10 mM NaOAc buffer pH 6.0. M = 13 mer single 
strand marker. 
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The sensitivity of this detection method, at this stage, was investigated by PAGE 
quantification. ODN 16f, the probe ODN 16e with a fluorescein tag was prepared for 
imaging. ODN 13 (contains fdC) and 12a (C instead of fdC) were mixed in different 
ratios and reacted with ODN 16e. In both methods, photographed directly for 6-FAM 
and photographed after SYBR Green dying, 10% of fdC can be observed, which 
equals to 0.5 pmol and 200 nM. The fdC probe reaction can of course be coupled to 
other techniques, e.g. PCR, LC-MS, etc., to reach a even better detection limit. 
 
Figure 5-12 Denaturing PAGE assay shows the duplex formation of ODN 16e with different ratios of 
ODN 13 and ODN 12: a) photographed directly for 6-FAM; b) photographed after SYBR Green I 
dyeing. Conditions: 2 μM oligonucleotides, 100 mM NaCl, 10 mM NaOAc buffer pH 6.0. Loading 
volume: 2.5 μL+ loading buffer. M = single strand marker 13. 
 
5.2.2.3.  Sequence specificity 
Next, to check if the probe could tolerate any mismatch pairs inside the duplex, three 
duplexes were synthesized as negative control experiment: one with T-C pair outside 
the N to N+4 area (mismatch duplex 1, ODN 13/20c, Table 5-7); one with G-T pair 
inside the N to N+4 area (mismatch duplex 2, ODN 21/16e). The third mismatch 
duplex consists of ODN 22 with fdC at the same position as in ODN 13. 
At 25°C, both mismatched duplexes 1 and 2 showed high aldoxime formation 
efficiencies of 92% and 88% respectively, compare to the positive experiment (95%, 
Figure 5-13). This means the fdC probe cannot discriminate a single mismatch at 
25°C. Random mismatch duplex 3 showed a yield of 7% after 24h, suggested that the 
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two single strand could hardly approach each other to provide a suitable spatial 
location for aldoxime formation. 
Table 5-7 Synthesized oligonucleotides for sequence selectivity study. Bold and red letters represent 
alkyne modifiers. *: contain one sodium ion. 
Entry 5' ----------- 3' mer calc. found 
20a CCU ATC GCA TTA C 13 /  /  
20b CCU-L-MMTr ATC GCA TTA C  13 4310.2 4310.3  
  20c CCU-L-ONH2 ATC GCA TTA C 13 4059.8* 4064.3 
 21 GTG ATG fCGC TAG G 13 4056.9 4055.5 
 22 CTA GCA fCGT CTC G 13 3936.8 3933.6 
 
 
Figure 5-13 Denaturing PAGE shows the mismatched duplex crosslinking: a) positive control, 13/16e; 
b) mismatch 1, 13/20c; c) mismatch 2, 21/16e; d) mismatch 3, 22/16e at 25 °C for 24 h; e) 
quantification of DNA duplex formation along the reaction. Error bars represent the standard error of 
mean calculated from three replicates. Conditions: 2 μM oligonucleotides, 100 mM NaCl, 10 mM 
NaOAc buffer pH 6.0, 4-methoxyaniline as catalyst. M = single strand marker 13. 
The low discriminability evoked us to study the thermostability of these duplexes. 
Duplex 13/12b (T instead of modified U in 16e) showed a melting temperature of 
51°C while mismatch duplex 1 and 2 had a TM of 32°C and 44°C respectively (Figure 
5-14). It was therefore found that at a higher reaction temperature, e.g. 45°C instead 
of 25°C, duplexes with mismatch pairs should be less stable so that aldoximes could 
potentially not form.  
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Figure 5-14 UV melting curves of duplexes 13/12b (control), 13/20d (mismatch 1), and 21/12b 
(mismatch 2). Italic letters G and T indicate mismatch position. Condition: 1 μM oligonucleotides, 100 
mM NaCl, 10 mM NaOAc buffer pH 6.0, the final volume of 200 μL.  
The same experiments were therefore repeated with the difference that the incubation 
temperature was raised to 45°C. The yield of positive experiment and mismatch 
duplex 1 are similar to that at 25°C, i.e. 94% and 88% while the yield now obtained 
for the mismatched duplex 2 decreases to 59%. Random mismatched duplex 3 shows 
little crosslinking, 7% (Figure 5-15). As 45°C is similar to the melting temperature of 
duplex 2 (44°C) but higher than duplex 1 (32 °C), the mismatched situation can 
therefore be discriminated at an elevated temperature. 
 
Figure 5-15 Denaturing PAGE assay shows the duplex formation of a) control: 13/16e b) mismatch 1: 
13/20c c) mismatch 2: 21/16e and d) mismatch 3: 22/16e at 45 °C for 24 h. e) Quantification of DNA 
duplex formation along the reaction. Error bars represent the standard error of the mean calculated 
from three replicates. Conditions: 2 μM oligonucleotides, 100 mM NaCl, 10 mM NaOAc buffer pH 6.0, 
p-methoxyamine as catalyst. M = single strand marker 13. 
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5.2.2.4.  Detection selectivity with multiple probes 
In order to test the method in a more complicated scenario, the target strand ODN 23 
containing three fdCs was prepared. ODN 24, 25 and 26 were prepared as the three 
probes of 12, 13, and 14 mer respectively. They are designed for reaction with the 
three different fdCs on ODN 23. Follow the procedure mentioned above, these three 
probes were reacted with ODN 23, to give slower migrating bands than ODN 23 
alone on PAGE due to specific crosslink formation (Figure 5-16). However, these 
three duplexes, which were different in only one nucleoside, showed quite similar 
migration distance. To clarify the difference of crosslinking between the target and 
each probe strand, the primer extension experiment with Klenow Fragment (exo-) was 
performed. As the catalyst in DMSO solution and acidic buffer may not suitable for 
the enzyme, a working solution of 20 μM was made for aldoxime formation, followed 
by dilution to 2 μM with polymerase reaction buffer. After the extension, clear 
distinction of three kinds of crosslink is observed, i.e. duplexes of 30 mer template 
strand with 15 mer (ODN 24), 24 mer (ODN 25) and 30 mer counter strand (ODN 
26). Here, the position specificity of the method is proved. 
When ODN 24 is connected to ODN 23, position 5-15, there would be enough room 
to place another probe ODN 26 on 17-30 base position. The situation should be same 
if ODN 26 is placed firstly. However, if ODN 25 occupies the 9-20 base position, 
neither ODN 24 nor ODN 26 could be able to attach to the sample strand. The 
experimental results proved this idea (Figure 5-17). Line 3 and line 5 are of the same 
height, indicating that a single strand is connected with two counter strands of 12 and 
14 bases. No clear difference is shown when ODN 25 is bound to ODN 23 followed 
by addition of ODN 24 or ODN 26. Notably, lines 7 and 8 show a double band 
around the shift position of the sample and one probe strand, which is caused by 
strands replacement. The uppermost band, slower than a 30 mer duplex in the gel shift, 
is presumably due to unspecific reaction or aggregation. 
Once an oligonucleotide with two linkers is synthesized, together with a strand 
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containing two fdC or abasic sites, a self-assembled duplex structure will come out. 
More complicated nano-object can be constructed based on the mixture of covalent 
bond and hydrogen bridge, which makes the structure resistant to denaturing. Further 
investigation should be fascinating although it is not the research purpose here. 
 
Figure 5-16 Study of detection selectivity I. a) synthesized oligonucleotides for this study. Bold and red 
letters represent alkyne modifiers and fdC. Found values indicate the mass results measured by 
MALDI-TOF. *: contain one sodium ion. b) Sequences of the ODN 23-26 and schematic 
representation of primer extension experiment. c) Lego building block shows the primer extension 
experiment. d) Denaturing PAGE assay shows crosslink between ODN 23 and three probes before 
(-KF) and after extension with Klenow Fragment (+KF). Condition: 2 μM crosslink, 200 μM dNTP, 6 
U Klenow Fragment, 1× NEB buffer 2, the final volume of 30 μL, dyed with SYBR Green. 
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Figure 5-17 Study of detection selectivity II. a), b), and c) Logo building block shows the probe 
blocking experiments. The white block represents ODN 23, blue ODN 24, gray ODN 25, and red ODN 
26. d) Denaturing PAGE assay shows crosslink of ODN 23 with double probes: 1) ODN 23 (30 mer), 2) 
duplex 23/24 (30+12 mer), 4) duplex 23/26 (30+14 mer), 6) duplex 23/25 (30+13 mer). Line 3 and 5 
show ODN 23 with two non-overlapping probes 24 and 26 corresponding to a) and b); line 7 and 8 
show ODN 23/25 with two non-overlapping probes 24 and 26, corresponding to c). Double bands of 
line 7 and 8 are due to incomplete reaction of ODN 24 and 26. Condition: 2 μM ODN 23, 24, 25, and 
26, 100 mM NaCl, 10 mM NaOAc buffer pH 6.0, dyed with SYBR Green.
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5.3. fdC profiling in synthetic DNA duplexes  
The fdC-probe method is intended to be implemented later in a workflow coupling to 
LC-MS, PCR, etc. for genomic DNA detection. LC-MS directly detects the 
crosslinked nucleosides whereas PCR amplifies the signal in an exponential way. We 
first explored the MS-based detection possibility. 
 
5.3.1.  LC-MS study with crosslinked duplex  
 
Figure 5-18 Schematic representation of LC-MS workflow of crosslinked duplex. 
In the MS-mode, the 15 mer duplex ODN 13/16e was first digested with nuclease S1, 
antarctic phosphatase, and snake venom phosphodiesterase I using the conventional 
protocol from our group.229 Afterward, the mixture was analyzed with oribitrap 
LC-MS (Figure 5-18a). Indeed, in model studies, the four canonical bases, fdC, U 
with hydroxylamine linker, and also the U crosslinked dinucleoside were observed 
(Figure 5-19). Additionally, we observed 0.5% of fdC-U dinucleoside, 0.2% of fdC, 
and 0.1% of deaminated dC relative to dC. The results confirm that the cross-linked 
oligonucleotides can be fully digested to give the dinucleoside together with others 
Slight deamination is also detected. This problem could be solved by adding 
tetrahydrouridine (THU), a deamination inhibitor known since 1968.341 
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Figure 5-19 Orbitrap LC-MS spectroscopy of digested duplex ODN 13/16e. Condition: 0-20% buffer B 
in 45 min. Buffer A: 2 mM HCOONH4 aq., buffer B: 2 mM HCOONH4 in 80% MeCN. Retention time: 
dA 24.5 min, dC 13.1 min, dG 19.4 min, dT 21.5 min, fdC-U 46.7 min, fdC 21.1 min, U-linker 35.81 
min.   
Next, we used the biotin-avidin interaction to enrich the cross-linked probe strand and 
the target strand. Avidin is a protein derived from both avians and amphibians and 
shows a considerable affinity for biotin, or vitamin H, a co-factor that plays a role in 
multiple eukaryotic biological processes.342 The interaction between biotin and avidin 
is highly specific with an affinity of Ka = 1015 M-1,343 the strongest known 
non-covalent interaction between a protein and a ligand. Avidin and other 
biotin-binding proteins, including streptavidin, can bind up to four biotin molecules, 
making it ideal for both purification and detection strategies. 
ODN 13 containing a fdC was connected to a biotin as ODN 27; ODN 12a containing 
a dC was connected with a biotin as ODN 28 (Table 5-8). Streptavidin magnetic 
particles were added to the solution of duplex ODN 27/16e and 28/16e. Digestion was 
carried out directly on the particles after the enrichment, with THU as additive. The 
mixture was then injected for orbitrap measurement (Figure 5-18b, Figure 5-20). 
5.3 fdC profiling in synthetic DNA duplex 
111 
 
fdC-U dinucleoside and fdC is present in the case of ODN 27/16e, and absent in 
duplex 28/16e, where U with linker can be observed. In both situations, deamination 
of fdC-U crosslinked dinucleoside and fdC are undetectable while deaminated 
cytosine is still present.  
 
Table 5-8 Synthesized oligonucleotides for LC-MS study. Red letters represent to alkyne modifiers and 
cytosine modification. *: contain one sodium ion. 
 
Figure 5-20 Oribtrap LC-MS spectrometry of digested duplex a) ODN 27/16e and b) 28/16e. Condition: 
0-30% buffer B in 45 min. Buffer A: 2 mM HCOONH4 aq., buffer B: 2 mM HCOONH4 in 80% MeCN. 
Retention time: fdC-U 34.0 min, fdC 16.8 min, U-linker 22.40 min, dC 11.2 min, deaminated dC 11.5 
min. 
Here, we confirmed that the crosslinked duplex can be digested into the reacted 
dinucleoside; connected with an aliphatic linker; the dinucleoside cannot be further 
Entry 5' ----------- 3' mer calc. found 
27 GTA ATG fCGC TAG G-Biotin 13 4610.5 4608.0 
28 GTA ATG CGC TAG G-Biotin 13 4582.3 4578.8 
  16e CCU-L-ONH2 AGC GCA TTA C 13 4084.8* 4082.2 
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digested into nucleosides. The orbitrap LC-MS has as expected an insufficient 
detection limit, which is not suitable for the project. Therefore the MS method was 
adpoted for Triple-Quad quantification.  
 
5.3.2.  Synthesis of the standard compounds 
For the triple-quad MS standards, the corresponding dinucleotides and their isotope 
labeled counterparts had to be synthesized as standard compounds. Scheme 5-3 shows 
a typical synthetic route where cytosine is taken as a representative base. 
The synthesis toward the crosslinked cytosine-fdC dinucleoside started from 
commercially available cytidine (48). The 5’-hydroxy group was deprotonated with 
sodium hydride. Intramolecular proton exchange gave a mixture of the deprotonated 2’ 
and 3’ hydroxy group intermediates. Substitution with propargyl bromide gave the 2’- 
and 3’-O-propargyl compound as a mixture, which was separated followed by 
acetylation and crystallization. Pure 2’-O-propargyl precursor 49 was in this way 
obtained. The 1,3-dipolar cycloadditon reaction connected the MMTr protected linker 
47 to 49. After deacetylation and detritylation, 52 was obtained after reverse phase 
HPLC. Connection of 52 and fdC nucleoside with 4-methoxyaniline gave the 
crosslinked dinucleoside 53. Crosslinked uridine-fdC 54 and guanine-fdC 55 
dinucleotides were synthesized similarly (Figure 5-21). 
 
Scheme 5-3 Synthesis of the crosslinked cytidine-uridine dinucleoside 53. a) tetrabutylammonium 
iodide, NaH, propargyl bromide, DMF, 0 °C; b) acetic anhydride, DMF, rt, 33% over 2 steps; c) 47, 
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CuSO4 5H2O, sodium ascorbate, DIPEA, H2O, MeCN, rt, 99%; d) NH3, MeOH, rt; e) HOAc, H2O, 
25 °C, quant.; f) fdC nucleoside, 4-methoxyaniline, MeCN, H2O, 25 °C, quant. 
 
Figure 5-21 Synthesized canonical base-crosslinked fdC dinucleotides. 
In order to obtain the isotope labeled dinucleotides, an aliphatic linker with 15N was 
first synthesized. As depicted in Scheme 5-4, phthalimide 56 was first amidated to 57. 
With 15N labeled hydroxylamine hydrochloride, the nitrogen atom was subsituted with 
its heavy isotope in 58. Isotope-labelled linker 61 was obtained following a procedure 
shown in Scheme 5-1. When sodium azide-1-15N (Scheme 5-3, step d) is used for 
substitution, an aliphatic linker with double isotope labeling can be obtained. 
 
 
Scheme 5-4 Synthesis of isotope labeled linker 61. a) di-tert-butyldicarbonate, DMAP, MeCN, rt, 
quant.; b) hydroxylamine-15N hydrochloride, NaOH, H2O, MeCN, rt, quant.; c) N-hydroxyphthalimide, 
triethylamine, DMF, rt; d) NaN3, DMF, rt, 64% for 2 steps; e) i) N2H4•H2O, DCM, rt, ii) MMTr, 
DIPEA, DCM, rt, 72%. 
 
5.3.3.  Primer extension study with crosslinked duplex  
Towards coupling the fdC probe with PCR, we started with a model duplex to check if 
the crosslinker will block the primer extension reaction. A 31 mer template ODN 29a 
containing a fdC base, or ODN 29b with a cytosine, a 12 mer probe ODN 24, and a 
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14 mer primer ODN 30 with a fluorescein at the 5’ terminus were prepared (Figure 
5-22).  
 
Figure 5-22 Primer extension study with crosslinked template: a) schematic representation of the 
primer extension experiment; b) synthesized and purchased oligonucleotides for this study. Bold and 
red letters represent alkyne modifiers, fC, and fluorescein. Found values indicate the mass results 
measured by MALDI-TOF. *: contain one sodium ion. 
First，the ODN 29a was crosslinked with the probe ODN 24 and used as a template 
for primer extension. An extended primer can be seen from the PAGE (Figure 5-23, 
mixture 2 and 10 min). Because of the incomplete crosslinking of the probe and the 
template, the extended primer may result from the uncrosslinked ODN 29a or the 
ODN 29a-anisidine conjugate. The crosslinked template was then purified using 
RP-HPLC; the pure crosslinked duplex was obtained without anisidine and the 
fdC-template remained. No extended primer could be observed after 10 min at 60°C 
with Taq polymerase (Figure 5-23, purified 2 and 10 min). In contrast, on the template 
containing C (ODN 29b) mixed with fdC-probe, the primer extended to full length 
after 2 min.  
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Figure 5-23 Primer extension study on the model duplex. After PAGE assay, the gel was photographed 
a) directly for 6-FAM or b) after SYBR Green I dyeing. Condition: 1.5 μM crosslinked ODN 24/29a 
before and after purification and 24/29b, 1.0 μM primer 30, 200 μM dNTP, 1× Thermopol buffer, and 5 
U Taq polymerase, the final volume 40 μL, 60°C. 
While these experiments were performed, K. Gates showed Bacteriophage Φ29 DNA 
polymerase was blocked by a counter-strand tied by dG-Ap and dA-Ap crosslinks.131 
They believed that the active site entry tunnel in Φ29 is created by a dynamic flap that 
can open to allow substrate access. If the tunnel is a rigid structure, the interstrand 
crosslinks will have stalled primer extension several nucleotides prior to the cross-link 
lesion, rather than at the last unmodified nucleotide. These explain the reason that the 
fdC probe is blocked at 15 or 16 mer.  
The crosslinking efficiency can never be 100%. However, in the PCR reaction, an 
excessive of probe will be used. The unreacted template, if any, should be negligible. 
Second, we tested if the fdC-anisidine conjugate and the free anisidine will inhibit the 
Taq polymerase. ODN 29a was incubated with catalytic 4-anisidine to form the 
conjugation. As shown in Figure 5-24 line 3, fdC-anisidine alone does not block 
replication, which is in accordance with results from Wang et al.324 and He et al.,271 
who showed that DNA pol I can go through 9-(hydrazinylmethyl)-acridine-fdC and 
(4-aminomethyl)-benzyl-azide-cadC adducts on DNA template. Moreover, with a 
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concentration less than 500 μM, 4-anisidine makes little effect on the polymerase 
(Figure 5-24, line 4-7). 
 
Figure 5-24 Primer extension study with fdC-conjugated and free 4-anisidine. Line 1: ODN 29b as a 
marker. Line 2, 3: ODN 29a-cat. as a template for replication in 10 min. Line 4-7: using ODN 29a as a 
template for extension for 10 min with 0, 5, 50, and 500 μM 4-anisidine. The gel was photographed 
after SYBR Green I dyeing. Condition: 1.5 μM template, 1.0 μM primer 30, 200 μM dNTP, 1× 
Thermopol buffer, and 2.5 U Taq polymerase, the final volume 20 μL, 60°C. 
Third, in the PCR cycle, the genome is heated up to 95°C for 2~10 min to denature 
the genome and activate the polymerase. Linker stability was therefore tested to see if 
the covalent oxime bond will be disrupted under this harsh condition. Purified 
crosslinked ODN 14-29a was dissolved in Thermopol buffer, and incubated at 95°C 
for 20 min. PAGE assay showed no sign of degradation (Figure 5-25). Therefore, it is 
believed that once the probe is crosslinked to the fdC sites in the target strand, the 
oxime bond is irreversible and will not detach in the PCR cycle.  
 
Figure 5-25 Crosslinker stability experiment: a) schematic representation of the crosslink ODN 14-29a; 
b) denaturing PAGE assay shows crosslink along the time. Mark (M) shows crosslink ODN 14-29a and 
29a. Condition: 1.5μM crosslink ODN 14-29a, 1× Thermopol buffer, 95°C 
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5.4. fdC profiling in genomic DNA 
5.4.1. Profiling Strategy: design and validation 
Quantiative detection of fdC in genomic DNA is much more challenging than in the 
synthetic DNA duplex. The task is divided into two steps. Figure 5-26 shows the mind 
map. 
 
Figure 5-26 Mindmap of trial and error towards a probe-assistant loci-specific fdC detection strategy.  
The first step is to react the probe with the gDNA, a “mega-biomolecule”. To our best 
knowledge, only a few examples can be compared to our case: in PCR and 
fluorescence in situ hybridization (FISH), oligonucleotides, primers or probes, are 
hybridized with the gDNA. Padlock probes344 require the probe to first hybridize to 
the target strands. Then the head and the tail are joined with ligase, creating circular 
DNA molecules complementary to the target sequence. 
In theory, counter-strand oligonucleotides that recognize DNA sequences of at least 
16 mer would have no off-target effects in the human genome or other higher 
eukaryotic genomes because the complexity of 16-bp sequences (416 = 4.3×109) is 
greater than the size of the haploid human genome (3.2×109). Therefore, here we 
designed the fdC probes longer than a 20 mer. 
The second step is to distinguish the fdC from the canonical cytosine base with the 
help of the probe. As mentioned in Chapter 5.3, LC-MS detects fdC signal without 
amplification. In a volume of 20 μL solution containing 100 ng gDNA, assuming that 
10% dC at one site has changed to fdC, the fdC concentration would be 250 aM 
(2.5×10-16 mol/L), coresponding to less than 50,000 molecules in total. While the 
Triple-Quadupole-MS method provide in principle that sensitivity, we thought that 
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amplification by PCR would ba prefect strategy.   
Many linear amplification strategies for DNA detection and other biomolecules have 
been developed and are summarized by I. Willner et al. Among these strategies, the 
lowest detection limit is 10 fM of target DNA.345 But still, this detection level is 
higher than what is need in our project. 
At this stage, the fdC signals should be amplified in an exponential way, i.e. PCR. 
Either the fdC-containing strand is amplified, which provides a positive signal, or the 
non-fdC-containing strand is amplified, which given in total negative signal. After 
extensive optimization, a system is designed as depicted in Figure 5-27 a-c with 
sequence details. The synthetic oligonucleotides used in this part are listed in Table 
5-9. 
Table 5-9 Synthesized and purchased oligonucleotides for position 1 detection. Bold and red letters 
represent nucleoside modifications or functional group. G, alkyne modifier with the linker; p, 
phosphate group at 5’ terminus; F, FAM; H, HEX; Q, BHQ-1. MALDI-TOF: 31a, calc. 5505.9, found 
5500.3; 32, calc.7951.5, found 7948.5, contain one sodium ion. 
 
We focused on the 30,020,539th nucleoside of chromosome 16 (position 1) from Mus 
musculus genome (MM9) in the exon 3 of 632428C04Rik, where it is claimed to 
contain 23% of fdC in a previous report using the redBS-Seq method.268 A 25 mer fdC 
probe (ODN 32) was first incubated with the genomic DNA. A ratio of 1.2 ng gDNA 
and 2 pmol probe in a volume of 20 μL ensured complete hybridization; 
p-phenylenediamine was chosen as a catalyst for the benefit of crosslinking yield.  
Description 5' ----------- 3' mer
31 fdC target
TAAAAAACTAGGAGCCAGGGGCCTCAAAACCAGCCCTGCGAT
TTTATfCGGTCATC
55
31a Part I GCGATTTTATfCGGTCATC 18
31b Part II TAAAAAACTAGGAGCCAGGGGCCTCAAAACCAGCCCT 37
31c ligation bridge TAAAATCGCAGGGCTGG 17
32 fdC probe GAGATGACCGATAAAATCGCAGGGC 25
33 reporter strand
pTGGTTTTGAGGCCCCTGGTGTAGCTTGCTGTGGCGCAGGGAC
TCTGTGATGTCTGGAGCGATTCATTCTC
70
34 reporter-probe
ACCGATAAAATCGCAGGGCTGGTTTTGAGGTAGCTTGCTGTGG
CGCAGGGACTCTGTGATGTCTGGAGCGATTCATTCTC
80
35 detection forward primer CCGATAAAATCGCAGGGCTG 20
36 detection reverse primer GAGAATGAATCGCTCCAGAC 20
37 detection TaqMan probe F-ACAGAGTCCCTGCGCCACAGCAAG-Q 24
38 reference forward primer GGCTGGACTCAAGCAACTAA 20
39 reference reverse primer ACACACCTCTGTCCTCAGAT 20
40 reference TaqMan probe H-CGGTTTAGTTTGGAGATGACCGAT-Q 24
ODN
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Subsequently, a 70 mer reporter strand (ODN 33) with a phosphate group at the 
5’-terminus was added together with a Taq Ligase or Ampligase to connect to the fdC 
probe. A part of the reporter strand is complementray to the genome sequence nearby 
the probe while the other part is not hybridizing to the genome and facilitates signal 
amplification including a reverse primer and a TaqMan probe sequence. Apart from 
the TaqMan probes, molecular beacons, scorpions, dual-labeled probes, etc. could be 
used for sequence detection in PCR as well.178 TaqMan is chosen here for design 
simplicity and increased sensitivity. 
 
 
Figure 5-28 Real-time PCR curves and crosslink stability for idea validation: a) real-time PCR of 
detection primer pair with ligated reporter strand as positive control, with or without gDNA as negative 
control, using SYBR Green Supermix; b) rtPCR of detection primer pair with ligated reporter strand as 
positive control, with Taq ligase as experiment entry, without Taq Ligase or gDNA as negative control, 
using TaqMan probe. c) crosslinked duplex 31/32 after ligation cycle (line 4); line 1, ODN 32; line 2, 
template duplex 31/32; line 3, ODN 31. Ligation condition: 95°C for 3 min followed by 10 cycles of 
94°C for 1 min and 60°C for 1 h; 10 U Taq Ligase, 1 pM template duplex 31/32, 265 nM reporter 
strand ODN 33, the final volume of 20 μL. PCR condition: 0.2 pM template duplex 31/32, 0.2 pM 
ligated reporter strand ODN 34, 900 nM each primers ODN 35,36, 80 ng gDNA, 250 nM TaqMan 
probe ODN 37, 5 U Taq polymerase, 200 μM each dNTP, final volume of 20 μL; annealing 
temperature 60°C for SYBR Green, 64°C for TaqMan probes. 
After ligation, unreacted fdC probe, catalyst, salts, etc. were removed using a PCR 
purification Kit from NEB. A forward primer (ODN 35) which binds to the fdC probe 
with 18 nt and left 2 nt overlap on the reporter strand, and a reverse primer (ODN 36) 
which is orthogonal to the genomic DNA and pairs with the reporter strand are used. 
The two primers without or with gDNA showed little amplification on real-time PCR 
(Figure 5-28a, black and blue line), neither with the reporter strand (Figure 5-28b, 
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green line). The 2-nt overlap of the reporter strand is not enough for the forward 
primer to anneal. Only if the reporter strand ligates with the fdC probe, the forward 
primer can hybridize and work together with the reverse primer and the TaqMan 
probe (ODN 36, 37). The primers and TaqMan probes designs are based on 
Primer3Plus,346 Mfold and general rules. 
Ligation conditions were scanned and optimized using a synthetic strand (ODN 31)  
containing one fdC (Figure 5-27d). Different conditions were tried with 1 pM 
crosslinked dsDNA and 265 nM reporter strand. After ligation, rtPCR (Figure 5-28b) 
was conducted to check the product compared with the positive control (ODN 34, 
Figure 5-27c). To reach a complete conversion, denaturing and annealing/ligation 
cycles should be executed. With Taq DNA Ligase or Ampligase, 20 cycles of 94°C 
denaturation for 1 min followed by 60°C reannealing and ligation for 1 h are 
sufficient for completely ligation according to rtPCR results, similar to reported 
protocols.321, 347 Figure 5-28b shows that the experiment entry gave a Ct number 
comparable to the positive control. Besides, the crosslinker is stable enough to endure 
the ligation cycles (Figure 5-31c). 
The ligated reporter strand generates the detection signal while the amplicon on 
gDNA itself provides the reference signal (ODN 38-40, Figure 5-27a). Although the 
probe will block the reverse primer in the first cycle, the forward primer will 
synthesize an uncrosslinked template to accommodate the reverse primer in the 
second cycle. Detection signals and reference signals will be quantified using droplet 
digital PCR (ddPCR). Figure 5-29 shows the workflow of the method. 
Before discussing the signal quantification in gDNA, it is necessary to introduce the 
ddPCR. 
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Figure 5-29 Schematic representation of the probe-based fdC detection workflow. Two strands of the 
duplex are differentiate by red and black lines; black segments represent fdC probe; gray and purple 
segment represent reporter strand; arrows represent primers; segments with end points represent 
TaqMan probes. 
 
5.4.2. Droplet digital PCR: introduction and application 
5.4.2.1. ddPCR outperform rtPCR 
Real-time PCR (rtPCR), is the method that is used for quantification in the PCR 
experiments.178 In real-time PCR, the amplicons are analysed after each cycle. Dyes 
or hydrolysis probe is added into the ordinary PCR mixture. By monitoring 
fluorescence signals during the exponential amplification phase of the reaction, the 
initial quantity of the target can be determined with high precision.  
The threshold cycle (Ct) is the cycle number at which the fluorescent signal of the 
reaction crosses a certain threshold. Amplification occurs in an exponential manner 
with a base of 2 if the amplification efficiency is assumed to be 100%. So a difference 
of 10-fold in copy number results in a Ct value difference of log2 10 = 3.32. However, 
if only 20% of the template contains fdC while 80% contains non-fdC at the same 
position, the copy ratio of detection and reference would be 0.2 to 1. Thus, Ct 
difference will be log2 (1/0.2) = 0.30. In fact, according to S. Balasubramanian,268, the 
maximum probability of a particular fdC site is less than 40% compared to cytosine, 
and the level should be below 0.002% corresponding to cytosine in the whole genome. 
A Ct difference of 0.30, corresponding to 20% fdC at one locus, cannot be resovled in 
rtPCR. Therefore, a novel PCR method is necessary. 
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Droplet digital PCR (ddPCR) came up in 2011.348 Instead of analysing the PCR 
process, ddPCR measures the absolute quantity by counting nucleic acid molecules 
encapsulated in discrete water-in-oil droplet partitions. Figure 5-30 shows the ddPCR 
workflows. First, the reaction mixture is prepared as in rtPCR, either with EvaGreen 
or using TaqMan probe contains FAM, HEX or VIC. Second, uniform droplets are 
generated from the reaction mixture. Each microliter (μL) generates 1000 droplets. 
The target and background DNA samples are distributed randomly into the droplets 
together with the primers, the TaqMan probe, dNTP, and the polymerase. The process 
obeys the Poisson distribution. Third, the droplet is transferred to a PCR plate, and 
PCR cycle is conducted in the same manner as conventional PCR. Last, the PCR plate 
is placed in a droplet reader machine, which analyzes each droplet using a double 
wavelength detector.  
 
Figure 5-30 Schematic representation of the ddPCR workflow. The figure is adapted from reference.348 
More and more research taking advantage of the ddPCR principle came out in the past 
three years. A recent report applied the drop-based microfluides for the isolation and 
sequencing of the viral genome.349 Compared to the previous viral detection and 
sequencing method, droplet-based microfluidics followed by whole-genome 
amplification is a simple and applicable method to unknown viruses. This platform 
enables efficient isolation of single viral species from a mixture of other viruses and 
DNA contaminants, which was not feasible before. 
Compared to rtPCR, ddPCR achieves absolute quantification of the amplicons with 
high accuracy. In this project, ddPCR is applied to develop a probe-based fdC 
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detection method. The ligation condition will be further optimized for the ddPCR 
method. 
 
5.4.2.2. ddPCR: optimization and quantification modeling  
The encapsulation maximum of one target amplicon in one droplet to generate a 
positive or negative signal is the ideal scenario for our situation. If a droplet contains 
more than one detection amplicon, for example, one contains one fdC and one 
cytosine, it will show a positive signal, and the negative cytosine signal vanishes.  
The probability that two or more detection amplicons getting into one droplet can be 
calculated according to the Poisson distribution, i.e. a discrete random variable X 
complies the Poisson distribution with parameter λ > 0, if, for k = 0, 1, 2, …, the 
probability mass function of X is given by: 
	 ; λ Pr 	 X 	
λ
!
						 
where e is Euler's number and k! is the factorial of k.  
 
Table 5-10 Poisson distribution probabilities of genome copies in the droplet. 
input 
λ 
k 
ng 1 2 3 4 5 
3 0.05  4.8% 0.1% 0.0% 0.0% 0.0% 
6 0.10  9.0% 0.5% 0.0% 0.0% 0.0% 
9 0.15  12.9% 1.0% 0.0% 0.0% 0.0% 
10 0.17  14.1% 1.2% 0.1% 0.0% 0.0% 
15 0.25  19.5% 2.4% 0.2% 0.0% 0.0% 
20 0.33  23.9% 4.0% 0.4% 0.0% 0.0% 
30 0.50  30.3% 7.6% 1.3% 0.2% 0.0% 
40 0.67  34.2% 11.4% 2.5% 0.4% 0.1% 
 
For example, the mass of a mouse genome is approximately 3.0 pg (3.0×10-12 g). If 30 
ng for a 20 μL reaction is used, 10,000 genomes will be distributed into 20,000 
droplets. So, λ equals to 10,000 / 20,000 = 0.50. Let X = 1, then f (1; 0.50) = 0.303; let 
X = 2, then f (2; 0.50) = 0.076. This means 30.3% of the droplets, instead 50%, of the 
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droplet, contain a single copy while 7.6% of the droplets contain two copies. 
Extensive distribution probabilities are listed in Table 5-10. If less than 9 ng is settled 
in a 20 μL reaction, the probability to have two copies inside one droplet will be lower 
than 1%. For the ease of calculation, 6 ng gDNA is input in each reaction of 20 μL, 
corresponding to ca. 90 copy/μL. 
 
Figure 5-31 ddPCR output and modelling: a) 2-D plot of droplet fluorescence for illustration; b) 
clusters separation in four quadrants; c) algebraic simplification of counting numbers of the clusters. 
As shown in Figure 5-31, for ease of nomination, Ch1+Ch2+ (yellow) refers to 
droplets with both positive signals; Ch1+Ch2- (blue) refers to droplets with only 
detection (reporter strand) signal; Ch1-Ch2+ (green) refers to droplets with only 
reference (gDNA) signal; Ch1-Ch2- (black) refers to droplets without target locus; 
AD refers to all the droplets accepted; resolution refers to the separation of the 
clusters. 
In principle, Ch1+Ch2+ shows the droplets that containing fdC site in the target locus; 
Ch1+Ch2- indicates false-positive due to unspecific amplification; Ch1-Ch2+ shows 
the droplets contain non-fdC sites. Ideally, the ratio Ch1+Ch2+ to Ch2+ should be 
dependent on the gDNA sample. In reality, however, how the gDNA is treated and 
how the PCR is conducted impacts the resolution and signal to noise ratio. Therefore, 
it is crucial to optimize crosslinking, ligation and PCR conditions to separate the four 
clusters well. 
A series of fdC probe concentrations were tested with the same reporter strand 
concentration using Tdg-/- cells as a positive control and Dnmt TKO cell where there 
should be no fdC as a negative control. The results are judged by the ratio Ch1+Ch2+ 
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to Ch2+. The background noise arose with increasing amount of fdC probe. To get a 
lower noise and good differentiation between the positive and negative control; also 
consider the amount of probe available, a 100 nM concentration was chosen for the 
further experiment. 
From these experiments, it is concluded that ligation will not break the crosslinker 
(Figure 5-28c); Ampligase is superior to Taq Ligase in both specificity, i.e. Ch1+Ch2+ 
/ Ch1+Ch2-, and efficiency, i.e. Ch1+Ch2+ / Ch2+; ligation temperature should 
approach melting temperature of the reporter strand hybridization part; dilution of the 
ligation reaction mixture makes no difference in ligation specificity and efficiency.  
Figure 5-32 1-D plot of droplet fluorescence of detection primer pair (Ch1) and reference primer pair 
(Ch2) at 68-60°C. Well A 68.0°C, B 67.4°C, C 66.4°C, D 64.9°C, E 63.1°C, F 61.6°C, G 60.6°C, H 
60.0°C. PCR was conducted for 35 cycles. 
The lower the PCR annealing temperature was set, the more background noise in Ch1 
but the better resolution in Ch2 (Figure 5-32) was obtained. 64°C was finally chosen 
as annealing temperature. When increasing the numbers of PCR cycles, the higher the 
Ch2 resolution; the faster the PCR ramps, the higher the resolution in Ch1 and Ch2 
(Figure 5-33). 2°C/s and 1 nM reporter strand were chosen for an ideal outcome. Ch1 
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primer amplification promotes Ch2 primer replication in droplet numbers slightly and 
lowers Ch2 resolution (Figure 5-34). For the same sample resulted from the two-step 
reaction from replicates the Ch1+Ch2+ / Ch2+ ratios are stable and reproducible. 
 
Figure 5-33 1-D plot of droplet fluorescence of different temperature ramping with varied reporter 
strand concentration: a) 0.4°C/s; b) 2°C/s. Reporter strand concentration: well A, 2 nM, well C, 1 nM; 
well E, 0.5 nM. PCR was conducted at 64°C for annealing and 35 cycles. 
 
Figure 5-34 Double and single primer pair test: a) raw numbers of ddPCR results; b) 1-D plot of droplet 
fluorescence showing double primer pairs (well A), only detection primer pair ODN 35/36 (well G), 
only reference primer pair ODN 38/39 (well H). 
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Positive and negative controls were preformed on ddPCR. For negative control, a 
probe of position 2 (ODN 41, Chr 15, 8,846,677th, MM9, see Chapter 5.4.3) instead 
of probe ODN 32 was used (Figure 5-35a); no reporter strand ODN 33 (Figure 5-35b) 
or no ligase (Figure 5-35c) was added. None of the three negative controls showed a 
Ch1+Ch2+ cluster, confirming that the correct combination of probe for the right 
position, the reporter strand and the ligase are the prerequisites for the detection. 
When a ligated reporter strand ODN 34 was added to the reaction mixture, which 
served as a positive control, Ch1+Ch2+ and Ch1+Ch2- clusters appeared.  
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Figure 5-35 2-D plot of droplet fluorescence for negative and positive control of position 1: a) probe 
ODN 41 was used; b) no reporter strand ODN 33; c) no ligase; d) positive control. Condition: 80 U Taq 
Ligase, PCR extended at 64°C, 40 cycles. 
 
Figure 5-36 Agarose gel shows gDNA degradation: Line 1, log 2 marker; line 2,3, gDNA (150 ng) after 
crosslinking; line 4,5, gDNA (150 ng) after ligation cycle, 95°C for 3min, then 10 cycles of 94°C for 
1min and 60°C for 1h; liner 6,7, gDNA (150 ng). 
Without considering the dissociation of the ligated products, the unreacted probe, 
which remained in the system, will cause unspecific amplification, i.e. Ch1+Ch2- 
signals. Catalyst, acid buffer, and ligation cycles will cause gDNA degradation 
(Figure 5-36), giving more Ch1+Ch2- false-negative signals. However, Ch1+Ch2- 
and Ch1+Ch2- / Ch1-Ch2- resolution do not play a role in the mathematical 
modelling. 
Assuming that all fdC at the target site is converted to the reporter strand via 
crosslinking and ligation, the yield is 100%. Assume that there are less than 150 
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copies in 1 μL so that the Poisson distribution is exclusive in our model. 
Let a = Ch1+Ch2-, b = Ch1+Ch2+, c = Ch1-Ch2+, (Figure 5-31c) A = Accepted 
droplet for the experiment entry, respectively, a’, b’, c’, and A’ for the control, i.e. TET 
knockout cell line. 
Let η = fdC content of the target site. 
Then,  
η
a b 	 ′
′ /η
 
where a  refers to the degraded gDNA copy containing fdC at the target site 
that does not show in Ch2, a /η refers to all the degraded gDNA copies. 
So,   
η
b ′ b′  
Herein, in this ideal model, without considering the dissociation of the ligated products, 
η is independent of a, a’, and c’, i.e. genome degradation and unspecific ligation do not 
affect fdC percentage. Ch1+Ch2- only be resulted from the dissociation of the ligated 
products. Also, As shown in Figure 5-35 a-c, b’ can be omitted. Simplified η'	
η′
a b
 
is calculated to indicate relative abundance of fdC at the target site. 
To this point, the ddPCR-based profiling method was verified and optimized; a 
mathematical model was established. 
 
5.4.3. fdC profiling: results and discussion 
We next optimized the procedure, the experimental parameters and conditions are 
analysis to achieve the best resolution and lowest background. Finally, Tdg-/-, Tdg+/-, 
and Dnmt triple knockout (Dnmt TKO) ES cells were investigated using the method. 
After extraction from the cells, gDNA was denatured and reannealed with the fdC 
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probe. Crosslinking was catalyzed by p-phenylenediamine. After crosslinking, 
catalyst and excessive probe were removed using the DNA cleanup kit and then 
ligated with the reporter strand. After a second purification, the gDNA was used as 
template in ddPCR and the fdC content was calculated as decribed in Chapter 5.4.3. 
Cluster ratios are summarized in Figure 5-37a; the typical 2-D plot of droplet 
fluorescence for each cell sample are shown in Figure 5-38. 
Different droplets distribution from different cell samples can be observed in Figure 
5-38. Tdg-/- cells contain 28.5% of fdC at the target site, 2-fold higher than Tdg+/- cells 
which gave a value of 15.7%, and 5-fold higher than Dnmt TKO cells (5.2%). The 
global mdC, hmdC, fdC, and cadC levels in the sample were analyzed using the 
known LC-MS method (Chapter 3.2.3.2) as shown in Figure 5-39.  
 
Figure 5-37 Cluster ratios of ddPCR 2-D plot for the position 1: a) Tdg-/-, Tdg+/-, and Dnmt TKO mES 
cells; b) 0, 2, 4, 6 days during priming of wild-type mES cells. 
Next, five samples from 0 to 6 days of mESC priming were tested. It was found that 
the fdC content first increases to peak then decreases a bit along the days during 
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priming from 0 to 6 days to become finally stable (Figure 5-37b). For each cell sample, 
at least two “crosslink-ligation” replicates were conducted. After ligation and cleanup, 
at least four measurements were performed for each sample. The standard error of 
measurements and samples are 0.1~0.8% with a median of 0.36%.  
 
Table 5-11 Synthesized and purchased oligonucleotides for position 2 detection. Bold and red letters 
represent nucleoside modifications or functional group.A, alkyne modifier with the linker; p, phosphate 
group at 5’ terminus; F, FAM; H, HEX; Q, BHQ-1. MALDI-TOF: 41, calc. 7672.5, found 7671.0, 
contains one sodium ion. 
 
Next, the detection method was applied to a record position (8846677th of 
chromosome 15, MM9). The site sits in a non-coding DNA context where it is 
claimed to contain 32% of fdC according to the redBS-Seq method.268 Probes, 
reporter strand, and primers were designed similarly and are listed in Table 5-11. 19.8% 
of fdC in Tdg-/- and 9.2% of fdC in Tdg+/- mES cells were observed. 
In both sites, 1.8~2.2-fold in mean of fdC in Tdg-/- compared to Tdg+/- was obtained. 
Globally, Tdg-/- contains 4.9-fold more fdC than Tdg+/-. The preferred explanation is 
that the content is not identical among different sites. Tdg may work differently at 
different sites. Another is that the detection method cannot reach a quantitative 
accuracy without calibration. 
Description 5' ----------- 3' mer
41 fdC probe CAAGCGAAGCAGGGCAAATGGCGA 24
42 reporter strand
pTCTCGAACCTCTGCCAGCCTAGCTTGCTGTGGCGCAGGGACT
CTGTGATGTCTGGAGCGATTCATTCTC
69
43 detection forward primer AAGCAGGGCAAATGGCGA 19
36 detection reverse primer GAGAATGAATCGCTCCAGAC 20
37 detection TaqMan probe F-ACAGAGTCCCTGCGCCACAGCAAG-Q 24
44 reference forward primer CCAGGGAGCATCTGTGAAAA 20
45 reference reverse primer AAAAGCCCATCTGGGAAACA 20
46 reference TaqMan probe H-CCCCTTCAGACGCAAGCGAAGCAG-Q 24
ODN
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Figure 5-38 2-D plot of droplet fluorescence for the position 1: a) Tdg-/-; b) Tdg+/-; c) Dnmt TKO mES 
cells. Condition: 10 U Ampliagse, PCR extended at 64°C, 35 cycles. 
Absolute quantification can be realized if the method is calibrated with a synthesized 
reference amplicon containing cytosine or fdC at the specific site. The method should 
also be available for mdC and hmdC site-specific detection if they are treated towards 
fdC.214 According to the loci of interest, the method can track the epigenetic changes 
of cellular development, phenotype differentiation, memory consolidation,350 etc. 
Once DNA array and multi-channel droplet counting technology are combined with 
ddPCR, multiple sites detection is insight.351 
Compared to bisulfite variant NGS, the probe-ddPCR-based sequencing method 
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shortens and simplifies the sample preparation time and saves data analysis effort. 
Results can be read directly after droplet counting. Different from redRS-Seq and 
fdCAB-Seq,233, 268 this method only provides information on the specific site, so it is 
not a substitution of BS-derived methods. Different probes, reporter strands, and 
primers have to be designed for different positions.  
 
 
Figure 5-39 Global mdC, hmdC, fdC, and cadC quantification: Tdg-/-, Tdg+/-, and Dnmt TKO mES cells 
and 0, 2, 4, 6 days during priming of wild-type mES cells. LC-MS analysis was performed by 
co-worker Mirko Wagner. *: < LOQ, below the limit of quantification. 
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5.5. Summary: Part II 
Concerning on oligonucleotide functionalization, in this chapter, an oligonucleotide- 
probe was developed and applied for fdC position-specific detection and relative 
quantification. 
The most suitable combination of the linker 32 and modifier position (n+4) was 
selected out of a library of 6 azide linkers and 12 positions. The linker was attached to 
the probe strand using solid-phase synthesis via Cu-catalyzed Huisgen cycloaddition. 
The crosslinking was completed in 24 h with 4-anisidine as the catalyst and 
accelerated to 4 h with the catalyst p-phenylenediamine. Tolerance to a mismatch in 
the duplex depends on the crosslinking temperature. The probe is specific for fdC 
does not react with other epigenetic C-base. Reaction occurs specific at the loci 
targeted by the probe strand. Multiple probes can react with different targets 
simultaneously. 
Crosslinked dinucleoside do not inhibit nuclease and phosphatase. So digestionto 
nucleoside level is possible, but the conjugate itself cannot be digested which given a 
specific dinucleotide. Once the probe reacted with fdC on the target strand, primer 
extension using the target as a template is blocked. The crosslink is stable enough to 
survive denaturing and reannealing cycles. 
With the help of a reporter strand, the probe can react with genomic DNA for relative 
fdC quantification in the genome. Optimal ddPCR parameters and procedure can 
differentiate fdC- and non-fdC-base at specific genome site. In Tdg-/- mouse ES cells, 
a 5-fold increase of fdC at one exon position is observed compared to Dnmt TKO 
cells, and 2-fold compared to Tdg+/- cells. Percentages of fdC at this site follow the 
same trend with global fdC content along priming. 
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6. Experimental part   
6.1. General methods and materials 
 
Organic synthesis 
All experiments involving air and/or moisture-sensitive compounds were performed 
using flame- or oven-dried glassware under nitrogen or argon atmosphere. Chemicals 
were purchased from Sigma-Aldrich, TCI, and Alfa-Aesar. Solvents for organic 
synthesis were of reagent grade and purified by distillation.  
Solutions were concentrated in vacuum a Heidolph rotary evaporator with a Vario 
PC2001 diaphragm pump by Vacuubrand. All mixed solvent systems are reported as 
v/v solutions. All reactions were monitored by thin-layer chromatography (TLC), 
performed on Merck 60 (silica gel F254) plates. Chromatographic purification of 
products was accomplished using flash column chromatography on silica gel (230-400 
mesh) purchased from Merck.  
1H-, 13C-, 15N-, 31P-NMR and further 2D spectra were recorded in deuterated solvents 
on Bruker ARX 300, Varian VXR400S, Varian Inova 400 and Bruker AMX 600 
spectrometers and calibrated to the residual solvent peak. Chemical shifts (δ, ppm) are 
adapted relative to the residual solvent peak as internal standard and coupling constants 
(J) are corrected and adapted to the nearest 0.1 Hz. Multiplicities are abbreviated as 
follows: s = singlet, d = doublet, t = triplet, m = multiplet, br = broad. 
 
Oligonucleotides solid-phase synthesis 
Commerical unavailable oligonucleotide synthesis was performed on an Applied 
Biosystems Incorporated 394 automated synthesizer, otherwise were purchased from 
Metabion. Phosphoramidites and solid supports columns were purchased from Glen 
Research, Link Technology, and ChemGene Corporation. Oligodeoxynucleotides were 
synthesized on 1 μmol scale with standard DNA synthesis cycles (trityl off mode). 
Coupling time for modified nucleosides was extended to 10 min. The oligonucleotide 
was cleaved using 1:1 mixture of ammonium hydroxide aq. (28%) and methylamine aq. 
(40%) at 65 °C for 10 min. The aqueous layer was then collected and removed in a 
SpeedVac concentrator, and the pellet redissolved in ddH2O. Oligonucleotides 
contained mdC, hmdC, fdC, caC and abasic site were synthesized according to the 
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previous report.352 
 
HPLC analysis and purification 
Analytical RP-HPLC was performed using a Macherey-Nagel Nucleodure 100-3 
C18ec column on Waters Alliance 2996 Photodiode Array Detector, 2695 Separation 
Module using a flow of 0.5 mL/min. Semi-preparative RP-HPLC was performed using 
a Macherey-Nagel C18 column (5 mm, 9.4×250 mm) on Waters Breeze 2487 Dual λ 
Array Detector, 1525 Binary HPLC Pump. Conditions: Buffer A, 0.1M TEAA 
(triethylammonium acetate) in water; Buffer B, 0.1M TEAA in 80% acetonitrile, flow 
rate 5 mL/min. HPLC grade acetonitrile was purchased from VWR. 
The purified fractions were concentrated in a SpeedVac concentrator and characterized 
by Matrix Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF) on 
Bruker Daltonics Autoflex II. MALDI matrix was made up of diammonium hydrogen 
citrate (10 mg), 3-hydroxypicolinic acid (50 mg), 15-crone-5 (10 μL) in ddH2O (1 
mL). 
Concentration of oligonucleotide solutions was calculated from the UV absorbance at 
260 nm on a Nanodrop ND-1000 spectrophotometer. Extinction coefficients of the 
oligonucleotides at 260 nm were calculated by addition of the extinction coefficients of 
the individual nucleobases: dA 15.0 L/(mmol⋅cm), dC 7.1 L/(mmol⋅cm), dG 12.0 
L/(mmol⋅cm), dT 8.4 L/(mmol⋅cm), Pz 7.6 L/(mmol⋅cm), Pm 5.7 L/(mmol⋅cm), mdC 
7.8 L/(mmol⋅cm), hmdC 8.7 L/(mmol⋅cm), fdC 11.3 L/(mmol⋅cm), cadC 7.1 
L/(mmol⋅cm), 6-FAM 13.7 L/(mmol⋅cm). The 1,2,3-triazole, abasic monomer, and 
biotin are transparent at 260 nm. 
 
Molecular biology 
Enzymes and specific buffers were purchased from New England BioLab unless 
otherwise stated. H2O for dilution and solution was obtained from Sartorius Stedim 
arium pro system.  
Denaturing urea polyacrylamide gel electrophoresis (PAGE) assay was processed on 
20 cm long or 10 cm long, 0.75 mm thick gel in Bio-Rad Protein II chamber. The gel 
consisted of sequencing gel (8 mL), TBE buffer (10×, 1 mL), urea aq. (8 M, 1 mL), 
ammonium persulfate (APS) aq. (10% w/v, 200 μL), and tetramethylethylenediamine 
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(TEMED, 20 μL). The loading buffer (2×) consisted of TBE (10×, 6 mL), Ficoll (3.60 
g), bromophenol blue (3 mg), Xylene-Cyanol-FF (6 mg), urea (12.6 g) filled with 
ddH2O up to 30 mL. The gel was dyed with SYBR Green I (0.1‰, i.e. 1 μL in 10 mL 
1× TBE buffer) for 10 min, photographed by FUJIFILM LAS-3000 and quantified by 
built-in software Aida Image Analyzer v.450. 
Agarose gel loading buffer (6×) consisted of Ficoll (1.50 g), Xylene-Cyanol-FF (25 
mg) filled with ddH2O up to 10 mL. Agarose gel was made of agarose (500 mg) and 
(2 μL) in TAE buffer (1×, 40 mL, i.e. 1.25%) and run in TAE buffer (0.5×) with 100 V 
for ca. 1 h. The gel was photographed and visualized by E-Box VX5. 
PCR was performed on Bio-Rad T100 Thermal Cycler and Eppendorf Mastercycler 
personal. Real-time PCR was performed on Eppendorf Realplex. iTaq Universal 
SYBR Green Supermix was purchased from Bio-Rad. Cycle threshold numbers (Ct 
values) were calculated by CalQplex method. 
Buffers: 10×TBE: 2-amino-2-hydroxymethyl-propane-1,3-diol (Tris, 108.0 g), boric 
acid (55.0 g), EDTA-Na2 (9.3 g), add H2O to 1 L. 50×TAE: Tris (242.3 g), 
EDTA-2Na2 (37.2 g), adjust with acetic acid until pH = 8.3, and then add H2O to 1 L. 
20×SSC: sodium chroloride (175.3 g), trisodium citrate 2H2O (83.2 g), add HCl 
nutrulized to pH = 7.0, and then add H2O to 1 L.
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6.2. Part I: Synthesis of pyrazole ligandoside and its derivates 
 
1-(4-Bromo-2-methoxyphenyl)-1H-pyrazole (4) 
 
4-Bromo-2-methoxyaniline (3) (5.00 g, 24.7 mmol) was dissolved in 20% HCl (25 mL). 
The solution was stirred and cooled in an ice bath while a solution of sodium nitrite 
(1.79 g, 26.0 mmol) in 4 mL of H2O was added dropwise. The mixture was stirred for 
further 1 h at 0°C. Stannous chloride dihydrate (11.2 g, 49.5 mmol) in 35% HCl (15 mL) 
was then added slowly. The mixture was allowed to warm to room temperature whilst 
stirring for another 2 h before being filtered. The brown residue was washed with 35% 
HCl (20 mL) twice and cold ethanol (20 mL) dried under vacuum to give 
(4-bromo-2-methoxyphenyl)hydrazine as light blue solid (4.12 g, 16.25 mmol, 66% 
yield). The resulted light blue diazonium salt (4.12 g, 16.25 mmol) was dissolved in 
methanol (100 mL) as a dark green solution and was dropwise added to a solution of 
1,1,3,3-tetramethoxypropane (8.15 mL, 49.5 mmol) in methanol (50 mL) and 35% HCl 
(5.0 mL) at room temperature. The reaction was refluxed at 65°C for 12 h and then 
concentrated under vacuum. The residue was dissolved in water (100 mL).The aqueous 
phase was extracted with dichloromethane (3×100 mL). The combined organic layers 
were washed with NaHCO3 (3×100 mL), brine (100 mL), and then dried over MgSO4 
and filtered. The solvent was removed under reduced pressure. The crude was purified 
by flash chromatography on silica gel (isohexane / ethyl acetate 10:1) to give 4 as light 
yellow oil (3.51 g, 13.9 mmol, 85% yield).  
Rf (isohexane / dichloromethane = 1/1) = 0.11. 
1H-NMR (300 MHz, CDCl3): δ = 8.02 (dd, J = 2.5, 0.6 Hz, 1H, C(5)H), 7.74 – 7.67 (m, 
1H, C(3)H), 7.63 (dd, J = 8.3, 0.4 Hz, 1H, CarH), 7.19 (dt, J = 2.8, 1.9 Hz, 2H, CarH), 
6.43 (dd, J = 2.5, 1.8 Hz, 1H, C(2)H), 3.89 (s, 3H, CarOCH3). 
13C-NMR (75 MHz, CDCl3): δ = 151.6 (CarOCH3), 140.3 (C(3)H), 131.4 (C(5)H), 
128.9 (CarN), 126.2 (CarH), 124.2 (CarH), 120.7 (CarBr), 115.8 (CarH), 106.5 (C(2)H), 
56.3 (CarOCH3).  
HRMS (ESI+): calculated for C10H10BrN2O+ [M+H]+: 252.9971, found: 252.9972. 
6. Experimental part   
140 
   
1-(4-Bromo-2-hydroxyphenyl)-1H-pyrazole (5) 
 
1-(4-Bromo-2-methoxyphenyl)-1H-pyrazole (4) (5.08 g, 20.1 mmol) was dissolved in 
anhydrous dichloromethane (100 mL) at -78°C. BBr3 (1 M solution in dichloromethane, 
24.1 mL, 24.1 mmol) was added dropwise in 1 h and then stirred for 12 h. The reaction 
was quenched with methanol and warmed to room temperature. The solution was 
diluted with dichloromethane (300 mL), washed with water (2×300 mL), and then dried 
over MgSO4 and filtered. The solvent was removed under reduced pressure. The crude 
was purified by flash chromatography on silica gel (isohexane / dichloromethane 3:1) 
to give 5 as a white powder (3.25 g, 13.6 mmol, 68% yield).  
Rf (isohexane / dichloromethane = 1/1) = 0.51. 
1H-NMR (300 MHz, CDCl3): δ = 11.58 (br, 1H, OH), 7.97 (d, J = 2.6 Hz, 1H, C(5)H), 
7.73 (d, J = 1.9 Hz, 1H, C(3)H), 7.27 (d, J = 2.2 Hz, 1H, CarH), 7.23 (d, J = 8.6 Hz, 1H, 
CarH), 7.06 (dd, J = 8.6, 2.2 Hz, 1H, CarH), 6.53 (t, J = 2.2 Hz, 1H, C(4)H). 
13C-NMR (75 MHz, CDCl3): δ = 150.2 (CarOH), 139.0 (C(3)H), 126.6 (C(5)H), 124.1 
(CarN), 122.4 (CarH), 122.1 (CarH), 120.1 (CarBr), 118.7 (CarH), 107.1 (C(4)H).  
HRMS (ESI+): calculated for C9H8BrN2O+ [M+H]+: 238.9815, found: 238.9815. 
 
1-[4-Bromo-2-[(triisopropylsilyl)oxy]phenyl]2-1H-pyrazole (6) 
 
1-(4-Bromo-2-hydroxyphenyl)-1H-pyrazole (5) (2.41 g, 10.1 mmol) was dissolved in 
dichloromethane (50 mL) and N,N-diisopropylethylamine (4.18 mL, 25.2 mmol) at 0°C. 
Triisopropylsilyl trifluoromethanesulfonate (4.06 mL, 15.1 mmol) was added dropwise. 
The mixture was allowed to warm to room temperature while stirring for 1 h, diluted 
with dichloromethane (150 mL) and washed with water (2×300 mL), and then dried 
over MgSO4 and filtered. Solvent was removed under reduced pressure. The crude was 
purified by flash chromatography on silica gel (isohexane / ethyl acetate 20:1) to give 6 
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as yellowish oil (4.39 g, 10.0 mmol, 99% yield).  
Rf (isohexane / ethyl acetate = 10/1) = 0.66. 
1H-NMR (300 MHz, CDCl3): δ = 7.91 (dd, J = 2.4, 0.6 Hz, 1H, C(5)H), 7.67 (dd, J = 
1.8, 0.6 Hz, 1H, C(3)H), 7.51 (d, J = 8.6 Hz, 1H, CarH), 7.21 – 7.15 (m, 1H, CarH), 7.13 
(d, J = 1.9 Hz, 1H, CarH), 6.41 (dd, J = 2.4, 1.8 Hz, 1H, C(4)H), 1.30 – 1.11 (m, 3H, 
CH(CH3)2), 1.09 – 0.92 (m, 18H, CH(CH3)2). 
13C-NMR (75 MHz, CDCl3): δ = 149.0 (CarOSi), 140.2 (C(3)H), 131.3 (C(5)H), 131.0 
(CarN), 127.2 (CarH), 124.7 (CarH), 123.2 (CarH), 120.5 (CarBr), 106.3 (C(4)H), 17.7 
(6×CH(CH3)2), 12.85 (3×CH(CH3)2).  
HRMS (ESI+): calculated for C18H28BrN2OSi+ [M+H]+: 395.1154, found: 395.1148. 
 
1-O-Methyl-3,5-di-o-toluoyl-2-deoxy-L-riboside (11) 
O
OTol
TolO
OMe
 
2-Deoxy-D-ribose (9) (13.7 g, 102 mmol), acetyl chloride (0.5 mL) were dissolved in 
anhydrous methanol (300 mL) and stirred at room temperature for 30 min. Then silver 
carbonate (4.50 g, 16.3 mmol) was added, the mixture was filtered, and the alcohol 
solution was concentrated. Anhydrous pyridine (2×3 mL) was added for co- 
evaporation. The residue (10) was dissolved in pyridine (60 mL) in the ice bath and 
stirred for 20 min before 4-methylbenzoyl chloride (26.5 mL, 204 mmol) was dropped 
in. The mixture was then raised to 45°C and further stirred for 2 h. H2O (300 mL) was 
added and extracted with ethyl acetate (3×300 mL). The combined organic layer was 
washed with HCl (2 M, 2×1000 mL) and NaHCO3 aq. (1000 mL) and dried, filtered, 
concentrated and purified by flash column chromatography (isohexane / ethyl acetate 
4:1) to give 11 as a colorless oil (33.9 g, 88.3 mmol, 87% yield, α/β (R/S) mixture). 
Rf (isohexane / ethyl acetate = 2/1) = 0.86. 
1H-NMR (400 MHz, CDCl3): δ = 8.08 – 7.83 (m, 8H, CarH, α/β), 7.39 – 7.08 (m, 8H, 
CarH, α/β), 5.61 – 5.58 (m, 1H, C(1’)H, α), 5.41 (ddd, J = 8.2, 3.7, 2.2 Hz, 1H, C(1’)H, 
β), 5.23 (dd, J = 5.4, 2.2 Hz, 1H, C(4’)H, β), 5.19 (dd, J = 5.3, 1.0 Hz, 1H, C(4’)H, α), 
4.71 – 4.35 (m, 6H, C(3’)H, C(5’)H2, α/β), 3.42 (s, 3H, OCH3, β), 3.36 (s, 3H, OCH3, 
α), 2.59 – 2.17 (m, 16H, C(2’)H2, 2×CarCH3, α/β). 
13C-NMR (100 MHz, CDCl3): δ = 166.5 – 166.1 (COO), 144.0 – 143.7 (CarCH3), 
129.8 – 129.0 (CarH), 127.2 – 126.9 (CarCO), 105.6 (C(1’)), 105.0 (C(1’)), 81.9 (C(4’)), 
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80.9 (C(4’)), 75.4 (C(3’)), 74.6 (C(3’)), 65.1 (C(5’)), 64.3 (C(5’)), 55.2 (C(2’)), 55.1 
(C(1’)OCH3), 39.3 (C(2’)), 21.7 (CarCH3). 
HRMS (ESI+): calculated for C22H24O6Na+ [M+Na]+:407.1471, found: 407.1463.  
 
α-3’,5’-Biostoluoyl-1’-ribosyl chloride (8) 
 
1-O-Methyl-3,5-di-O-toluoyl-2-deoxy-L-riboside (11) (33.9 g, 88.3 mmol) was 
dissolved in acetic acid (60 mL) and H2O (5 mL) on an ice bath. Acetyl chloride (18.7 
mL, 265 mmol) was added to the mixture dropwise. As the system solidified, the flask 
was warmed to room temperature. The mixture was then filtered, and the filter cake 
was washed with anhydrous ether (2×30 mL) to give 8 as a gray solid (19.0 g, 48.8 
mmol, 55% yield). 
Rf (isohexane / ethyl acetate = 2/1) = 0.41. 
1H-NMR (200 MHz, CDCl3): δ = 8.01 – 7.87 (m, 4H, CarH), 7.27 – 7.21 (m, 4H, CarH), 
6.48 – 6.45 (m, 1H, C(1’)H,), 5.73 – 5.32 (m, 1H, C(3’)H), 4.84 (m, 1H, C(4’)H), 4.64 
(m, 2H, C(5’)H), 2.84 (m, 2H, C(2’)H2), 2.41 (s, 6H, CarCH3). 
13C-NMR (75 MHz, CDCl3): δ = 166.4 – 166.0 (COO), 144.6 – 143.2 (CarCH3), 130.2 
– 129.0 (CarH), 127.1 – 126.5 (CarCH3), 110.6 (C(1’)), 84.7 (C(4’)), 73.5 (C(3’)), 63.5 
(C(5’)), 44.5 (C(2’)), 21.7 (CarCH3). 
HRMS (ESI+): calculated for C21H21O5+ [M-Cl]+:353.1394, found: 353.1367.  
 
5-[4-(1H-Pyrazol-1-yl)-3-[(triisopropylsilyl)oxy]phenyl]-2-[[(4-methylbenzoyl)oxy
]methyl]tetrahydrofuran-3-yl 4-methylbenzoate (12) 
 
1-[4-Bromo-2-[(triisopropylsilyl)oxy]phenyl]-1H-pyrazole (6) (3.52 g, 8.04 mmol) 
was dissolved in anhydrous diethyl ether (20 mL) and cooled to -78°C. t-BuLi in 
pentane (1.6 M, 10.1 mL, 16.1 mmol) was added dropwise over 30 min. The reaction 
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was kept at -78°C for another 2 h and then transferred to a precooled (-78°C) 
suspension of copper(I) bromide-disulfide complex (826 mg. 4.20 mmol) in ether (20 
mL). The mixture was slowed warmed to -30°C and stirred for 20 min as all the copper 
dissolved. The resulted clear yellow solution was then cooled down to -78°C and 
transferred to a precooled gray solution of α-3’,5’-biostoluoyl-1’-ribosyl chloride (8) 
(1.04 g, 2.68 mmol) in anhydrous dichloromethane (20 mL). The reaction mixture was 
allowed to warm up to room temperature for 12 h. The reaction was quenched by 
saturated NH4Cl and ammonia aq. (2 M, 1 mL). The aqueous phases were extracted 
three times with ether (3×100 mL). The combined organic phases were washed with 
NH4Cl aq. (2×300 mL), brine (300 mL), then dried over MgSO4 and filtered. Solvent 
was removed under reduced pressure. The crude was purified by flash chromatography 
on silica gel (isohexane / ethyl acetate 10:1) to give 12 as yellowish oil (944 mg, 1.41 
mmol, 53% yield).  
Rf (isohexane / ethyl acetate = 10/1) = 0.18 (β), 0.12 (α). 
1H-NMR (600 MHz, CDCl3): δ = 7.99 (d, J = 8.4 Hz, 2H, CarH), 7.92 (d, J = 2.4 Hz, 1H, 
C(5)H), 7.91 (d, J = 8.6 Hz, 2H, CarH), 7.67 (dd, J = 1.8, 0.5 Hz, 1H, C(3)H), 7.59 (d, J 
= 8.4 Hz, 1H, CarH), 7.31 – 7.27 (m, 2H, CarH), 7.22 – 7.19 (m, 2H, CarH), 7.09 (d, J = 
1.7 Hz, 1H, CarH), 7.05 – 7.01 (m, 1H, CarH), 6.41 – 6.37 (m, 1H, C(4)H), 5.61 (dd, J = 
6.0, 0.8 Hz, 1H, C(3’)H), 5.25 (dd, J = 10.9, 5.0 Hz, 1H, C(1’)H), 4.60 (dd, J = 4.2, 2.7 
Hz, 2H, C(5’)H2), 4.57 (dd, J = 4.2, 1.9 Hz, 1H, C(4’)H), 2.58 (dd, J = 13.7, 5.1 Hz, 1H, 
C(2’)HH), 2.43 (s, 3H, OCH3), 2.41 (s, 3H, OCH3), 2.20 (ddd, J = 13.8, 11.0, 6.0 Hz, 
1H, C(2’)HH), 1.18 – 1.10 (m, 3H, CH(CH3)2), 1.00 – 0.91 (m, 18H, CH(CH3)2). 
13C-NMR (151 MHz, CDCl3): δ = 166.3 (COO), 166.1 (COO), 148.3 (CarOSi) , 144.2 
(CarC(1’)), 143.8 (CarCH3), 141.0 (CarCH3), 139.9 (C(3)H), 131.4 (C(5)H), 131.0 (Car), 
129.7 (4×CarH), 129.2 (4×CarH), 129.0 (2×CarCO), 127.0 (CarH), 126.0 (CarH), 118.7 
(CarH), 117.1 (CarH), 105.9 (Car(4)H), 82.9 (C(4’)), 80.0 (C(1’)), 77.1 (C(3’)), 65.0 
(C(5’)), 41.7 (C(2’)), 21.7 (CarCH3), 21.6 (CarCH3), 17.7 (6×CH(CH3)2), 12.9 
(3×CH(CH3)2). 
HRMS (ESI+): calculated for C39H49N2O6Si+ [M+H]+: 669.3360, found: 669.3339. 
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5-[4-(1H-Pyrazol-1-yl)-3-[(triisopropylsilyl)oxy]phenyl]-2-(hydroxymethyl)tetra-
hydrofuran-3-ol (13) 
 
5-[4-(1H-Pyrazol-1-yl)-3-[(triisopropylsilyl)oxy]phenyl]-2-[[(4-methylbenzoyl)oxy]m
ethyl]tetrahydrofuran-3-yl 4-methylbenzoate (12) (1.68 g, 2.52 mmol), and potassium 
carbonate (764 mg, 5.53 mmol) were dissolved in methanol (20 mL), stirred at room 
temperature for 1 h, then diluted with water (100 mL). The aqueous phases were 
extracted three times with chloroform (3×100 mL). The combined organic phases were 
dried over MgSO4 and filtered. Solvent was removed under reduced pressure. The 
crude was purified by flash chromatography on silica gel (chloroform / methanol 20:1) 
to give 13 as colorless oil (712 mg, 1.65 mmol, 65% yield).  
Rf (chloroform / methanol = 10/1) = 0.32. 
1H-NMR (400 MHz, MeOH-d4): δ = 7.96 – 7.87 (m, 1H, C(5)H), 7.67 (dd, J = 1.9, 0.6 
Hz, 1H, C(3)H), 7.43 (d, J = 8.1 Hz, 1H, CarH), 7.15 (d, J = 1.8 Hz, 1H, CarH), 7.08 
(ddd, J = 8.1, 1.8, 0.5 Hz, 1H, CarH), 6.48 (dd, J = 2.4, 2.0 Hz, 1H, C(4)H), 5.14 (dd, J 
= 10.5, 5.5 Hz, 1H, C(1’)H), 4.34 (dt, J = 3.9, 1.7 Hz, 1H, C(3’)H), 4.03 – 3.95 (m, 1H, 
C(4’)H), 3.69 (dd, J = 11.4, 5.1 Hz, 1H, C(5’)HH), 3.60 (ddd, J = 9.2, 6.4, 3.9 Hz, 1H, 
C(5’)HH), 2.24 (ddd, J = 13.1, 5.5, 1.7 Hz, 1H, C(2’)HH), 1.96 – 1.84 (m, 1H, 
C(2’)HH), 1.28 – 1.12 (m, 3H, 3×CH(CH3)2), 1.01 (dt, J = 7.8, 3.9 Hz, 18H, 
6×CH(CH3)2). 
13C-NMR (100 MHz, MeOH-d4): δ = 150.5 (CarOSi), 145.2 (CarC(1’)), 141.0 (C(3)H), 
133.4 (C(5)H), 131.7 (Car), 127.5 (CarH), 120.2 (CarH), 118.5 (CarH), 107.2 (C(4)H), 
89.2 (C(4’)), 80.7 (C(1’)), 74.5 (C(3’)), 64.2 (C(5’)), 45.0 (C(2’)), 18.3 (6×CH(CH3)2), 
14.1 (3×CH(CH3)2). 
HRMS (ESI+): calculated for C23H37N2O4Si+ [M+H]+: 433.2523, found: 433.2513. 
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5-[4-(1H-Pyrazol-1-yl)-3-[(triisopropylsilyl)oxy]phenyl]-2-[[bis(4-methoxyphenyl)
(phenyl)methoxy]methyl]tetrahydrofuran-3-ol (14) 
 
5-[4-(1H-Pyrazol-1-yl)-3-[(triisopropylsilyl)oxy]phenyl]-2-(hydroxymethyl)tetra- 
hydrofuran-3-ol (13) (712 mg, 1.65 mmol) and 4,4’-dimethoxytrityl chloride (613 mg, 
1.81 mmol) were dissolved in anhydrous dichloromethane (30 mL) and stirred at 0°C. 
Then N, N-diisopropylethylamine (683 μL, 4.11 mmol) was added dropwise. The 
reaction was allowed to reach room temperature for 1 h and diluted with 
dichloromethane (200 mL). The organic phase was washed two times with sat aqueous 
NaHCO3 (2×200 mL), then dried over MgSO4 and filtered. The solvent was removed 
under reduced pressure. The crude was purified by flash chromatography on silica gel 
(isohexane / ethyl acetate 2:1 +3% triethylamine) to give 7 as a yellowish foam (893 
mg, 1.22 mmol, 74% yield). 
Rf (isohexane / ethyl acetate = 2/1) = 0.38. 
1H-NMR (400 MHz, CDCl3): δ = 7.91 (dd, J = 2.4, 0.7 Hz, 1H, C(5)H), 7.66 (dd, J = 
1.8, 0.6 Hz, 1H, C(3)H), 7.55 (d, J = 8.2 Hz, 1H, CarH), 7.48 – 7.41 (m, 2H, CarH, 
DMTr), 7.38 – 7.15 (m, 7H, CarH, DMTr), 7.09 – 6.98 (m, 1H, CarH), 6.91 (d, J = 1.8 
Hz, 1H, CarH), 6.87 – 6.78 (m, 4H, CarH, DMTr), 6.39 (dd, J = 2.4, 1.8 Hz, 1H, C(4)H), 
5.12 (dd, J = 10.1, 5.6 Hz, 1H, C(1’)H), 4.40 (dd, J = 5.4, 2.8 Hz, 1H, C(3’)H), 4.06 
(ddd, J = 7.1, 4.6, 2.6 Hz, 1H, C(4’)H), 3.79 (d, J = 2.4 Hz, 6H, CarOCH3, DMTr), 3.42 
(dd, J = 9.6, 4.7 Hz, 1H, C(5’)HH), 3.19 (dd, J = 9.6, 6.7 Hz, 1H, C(5’)HH), 2.28 – 
2.15 (m, 1H, C(2’)HH), 1.92 (ddd, J = 13.1, 10.1, 6.0 Hz, 2H, C(2’)HH), 1.20 – 1.07 
(m, 3H, 3×CH(CH3)2), 1.01 – 0.83 (m, 18H, 6×CH(CH3)2). 
13C-NMR (100 MHz, CDCl3): δ = 158.5 (2×CarOCH3, DMTr), 148.1 (CarOSi), 144.7 
(Car, DMTr), 142.1 (CarC(1’)), 139.8 (C(5)H), 135.9 (2×Car, , DMTr), 131.4 (C(3)H), 
130.8 (CarN), 130.0 (2×Car, DMTr), 128.1 (2×Car, DMTr), 127.8 (4×Car, DMTr), 126.8 
(CarH, DMTr), 126.0 (CarH), 118.7 (CarH), 117.5 (CarH), 113.1 (4×CarH, DMTr), 105.8 
(C(2)H), 86.3 (C(4’)), 86.2 (OCCar, DMTr), 79.2 (C(1’)), 74.7 (C(3’)), 64.4 (C(5’)), 
55.2 (2×CarOCH3, DMTr), 43.5 (C(2’)), 17.7 (6×CH(CH3)2), 12.8 (3×CH(CH3)2).  
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HRMS (ESI+): calculated for C44H55N2O6Si+ [M+H]+: 735.3829, found: 735.3820. 
 
5-[4-(1H-Pyrazol-1-yl)-3-[(triisopropylsilyl)oxy]phenyl]-2-[[bis(4-methoxyphenyl)
(phenyl)methoxy]methyl]tetrahydrofuran-3-yl-2-cyanoethyl)diisopropyl- 
phosphoramidite (15) 
 
In a Schlenck tube, the DMTr-protected nucleoside 14 (237 mg, 322 μmol) and 
diisopropyl ammonium tetrazolide (221 mg, 1.29 mmol) were dissolved in rigorously 
degassed dichloromethane (3 mL). The solution was then degassed three more times. 
Bis(diisopropylamino)(2-cyanoethoxy)phosphine (205 μL, 645 μmol) was added to the 
solution. The reaction mixture was stirred at room temperature for 40 min under argon 
atmosphere, then directly purified by flash chromatography on silica gel (isohexane / 
ethyl acetate 2:1 +3% triethylamine) to give 15 as a yellowish foam (301 mg, 322 μmol, 
quant.).  
Rf (isohexane / ethyl acetate = 2/1) = 0.71. 
31P-NMR (81 MHz, CDCl3): δ = 149.25, 149.07.  
HRMS (ESI+): calculated for C53H72N4O7PSi+ [M+H]+: 935.4908, found: 935.4902. 
 
5-[3-Hydroxy-4-(1H-pyrazol-1-yl)phenyl]-2-(hydroxymethyl)tetrahydrofuran-3-o
l (16) 
 
5-[4-(1H-Pyrazol-1-yl)-3-[(triisopropylsilyl)oxy]phenyl]-2-[[(4-methylbenzoyl)oxy]m
ethyl]tetrahydrofuran-3-yl 4-methylbenzoate (3) (393 mg, 588 μmol) and potassium 
carbonate (233 mg, 1.69 mmol) were dissolved in methyl alcohol (10 mL). A solution 
of tetra-n-butyl ammonium fluoride in THF (1 M, 0.60 mL) was added to the mixture 
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and then stirred at room temperature for 2 h. Solvents were removed under reduced 
pressure. The residue was purified by flash chromatography on silica gel (chloroform / 
methanol 20:1) to give 16 as a white amorphous solid (141 mg, 511 μmol, 87% yield). 
Further crystallization was achieved in an ethyl acetate solution of 16. 
Rf (chloroform / methanol = 10/1) = 0.23. 
1H-NMR (400 MHz, MeOH-d4): δ = 8.24 (dd, J = 2.5, 0.6 Hz, 1H, C(5)H), 7.72 (dd, J 
= 1.9, 0.5 Hz, 1H, C(3)H), 7.52 (d, J = 8.3 Hz, 1H, CarH), 7.11 – 7.03 (m, 1H, CarH), 
6.97 (ddd, J = 8.3, 1.9, 0.5 Hz, 1H, CarH), 6.51 (dd, J = 2.5, 2.0 Hz, 1H, C(4)H), 5.10 
(dd, J = 10.4, 5.4 Hz, 1H, C(1’)H), 4.32 (dt, J = 4.1, 1.9 Hz, 1H, C(3’)H), 3.96 (dt, J = 
5.2, 2.4 Hz, 1H, C(4)H), 3.79 – 3.59 (m, 2H, C(5’)H), 2.21 (ddd, J = 13.1, 5.5, 1.7 Hz, 
1H, C(2’)HH), 1.95 (ddd, J = 13.1, 10.4, 5.9 Hz, 1H, C(2’)HH). 
13C-NMR (100 MHz, MeOH-d4)：δ = 150.5 (CarOH), 143.6 (CarC(1’)), 140.3 (C(3)H), 
130.7 (C(5)H), 126.8 (CarN), 122.4 (CarH), 118.4 (CarH), 116.2 (CarH), 107.4 (CarH), 
89.2 (C(4’)), 80.9 (C(1’)), 74.4 (C(3’)), 64.1 (C(5’)), 44.8 (C(2’)). 
HRMS (ESI+): calculated for C14H17N2O4+ [M+H]+: 277.1183, found: 277.1186.  
UV λmax  = 285 nm, 246 nm. 
 
5-[3-Hydroxy-4-(1H-pyrazol-1-yl)phenyl]-2-[[(4-methylbenzoyl)oxy]methyl]tetra
hydrofuran-3-yl 4-methylbenzoate (17) 
 
5-[4-(1H-Pyrazol-1-yl)-3-[(triisopropylsilyl)oxy]phenyl]-2-[[(4-methylbenzoyl)oxy]-
methyl]tetrahydrofuran-3-yl 4-methylbenzoate (12) (1.19 g, 1.78 mmol) was dissolved 
in THF (10 mL) and tetrabutylammonium fluoride solution (1.0 M in THF, 2 mL) was 
added dropwise at room temperature. The mixture was stirred for 30 min and then 
diluted with dichloromethane (200 mL). The organic phase was washed three times 
with water (3×200 mL), then dried over MgSO4 and filtered. Solvent was removed 
under reduced pressure. The crude was purified by flash chromatography on silica gel 
(isohexane / ethyl acetate 4:1) to give 17 as white foam (760 mg, 1.48 mmol, 83% 
yield).  
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Rf (isohexane / ethyl acetate = 2/1) = 0.61. 
1H-NMR (600 MHz, CDCl3): δ = 7.99 (m, 3H, 2×CarH, C(3)H), 7.92 (m, 2H, CarH), 
7.72 (dd, J = 1.8, 0.5 Hz, 1H, C(5)H), 7.31 (d, J = 8.4 Hz, 1H, CarH), 7.29 – 7.27 (m, 2H, 
CarH), 7.22 – 7.21 (m, 2H, CarH), 7.14 (d, J = 1.7 Hz, 1H, CarH), 6.98-6.97 (m, 1H, 
CarH), 6.50 (dd, 1H, C(4)H), 5.60 (m, 1H, C(3’)H), 5.23 (dd, J = 10.9, 5.0 Hz, 1H, 
C(1’)H), 4.64 (dd, J = 4.2, 2.7 Hz, 2H, C(5’)H2), 4.54 (dd, J = 4.2, 1.9 Hz, 1H, C(4’)H), 
2.55 (dd, J = 13.8, 5.2, 0.9 Hz, 1H, C(2’)HH), 2.43 (s, 3H, OCH3), 2.41 (s, 3H, OCH3), 
2.24 (ddd, J = 13.8, 11.0, 6.0 Hz, 1H, C(2’)HH). 
13C-NMR (151 MHz, CDCl3): δ = 166.4 (COO), 166.1 (COO), 149.3 (CarOH), 144.1 
(CarCH3), 143.8 (CarCH3), 140.6 (CarC(1’)), 138.8 (C(5)H), 129.7 (4×CarH), 129.2 
(4×CarH), 127.0 (2×CarCO), 126.6 (C(3)H), 124.3 (CarN), 118.0 (CarH), 116.7 (CarH), 
116.4 (CarH), 106.8 (C(4)H), 83.0 (C(4’)), 80.1 (C(1’)), 77.1 (C(3’)), 64.7 (C(5’)), 41.5 
(C(2’)), 21.7 (CarCH3), 21.6 (CarCH3).  
HRMS (ESI+): calculated for C30H29N2O6+ [M+H]+: 513.2026, found: 513.2028. 
 
5-[3-Methoxy-4-(1H-pyrazol-1-yl)phenyl]-2-[[(4-methylbenzoyl)oxy]methyl]tetra
hydrofuran-3-yl 4-methylbenzoate (18) 
 
5-[3-Hydroxy-4-(1H-pyrazol-1-yl)phenyl]-2-[[(4-methylbenzoyl)oxy]methyl]tetra- 
hydrofuran-3-yl-4-methylbenzoate (17) (741 mg, 1.45 mmol) was dissolved in 
anhydrous DMF (10 mL) at 0°C and sodium hydride (60 % dispersion in mineral oil, 
116 mg, 2.89 mmol) was added slowly. The mixture was stirred for 30 min before the 
addition of CH3I (108 μL, 1.74 mmol). The system was allowed to reach room 
temperature gradually for further 2 h and then diluted with dichloromethane (150 mL). 
The organic phase was washed with brine (150 mL) and water (2×100 mL), and then 
dried over MgSO4 and filtered. The solvent was removed under reduced pressure. The 
crude was purified by flash chromatography on silica gel (isohexane / ethyl acetate 5:1) 
to give 18 as a colorless oil (582 mg, 1.10 mmol, 76% yield). 
Rf (isohexane / ethyl acetate = 2/1) = 0.85. 
1H-NMR (600 MHz, CDCl3): δ = 7.99 (m, 2H, CarH), 7.92 (m, 2H, CarH), 7.70 (dd, J = 
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1.8, 0.5 Hz, 1H, C(5)H), 7.66 (s, 1H, C(3)H), 7.65 (s, 1H, C(5)H), 7.29 – 7.27 (m, 3H, 
CarH), 7.22 – 7.21 (m, 2H, CarH), 7.11 (d, J = 1.7 Hz, 1H, CarH), 7.02 (m, 1H, CarH), 
6.41 (dd, J = 2.4, 1.9 Hz, 1H, C(4)H), 5.65 (m, 1H, C(3’)H), 5.28 (m, 1H, C(1’)H), 
4.79 (dd, J = 11.8, 3.5 Hz, 1H, C(5’)HH), 4.63 (dd, J = 11.8, 3.7 Hz, 1H, C(5’)HH), 
4.16 (dt, J = 3.6, 1.9 Hz, 1H, C(4’)H), 3.70 (s, 3H, CarOCH3), 2.59 (dd, J = 13.8, 5.1 Hz, 
1H, C(2’)HH), 2.44 (s, 3H, CarCH3), 2.39 (s, 3H, CarCH3), 2.24 (ddd, J = 13.8, 11.0, 
6.0 Hz, 1H, CarCH3). 
13C-NMR (151 MHz, CDCl3): δ = 166.3 (COO), 166.2 (COO), 151.4 (CarOCH3), 144.2 
(CarCH3), 144.0 (CarCH3), 141.0 (CarC(1’)), 139.9 (C(5)H), 131.5 (C(3)H), 129.7 
(2×CarH), 129.6 (2×CarH), 129.2 (4×CarH), 128.9 (CarN), 127.0 (2×CarCO), 125.1 
(CarH), 118.5 (CarH), 109.3 (CarH), 106.1 (C(4)H), 83.3 (C(4’)), 80.4 (C(1’)), 77.3 
(C(3’)), 64.6 (C(5’)), 55.7 (CarOCH3), 42.1 (C(2’)), 21.7 (2×CarCH3). 
HRMS (ESI+): calculated for C31H31N2O6+ [M+H]+: 527.2182, found: 527.2185. 
 
2-(Hydroxymethyl)-5-[3-methoxy-4-(1H-pyrazol-1-yl)phenyl]tetrahydrofuran-3-
ol (19) 
 
5-[3-Methoxy-4-(1H-pyrazol-1-yl)phenyl]-2-[[(4-methylbenzoyl)oxy]methyl]tetra- 
hydrofuran-3-yl- 4-methylbenzoate (18) (570 mg, 1.08 mmol) and potassium carbonate 
(329 mg, 2.38 mmol) were dissolved in menthol (5 mL). The mixture was stirred at 
room temperature for 2 h then diluted with water (50 mL). The aqueous phase was 
extracted with chloroform (4×50 mL). The combined organic layer was dried over 
MgSO4 and filtered. Solvent was removed under reduced pressure. The crude was 
purified by flash chromatography on silica gel (chloroform / methanol 20:1) to give 19 
as white foam (283 mg, 975 μmol, 90% yield).  
Rf (chloroform / methanol = 10/1) = 0.30. 
1H-NMR (600 MHz, MeOH-d4): δ = 8.01 (dd, J = 2.5, 0.6 Hz, 1H, C(3)H), 7.67 (dd, J 
= 1.9, 0.5 Hz, 1H, C(5)H), 7.50 (d, J = 8.1 Hz, 1H, CarH), 7.29 (d, J = 1.6 Hz, 1H, CarH), 
7.09 (ddd, J = 8.2, 1.7, 0.6 Hz, 1H, CarH), 6.46 (dd, J = 2.4, 2.0 Hz, 1H, C(4)H), 5.19 
(dd, J = 10.3, 5.6 Hz, 1H, C(1’)H), 4.34 (dt, J = 5.9, 2.1 Hz, 1H, C(3’)H), 3.98 (td, J = 
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4.9, 2.6 Hz, 1H, C(4’)H), 3.89 (s, 3H, CarOCH3), 3.71 (d, J = 4.9 Hz, 2H, C(5’)H2), 
2.26 (ddd, J = 13.1, 5.6, 1.8 Hz, 1H, C(2’)HH), 2.07 – 1.94 (m, 1H, C(2’)HH). 
13C NMR (151 MHz, MeOH-d4): δ = 153.4 (CarOCH3), 145.0 (CarC(1’)), 140.9 
(C(5)H), 133.4 (C(3)H), 129.7 (CarN), 126.4 (CarH), 119.4 (CarH), 111.3 (CarH), 107.2 
(C(4)H), 89.3 (C(4’)), 81.1 (C(1’)), 74.3 (C(3’)), 64.0 (C(5’)), 56.5 (CarOCH3), 45.1 
(C(2’)).  
HRMS (ESI+): calculated for C15H19N2O4+ [M+H]+: 291.1339, found: 291.1345. 
UV λmax = 284.5, 248.7 nm. 
 
2-[(Bis(4-methoxyphenyl)(phenyl)methoxy]methyl]-5-[3-methoxy-4-(1H-pyrazol-
1-yl)phenyl]tetrahydrofuran-3-ol (20) 
 
2-(Hydroxymethyl)-5-[3-methoxy-4-(1H-pyrazol-1-yl)phenyl]tetrahydrofuran-3-ol 
(19) (265 mg, 913 μmol) and 4,4’-dimethoxytrityl chloride (340 mg, 1.00 mmol) were 
dissolved in anhydrous dichloromethane (10 mL) and stirred at 0°C. Then N, 
N-diisopropylethylamine (378 μL, 2.28 mmol) was added dropwise. The reaction was 
allowed to reach room temperature for 3 h and then diluted with dichloromethane (150 
mL). The organic phase was washed twice with saturated NaHCO3 (2×150 mL), and 
then dried over MgSO4 and filtered. The solvent was removed under reduced pressure. 
The crude was purified by flash chromatography on silica gel (isohexane / ethyl acetate 
2:1 +3% triethylamine) to give 20 as a white foam (408 mg, 688 μmol, 75% yield). 
Rf (isohexane / ethyl acetate = 2/1) = 0.32. 
1H-NMR (600 MHz, CDCl3): δ = 8.00 (dd, J = 2.4, 0.6 Hz, 1H, C(3)H), 7.69 (dd, J = 
1.8, 0.5 Hz, 1H, C(3)H), 7.66 (d, J = 8.1 Hz, 1H, CarH), 7.49 – 7.43 (m, 2H, CarH, 
DMTr), 7.39 – 7.31 (m, 3H, CarH, DMTr), 7.30 – 7.25 (m, 3H, CarH, DMTr), 7.21 (dt, 
J = 9.2, 4.3 Hz, 1H, CarH), 7.15 (d, J = 1.6 Hz, 1H, CarH), 7.06 – 6.99 (m, 1H, CarH), 
6.86 – 6.76 (m, 4H, DMTr), 6.41 (dd, J = 2.4, 1.9 Hz, 1H, C(4)H), 5.20 (dd, J = 10.2, 
5.5 Hz, 1H, C(1’)H), 4.67 – 4.36 (m, 1H, C(3’)H), 4.11 – 4.06 (m, 1H, C(4’)H), 3.78 (s, 
6H, CarOCH3, DMTr), 3.68 (s, 3H, CarOCH3), 3.36 (ddd, J = 13.8, 9.9, 4.5 Hz, 2H, 
C(5’)H2), 2.30 – 2.24 (m, 1H, C(2’)HH), 2.11 (ddd, J = 13.1, 10.2, 6.0 Hz, 1H, 
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C(2’)HH). 
13C-NMR (151 MHz, CDCl3): δ = 158.5 (2×CarOCH3, DMTr), 151.4 (CarOCH3), 144.8 
(OCCar, DMTr), 142.2 (CarC(1’)), 140.0 (C(5)H), 136.0 (2×OCCar, DMTr), 131.4 
(C(3)H), 130.1 (4×CarH, DMTr), 128.9 (CarN), 128.2 (2×CarH, DMTr), 127.8 (2×CarH, 
DMTr), 126.8 (CarH, DMTr), 125.0 (CarH), 118.7 (CarH), 113.1 (4×CarH, DMTr), 
109.7 (CarH), 106.1 (C(2)H), 86.5 (C(4’)), 86.2 (OCCar, DMTr), 79.8 (C(1’)), 74.6 
(C(3’)), 64.2 (C(5’)), 55.8 (CarOCH3), 55.2 (2×CarOCH3, DMTr), 44.3 (C(2’)). 
HRMS (ESI+): calculated for C36H37N2O6+ [M+H]+: 593.2652, found: 593.2653. 
 
2-[[Bis(4-methoxyphenyl)(phenyl)methoxy]methyl]-5-[3-methoxy-4-(1H-pyrazol-
1-yl)phenyl]tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite (21) 
 
In a Schlenck tube, the DMTr-protected nucleoside 20 (93 mg, 157 μmol) and 
diisopropylammonium tetrazolide (107 mg, 628 μmol) were dissolved in rigorously 
degassed dichloromethane (3 mL). The solution was then degassed three more times. 
Bis(diisopropylamino)(2-cyanoethoxy)phosphine (100 μL, 314 μmol) was added to the 
solution. The reaction mixture was stirred at room temperature for 20 min under argon 
atmosphere, then directly purified by flash chromatography on silica gel (isohexane / 
ethyl acetate 2:1 +3% triethylamine) to give 21 as a white foam (123 mg, 157 μmol, 
quant.). 
Rf (isohexane / ethyl acetate = 2/1) = 0.65. 
31P-NMR (81 MHz, CDCl3): δ = 149.01, 148.87. 
HRMS (ESI+): calculated for C45H53N4O7P+ [M+H]+:793.3730, found: 793.3731. 
 
 
(3-Hydroxy-5-(3-hydroxy-4-(1H-pyrazol-1-yl)phenyl)tetrahydrofuran-2-yl)methy
l tetrahydrogen triphosphate (dPzTP, 22) 
To a stirring solution of bis-tetrabutylammonium pyrophosphate (239 mg, 362 µmol) 
in anhydrous DMF (0.25 mL) under argon, anhydrous tributylamine (0.3 mL, 
1.26 mmol) was added. This solution was transferred to a flask containing a solution of 
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2-chloro-1,3,2-benzodioxaphosphorin-4-one (73 mg, 362 µmol) in anhydrous DMF 
(0.25 mL) and stirred for 30 min at room temperature. Then, this mixture was added to 
the anhydrous DMF solution of 16 (50 mg, 181 µmol) and stirred for 1 h. When TLC 
(dichloromethane / methanol = 5/1) indicated complete conversion of the nucleoside, 
the mixture was oxidized with an iodine solution (3% I2 in pyridine / H2O 9:1) until a 
brown permanent color was observed (about 1.6 mL) and stirred for 15 min. Water 
(2 mL) was added and stirring continued for 1.5 h. The resulting solution was 
transferred to a 50 mL centrifuge tube, and NaCl (3 M, 0.5 mL) was added followed by 
ethanol (95%, 15 mL) and then vortexed. After 1 h stand still at -80 °C, the precipitate 
was collected by centrifugation (20 min, 3200 xg) and the resulting pellet was purified 
twice by preparative RP-HPLC (0-30% Buffer B in 45 min). This afforded the dPzTP 
22 (11% yield according to concentration calculated from UV absorbance) as a slight 
yellow tris- to tetrakis-triethylammonium salt after freeze-drying.  
31P-NMR (162 MHz, D2O): δ  = -11.3 (m, 2P, -, -P), -23.6 (t, 1P, J = 19.3 Hz, -P).  
HRMS (ESI-): calculated for C14H18N2O13P3－ [M-H]－: 515.0027; found: 515.0017.  
 
3-Phenyl-1-(2-pyridyl)prop-2-en-1-one (24) 
 
To a stirred aqueous solution of sodium hydroxide (10%, 1.0 mL) and ethanol 
solution (20 mL) of benzaldehyde (1.68 mL, 16.5 mmol), 2-acetylpyridine (1.91 mL, 
17.0 mmol) was added dropwise over 2h. The temperature was kept at 0 °C. After 
being stirred for another 2 h, the reaction mixture was filtered to give 24 as a faint 
yellow solid (2.97 g, 14.2 mmol, 86%). 
Rf (isohexane / ethyl acetate = 10/1) = 0.53. 
1H NMR (300 MHz, CDCl3): δ  = 8.75 (m, 1H), 8.32 (d, J = 15 Hz, 1H), 8.20 (m, 1H), 
8.00 (d, J = 15 Hz, 1H), 7.89 (m, 1H), 7.74 (m, 2H), 7.49 (m, 1H), 7.42 (m, 3H).  
13C NMR (75 MHz, CDCl3): δ  = 189.3, 154.1, 148.7, 144.8, 137.1, 135.1, 130.6, 
128.8 (4C), 126.9, 122.9, 120.9. 
HRMS (ESI+): calculated for C14H12NO+ [M+H]+: 210.0913; found: 210.0912. 
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(3-Phenylbicyclo[2.2.1]hept-5-en-2-yl)(pyridin-2-yl)methanone (26) 
 
3-Phenyl-1-(2-pyridyl)prop-2-en-1-one (24) (209 mg, 1.0 mmol, 1 eq.), freshly 
distilled cyclopentadiene (25) (84 µL, 1.0 mmoL, 1 eq.), and Cu(NO3)2•2.5H2O (23.2 
mg, 0.1 mmol, 0.1 eq.) were dissolved in a mixture of H2O and acetonitrile (v/v 1/1, 5 
mL). The mixture was stirred at room temperature for 4 h, diluted with H2O (10 mL). 
exacted twice with ethyl acetate (2×15 mL), dried over MgSO4 and filtered. The solvent 
was removed under reduced pressure. The crude was purified by flash chromatography 
on silica gel (isohexane / ethyl acetate 10:1) to give endo/exo mixture 26 as a colorless 
oil (269 mg, 0.98 mmol, 98%). 
Rf (isohexane / ethyl acetate = 10/1) = 0.65. 
1H NMR (600 MHz, CDCl3): δ  = 8.69 (m, 1H), 8.02 (d, J = 7.9 Hz, 1H), 7.84 (t, J = 
7.9 Hz, 1H), 7.47 (m, 1H), 7.30 (m, 4H), 7.16 (t, J = 7.2 Hz, 1H), 6.50 (s, 1H), 5.83 
(m, 1H), 4.55 (m, 1H), 3.55 (s, 1H), 3.45 (d, J = 4.8 Hz, 1H), 3.09 (s, 1H), 2.08 (d, J = 
8.4 Hz, 1H), 1.60 (d, J = 8.4 Hz, 1H). 
13C NMR (150 MHz, CDCl3): δ  = 200.8, 153.3, 148.6, 144.5, 139.5, 137.1, 132.8, 
128.4 (2C), 127.6 (2C), 126.9, 125.8, 122.3, 54.3, 49.4, 48.7, 48.2, 45.6. 
HRMS (ESI+): calculated for C19H18NO+ [M+H]+: 276.1388; found: 276.1382. 
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6.3. Part I: Experimental details for evaluation and application 
 
Sample preparation and melting point experiments 
Melting profiles were measured on a JASCO V-650 spectrometer using quartz glass 
cuvettes with 10.00 mm path length. The samples contained 150 mM NaCl, 10 mM 
CHES buffer and 1 μM of each strand in a final volume of 200 μL. For strands ODN 1, 
3-7a/b the oligonucleotides with Cu2+ were hybridized by slowly cooling down the 
samples from 90 °C to room temperature overnight. Each sample was prepared and 
measured at least three times in parallel. The solutions were covered with silicon oil and 
tightly plugged. UV Absorbance was recorded in the forward and reverse direction at 
temperatures from 20 °C to 80 °C with a slope of 1 °C/min. Three denaturing and 
renaturing ramps were performed for each sample and averaged for evaluation of the 
melting point. TM values were calculated as the zero-crossing of 2nd derivate of the 349 
nm background corrected change in hyperchromicity at 260 nm.  
 
UV / CD spectra measurements 
UV and CD spectra were measured on a JASCO V-650 or J-810 spectrometer using 
quartz glass cuvettes with 10.00 mm path length. For the strands with mixed salen and 
pyrazole bases, ODN 8a/b, 9a/b and 10a/b, the duplex (3 μM of each strand) was first 
reannealed in 150 mM NaCl, 10 mM CHES buffer without Cu2+ ions or 
ethylenediamine overnight. Then an excess of ~30 fold ethylenediamine, diluted in 
degassed ddH2O, was added, and the solution was incubated at 4 °C overnight. Finally, 
different amounts of Cu2+ were added into individual samples and the final volume 
was constant (200 μL). After Cu2+ had been added, the samples were kept at 4 °C and 
measured in 2 h. Each sample was prepared and measured at least twice in parallel at 
20 °C. For UV measurements, five spectra were accumulated. For CD measurements, 
ten spectra from 320 nm to 210 nm were accumulated at 20°C with a scanning speed 
of 500 nm/min. A blank correction was made of an aqueous solution of buffer and salt 
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and measured for each series of titration measurement. 
 
ESI-Mass measurements 
For duplex ODN 8a/b, 30 μM of the duplex was hybridized in 150 mM NH4OAc as 
above. Here, no CHES buffer and NaCl aq. were used. After addition of 
ethylenediamine, the mixture was incubated at 4 °C overnight; then Cu2+ (3 eq.) was 
added. Before ESI measurement, a mixture (10 μL) of imidazole (250 mM) and 
piperidine (250 mM) in 80 % aq. acetonitrile was added to the sample (40 μL). 
 
MALDI-TOF Mass measurements 
For confirmation of the primer extension product, the corresponding gel was cut into 
pieces and immersed in 1×TBE buffer at 35°C for 4 hrs. The solution was then 
concentrated, desalted on Sep-Pak C18 column, and further concentrated before 
MALDI measurement. Alternatively, at the end of the reaction, the primer extension 
assays were combined (8×20 μL) with H2O (40 μL). Phenol (200 μL) was added and 
mixed. Then the aqueous phase was transferred to a fresh tube and extracted twice 
with chloroform (200 μL). The aqua phase was concentrated, desalted via Zip Tip C18 
and further concentrated before MALDI measurement. 
 
Primer extension experiments and PAGE assay 
The reaction system consisted of 1.5 μM fluorescein-labeled primer, 2 μM template, 
1× corresponding buffer, additive copper ion and magnesium ion and water. The 
mixture was first heated to 90°C for 4 min and then cooled down to 15°C for 1 h. 
Then, DNA polymerase (2 U/μL, 0.5 μL, 1 U) was added; the mixture was incubated 
at 37°C for another 15 min before the triphosphate added to start the reaction. For 
competitive extension experiments, different amount of dPzTP and dNTP were mixed 
prior to the addition. After the reaction had been stopped, the sample was immediately 
cool down in an ice bath, centrifuged and mixed with 1:1 with 2× loading buffer. The 
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mixture was heated to 90°C for 10 min for denaturing the polymerase. PAGE assay 
was run at a constant electric current of 35 mA at 40°C.  
 
Procedure of Diels-Alder reaction using pyrazole ligandoside based catalyst 
Duplex ODN 6a/b (5 nmol), Cu2+ salts (1 mM, 25 μL, 25 nmol, 5 eq., 2.5 mol%), 
ammonium acetate aq. (pH = 9.0, 0.1 M, 30 μL), NaCl aq. (0.5 M, 100 μL) and 
Milli-Q water (145 μL) were mixed to a final volume of 300 μL. The duplex was 
hybridized by heating at 90 °C for 5 min, then slowly cooled down to room 
temperature in a water bath. The solution was lyophilized to dryness and redissolved 
in MOPS buffer (pH = 6.5, 7.4 or 9.0, 20 mM, 1 mL). Acetonitrile solution of 
dienophile 24 (0.1 M, 10 μL, 1 μmol) was added. Freshly distilled cyclopentadiene 25 
(7.5 μL, excessive), was added to initiate the reaction. The mixture was shaken for 24 
hours at 4 °C, followed by the extraction with diethyl ether (3×4 mL), dried over 
MgSO4, filtered and concentrated. The crude product was dissolved in heptane and 
2-propanol (v/v 99/1) and analyzed by normal phase chiral HPLC directly, i.e. 
Shimadzu CBM-20A communication bus module, SPD-M20A prominence diode 
array detector and Daicel Chiralpak IB 81325, 250 mm × 4.6 mm. Conditions: 1% 
2-propanol in heptanes, 0.5 mL/min, column temperature 40 °C, detected from 190 
nm to 500 nm, integration at 212 nm. Conversion of 24 was calculated using the 
following formula: (PA: peak area) 
 
Conversion of 24 (%) =  , 
where PA24 and PA26 are the HPLC peak areas of 24 and 26, respectively, and f is the 
correction factor determined to be 0.69 from the fitting curve.  
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6.4. Part II: Synthesis of azide linkers and related compounds 
 
General procedure of hydroxylamine linker 31-33 
 
Dibromine alkane 37 (1.5 eq.) was added to the solution of N-hydroxy-phthalimide 
(PhthNOH, 1.0 eq.) and triethylamine (2.5 eq.) in anhydrous dimethylformamide. The 
mixture was stirred at room temperature for 24 h. The reaction was diluted with water, 
and the aqueous phases were extracted three times with ethyl acetate. The combined 
organic phases were dried over MgSO4, filtered and concentrated to give the crude 
product 38 as a white solid, which was dissolved in anhydrous dimethylformamide and 
sodium azide (1.2 eq.) was added. The mixture was stirred at room temperature for 2 h, 
diluted with water and extracted with ethyl acetate three times. The combined organic 
phases were dried over MgSO4, filtered and concentrated. The crude was purified by 
flash chromatography on silica gel (isohexane/ethyl acetate 10:1→ 2:1) to give 39 as a 
yellow oil. The oil was redissolved in hydrazine monohydrate (1.5 eq.) and 
dichloromethane. The mixture was stirred at room temperature for 24 h and then 
filtered. The solution was diluted with dichloromethane and washed with NaCl aq. 
three times. The combined organic phases were dried over MgSO4, filtered and 
concentrated to give 31-33 as a colorless oil. 
 
O-(3-Azidopropyl)hydroxylamine (31) 
67% yield for three steps. 
Rf (DCM / MeOH = 10/1) = 0.42. 
1H-NMR (400 MHz, CDCl3): δ = 3.78 (t, J = 6.4 Hz, 2H, C(1)H2), 3.38 (t, J = 6.8 Hz, 
2H, C(3)H2), 1.91−1.83 (m, 2H, C(2)H2). 
13C-NMR (100 MHz, CDCl3): δ = 72.4 (C(1)H2), 48.3 (C(3)H2), 27.8 (C(2)H2).  
HRMS (ESI+): calculated for C3H9N4O+ [M+H]+: 117.0771, found: 117.0771. 
 
O-(4-Azidobutyl)hydroxylamine (32) 
57% yield for three steps. 
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Rf (DCM / MeOH = 10/1) = 0.42. 
1H-NMR (400 MHz, CDCl3): δ = 3.70 (t, J = 5.6 Hz, 2H, C(1)H2), 3.38 (t, J = 6.4 Hz, 
2H, C(4)H2), 1.68−1.64 (m, 4H, C(2)H2-C(3)H2).   
13C-NMR (100 MHz, CDCl3): δ = 75.1 (C(1)H2), 51.2 (C(4)H2), 25.6 (CH2), 25.5 
(CH2). 
HRMS (ESI+): calculated for C4H11N4O+ [M+H]+: 131.0927, found: 131.0928. 
 
O-(5-Azidopentyl)hydroxylamine (33) 
52% yield for three steps. 
Rf (DCM / MeOH = 10/1) = 0.38. 
1H-NMR (400 MHz, CDCl3): δ = 3.63 (t, J = 6.4 Hz, 2H, C(1)H2), 3.21 (t, J = 6.5 Hz, 
2H, C(5)H2), 1.59−1.51 (m, 4H, C(2)H2, C(4)H2), 1.40−1.34 (m, 2H, C(3)H2). 
13C-NMR (100 MHz, CDCl3): δ = 75.6 (C(1)H2), 51.2 (C(5)H2), 28.6 (C(4)H2), 27.8 
(C(2)H2), 23.1 (C(3)H2). 
HRMS (ESI+): calculated for C5H13N4O+ [M+H]+: 145.1084, found: 145.1084. 
 
General procedure of hydrazide linker 34-36 
 
ω-Bromine aliphatic carboxylic acid 40 (1.0 eq.) was dissolved in methanol. Sulfuric 
acid (98%, 2.5 eq.) was then added to the solution slowly. The mixture was refluxed for 
4 h. After cooled down to room temperature, the solvent was evaporated, and the 
residue was neutralized with 10% NaOH aq. and extracted with dichloromethane. The 
combined organic phase was dried over MgSO4, filtered and concentrated to give the 
respective methyl ester 41 as a yellowish oil. The crude ester and sodium azide (2.0 eq.) 
were then redissolved in anhydrous dimethylformamide. The mixture was stirred at 
room temperature for 24 h, diluted with water and extracted with ethyl acetate three 
times. The combined organic phases were dried over MgSO4, filtered and concentrated. 
The crude was purified by flash chromatography on silica gel (isohexane / ethyl acetate 
15:1) to give 42 as a yellowish oil. Hydrazine monohydrate (10 eq.) was added to the 
methanol solution of ester 42. The mixture was reflux for 4 h. After cooled down to 
room temperature, the mixture was diluted with H2O and extracted with 
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dichloromethane. The combined organic phase was washed with NaCl aq. and dried 
over MgSO4, filtered and concentrated to give the 34-36 as a colorless oil. 
 
4-Azidobutanhydrazide (34) 
69% yield for three steps. 
Rf (isohexane / ethyl acetate = 10/1) = 0.38. 
1H-NMR (400 MHz, CDCl3): δ = 8.21 (br, 1H, NH-NH2), 3.37 (t, J = 4.8 Hz, 2H, 
C(2)H2), 2.73 (t, J = 4.8 Hz, 2H, C(4)H2), 1.98−1.94 (m, 2H, C(3)H2).       
13C-NMR (100 MHz, CDCl3): δ = 174.1 (CO), 50.9 (C(4)H2), 29.5 (C(2)H2), 23.7 
(C(3)H2).  
HRMS (ESI-): calculated for C5H10N5O3－ [M+HCO2]－: 188.0789, found: 188.0791. 
 
5-Azidopentanhydrazide (35) 
65% yield for three steps. 
Rf (isohexane / ethyl acetate = 10/1) = 0.30. 
1H-NMR (400 MHz, CDCl3): δ = 8.7 (br, 1H, NH-NH2), 3.6 (br, 2H, NH-NH2), 3.29 (t, 
J = 7.0 Hz, 2H, C(2)H2),2.18 (t, J = 7.0 Hz, 2H, C(5)H2), 1.77−1.69 (m, 2H, C(3)H2), 
1.65−1.58 (m, 2H, C(4)H2). 
13C-NMR (100 MHz, CDCl3): δ = 173.2 (CO), 51.1 (C(5)H2), 33.7 (C(2)H2), 28.3 
(C(4)H2), 22.6 (C(3)H2).  
HRMS (ESI-): calculated for C6H12N5O3－ [M+HCO2]－: 202.0946, found: 202.0947. 
 
6-Azidohexanhydrazide (36)  
64% yield for three steps. 
Rf (iso-hexane/ ethyl acetate = 10/1) = 0.25. 
1H-NMR (400 MHz, CDCl3): δ = 8.50 (br, 1H, NH-NH2), 3.27 (t, 3JH,H = 8.8 Hz, 2H, 
C(2)H2), 2.16 (t, 3JH,H = 10.0 Hz, 2H, C(6)H2), 1.73−1.56 (m, 4H, C(5)H2, C(3)H2), 
1.45−1.37 (m, 2H, C(4)H2).   
13C-NMR (100 MHz, CDCl3): δ = 173.4 (CO), 51.1 (C(6)H2), 34.2 (C(2)H2), 28.5 
(C(5)H2), 26.3 (C(4)H2), 24.9 (C(3)H2).  
HRMS (ESI-): calculated for C7H14N5O3－ [M+HCO2]－: 216.1102, found: 216.1103. 
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O-(4-Azidobutyl)-N-[(4-methoxyphenyl)diphenylmethyl]hydroxylamine (47) 
 
O-(4-Azidobutyl)hydroxylamine 32 (1.88 g, 14.4 mmol, 1.0 eq.) was solved in 
anhydrous dichloromethane (40 mL). 4-Monomethoxytritylchloride (MMTr-Cl, 4.91 g, 
15.9 mmol, 1.1 eq.) and diisopropylethylamine (5.0 mL, 28.9 mmol, 2.0 eq.) was added 
to the mixture at 0°C. The reaction was stirred at room temperature for 2 h, diluted with 
dichloromethane and washed with NaHCO3 aq., dried over MgSO4, filtered and 
concentrated. The crude was purified by flash chromatography on silica gel 
(isohexanes/ethyl acetate 15:1 + 3% triethylamine) to give 47 as a yellowish oil (4.89 
4g, 12.2 mmol, 84%). 
Rf (isohexane / ethyl acetate = 10/1 + 3% triethylamine) = 0.64. 
1H-NMR (400 MHz, CDCl3): δ = 7.31−7.18 (m, 12H, 12 × CArH), 6.79 (d, J = 8.8 Hz, 
2H, 2 × CH3-O-C-CH), 3.76 (s, 3H, O-CH3),3.65 (t, J = 6.0 Hz, 2H, C(1)H2), 3.05 (t, J 
= 6.8 Hz, 2H, C(4)H2), 1.52−1.37 (m, 4H, C(2)H2, C(3)H2).  
13C-NMR (100 MHz, CDCl3): δ = 158.3 (CH3-O-CAr, MMTr), 144.6 (2 × CAr, MMTr), 
136.6 (2 × CAr), 130.2 (2 × CAr), 129.0 (4 × CAr), 127.6 (4 × CAr), 126.7 (2 × CAr), 112.9 
(2 × CAr), 77.2 (O-NH-C), 73.2 (C(1)H2), 55.2 (O-CH3), 51.1 (C(4)H2), 25.8 (C(3)H2), 
25.5 (C(2)H2). 
HRMS (ESI-): calculated for C25H27N4O4－ [M+HCO2]－: 447.2038, found: 447.2040. 
 
2’-O-Propargyl-N4-acetyl-cytidine (49) 
 
To a solution of cytidine (48) (4.00 g, 16.4 mmol) in DMF (160 mL) at 0 °C were 
added tetrabutylammonium iodide (1.21 g, 3.28 mmol, 0.2 eq.), propargyl bromide 
(80% in toluene, 2.30 mL, 21.3 mmol, 1.3 eq.) and sodium hydride (60% in mineral 
oil, 984 mg, 24.6 mmol, 1.5 eq.). The reaction mixture was warmed up to room 
temperature and stirred for 18 h. After evaporated of the volatiles, the residue was 
purified by flash chromatography on silica gel (dichloromethane/ methanol 15:1) to 
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give a mixture of 2’-O-propargyl-cytidine 43 and 3’-O-propargylcytidine (3.61 g, 
12.8 mmol, 78% yield) as a yellow foam. The mixture of isomers (1.13 g, 4.00 mmol, 
1 eq.) was dissolved in DMF (20 mL) and treated with acetic anhydride (0.57 mL, 
6.00 mmol, 1.5 eq.). After 16 h stirring at room temperature, the reaction mixture was 
evaporated to dryness and dissolved in MeOH. The white solid formed was filtered 
and washed twice with cold methanol. The filter cake was collected and dried under 
high vacuum to give 49 as a white solid (420 mg, 1.30 mmol, 33% yield). COSY 
experiment in DMSO-d6 confirmed the nature of the isomer by the coupling of HO 
with H3’.  
Rf (chloroform / methanol = 10/1) = 0.31.  
For the byproduct 3’-O-propargyl-N4-acetyl-cytidine, Rf = 0.34. 
1H-NMR (400 MHz, DMSO-d6): δ = 10.91 (br., 1H, NH) , 8.36 (d, J = 3.7 Hz, 1H, 
C(6)H), 7.20 (d, J = 3.7 Hz, 1H, C(5)H), 5.86 (d, J = 14.6 Hz, 1H, C(1’)H), 5.22-5.19 
(m, 2H, OH), 4.39 (d, J = 1.2 Hz, 2H, CH2CCH), 4.09 (m, 1H, C(3’)H), 3.99 (dd, J = 
14.6, 4.9 Hz, 1H, C(2’)H), 3.92-3.89 (m, 1H, C(4’)H), 3.78-3.73 (m, 1H, C(5’)HH), 
3.63-3.58 (m, 1H, C(5’)HH), 3.42 (t, J = 2.4 Hz, 1H, CCH), 2.10 (s, 3H, CH3CO).  
13C-NMR (100 MHz, DMSO-d6): δ = 171.1 (COCH3), 162.5 (C(4)), 154.5 (C(2)), 
145.1 (C(6)H), 95.3 (C(5)H), 87.9 (C(1’)), 84.4 (C(4’), 81.0 (C(2’)), 80.2 (CCH), 77.4 
(CCH), 67.5 (C(3’)), 59.5 (C(5’)), 57.0 (CH2CCH) , 24.4 (CH3CO)  
HRMS (ESI+): calculated for C14H18N3O6+ [M+H]+: 324.1190, found: 324.1192. 
 
2’-O-Propargyl-N4-acetyl-cytidine connected to MMTr protected linker 32 (50) 
 
49 (403 mg, 1 mmol, 1 eq.), 47 (281 mg, 1 mmol, 1 eq.), CuSO4•5H2O (25 mg, 0.1 
mmol, 0.1 eq.), sodium ascorbate (39 mg, 0.2 mmol, 0.2 eq.) and DIPEA (88 μL, 0.5 
mmol, 0.5 eq.) were dissolved in H2O (3 mL) and MeCN (3 mL) and stirred at room 
temperature. After 2 h, another CuSO4•5H2O (25 mg, 0.1 mmol, 0.1 eq.), sodium 
ascorbate (39 mg, 0.2 mmol, 0.2 eq.) were added and stirred for further 2 h. Then the 
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mixture was directly purified by flash chromatography on silica gel (chloroform / 
methanol 10:1 + 3% triethylamine) to give 50 (715 mg, 0.99 mmol, 99%) as a light 
yellow foam.  
Rf (chloroform/ methanol = 10/1 + 3% triethylamine) = 0.50.  
1H-NMR (400 MHz, CDCl3): δ = 8.48 (d, J = 7.4 Hz, 1H, C(6)H), 7.42 (d, J = 7.4 
Hz, 1H, C(5)H), 7.39 (s, 1H, CazoleH), 7.35-7.22 (m, 12H, CArH), 6.85-6.82 (m, 2H, 
CArH), 5.90 (d, J = 1.5 Hz, 1H, C(1’)H), 5.02 (dd, 2H, J = 6.4, 11.5 Hz, C(5’)H2), 
4.32-4.11 (m, 5H, C(2’)H, C(3’)H, C(4’)H, CazoleNCH2CH2), 4.00 (dd, J = 5.0, 62 Hz, 
2H, OCH2Cazole), 3.80 (s, 3H, OCH3), 3.73 (t, J = 6.0 Hz, 2H, CH2CH2ON), 2.24 (s, 
3H, CH3CO), 1.77 (dt, J = 7.0, 14.2 Hz, 2H, CazoleNCH2CH2), 1.47 (dt, J = 6.4, 12.9 
Hz, 2H, CH2CH2ON). 
13C-NMR (100 MHz, CDCl3): δ = 170.5 (COCH3), 162.5 (C(4)), 158.3 (CH3-O-CAr, 
MMTr), 155.4 (C(2)), 146.1 (OCH2CazoleH), 144.6 (2 × CAr, MMTr), 143.8 (C(6)H), 
136.5 (2 × CAr, MMTr), 130.2 (2 × CAr, MMTr), 129.0 (4 × CAr, MMTr), 127.7 (4 × 
CAr, MMTr), 126.8 (2 × CAr, MMTr), 123.1 (CazoleHNCH2CH2), 113.0 (2 × CAr, 
MMTr), 96.5 (C(5)H), 90.9 (C(1’)), 84.9 (C(4’), 81.4 (C(2’)), 77.2 (O-NH-C, MMTr), 
73.5 (CazoleHNCH2CH2), 73.3 (CH2CH2ON), 67.6 (C(3’)), 63.6 (OCH2Cazole), 60.1 
(C(5’)), 55.2 (O-CH3, MMTr), 27.4 (CH3CO), 25.1 (CazoleNCH2CH2), 25.0 
(CH2CH2ON). 
HRMS (ESI+): calculated for C38H44N7O8+ [M+H]+: 726.3251, found: 726.3255. 
UV λmax = 273 nm. 
 
2’-O-Propargyl-cytidine connected to linker 32 (52) 
 
50 (700 mg, 0.97 mmol) was dissolved in methanol solution of ammonia (7 M, 5 mL) 
and stirred at room temperature overnight. TLC showed a quantitative deprotection to 
give 51. The solution was then concentrated to dryness and a part of the remains (10 
mg) redissolved in acetate acid aq. (v/v 50%, 1 mL) in a 2 mL Eppendorf tube. The 
tube was shaken at 25 °C overnight until the mixture became a milky turbid solution. 
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The mixture was extracted with ethyl acetate twice then concentrated to dryness to 
give 52 as a while solid. Analytical HPLC showed a quantitative deprotection. 0% - 
70% Buffer B in 45 min.  
Retention time: 14.9 min. 
1H-NMR (800 MHz, D2O): δ = 7.98 (s, 1H, CazoleH), 7.69 (d, J = 7.6 Hz, 1H, C(6)H), 
5.88 (d, J = 5.2 Hz, 1H, C(5)H), 4.81 (m, 1H, C(1’)H ), 4.78 (dd, 2H, J = 6.6, 11.0 Hz, 
C(5’)H2), 4.40 (t, J = 7.0 Hz, 2H, CH2CH2ON), 4.31 (t, J = 5.0 Hz, 1H, C(3’)H), 4.21 
(t, J = 5.4 Hz, 1H, C(4’)H), 4.10 (dd, J = 2.0, 7.4 Hz, 1H, C(2’)H), 3.88 (t, J = 6.0 Hz, 
2H, OCH2Cazole), 3.81 (ddd, J = 1.4, 12.7, 60.8 Hz, 2H, CazoleNCH2CH2), 1.94 (dt, J = 
11.2, 3.5 Hz, 2H, CazoleNCH2CH2), 1.57 (dt, J = 7.5, 3.2 Hz, 2H, CH2CH2ON). 
HRMS (ESI+): calculated for C16H26N7O6+ [M+H+]+:412.1939, found: 412.1942. 
UV λmax = 271 nm. 
 
Crosslinker dinucleoside rC-fdC (53) 
 
52 (12.0 μmol, 1.02 eq.) and fdC nucleoside (3.00 mg, 11.75 μmol, 1 eq.) were 
dissolved in acetonitrile (400 μL) and H2O (200 μL) in 2 mL Eppendorf tube. To the 
solution, 4-methoxyaniline solution in ddH2O/DMSO (v/v 9/1, acidified to pH = 5.5 
with acetate acid, 9.6 μL, 250 mM, 2.4 μmol, 0.2 eq.) was added. The tube was shaken 
at 25 °C, 400 rpm for 12 h, then purified with HPLC: 0% - 70% Buffer B in 45 min, 
quant. 
Retention time: 21.0 min. 
1H-NMR (800 MHz, D2O): δ = 8.14 (s, 1H), 7.98 (d, J = 23.6 Hz, 2H), 7.58 (d, J = 7.6 
Hz, 1H), 6.87 (m, 2H), 6.82 (m, 2H), 6.22 (t, J = 6.4 Hz, 1H), 5.91 (d, J = 7.6 Hz, 1H), 
5.83 (d, J = 5.4 Hz, 1H), 4.63 (d, J = 13.3 Hz, 1H), 4.41 (m, 3H), 4.29 (t, J = 5.0 Hz, 
1H), 4.15 (t, J = 5.4 Hz, 1H), 4.10 (m, 4H), 3.85 (m, 2H), 3.76 (m, 2H), 2.48 (m, 1H), 
2.31 (m, 1H), 1.98 (m, 2H), 1.62 (m, 2H). 
HRMS (ESI+): calculated for C26H37N10O10+ [M+H]+: 649.2689, found: 649.2689. 
UV λmax = 267 nm. 
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Uridine and fdC conjugation via linker 32 (54) 
 
2’-O-Propargyl-uridine (2.32 mg, 8.22 μmol, 1 eq.) was dissolved in DMSO (200 μL) 
in a 2 mL Eppendorf tube. To the solution, DIPEA (acetonitrile solution, 200 mM, 60 
μL, 12.0 μmol, 1.5 eq.), ascorbic sodium (aqueous solution, 500 mM, 40 μL, 20.0 
μmol, 2.4 eq.), and CuSO4 (aqueous solution, 100 mM, 100 μL, 10.0 μmol, 1.2 eq.) 
were added. The mixture was shaken at 25°C for 30 min, before 32 (2.50 mg in 100 
μL DMSO, 8.90 μmol, 1.1 eq.) was added. The mixture was shaken for another 2 h at 
25°C, and then H2O (1.0 mL) was added. The tube was vortexed, centrifuged. The 
water layer was discarded. Acetonitrile (500 μL) was added to the residue, and the 
solution was divided into five tubes (100 μL each). To each tube, acetic acid (6% 
aqueous solution, 900 μL) was added. The tube was then shaken at 25°C for 40 min 
and lyophilized to dryness. In each tube, the dry powder was then redissolved in fdC 
nucleoside DMSO/H2O solution (v/v 1/1, 5 mM, 263 μL, 1.31 μmol, 0.8 eq.) with the 
above 4-methoxyaniline solution (250 mM, 5.2 μL, 1.30 μmol, 0.8 eq.). The mixture 
was shaken at 25°C for 2 h, and then purified by HPLC: 0% - 70% Buffer B in 45 min, 
quant. 
Retention time: 21.3 min. 
1H-NMR (800 MHz, D2O): δ = 8.17 (s, 1H), 8.02 (d, J = 15.8 Hz, 2H), 7.61 (d, J = 8.0 
Hz, 1H), 6.25 (d, J = 6.4 Hz, 1H), 5.90 (dd, J = 5.6, 46 Hz, 1H), 5.78 (dd, J = 8.0, 18 
Hz, 1H), 4.66 (d, J = 13.2 Hz, 1H), 4.44 (m, 4H), 4.34 (t, J = 5.0 Hz, 1H), 4.20 (t, J = 
5.4 Hz, 1H), 4.15 (t, J = 6.2 Hz, 2H), 4.12 (m, 3H), 3.88 (m, 2H), 3.79 (m, 2H), 2.52 
(m, 1H), 2.33 (m, 1H), 2.02 (m, 2H), 0.84 (m, 1H), 1.65 (m, 2H),  
HRMS (ESI+): calculated for C26H36N9O10+ [M+H]+: 650.2534, found: 650.2531. 
UV λmax = 264 nm. 
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Guanosine and formylcytosine conjugation via linker 32 (55) 
 
2’-O-Propargyl-guanosine (3.28 mg, 10.2 μmol, 1 eq.) was dissolved in DMSO (200 
μL) in a 2 mL Eppendorf tube. To the mixture, DIPEA (acetonitrile solution, 200 mM, 
76 μL, 15.3 μmol, 1.5 eq.), sodium ascorbate aq. (500 mM, 49 μL, 24 μmol, 2.4 eq.), 
and CuSO4 aq. (100 mM, 122 μL, 12.2 μmol, 1.2 eq.) were added. The mixture was 
shaken at 25°C for 30 min, before 32 (3.50 mg in 100 μL DMSO, 12.2 μmol, 1.2 eq.) 
was added. The mixture was shaken for another 6 h at 25°C, and then H2O (1.0 mL) 
was added. The tube was vortexed, centrifuged. The water layer was discarded. 
Acetonitrile (500 μL) was added to the residue, and the suspension was divided into 
five tubes (100 μL each). To each tube, acetic acid (6% aqueous solution, 900 μL) was 
added. The tube was then shaken at 25°C for 40 min and lyophilized to dryness. In 
each tube, the dry powder was redissolved in fdC nucleoside solution (DMSO/H2O: 
v/v 1/1, 5 mM, 245 μL, 1.22 μmol, 0.6 eq.) with the above 4-methoxyaniline solution 
(250 mM, 4.9 μL, 1.22 μmol, 0.6 eq.). The mixture was shaken at 25°C for 2 h, then 
purified by HPLC: 0% - 70% Buffer B in 45 min. 
Retention time: 20.2 min. 
1H-NMR (800 MHz, D2O): δ = 8.15 (s, 1H), 7.95 (s, 1H), 7.79 (s, 1H), 7.73 (s, 1H), 
6.26 (t, J = 6.4 Hz, 1H), 6.78 (d, J = 7.3 Hz, 1H), 4.66 (m, 1H), 4.56 (m, 2H), 4.45 (m, 
1H), 4.30 (m, 3H), 4.10 (m, 3H), 3.84 (m, 5H), 3.21 (m, 1H), 2.52 (m, 1H), 2.34 (m, 
1H), 1.92 (m, 2H), 1.57 (m, 2H), 1.29 (m, 2H). 
HRMS (ESI+): calculated for C27H37N12O10+ [M+H]+: 689.2756, found: 689.2754. 
UV λmax = 257 nm. 
 
tert-Butyl 1,3-dioxoisoindoline-2-carboxylate (57) 
 
To a suspension of phthalimide (56) (1.47 g, 10 mmol) in anhydrous acetonitrile (5 
mL) at room temperature, di-tert-butyldicarbonate (2.29 g, 10.5 mmol) was added, 
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followed by 4-dimethylaminopyridine (DMAP) (12 mg, 0.1 mmol). After 30 min at 
room temperature, a homogeneous solution was obtained. The solvent was removed 
under reduced pressure. The remaining solid was recrystallized from isohexane / ethyl 
acetate (9:1) to give 57 as slightly beige plates (2.47 g, 10 mmol, quant.). 
Rf (chloroform / methanol = 10/1) = 0.77. 
1H-NMR (400 MHz, CDCl3): δ = 7.94-7.92 (m, 2H, CArH), 7.81-7.79 (m, 2H, CArH), 
1.62 (s, 9H, C(CH3)3). 
13C-NMR (100 MHz, MeOH-d4): δ = 164.1 (2 × CArCO), 146.7 (NCOO), 135.1 (2 
×CAr), 131.1 (2 × CArCO), 124.2 (2 × CAr), 85.3 (C(CH3)3), 27.9 (3 × C(CH3)3). 
HRMS (ESI+): calculated for C13H13NO4Na+ [M+Na]+: 270.0737, found: 270.0741. 
 
15N-Hydroxyhothalimide (58) 
  
To a solution of 57 (742 mg, 3 mmol) in acetonitrile (5 mL) at room temperature was 
added an aqueous solution (4 mL) of hydroxylamine-15N hydrochloride (423 mg, 6 
mmol, 2eq.) and NaOH (240 mg, 6 mmol, 2 eq.). After stirring the mixture overnight 
at room temperature, the mixture was concentrated under vacuum. The residue was 
diluted with water and naturalized with HCl (2 M) until pH 1. The aqueous medium 
was extracted with ethyl acetate three times. The combined organic layers were dried 
over MgSO4, filtered and concentrated to give 58 as a white solid (492 mg, 3 mmol, 
quant.). 
Rf (chloroform / methanol = 10:1) = 0.56. 
1H-NMR (400 MHz, MeOH-d4): δ = 7.82−7.76 (m, 4H, CArH). 
13C-NMR (100 MHz, MeOH-d4): δ = 164.5 (2 × CO), 134.1 (2 × CAr), 129.1 (2 × 
CArCO), 122.6 (2 × CAr).  
15N-NMR (40 MHz, MeOH-d4): δ = -181.9. 
HRMS (ESI-): calculated for C8H415NO3－ [M-H]－: 163.0197, found: 163.0167. 
 
O-(4-Azidobutyl)-15N-[(4-methoxyphenyl)diphenylmethyl]hydroxylamine (61) 
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61 was synthesized according to the protocol of 47, except 58 was applied instead of 
N-hydroxy-phthalimide. 
Rf (isohexane / ethyl acetate = 10/1 + 3% triethylamine) = 0.64. 
1H-NMR (400 MHz, CDCl3): δ = 7.31−7.18 (m, 12H, 12 × CArH), 6.79 (d, J = 8.8 Hz, 
2H, 2 × CH3-O-C-CH), 3.76 (s, 3H, O-CH3),3.65 (t, J = 6.0 Hz, 2H, C(1)H2), 3.05 (t, J 
= 6.8 Hz, 2H, C(4)H2), 1.52−1.37 (m, 4H, C(2)H2, C(3)H2).  
13C-NMR (100 MHz, CDCl3): δ = 158.3 (CH3-O-CAr), 144.6 (2 × CAr), 136.6 (2 × CAr), 
130.3 (2 × CAr), 129.2 (4 × CAr), 127.6 (4 × CAr), 126.8 (2 × CAr), 112.9 (2 × CAr), 77.3 
(O-NH-C), 73.2 (C(1)H2), 55.2 (O-CH3), 51.1 (C(4)H2), 25.7 (C(3)H2), 25.5 (C(2)H2). 
15N-NMR (40 MHz, MeOH-d4): δ = -211.4. 
HRMS (ESI-): calculated for C25H2715NN3O4－ [M+HCO2]－: 448.2008, found: 
448.2012. 
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6.5. Part II: Experimental details for fdC probe 
 
Formation of Schiff base between fdC-oligonucleotides and azide linkers 
A mixture of ODN 13 (80 μM, 150 μL, 12 nmol, 1 eq.), azide linker (L31-36) in 
acetonitrile solution (24 mM, 10 μL, 240 nmol, 20 eq.), 4-methoxyaniline solution in 
ddH2O/DMSO (v/v 9/1, acidified to pH = 5.5 with acetate acid, 250 mM, 12 μL), 
NaOAc aq. (pH = 6.0, 400 mM, 30 μL) and ddH2O (98 μL) was prepared to make a 
final volume of 300 μL. The reaction was incubated at 37 °C for 24 h followed by 
HPLC analysis and purification.  
 
Click reaction of fdC-linker oligonucleotides and alkynes contained strands 
A mixture of ODN-13-L31-36 (15 μM, 20 μL, 0.3 nmol, 1 eq.), probe strand aqueous 
solution (ODN 14-17, 16a/b/c, 15 μM, 20 μL, 0.3 nmol, 1 eq.), NaCl aq. (1 M, 6 μL), 
NaOAc aq. (pH = 6.0, 100 mM, 6 μL) and ddH2O (8 μL) was prepared to make a final 
volume of 60 μL (oligonucleotide working concentration 5 μM). The mixture was 
heated to 85 °C for 5 min then slowly cooled down to room temperature. CuBr-TBTA 
(Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) solution in DMSO/t-BuOH (v/v 
3/1, 1.5 mM, 2 μL, 3 nmol, 10 eq.) was added, and the reaction was conducted at 20 °C. 
After 2 h, another 1 μL (5 eq.) of the freshly prepared above CuBr-TBTA solution was 
added. Aliquots (15 μL) were taken at 1, 2, 4 h and quenched by addition of loading 
buffer. The samples were heated at 85 °C for 3 min followed by denaturing urea PAGE 
(100 V, ca. 120 min). Percentage of duplex DNA was calculated based on the 
integrations: dsDNA % = Int.(dsDNA)/[Int.(dsDNA)+ Int.(ssDNA)].  
 
Click reaction on the solid support with azide linkers and deprotection 
After solid-phase synthesis (0.2 μmol scale, ca. 50% yield for 13 mer, calculated as 0.1 
μmol), the solid support was submerged in dimethyl sulfoxide (80 μL) and acetonitrile 
(25 μL). To the mixture, CuSO4 aq. (100 mM, 50 μL, 5.0 μmol, 50 eq.), sodium 
ascorbate aq. (500 mM, 20 μL, 10 μmol, 100 eq.), N,N-diisopropylethylamine solution 
in acetonitrile (200 mM, 75 μL, 15 μmol, 150 eq.), azide solution (L32) in acetonitrile 
(100 mM, 50 μL, 5.0 μmol, 50 eq.) were added. The reaction was conducted at 25 °C 
for 24 h. Afterward, the solid support was washed with dimethyl sulfoxide (2×1 mL), 
dilute NaHCO3 aq. (2×1 mL), acetonitrile (2×1 mL), ether (1 mL) and air-dried to a 
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powder. The solid-phase was then cleaved with conc. aqueous NH3 at 25 °C for 17 h, 
HPLC purified and lyophilized. Deprotection of MMTr group was carried out by 
dissolving the oligonucleotide in acetic acid aq. (20%, 200 μL) at 25°C for 30 min, 
precipitated by addition of sodium acetate solution (3 M, 60 μL) and EtOH (1040 μL), 
and then purified again with HPLC. 
 
Formation of Schiff base between fdC-oligonucleotides and probe strands 
A mixture of fC containing oligonucleotides ODN 13, or ODN 13a-e in respective 
control experiments (15 μM, 20 μL, 0.3 nmol, 1 eq.), probe strands ODN 16e (15 μM, 
20 μL, 0.3 nmol, 1 eq.), NaCl aq. (1 M, 15 μL), NaOAc aq. (pH = 6.0, 100 mM, 15 μL) 
and ddH2O (80 μL) was prepared to make a final volume of 150 μL (oligonucleotide 
working concentration 2 μM). The mixture was heated to 85 °C for 5 min then slowly 
cooled down to 25 °C for 3 h or 45 °C for 1 h 45 min. A First aliquot (15 μL) was taken 
and quenched before the 4-methoxyaniline solution (5.4 μL, working concentration 10 
mM) was added. The reaction was performed at 25 °C, 300 rpm for 24 h. Aliquots (15 
μL) were taken at 1, 2, 4, 6, 8, 12, 24 h and quenched by addition of loading buffer. All 
the samples were then heated at 85 °C for 3 min followed by PAGE assay as mentioned 
above. 
When using 1,4-benzenediamine as a catalyst, a stock solution of 1,4-benzenediamine 
(10 mM, 0.5% acetate acid aq.) was prepared.  
 
Melting point experiments 
Melting profiles were measured on a JASCO V-650 spectrometer using quartz glass 
cuvettes with 10.00 mm path length. The samples contained NaCl aq. (100 mM), 
NaOAc aq. (10 mM, pH 6.0) and each strand (1 μM) in a final volume of 200 μL. The 
measurements were repeated three times with independent samples. Before the 
measurement, the oligonucleotides were hybridized by slowly cooling down the 
samples from 85 °C to room temperature. The solutions were covered with silicon oil 
and tightly plugged. Absorbance was recorded in the forward and reverse direction at 
temperatures from 25 °C (or 15 °C) to 85 °C with a slope of 1 °C/min. TM values were 
calculated as the zero-crossing of 2nd derivate of the hyperchromicity change at 260 nm 
corrected with 339 nm background. 
 
6. Experimental part   
170 
   
Probe extension with Klenow Fragment 
A mixture of ODN 23 and ODN 24/25/26 (60 μM, 10 μL, 0.6 nmol, 1 eq.), NaCl aq. (1 
M, 3 μL), NaOAc aq. (pH = 6.0, 100 mM, 3 μL) and ddH2O (4 μL) was prepared to 
make a final volume of 30 μL (oligonucleotide working concentration 20 μM). The 
mixture was heated to 85 °C for 5 min and then slowly cooled down to 25 °C in 3 h. 
Then 1.2 μL of the mentioned 4-methoxyaniline solution was added to give a catalyst 
working concentration of 10 mM. The reaction was conducted at 25 °C, 500 rpm for 24 
h. Then, to 3 μL of the reaction mixture (60 pmol in theory), NEB buffer 2 (10×, 3 μL), 
dNTP (2 mM, 3 μL, 6 nmol), ddH2O (18 μL), and Klenow Fragment (3'→5' exo-) (5000 
U/mL, 1.2 μL, 6 U) were added. The mixture was incubated at 37 °C for 1 h. The 
reaction was quenched by addition of PAGE loading buffer. The samples were heated at 
85 °C for 3 min followed by denaturing urea polyacrylamide gel electrophoresis (150 V, 
3 h). 
 
Two probes react with ODN 23 in turn 
ODN 23 and the first probe ODN 24/25/26 (20 μM, 6 μL), NaCl aq. (1 M, 6 μL), 
NaOAc aq. (pH = 6.0, 100 mM, 6 μL) and ddH2O (42 μL) was prepared to make a final 
volume of 60 μL (oligonucleotide working concentration 2 μM). The mixture was 
heated to 85 °C for 5 min then slowly cooled down to 25 °C in 3 h. 2.4 μL of mentioned 
4-methoxyaniline solution was added to give a catalyst working concentration of 10 
mM. The reaction was conducted at 25 °C for 24 h. An aliquot (20 μL) was then taken 
out and the second probe (20 μM, 2 μL) was added. The mixture was further incubated 
for 24 h. The remaining mixture was quenched with loading buffer. All the samples 
were heated at 85 °C for 3 min followed by denaturing urea polyacrylamide gel 
electrophoresis (150 V, 3 h).
6.6 Part II: Experimental details for fdC detection 
171 
 
6.6. Part II: Experimental details for fdC detection 
 
LC-MS study with crosslinked duplex or gDNA 
Duplex crosslinking between fdC-oligonucleotides and probe strands is described in 
Chapter 7.5. Biotin enrichment using Streptavidin Magnetic Particles from Roche was 
conducted according to the manufacturer’s instructions. The reaction mixture (variable 
amount of dsDNA, 35 μL), with or without magnetic particles, was mixed with 
ZnSO4 aq. (4 mM, 0.9 μL), S1 nuclease (42 U/μL, 1.0 μL), Antarctica Phosphatase (5 
U/μL, 1.0 μL), and ddH2O (4.6 μL) and incubated at 37°C for 3 h. EDTA-Na2 aq. (1 
mM, 3.9 μL), snake venom phosphatase (0.1 U/μL, 1.0 μL), and ddH2O (2.6 μL) were 
then added to the mixture and incubated for additional 3 h. The mixture was then 
filtered and submitted to LC-MS analysis. 
 
Primer extension study with crosslinked duplex 
Duplex crosslinking between fdC-oligonucleotides and probe strands is described in 
Chapter 7.5. Primer extension study is stated in Chapter 7.3. 
 
Synthesis of the target strand ODN 31 and crosslinked duplex 
ODN 31a containing one fdC was synthesized on solid-phase. ODN 31b and 31c 
were purchased from Metabion. ODN 31a (5 nmol), T4 DNA ligase buffer (10×, 5 
μL), T4 polynucleotide kinase (10 U/μL, 4 μL, 40 U) and ddH2O were mixed to a 
final volume of 50 μL and incubated at 37°C for 4 h. To the mixture, ODN 31b (5 
nmol), ODN 31c (5.5 nmol), and ddH2O were added to a final volume of 96 μL. The 
reaction mixture was denatured at 85°C for 3 min and cooled down to room 
temperature in 2 h, and then T4 DNA ligase (400 U/μL, 4 μL, 1600 U) was added and 
further incubated at 16°C for 12 h. Afterwards, the mixture (100 μL) was mixed with 
loading buffer (100 μL, 90% formamide, 10% 0.1M EDTA, pH = 8.0) and purified 
with PAGE at 40°C, using power of 20 W for 2 h. The gel containing ODN 31 was 
then cut out, minced and extracted with TBE buffer (1×, 1 mL) at room temperature 
overnight, desalted with Waters Sep-Pak C18 cartridge and lyophilized to dryness. 
Duplex crosslinking between ODN 31 and probe strands is described in Chapter 7.5. 
Salts and catalyst were removed by NEB Monarch PCR DNA Cleanup Kit. 
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Genomic fdC detection study 
Isolation Cell lysates, kindly obtained from co-worker Angie Kirchner, were 
homogenized with Tissue Lyzer for 1 min at 30 Hz and centrifuged for 5 min at 21000 
xg. The lysates were then isolated with Zymo-Spin V column according to the 
manufacturer’s instructions. The concentration was measured using the Nanodrop, 
obtained 200-600 ng/μL. 
Probe crosslinking The gDNA solution obtained above (1.2 μg), fdC probe (1 μM, 2 
μL), NaH2PO4-Na2HPO4 buffer (200 mM, pH = 6.0, 2 μL), NaCl aq. (1.5 M, 2μL), 
and ddH2O were mixed to a final volume of 18 μL. The mixture was heated to 95 °C 
for 3 min, and then cooled down rapidly to 25 °C. 1,4-Benzenediamine aq. (10 mM, 2 
μL) was added and the reaction vial shaken (300 rpm) for 6 h at 25 °C. The mixture 
was neutralized with Na2HPO4 aq. (200 mM, 40 μL) before purified with NEB 
Monarch PCR DNA Cleanup Kit using the binding buffer (120 μL), eluted with 
elution buffer (30 μL). The eluted solution was quantified with Nanodrop, obtained 
22-32 ng/μL. UV spectra confirmed the main peak centered at 260 nm. 
Ligation The above gDNA solution (300 ng), arch strands (20 nM, 1 μL), Ampligase 
reaction buffer (10×, 2 μL), Ampligase from Epicenter (5 U/μL, 2 μL, 10 U) and 
ddH2O were mixed to a final volume of 20 μL. The mixture was heated to 95 °C for 3 
min, and then 94 °C for 1 min, 60 °C for 1 h and back to 94 °C for 10 cycles. Then, 
the reaction mixture was diluted with Tris-HCl buffer (200 mM, pH = 7.6, 50 μL) 
before purified with NEB Monarch PCR DNA Cleanup Kit using binding buffer (140 
μL), eluted with elution buffer (10 μL). The eluted solution was quantified with 
Nanodrop, obtained 20-32 ng/μL. UV spectra confirmed the main peak centered at 
260 nm. 
Real-time PCR Real-time PCR was conducted on an Eppendorf realplex. For a typical 
duplicate reaction, primers (18 μM each, 1 μL), iTaq Universal SYBR Green Supermix 
(2×, 10 μL) were used to a final volume of 20 μL. PCR cycle: 95°C 2 min, 95°C 15 sec 
and 60°C 1 min for 40 cycles. Threshold cycle numbers were calculated using the 
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CalQplex method. 
Droplet digital PCR ddPCR was conducted on a Bio-Rad QX100 ddPCR System. For 
one reaction, gDNA (6 ng), four primers (18 μM each, 1 μL), two TaqMan probes (5 
μM each, 1 μL), digital PCR Supermix for Probes (no dUTP, 2×, 10 μL), and ddH2O 
were mixed to a final volume of 20 μL with primer working concentration of 900 nM 
and TaqMan probe working concentration of 250 nM.  
PCR cycle was conducted on a Bio-Rad T100 Thermal cycler. PCR cycle: 95°C for 10 
min, 94°C for 30 sec and specific annealing temperature (64°C) for 1 min for 35 or 40 
cycles, then 98°C for 10 min and cooled down to 12°C. A temperature ramp of 2°C/s 
was used. Droplet generation and counting were conducted according to the 
manufacturer’s instructions, i.e. reaction mixture prepared as above (20 μL) and 
ddPCR droplet generate oil (70 μL) were used for one reaction. the Accounted droplet 
number was retained in 10000-18000. FAM for detection amplicon was set to channel 1; 
HEX for reference amplicon was set to channel 2.  
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Appendix 
Part I: Crystallographic data 
5-[3-Hydroxy-4-(1H-pyrazol-1-yl)phenyl]-2-(hydroxymethyl)tetrahydrofuran-3-ol (16) 
 
Net formula C14H16N2O4 
Mr /g mol−1 276.288 
Crystal size /mm 0.195 × 0.127 × 0.051 
T /K 173(2) 
Radiation 'Mo Kα 
Diffractometer 'Bruker D8Venture' 
Crystal system Monoclinic 
Space group P21 
a /Å 11.8630(13) 
b /Å 4.8437(7) 
c /Å 12.6119(16) 
α /° 90 
β /° 116.802(3) 
γ /° 90 
V /Å3 646.84(14) 
Z 2 
Calc. density /g cm−3 1.4186(3) 
μ /mm−1 0.105 
Absorption correction multi-scan 
Transmission factor range 0.9043–0.9580 
Refls. measured 8079 
Rint 0.0407 
Mean σ(I) /I 0.039 
θ range 3.18–25.41 
Refls. observed 2117 
x, y (weighting scheme) 0.0376, 0.1254 
Hydrogen refinement Mixed 
Flack parameter 1.7(11) 
Refls. in refinement 2358 
Parameters 193 
Restraints 1 
R(Fobs)  0.0327 
Rw(F2)  0.0809 
S 1.059 
Part I: Crystallographic data 
175 
 
shift/errormax 0.001 
Max electron density /e Å−3 0.154 
Min electron density /e Å−3 −0.168 
C-bound H: constr, O-bound H: refall. 
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Part II: Selected ddPCR results 
Raw data of fdC detection of position 1 in three cells types. 
 
 
Ch1 Ch2 1+2+ 1+2- 1-2+ 1-2- AD η Average
Tdg-/- 17.6 67.6 151 121 827 16399 17502 27.8%
Tdg-/- 17.6 63.7 101 93 590 12318 14896 28.1%
Tdg-/- 18.9 63.7 106 103 585 12308 13102 30.2%
Tdg-/- 28.8 103 181 149 1002 12743 14075 27.9%
Tdg+/- 11.6 74.0 54 56 676 11085 11878 15.1%
Tdg+/- 11.3 67.2 54 70 698 12722 13544 16.5%
Tdg+/- 10.7 69.6 52 83 806 13994 14935 15.7%
Tdg+/- 10.8 72.0 56 66 738 12490 13350 15.4%
Dnmt TKO 4.0 115.0 10 29 1049 10327 11415 3.7%
Dnmt TKO 3.1 61.1 11 17 625 11913 12566 4.4%
Dnmt TKO 4.1 58.0 14 30 620 12508 13174 6.9%
Dnmt TKO 2.8 60.6 8 21 600 11484 12119 4.8%
Dnmt TKO 5.7 96.0 35 28 986 11998 13047 6.2%
28.5%
15.7%
5.2%
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Tdg –/– ES cell sample 
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Tdg+/– ES cell sample. 
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Dnmt TKO ES cell sample. 
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Raw data of fdC detection of position 1 in wild -type cell along days during priming. 
 
 
 
Raw data of fdC detection of in Tdg-/-, Tdg+/-cells for locus 2. 
 
  
Ch1 Ch2 1+2+ 1+2- 1-2+ 1-2- AD η Average
WT0 5.4 108 20 34 1017 10787 11858 5.21%
WT0 6.8 110 30 58 1336 13841 15265 6.44%
WT0 6.6 112 26 53 1255 12738 14072 6.17%
WT0 7.8 108 23 58 1241 13060 14382 6.41%
WT2 9.7 89.2 40 98 1193 15552 16883 11.19%
WT2 10.2 88.7 35 105 1249 15948 17337 10.90%
WT2 10.8 93.0 35 96 1168 14476 15771 10.89%
WT2 10.2 96.0 54 94 1279 15637 17064 11.10%
WT2 6.3 56.2 19 65 744 15582 16410 11.01%
WT2 6.0 57.3 27 54 759 15780 16620 10.31%
WT4 6.2 68.0 19 30 501 8702 9252 9.42%
WT4 5.4 68.4 26 46 811 13942 14821 8.60%
WT4 4.5 59.0 14 24 477 9449 9964 7.74%
WT4 5.8 64.5 23 43 688 12579 13333 9.28%
WT6 11.1 117 42 67 1081 10691 11881 9.71%
WT6 8.2 114 28 41 888 9000 9957 7.53%
WT6 9.8 120 32 41 820 7909 8802 8.57%
WT6 8.5 114 43 57 1086 11010 12196 8.86%
6.06%
10.90%
8.76%
8.67%
Ch1 Ch2 1+2+ 1+2- 1-2+ 1-2- AD η Average
Tdg-/- 10.5 52 55 92 650 15671 16468 20.9%
Tdg-/- 20.8 115 88 133 1084 11285 12590 18.9%
Tdg-/- 22.5 114 98 173 1226 12805 14302 20.5%
Tdg-/- 20.1 109 94 149 1178 12927 14348 19.1%
Tdg-/- 21.8 116 90 159 1179 12141 13569 19.6%
Tdg+/- 5.5 66 28 49 884 15696 16657 8.4%
Tdg+/- 5.9 59 13 29 400 8002 8444 10.2%
Tdg+/- 8.3 96 43 78 1299 15749 17169 9.0%
Tdg+/- 8.1 93 39 73 1205 15070 16387 9.0%
19.8%
9.2%
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Abbreviations 
cadC 5-carboxycytosine 
fdC 5-formylcytosine 
hmdC 5-hydroxymethylcytosine 
mdC 5-methylcytosine 
AID activation-induced cytidine deaminase 
APS ammonium persulfate 
aq. aqueous 
ARP aldehyde reactive probe 
BAC bacterial artificial chromosome  
BER base excision repair 
β-GT β-glucosyltransferase 
BS-Seq bisulfite sequencing  
CD circular dichroism  
CGIs CpG islands  
CHES     2-(cyclohexylamino)ethanesulfonic acid 
ChIP chromatin immunoprecipitation 
DME DEMETER 
DMF dimethylformamide 
DMTr 4,4'-dimethoxytrityl  
DNA deoxyribonucleic acid  
DNMT DNA methyltransferase 
dNTP deoxyribonucleoside triphosphate 
DRM domains rearranged methyltransferase 
EDTA ethylenediaminetetraacetic acid  
ELISA enzyme-linked immunosorbent assay 
EPR electron paramagnetic resonance 
ES cells embryonic stem cells 
ESI electrospray ionisation mass spectrometry 
FAM fluorsescein 
FISH fluorescence in situ hybridization 
FNA flexible nucleic acids  
gDNA genomic DNA 
HDAC histone deacetylases 
HGP Human Genome Project  
HNA 1,5-anhydrohexitol nucleic acids 
HRMS high resolution mass spectrometry 
LV-PS low volume polystyrene 
MALDI-TOF matrix assisted laser desorption/ionization - time of flight 
MeDIP methylated DNA immunoprecipitation 
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MES 4-morpholinoethane-sulfonic acid 
MMTr 4-methoxytrityl  
NER nucleotides excision repair  
NMR nuclear magnetic resonance  
NOESY nuclear Overhauser effect spectroscopy  
PAGE polyacrylamide gel electrophoresis  
PCR polymerase chain reaction 
PhthN-OH N-hydroxy-phthalimide  
RNA ribonucleic acid  
ROS repressor of silencing 
RP-HPLC reverse phase high performance liquid chromatography 
RRBS reduced representation bisulfite sequencing 
SAH S-adenosylhomocysteine; 
SAM S-adenosyl-methionine 
SMRT single molecular real-time 
SMUG strand-selective monofunctional uracil-DNA glycosylase 
TDG thymine-DNA glycosylase  
TEMED tetramethylethylenediamine  
TET ten-eleven translocation  
TIPS triisopropylsilyl  
TLC thin layer chromatography  
TNA threose nucleic acids 
Tol toluene 
Tris 2-amino-2-hydroxymethyl-propane-1,3-diol 
UDP uridine 5′-diphosphate  
UV ultraviolate 
Reference 
183 
 
Reference 
1. Dunn, D. B.; Smith, J. D., The Occurrence of 6-Methylaminopurine in 
Deoxyribonucleic Acids. Biochem. J., 1958, 68, 627-636. 
2. Wion, D.; Casadesus, J., N6-Methyl-adenine: An Epigenetic Signal for DNA-protein 
Interactions. Nat. Rev. Micro., 2006, 4, 183-192. 
3. Ehrlich, M.; Gama-Sosa, M. A.; Carreira, L. H.; Ljungdahl, L. G.; Kuo, K. C.; Gehrke, 
C. W., DNA Methylation in Thermophilic Bacteria: N4-Methylcytosine, 
5-Methylcytosine, and N6-Methyladenine. Nucleic Acids Res., 1985, 13, 1399-1412. 
4. Watson, J. D.; Crick, F. H. C., Molecular Structure of Nucleic Acids: A Structure for 
Deoxyribose Nucleic Acid. Nature, 1953, 171, 737-738. 
5. Watson, J. D.; Crick, F. H. C., Genetical Implications of the Structure of 
Deoxyribonucleic Acid Nature, 1953, 171, 964-967. 
6. Herdewijn, P.; Marlière, P., Toward Safe Genetically Modified Organisms through the 
Chemical Diversification of Nucleic Acids. Chem. Biodivers., 2009, 6, 791-808. 
7. Merrifield, R. B., Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. J. 
Am. Chem. Soc., 1963, 85, 2149-2154. 
8. Letsinger, R. L.; Kornet, M. J., Popcorn Polymer as a Support in Multistep Syntheses. 
J. Am. Chem. Soc., 1963, 85, 3045-3046. 
9. Letsinger, R. L.; Kornet, M. J.; Mahadevan, V.; Jerina, D. M., Reactions on Polymer 
Supports. J. Am. Chem. Soc., 1964, 86, 5163-5165. 
10. Letsinger, R. L.; Mahadevan, V., Oligonucleotide Synthesis on a Polymer Support J. 
Am. Chem. Soc., 1965, 87, 3526-3527. 
11. Letsinger, R. L.; Ogilvie, K. K., Nucleotide Chemistry. XIII. Synthesis of 
Oligothymidylates via Phosphotriester Intermediates. J. Am. Chem. Soc., 1969, 91, 
3350-3355. 
12. Letsinger, R. L.; Miller, P. S., Nucleotide Chemistry. XIV. Protecting Groups for 
Nucleosides Used in Synthesizing Oligonucleotides. J. Am. Chem. Soc., 1969, 91, 
3356-3359. 
13. Letsinger, R. L.; Ogilvie, K. K.; Miller, P. S., Nucleotide Chemistry. XV. 
Developments in Syntheses of Oligodeoxyribonucleotides and their Organic 
Derivatives. J. Am. Chem. Soc., 1969, 91, 3360-3365. 
14. Letsinger, R. L.; Finnan, J. L.; Heavner, G. A.; Lunsford, W. B., Nucleotide Chemistry. 
XX. Phosphite Coupling Procedure for Generating Internucleotide Links. J. Am. Chem. 
Soc., 1975, 97, 3278-3279. 
15. Letsinger, R. L.; Lunsford, W. B., Synthesis of Thymidine Oligonucleotides by 
Phosphite Triester Intermediates. J. Am. Chem. Soc., 1976, 98, 3655-3661. 
16. Matteucci, M. D.; Caruthers, M. H., Synthesis of Deoxyoligonucleotides on a Polymer 
Support. J. Am. Chem. Soc., 1981, 103, 3185-3191. 
17. McBride, L. J.; Caruthers, M. H., An Investigation of Several Deoxynucleoside 
Phosphoramidites Useful for Synthesizing Deoxyoligonucleotides. Tetrahedron Lett., 
Reference   
184 
   
1983, 24, 245-248. 
18. Eckstein, F., A Dinucleoside Phosphorothioate. Tetrahedron Lett., 1967, 8, 1157-1160. 
19. Wilson, C.; Keefe, A. D., Building Oligonucleotide Therapeutics using Non-natural 
Chemistries. Curr. Opin. Chem. Biol. , 2006, 10, 607-614. 
20. Huang, Z.; Schneider, K. C.; Benner, S. A., Building Blocks for Oligonucleotide 
Analogs with Dimethylene Sulfide, Sulfoxide, and Sulfone Groups Replacing 
Phosphodiester Linkages. J. Org. Chem., 1991, 56, 3869-3882. 
21. Mori, K.; Boiziau, C.; Cazenave, C.; Matsukura, M.; Subasinghe, C.; Cohen, J. S.; 
Broder, S.; Toulmé, J. J.; Stein, C. A., Phosphoroselenoate Oligodeoxynucleotides: 
Synthesis, Physico-chemical Characterization, Anti-sense Inhibitory Properties and 
Anti-HIV Activity. Nucleic Acids Res., 1989, 17, 8207-8219. 
22. Vyazovkina, E. V.; Rife, J. P.; Lebedev, A. V.; Wickstrom, E., Preparation of Trimers 
and Tetramers of Mixed Sequence Oligodeoxynucleoside Methylphosphonates and 
Assignment of Configurations at the Chiral Phosphorus. Nucleic Acids Res., 1993, 21, 
5957-5963. 
23. Koole, L. H.; Moody, H. M.; Broeders, N. L. H. L.; Quaedflieg, P. J. L. M.; Kuijpers, 
W. H. A.; Van Genderen, M. H. P.; Coenen, A. J. J. M.; Van der Wal, S.; Buck, H. M., 
Synthesis of Phosphate-methylated DNA Fragments using 9-Fluorenyl- 
methoxycarbonyl as Transient Base Protecting Group. J. Org. Chem., 1989, 54, 
1657-1664. 
24. Kutateladze, T.; Beabealashvili, R.; Azhayev, A.; Krayevsky, A., 3′-Deoxy-3′- 
aminonucleoside 5′-Triphosphates-Terminators of RNA Synthesis, Catalyzed by 
DNA-dependent RNA Polymerase from Escherichia coli. FEBS Lett., 1983, 153, 
420-426. 
25. Pannecouque, C.; Wigerinck, P.; Van Aerschot, A.; Herdewijn, P., Dimeric Building 
Blocks with N-cyanoguanidine Linkage for Oligonucleotide Synthesis. Tetrahedron 
Lett., 1992, 33, 7609-7612. 
26. Sood, A.; Shaw, B. R.; Spielvogel, B. F., Boron-containing Nucleic Acids. 2. Synthesis 
of Oligodeoxynucleoside Boranophosphates. J. Am. Chem. Soc., 1990, 112, 9000-9001. 
27. Li, P.; Sergueeva, Z. A.; Dobrikov, M.; Shaw, B. R., Nucleoside and Oligonucleoside 
Boranophosphates: Chemistry and Properties. Chem. Rev., 2007, 107, 4746-4796. 
28. Roy, S.; Olesiak, M.; Padar, P.; McCuen, H.; Caruthers, M. H., Reduction of Metal 
Ions by Boranephosphonate DNA. Org. Bio. Chem., 2012, 10, 9130-9133. 
29. Roy, S.; Olesiak, M.; Shang, S.; Caruthers, M. H., Silver Nanoassemblies Constructed 
from Boranephosphonate DNA. J. Am. Chem. Soc., 2013, 135, 6234-6241. 
30. Kawasaki, A. M.; Casper, M. D.; Freier, S. M.; Lesnik, E. A.; Zounes, M. C.; Cummins, 
L. L.; Gonzalez, C.; Cook, P. D., Uniformly Modified 2'-Deoxy-2'-fluoro- 
phosphorothioate Oligonucleotides as Nuclease-resistant Antisense Compounds with 
High Affinity and Specificity for RNA Targets. J. Med. Chem., 1993, 36, 831-841. 
31. Allerson, C. R.; Sioufi, N.; Jarres, R.; Prakash, T. P.; Naik, N.; Berdeja, A.; Wanders, L.; 
Griffey, R. H.; Swayze, E. E.; Bhat, B., Fully 2'-Modified Oligonucleotide Duplexes 
with Improved in Vitro Potency and Stability Compared to Unmodified Small 
Reference 
185 
 
Interfering RNA. J. Med. Chem., 2005, 48, 901-904. 
32. Prakash, T. P.; Allerson, C. R.; Dande, P.; Vickers, T. A.; Sioufi, N.; Jarres, R.; Baker, B. 
F.; Swayze, E. E.; Griffey, R. H.; Bhat, B., Positional Effect of Chemical Modifications 
on Short Interference RNA Activity in Mammalian Cells. J. Med. Chem., 2005, 48, 
4247-4253. 
33. Hendel, A.; Bak, R. O.; Clark, J. T.; Kennedy, A. B.; Ryan, D. E.; Roy, S.; Steinfeld, I.; 
Lunstad, B. D.; Kaiser, R. J.; Wilkens, A. B.; Bacchetta, R.; Tsalenko, A.; Dellinger, D.; 
Bruhn, L.; Porteus, M. H., Chemically Modified Guide RNAs Enhance CRISPR-Cas 
Genome Editing in Human Primary Cells. Nat. Biotech., 2015, 33, 985-989. 
34. Rahdar, M.; McMahon, M. A.; Prakash, T. P.; Swayze, E. E.; Bennett, C. F.; Cleveland, 
D. W., Synthetic CRISPR RNA-Cas9-guided Genome Editing in Human Cells. Proc. 
Natl. Acad. Sci. USA, 2015, 112, E7110-E7117. 
35. Fauster, K.; Kreutz, C.; Micura, R., 2′-SCF3 Uridine: A Powerful Label for Probing 
Structure and Function of RNA by 19F NMR Spectroscopy. Angew. Chem., Int. Ed., 
2012, 51, 13080-13084. 
36. Košutić, M.; Jud, L.; Da Veiga, C.; Frener, M.; Fauster, K.; Kreutz, C.; Ennifar, E.; 
Micura, R., Surprising Base Pairing and Structural Properties of 2′-Trifluoro- 
methylthio-Modified Ribonucleic Acids. J. Am. Chem. Soc., 2014, 136, 6656-6663. 
37. Höbartner, C.; Micura, R., Chemical Synthesis of Selenium-Modified 
Oligoribonucleotides and Their Enzymatic Ligation Leading to an U6 SnRNA 
Stem-loop Segment. J. Am. Chem. Soc., 2004, 126, 1141-1149. 
38. Aigner, M.; Hartl, M.; Fauster, K.; Steger, J.; Bister, K.; Micura, R., Chemical 
Synthesis of Site-specifically 2′-Azido-modified RNA and Potential Applications for 
Bioconjugation and RNA Interference. ChemBioChem, 2011, 12, 47-51. 
39. Fauster, K.; Hartl, M.; Santner, T.; Aigner, M.; Kreutz, C.; Bister, K.; Ennifar, E.; 
Micura, R., 2'-Azido RNA, a Versatile Tool for Chemical Biology: Synthesis, X-ray 
Structure, siRNA Applications, Click Labeling. ACS Chem. Bio., 2012, 7, 581-589. 
40. Büttner, L.; Javadi-Zarnaghi, F.; Höbartner, C., Site-specific Labeling of RNA at 
Internal Ribose Hydroxyl Groups: Terbium-assisted Deoxyribozymes at Work. J. Am. 
Chem. Soc., 2014, 136, 8131-8137. 
41. Shealy, Y. F.; O'Dell, C. A., The Carbocyclic Analog of Cytidine, Synthesis and 
Antineoplastic Activity. J. Heterocyclic Chem., 1976, 13, 1353-1354. 
42. Varaprasad, C. V.; Averett, D.; Ramasamy, K. S.; Wu, J., Synthesis and Structural 
Studies of Monocyclic 4′-Aza-L-nucleosides. Tetrahedron, 1999, 55, 13345-13368. 
43. Hancox, E. L.; Connolly, B. A.; Walker, R. T., Synthesis and Properties of 
Oligodeoxynucleotides Containing the Analogue 2′-Deoxy-4′-thiothemidine. Nucleic 
Acids Res., 1993, 21, 3485-3491. 
44. Hoshika, S.; Minakawa, N.; Matsuda, A., Synthesis and Physical and Physiological 
Properties of 4′-thioRNA: Application to Post-modification of RNA Aptamer toward 
NF-κB. Nucleic Acids Res., 2004, 32, 3815-3825. 
45. Jeong, L. S.; Tosh, D. K.; Kim, H. O.; Wang, T.; Hou, X.; Yun, H. S.; Kwon, Y.; Lee, S. 
K.; Choi, J.; Zhao, L. X., First Synthesis of 4'-Selenonucleosides Showing Unusual 
Reference   
186 
   
Southern Conformation. Org. Lett., 2007, 10, 209-212. 
46. Watts, J. K.; Johnston, B. D.; Jayakanthan, K.; Wahba, A. S.; Pinto, B. M.; Damha, M. 
J., Synthesis and Biophysical Characterization of Oligonucleotides Containing a 
4'-Selenonucleotide. J. Am. Chem. Soc., 2008, 130, 8578-8579. 
47. Renneberg, D.; Leumann, C. J., Watson-Crick Base-pairing Properties of 
Tricyclo-DNA. J. Am. Chem. Soc., 2002, 124, 5993-6002. 
48. Dupouy, C.; Iché-Tarrat, N.; Durrieu, M.-P.; Rodriguez, F.; Escudier, J.-M.; Vigroux, A., 
Watson-Crick Base-Pairing Properties of Nucleic Acid Analogues with 
Stereocontrolled α and β Torsion Angles (α,β-D-CNAs). Angew. Chem., Int. Ed., 2006, 
45, 3623-3627. 
49. Wengel, J., Synthesis of 3'-C- and 4'-C-Branched Oligodeoxynucleotides and the 
Development of Locked Nucleic Acid (LNA). Acc. Chem. Res., 1998, 32, 301-310. 
50. Imanishi, T.; Obika, S., BNAs: Novel Nucleic Acid Analogs with a Bridged Sugar 
Moiety. Chem. Commun., 2002, 38, 1653-1659. 
51. Seth, P. P.; Pallan, P. S.; Swayze, E. E.; Egli, M., Synthesis, Duplex Stabilization and 
Structural Properties of a Fluorinated Carbocyclic LNA Analogue. ChemBioChem, 
2013, 14, 58-62. 
52. Morihiro, K.; Kodama, T.; Kentefu; Moai, Y.; Veedu, R. N.; Obika, S., 
Selenomethylene Locked Nucleic Acid Enables Reversible Hybridization in Response 
to Redox Changes. Angew. Chem., Int. Ed., 2013, 52, 5074-5078. 
53. Kaur, H.; Babu, B. R.; Maiti, S., Perspectives on Chemistry and Therapeutic 
Applications of Locked Nucleic Acid (LNA). Chem. Rev., 2007, 107, 4672-4697. 
54. Obika, S.; Uneda, T.; Sugimoto, T.; Nanbu, D.; Minami, T.; Doi, T.; Imanishi, T., 
2'-O,4'-C-Methylene Bridged Nucleic Acid (2',4'-BNA): Synthesis and Triplex-forming 
Properties. Bioorg. Med. Chem., 2001, 9, 1001-1011. 
55. Koizumi, M.; Morita, K.; Daigo, M.; Tsutsumi, S.; Abe, K.; Obika, S.; Imanishi, T., 
Triplex Formation with 2'-O,4'-C-ethylene-bridged Nucleic Acids (ENA) having 
C3′-endo Conformation at Physiological pH. Nucleic Acids Res., 2003, 31, 3267-3273. 
56. K. Singh, S.; A. Koshkin, A.; Wengel, J.; Nielsen, P., LNA (locked nucleic acids): 
Synthesis and High-affinity Nucleic Acid Recognition. Chem. Commun., 1998, 
455-456. 
57. Brunet, E.; Alberti, P.; Perrouault, L.; Babu, R.; Wengel, J.; Giovannangeli, C., 
Exploring Cellular Activity of Locked Nucleic Acid-modified Triplex-forming 
Oligonucleotides and Defining its Molecular Basis. J. Biol. Chem., 2005, 280, 
20076-20085. 
58. Hanessian, S.; Schroeder, B. R.; Giacometti, R. D.; Merner, B. L.; Østergaard, M.; 
Swayze, E. E.; Seth, P. P., Structure-based Design of a Highly Constrained Nucleic 
Acid Analogue: Improved Duplex Stabilization by Restricting Sugar Pucker and 
Torsion Angle γ. Angew. Chem., Int. Ed., 2012, 51, 11242-11245. 
59. Schneider, K. C.; Benner, S. A., Oligonucleotides Containing Flexible Nucleoside 
Analogs. J. Am. Chem. Soc., 1990, 112, 453-455. 
60. Wang, R.; Wang, C.; Cao, Y.; Zhu, Z.; Yang, C.; Chen, J.; Qing, F.-L.; Tan, W., 
Reference 
187 
 
Trifluoromethylated Nucleic Acid Analogues Capable of Self-assembly through 
Hydrophobic Interactions. Chem. Sci., 2014, 5, 4076-4081. 
61. Nielsen, P.; Dreiøe, L. H.; Wengel, J., Synthesis and Evaluation of 
Oligodeoxynucleotides Containing Acyclic Nucleosides: Introduction of Three Novel 
Analogues and a Summary. Bioorg. Med. Chem., 1995, 3, 19-28. 
62. Zhang, L.; Peritz, A.; Meggers, E., A Simple Glycol Nucleic Acid. J. Am. Chem. Soc., 
2005, 127, 4174-4175. 
63. Karri, P.; Punna, V.; Kim, K.; Krishnamurthy, R., Base-pairing Properties of a 
Structural Isomer of Glycerol Nucleic Acid. Angew. Chem., Int. Ed., 2013, 52, 
5840-5844. 
64. Li, P.; Sun, J.; Su, M.; Yang, X.; Tang, X., Design, Synthesis and Properties of 
Artificial Nucleic Acids from (R)-4-amino-butane-1,3-diol. Org. Bio. Chem., 2014, 12, 
2263-2272. 
65. Asanuma, H.; Toda, T.; Murayama, K.; Liang, X.; Kashida, H., Unexpectedly Stable 
Artificial Duplex from Flexible Acyclic Threoninol. J. Am. Chem. Soc., 2010, 132, 
14702-14703. 
66. Kashida, H.; Murayama, K.; Toda, T.; Asanuma, H., Control of the Chirality and 
Helicity of Oligomers of Serinol Nucleic Acid (SNA) by Sequence Design. Angew. 
Chem., Int. Ed., 2011, 50, 1285-1288. 
67. Campbell, M. A.; Wengel, J., Locked vs. Unlocked Nucleic Acids (LNA vs.UNA): 
Contrasting Structures Work Towards Common Therapeutic Goals. Chem. Soc. Rev., 
2011, 40, 5680-5689. 
68. Nielsen, P.; Egholm, M.; Berg, R.; Buchardt, O., Sequence-selective Recognition of 
DNA by Strand Displacement with a Thymine-substituted Polyamide. Science, 1991, 
254, 1497-1500. 
69. Braasch, D. A.; Corey, D. R., Synthesis, Analysis, Purification, and Intracellular 
Delivery of Peptide Nucleic Acids. Methods, 2001, 23, 97-107. 
70. Gildea, B. D.; Casey, S.; MacNeill, J.; Perry-O'Keefe, H.; Sørensen, D.; Coull, J. M., 
PNA Solubility Enhancers. Tetrahedron Lett., 1998, 39, 7255-7258. 
71. Clivio, P.; Guillaume, D.; Adeline, M.-T.; Fourrey, J.-L., A Photochemical Approach to 
Highlight Backbone Effects in PNA. J. Am. Chem. Soc., 1997, 119, 5255-5256. 
72. Pinheiro, V. B.; Taylor, A. I.; Cozens, C.; Abramov, M.; Renders, M.; Zhang, S.; 
Chaput, J. C.; Wengel, J.; Peak-Chew, S.-Y.; McLaughlin, S. H.; Herdewijn, P.; 
Holliger, P., Synthetic Genetic Polymers Capable of Heredity and Evolution. Science, 
2012, 336, 341-344. 
73. Heuberger, B. D.; Switzer, C., A Pre-RNA Candidate Revisited:  Both Enantiomers of 
Flexible Nucleoside Triphosphates are DNA Polymerase Substrates. J. Am. Chem. Soc., 
2007, 130, 412-413. 
74. Yu, H.; Zhang, S.; Dunn, M. R.; Chaput, J. C., An Efficient and Faithful in vitro 
Replication System for Threose Nucleic Acid. J. Am. Chem. Soc., 2013, 135, 
3583-3591. 
75. Nguyen, H. V.; Sallustrau, A.; Male, L.; Thornton, P. J.; Tucker, J. H. R., 
Reference   
188 
   
1,1′-Homodisubstituted Ferrocenes Containing Adenine and Thymine Nucleobases: 
Synthesis, Electrochemistry, and Formation of H-Bonded Arrays. Organometallics, 
2011, 30, 5284-5290. 
76. Nguyen, H. V.; Zhao, Z.-y.; Sallustrau, A.; Horswell, S. L.; Male, L.; Mulas, A.; Tucker, 
J. H. R., A Ferrocene Nucleic Acid Oligomer as an Organometallic Structural Mimic of 
DNA. Chem. Commun., 2012, 48, 12165-12167. 
77. Nguyen, H. V.; Sallustrau, A.; Balzarini, J.; Bedford, M. R.; Eden, J. C.; Georgousi, N.; 
Hodges, N. J.; Kedge, J.; Mehellou, Y.; Tselepis, C.; Tucker, J. H. R., Organometallic 
Nucleoside Analogues with Ferrocenyl Linker Groups: Synthesis and Cancer Cell Line 
Studies. J. Med. Chem., 2014, 57, 5817-5822. 
78. Hirao, I.; Kimoto, M.; Yamashige, R., Natural versus Artificial Creation of Base Pairs 
in DNA: Origin of Nucleobases from the Perspectives of Unnatural Base Pair Studies. 
Acc. Chem. Res., 2012, 45, 2055-2065. 
79. Jaramillo, C.; Knapp, S., Synthesis of C-Aryl Glycosides. Synthesis, 1994, 1994, 1-20. 
80. Adamo, M. F. A.; Pergoli, R., Synthesis and Medicinal Properties of 2'-deoxyribose 
and Ribose C-Nucleosides. Curr. Org. Chem., 2008, 12, 1544-1569. 
81. Štambaský, J.; Hocek, M.; Kočovský, P., C-Nucleosides: Synthetic Strategies and 
Biological Applications. Chem. Rev., 2009, 109, 6729-6764. 
82. Jorgensen, W. L.; Pranata, J., Importance of Secondary Interactions in Triply Hydrogen 
Bonded Complexes: Guanine-cytosine vs Uracil-2,6-diaminopyridine. J. Am. Chem. 
Soc., 1990, 112, 2008-2010. 
83. Pranata, J.; Wierschke, S. G.; Jorgensen, W. L., OPLS Potential Functions for 
Nucleotide Bases. Relative Association Constants of Hydrogen-bonded Base Pairs in 
Chloroform. J. Am. Chem. Soc., 1991, 113, 2810-2819. 
84. Papmeyer, M.; Vuilleumier, C. A.; Pavan, G. M.; Zhurov, K. O.; Severin, K., 
Molecularly Defined Nanostructures Based on a Novel AAA-DDD Triple 
Hydrogen-Bonding Motif. Angew. Chem., Int. Ed., 2016, 55, 1685-1689. 
85. Switzer, C.; Moroney, S. E.; Benner, S. A., Enzymatic Incorporation of a New Base 
Pair into DNA and RNA. J. Am. Chem. Soc., 1989, 111, 8322-8323. 
86. Piccirilli, J. A.; Krauch, T.; Moroney, S. E.; Benner, S. A., Enzymatic Incorporation of 
a New Base Pair into DNA and RNA Extends the Genetic Alphabet. Nature, 1990, 343, 
33-37. 
87. Piccirilli, J. A.; Krauch, T.; MacPherson, L. J.; Benner, S. A., A Direct Route to 
3-(D-Ribofuranosyl)pyridine Nucleosides. Helv. Chim. Acta, 1991, 74, 397-406. 
88. Voegel, J. J.; Benner, S. A., Nonstandard Hydrogen Bonding in Duplex Oligo- 
nucleotides. The Base Pair between an Acceptor-Donor-Donor Pyrimidine Analog and 
a Donor-Acceptor-Acceptor Purine Analog. J. Am. Chem. Soc., 1994, 116, 6929-6930. 
89. von Krosigk, U.; Benner, S. A., pH-Independent Triple Helix Formation by an 
Oligonucleotide Containing a Pyrazine Donor-Donor-Acceptor Base. J. Am. Chem. 
Soc., 1995, 117, 5361-5362. 
90. Switzer, C. Y.; Moroney, S. E.; Benner, S. A., Enzymic Recognition of the Base Pair 
Between Isocytidine and Isoguanosine. Biochemistry, 1993, 32, 10489-10496. 
Reference 
189 
 
91. Bain, J. D.; Switzer, C.; Chamberlin, R.; Bennert, S. A., Ribosome-mediated 
Incorporation of a Non-standard Amino Acid into a Peptide through Expansion of the 
Genetic Code. Nature, 1992, 356, 537-539. 
92. Sismour, A. M.; Benner, S. A., The Use of Thymidine Analogs to Improve the 
Replication of an Extra DNA Base Pair: A Synthetic Biological System. Nucleic Acids 
Res., 2005, 33, 5640-5646. 
93. Horlacher, J.; Hottiger, M.; Podust, V. N.; Hübscher, U.; Benner, S. A., Recognition by 
Viral and Cellular DNA Polymerases of Nucleosides Bearing Bases with Nonstandard 
Hydrogen Bonding Patterns. Proc. Natl. Acad. Sci. USA, 1995, 92, 6329-6333. 
94. Lutz, M. J.; Held, H. A.; Hottiger, M.; Hübscher, U.; Benner, S. A., Differential 
Discrimination of DNA Polymerases for Variants of the Non-standard Nucleobase Pair 
Between Xanthosine and 2,4-Diaminopyrimidine, Two Components of an Expanded 
Genetic Alphabet. Nucleic Acids Res., 1996, 24, 1308-1313. 
95. Benner, S. A., Understanding Nucleic Acids Using Synthetic Chemistry. Acc. Chem. 
Res., 2004, 37, 784-797. 
96. Hirao, I.; Ohtsuki, T.; Fujiwara, T.; Mitsui, T.; Yokogawa, T.; Okuni, T.; Nakayama, H.; 
Takio, K.; Yabuki, T.; Kigawa, T.; Kodama, K.; Yokogawa, T.; Nishikawa, K.; 
Yokoyama, S., An Unnatural Base Pair for Incorporating Amino Acid Analogs into 
Proteins. Nat. Biotech., 2002, 20, 177-182. 
97. Hirao, I.; Harada, Y.; Kimoto, M.; Mitsui, T.; Fujiwara, T.; Yokoyama, S., A Two- 
unnatural-base-pair System toward the Expansion of the Genetic Code. J. Am. Chem. 
Soc., 2004, 126, 13298-13305. 
98. Scopes, D.; Barrio; Leonard, N., Defined Dimensional Changes in Enzyme Cofactors: 
Fluorescent "Stretched-out" Analogs of Adenine Nucleotides. Science, 1977, 195, 
296-298. 
99. Liu, H.; Gao, J.; Lynch, S. R.; Saito, Y. D.; Maynard, L.; Kool, E. T., A Four-Base 
Paired Genetic Helix with Expanded Size. Science, 2003, 302, 868-871. 
100. Liu, H.; Gao, J.; Maynard, L.; Saito, Y. D.; Kool, E. T., Toward a New Genetic System 
with Expanded Dimensions: Size-expanded Analogues of Deoxyadenosine and 
Thymidine. J. Am. Chem. Soc., 2004, 126, 1102-1109. 
101. Lu, H.; He, K.; Kool, E. T., yDNA: A New Geometry for Size-expanded Base Pairs. 
Angew. Chem., Int. Ed., 2004, 43, 5834-5836. 
102. Delaney, J. C.; Gao, J.; Liu, H.; Shrivastav, N.; Essigmann, J. M.; Kool, E. T., Efficient 
Replication Bypass of Size-Expanded DNA Base Pairs in Bacterial Cells. Angew. 
Chem., Int. Ed., 2009, 48, 4524-4527. 
103. Minakawa, N.; Kojima, N.; Hikishima, S.; Sasaki, T.; Kiyosue, A.; Atsumi, N.; Ueno, 
Y.; Matsuda, A., New Base Pairing Motifs. The Synthesis and Thermal Stability of 
Oligodeoxynucleotides Containing Imidazopyridopyrimidine Nucleosides with the 
Ability to Form Four Hydrogen Bonds. J. Am. Chem. Soc., 2003, 125, 9970-9982. 
104. Hikishima, S.; Minakawa, N.; Kuramoto, K.; Fujisawa, Y.; Ogawa, M.; Matsuda, A., 
Synthesis of 1,8-Naphthyridine C-Nucleosides and Their Base- pairing Properties in 
Oligodeoxynucleotides: Thermally Stable Naphthyridine:Imidazopyridopyrimidine 
Reference   
190 
   
Base-pairing Motifs. Angew. Chem., Int. Ed., 2005, 44, 596-598. 
105. Minakawa, N.; Ogata, S.; Takahashi, M.; Matsuda, A., Selective Recognition of 
Unnatural Imidazopyridopyrimidine:Naphthyridine Base Pairs Consisting of Four 
Hydrogen Bonds by the Klenow Fragment. J. Am. Chem. Soc., 2009, 131, 1644-1645. 
106. Doi, Y.; Chiba, J.; Morikawa, T.; Inouye, M., Artificial DNA Made Exclusively of 
Nonnatural C-Nucleosides with Four Types of Nonnatural Bases. J. Am. Chem. Soc., 
2008, 130, 8762-8768. 
107. Shin, D.; Sinkeldam, R. W.; Tor, Y., Emissive RNA Alphabet. J. Am. Chem. Soc., 2011, 
133, 14912-14915. 
108. Rovira, A. R.; Fin, A.; Tor, Y., Chemical Mutagenesis of an Emissive RNA Alphabet. J. 
Am. Chem. Soc., 2015, 137, 14602-14605. 
109. Moran, S.; Ren, R. X. F.; Rumney; Kool, E. T., Difluorotoluene, a Nonpolar Isostere 
for Thymine, Codes Specifically and Efficiently for Adenine in DNA Replication. J. 
Am. Chem. Soc., 1997, 119, 2056-2057. 
110. Moran, S.; Ren, R. X.-F.; Kool, E. T., A Thymidine Triphosphate Shape Analog 
Lacking Watson-Crick Pairing Ability is Replicated with High Sequence Selectivity. 
Proc. Natl. Acad. Sci. USA, 1997, 94, 10506-10511. 
111. Matray, T. J.; Kool, E. T., A Specific Partner for Abasic Damage in DNA. Nature, 1999, 
399, 704-708. 
112. Schweitzer, B. A.; Kool, E. T., Aromatic Nonpolar Nucleosides as Hydrophobic 
Isosteres of Pyrimidines and Purine Nucleosides. J. Org. Chem., 1994, 59, 7238-7242. 
113. Schweitzer, B. A.; Kool, E. T., Hydrophobic, Non-hydrogen-bonding Bases and Base 
Pairs in DNA. J. Am. Chem. Soc., 1995, 117, 1863-1872. 
114. Morales, J. C.; Kool, E. T., Efficient Replication between Non-hydrogen-bonded 
Nucleoside Shape Analogs. Nat. Struct. Mol. Biol., 1998, 5, 950-954. 
115. Morales, J. C.; Kool, E. T., Minor Groove Interactions between Polymerase and DNA:  
More Essential to Replication than Watson-Crick Hydrogen Bonds? J. Am. Chem. Soc., 
1999, 121, 2323-2324. 
116. Hirao, I.; Kimoto, M.; Mitsui, T.; Fujiwara, T.; Kawai, R.; Sato, A.; Harada, Y.; 
Yokoyama, S., An Unnatural Hydrophobic Base Pair System: Site-specific 
Incorporation of Nucleotide Analogs into DNA and RNA. Nat. Methods, 2006, 3, 
729-735. 
117. Kimoto, M.; Mitsui, T.; Yokoyama, S.; Hirao, I., A Unique Fluorescent Base Analogue 
for the Expansion of the Genetic Alphabet. J. Am. Chem. Soc., 2010, 132, 4988-4989. 
118. Kimoto, M.; Mitsui, T.; Yamashige, R.; Sato, A.; Yokoyama, S.; Hirao, I., A New 
Unnatural Base Pair System between Fluorophore and Quencher Base Analogues for 
Nucleic Acid-based Imaging Technology. J. Am. Chem. Soc., 2010, 132, 15418-15426. 
119. McMinn, D. L.; Ogawa, A. K.; Wu, Y.; Liu, J.; Schultz, P. G.; Romesberg, F. E., Efforts 
toward Expansion of the Genetic Alphabet:  DNA Polymerase Recognition of a Highly 
Stable, Self-Pairing Hydrophobic Base. J. Am. Chem. Soc., 1999, 121, 11585-11586. 
120. Yu, C.; Henry, A. A.; Romesberg, F. E.; Schultz, P. G., Polymerase Recognition of 
Unnatural Base Pairs. Angew. Chem., Int. Ed., 2002, 41, 3841-3844. 
Reference 
191 
 
121. Matsuda, S.; Leconte, A. M.; Romesberg, F. E., Minor Groove Hydrogen Bonds and 
the Replication of Unnatural Base Pairs. J. Am. Chem. Soc., 2007, 129, 5551-5557. 
122. Hwang, G. T.; Romesberg, F. E., Unnatural Substrate Repertoire of A, B, and X Family 
DNA Polymerases. J. Am. Chem. Soc., 2008, 130, 14872-14882. 
123. Seo, Y. J.; Romesberg, F. E., Major Groove Derivatization of an Unnatural Base Pair. 
ChemBioChem, 2009, 10, 2394-2400. 
124. Seo, Y. J.; Hwang, G. T.; Ordoukhanian, P.; Romesberg, F. E., Optimization of an 
Unnatural Base Pair toward Natural-like Replication. J. Am. Chem. Soc., 2009, 131, 
3246-3252. 
125. Seo, Y. J.; Matsuda, S.; Romesberg, F. E., Transcription of an Expanded Genetic 
Alphabet. J. Am. Chem. Soc., 2009, 131, 5046-5047. 
126. Malyshev, D. A.; Seo, Y. J.; Ordoukhanian, P.; Romesberg, F. E., PCR with an 
Expanded Genetic Alphabet. J. Am. Chem. Soc., 2009, 131, 14620-14621. 
127. Betz, K.; Malyshev, D. A.; Lavergne, T.; Welte, W.; Diederichs, K.; Dwyer, T. J.; 
Ordoukhanian, P.; Romesberg, F. E.; Marx, A., KlenTaq Polymerase Replicates 
Unnatural Base Pairs by Inducing a Watson-Crick Geometry. Nat. Chem. Biol., 2012, 8, 
612-614. 
128. Malyshev, D. A.; Dhami, K.; Quach, H. T.; Lavergne, T.; Ordoukhanian, P.; Torkamani, 
A.; Romesberg, F. E., Efficient and Sequence-independent Replication of DNA 
Containing a Third Base Pair Establishes a Functional Six-letter Genetic Alphabet. 
Proc. Natl. Acad. Sci. USA, 2012, 109, 12005-12010. 
129. Malyshev, D. A.; Dhami, K.; Lavergne, T.; Chen, T.; Dai, N.; Foster, J. M.; Correa, I. 
R.; Romesberg, F. E., A Semi-synthetic Organism with an Expanded Genetic Alphabet. 
Nature, 2014, 509, 385-388. 
130. Tomás-Gamasa, M.; Serdjukow, S.; Su, M.; Müller, M.; Carell, T., “Post-It” Type 
Connected DNA Created with a Reversible Covalent Crosslink. Angew. Chem., Int. Ed., 
2015, 54, 796-800. 
131. Yang, Z.; Price, N. E.; Johnson, K. M.; Gates, K. S., Characterization of Interstrand 
DNA-DNA Cross-links Derived from Abasic Sites Using Bacteriophage Φ29 DNA 
Polymerase. Biochemistry, 2015, 54, 4259-4266. 
132. Johnson, K. M.; Price, N. E.; Wang, J.; Fekry, M. I.; Dutta, S.; Seiner, D. R.; Wang, Y.; 
Gates, K. S., On the Formation and Properties of Interstrand DNA-DNA Cross-Links 
Forged by Reaction of an Abasic Site with the Opposing Guanine Residue of 5′-CAp 
Sequences in Duplex DNA. J. Am. Chem. Soc., 2013, 135, 1015-1025. 
133. Katz, S., The Reversible Reaction of Sodium Thymonucleate and Mercuric Chloride. J. 
Am. Chem. Soc., 1952, 74, 2238-2245. 
134. Thomas, C. A., The Interaction of HgCl2 with Sodium Thymonucleate. J. Am. Chem. 
Soc., 1954, 76, 6032-6034. 
135. Katz, S., The Reversible Reaction of Hg (II) and Double-stranded Plynucleotides a 
Step-function Theory and its Significance. Biochim. Biophys. Acta, 1963, 68, 240-253. 
136. Atwell, S.; Meggers, E.; Spraggon, G.; Schultz, P. G., Structure of a Copper-mediated 
Base Pair in DNA. J. Am. Chem. Soc., 2001, 123, 12364-12367. 
Reference   
192 
   
137. Kaul, C.; Müller, M.; Wagner, M.; Schneider, S.; Carell, T., Reversible Bond Formation 
Enables the Replication and Amplification of a Crosslinking Salen Complex as an 
Orthogonal Base Pair. Nat. Chem., 2011, 3, 794-800. 
138. Ono, A.; Togashi, H., Highly Selective Oligonucleotide-based Sensor for Mercury(II) 
in Aqueous Solutions. Angew. Chem., Int. Ed., 2004, 43, 4300-4302. 
139. Miyake, Y.; Togashi, H.; Tashiro, M.; Yamaguchi, H.; Oda, S.; Kudo, M.; Tanaka, Y.; 
Kondo, Y.; Sawa, R.; Fujimoto, T.; Machinami, T.; Ono, A., Mercury(II)-mediated 
Formation of Thymine-Hg(II)-Thymine Base Pairs in DNA Duplexes. J. Am. Chem. 
Soc., 2006, 128, 2172-2173. 
140. Ono, A.; Cao, S.; Togashi, H.; Tashiro, M.; Fujimoto, T.; Machinami, T.; Oda, S.; 
Miyake, Y.; Okamoto, I.; Tanaka, Y., Specific Interactions between Silver(I) Ions and 
Cytosine-cytosine Pairs in DNA Duplexes. Chem. Commun., 2008, 44, 4825-4827. 
141. Okamoto, I.; Iwamoto, K.; Watanabe, Y.; Miyake, Y.; Ono, A., Metal-Ion Selectivity of 
Chemically Modified Uracil Pairs in DNA Duplexes. Angew. Chem., Int. Ed., 2009, 48, 
1648-1651. 
142. Ennifar, E.; Walter, P.; Dumas, P., A Crystallographic Study of the Binding of 13 Metal 
Ions to Two Related RNA Duplexes. Nucleic Acids Res., 2003, 31, 2671-2682. 
143. Kondo, J.; Yamada, T.; Hirose, C.; Okamoto, I.; Tanaka, Y.; Ono, A., Crystal Structure 
of Metallo DNA Duplex Containing Consecutive Watson-Crick-like T-Hg(II)-T Base 
Pairs. Angew. Chem., Int. Ed., 2014, 53, 2385-2388. 
144. Kondo, J.; Tada, Y.; Dairaku, T.; Saneyoshi, H.; Okamoto, I.; Tanaka, Y.; Ono, A., 
High-resolution Crystal Structure of Silver(I)-RNA Hybrid Duplex Containing 
Watson-Crick-like C-Silver(I)-C Metallo-Base Pairs. Angew. Chem., Int. Ed., 2015, 
13323-13326. 
145. Freeman, R.; Finder, T.; Willner, I., Multiplexed Analysis of Hg2+ and Ag+ Ions by 
Nucleic Acid Functionalized CdSe/ZnS Quantum Dots and Their Use for Logic Gate 
Operations. Angew. Chem., Int. Ed., 2009, 48, 7818-7821. 
146. Ihara, T.; Ishii, T.; Araki, N.; Wilson, A. W.; Jyo, A., Silver Ion Unusually Stabilizes the 
Structure of a Parallel-Motif DNA Triplex. J. Am. Chem. Soc., 2009, 131, 3826-3827. 
147. Urata, H.; Yamaguchi, E.; Funai, T.; Matsumura, Y.; Wada, S.-i., Incorporation of 
Thymine Nucleotides by DNA Polymerases through T-Hg(II)-T Base Pairing. Angew. 
Chem., Int. Ed., 2010, 49, 6516-6519. 
148. Funai, T.; Miyazaki, Y.; Aotani, M.; Yamaguchi, E.; Nakagawa, O.; Wada, S.-i.; 
Torigoe, H.; Ono, A.; Urata, H., AgI Ion Mediated Formation of a C-A Mispair by 
DNA Polymerases. Angew. Chem., Int. Ed., 2012, 51, 6464-6466. 
149. Johannsen, S.; Paulus, S.; Düpre, N.; Müller, J.; Sigel, R. K. O., Using in vitro 
Transcription to Construct Scaffolds for One-dimensional Arrays of Mercuric Ions. J. 
Inorg. Biochem., 2008, 102, 1141-1151. 
150. Tanaka, K.; Shionoya, M., Synthesis of a Novel Nucleoside for Alternative DNA Base 
Pairing through Metal Complexation. J. Org. Chem., 1999, 64, 5002-5003. 
151. Tasaka, M.; Tanaka, K.; Shiro, M.; Shionoya, M., A Palladium-mediated DNA Base 
Pair of a β-C-Nucleoside Possessing a 2-Aminophenol as the Nucleobase. Supramol. 
Reference 
193 
 
Chem., 2001, 13, 671-675. 
152. Cao, H.; Tanaka, K.; Shionoya, M., An Alternative Base-pairing of Catechol-bearing 
Nucleosides by Borate Formation. Chem. Pharm. Bull., 2000, 48, 1745-1748. 
153. Tanaka, K.; Tasaka, M.; Cao, H.; Shionoya, M., An Approach to Metal-assisted DNA 
Base Pairing: Novel β-C-Nucleosides with a 2-Aminophenol or a Catechol as the 
Nucleobase. Eur. J. Pharm. Sci., 2001, 13, 77-83. 
154. Tanaka, K.; Tengeiji, A.; Kato, T.; Toyama, N.; Shiro, M.; Shionoya, M., Efficient 
Incorporation of a Copper Hydroxypyridone Base Pair in DNA. J. Am. Chem. Soc., 
2002, 124, 12494-12498. 
155. Tanaka, K.; Yamada, Y.; Shionoya, M., Formation of Silver(I)-Mediated DNA Duplex 
and Triplex through an Alternative Base Pair of Pyridine Nucleobases. J. Am. Chem. 
Soc., 2002, 124, 8802-8803. 
156. Tanaka, K.; Tengeiji, A.; Kato, T.; Toyama, N.; Shionoya, M., A Discrete 
Self-assembled Metal Array in Artificial DNA. Science, 2003, 299, 1212-1213. 
157. Takezawa, Y.; Maeda, W.; Tanaka, K.; Shionoya, M., Discrete Self-assembly of Iron(III) 
Ions inside Triple-stranded Artificial DNA. Angew. Chem., Int. Ed., 2009, 48, 
1081-1084. 
158. Meggers, E.; Holland, P. L.; Tolman, W. B.; Romesberg, F. E.; Schultz, P. G., A Novel 
Copper-mediated DNA Base Pair. J. Am. Chem. Soc., 2000, 122, 10714-10715. 
159. Zimmermann, N.; Meggers, E.; Schultz, P. G., A Second-generation Copper(II)- 
mediated Metallo-DNA-base pair. Bioorg. Chem., 2004, 32, 13-25. 
160. Zimmermann, N.; Meggers, E.; Schultz, P. G., A Novel Silver(I)-mediated DNA Base 
Pair. J. Am. Chem. Soc., 2002, 124, 13684-13685. 
161. Böhme, D.; Düpre, N.; Megger, D. A.; Müller, J., Conformational Change Induced by 
Metal-ion-bnding to DNA Containing the Artificial 1,2,4-Triazole Nucleoside. Inorg. 
Chem., 2007, 46, 10114-10119. 
162. Seubert, K.; Guerra, C. F.; Bickelhaupt, F. M.; Muller, J., Chimeric GNA/DNA 
Metal-mediated Base Pairs. Chem. Commun., 2011, 47, 11041-11043. 
163. Zhang, L.; Meggers, E., An Extremely Stable and Orthogonal DNA Base Pair with a 
Simplified Three-Carbon Backbone. J. Am. Chem. Soc., 2004, 127, 74-75. 
164. Shin, D.; Switzer, C., A Metallo Base-pair Incorporating a Terpyridyl-like Motif: 
Bipyridyl-pyrimidinone-Ag(I)-4-pyridine. Chem. Commun., 2007, 43, 4401-4403. 
165. Heuberger, B. D.; Shin, D.; Switzer, C., Two Watson-Crick-Like Metallo Base-Pairs. 
Org. Lett., 2008, 10, 1091-1094. 
166. Switzer, C.; Sinha, S.; Kim, P. H.; Heuberger, B. D., A Purine-like Nickel(II) Base Pair 
for DNA. Angew. Chem., Int. Ed., 2005, 44, 1529-1532. 
167. Switzer, C.; Shin, D., A Pyrimidine-like Nickel(II) DNA Base Pair. Chem. Commun., 
2005, 41, 1342-1344. 
168. Weizman, H.; Tor, Y., 2,2‘-Bipyridine Ligandoside:  A Novel Building Block for 
Modifying DNA with Intra-duplex Metal Complexes. J. Am. Chem. Soc., 2001, 123, 
3375-3376. 
169. Brotschi, C.; Häberli, A.; Leumann, C. J., A Stable DNA Duplex Containing a Non- 
Reference   
194 
   
hydrogen-bonding and Non-shape-complementary Base Couple: Interstrand Stacking 
as the Stability Determining Factor. Angew. Chem., Int. Ed., 2001, 40, 3012-3014. 
170. Megger, D. A.; Fonseca Guerra, C.; Hoffmann, J.; Brutschy, B.; Bickelhaupt, F. M.; 
Müller, J., Contiguous Metal-mediated Base Pairs Comprising Two AgI Ions. Chem. 
Eur. J., 2011, 17, 6533-6544. 
171. Mei, H.; Röhl, I.; Seela, F., Ag+-Mediated DNA Base Pairing: Extraordinarily Stable 
Pyrrolo-dC–Pyrrolo-dC Pairs Binding Two Silver Ions. J. Org. Chem., 2013, 78, 
9457-9463. 
172. Sinha, I.; Fonseca Guerra, C.; Müller, J., A Highly Stabilizing Silver(I)-mediated Base 
Pair in Parallel-Stranded DNA. Angew. Chem., Int. Ed., 2015, 54, 3603-3606. 
173. Clever, G. H.; Polborn, K.; Carell, T., A Highly DNA-duplex-stabilizing Metal–salen 
Base Pair. Angew. Chem., Int. Ed., 2005, 44, 7204-7208. 
174. Clever, G. H.; Söltl, Y.; Burks, H.; Spahl, W.; Carell, T., Metal-Salen-Base-Pair 
Complexes Inside DNA: Complexation Overrides Sequence Information. Chem. Eur. J., 
2006, 12, 8708-8718. 
175. Clever, G. H.; Carell, T., Controlled Stacking of 10 Transition-metal Ions inside a DNA 
Duplex. Angew. Chem., Int. Ed., 2007, 46, 250-253. 
176. Tanaka, K.; Clever, G. H.; Takezawa, Y.; Yamada, Y.; Kaul, C.; Shionoya, M.; Carell, 
T., Programmable Self-assembly of Metal Ions inside Artificial DNA Duplexes. Nat. 
Nano, 2006, 1, 190-194. 
177. Jain, M. L.; Bruice, P. Y.; Szabó, I. E.; Bruice, T. C., Incorporation of Positively 
Charged Linkages into DNA and RNA Backbones: A Novel Strategy for Antigene and 
Antisense Agents. Chem. Rev., 2012, 112, 1284-1309. 
178. Navarro, E.; Serrano-Heras, G.; Castaño, M. J.; Solera, J., Real-time PCR Detection 
Chemistry. Clin. Chim. Acta, 2015, 439, 231-250. 
179. Johnson, T. B.; Coghill, R. D., Researches on Pyrimidines. C111. The Discovery of 
5-Methylcytosine in Tuberculinic Acid, the Nucleic Acid of the Tubercle Bacillus 1. J. 
Am. Chem. Soc., 1925, 47, 2838-2844. 
180. Holliday, R.; Pugh, J., DNA Modification Mechanisms and Gene Activity During 
Development. Science, 1975, 187, 226-232. 
181. Goll, M. G.; Bestor, T. H., Eukaryotic Cytosine Methyltransferases. Ann. Rev. 
Biochem., 2005, 74, 481-514. 
182. Cheng, X.; Blumenthal, R. M., Mammalian DNA Methyltransferases: A Structural 
Perspective. Structure, 2008, 16, 341-350. 
183. Chiang, P. K.; Gordon, R. K.; Tal, J.; Zeng, G. C.; Doctor, B. P.; Pardhasaradhi, K.; 
McCann, P. P., S-Adenosylmethionine and Methylation. FASEB J., 1996, 10, 471-80. 
184. Bird, A., DNA Methylation Patterns and Epigenetic Memory. Genes Dev., 2002, 16, 
6-21. 
185. Chan, S. W. L.; Henderson, I. R.; Jacobsen, S. E., Gardening the Genome: DNA 
Methylation in Arabidopsis Thaliana. Nat. Rev. Genet., 2005, 6, 351-360. 
186. Law, J. A.; Jacobsen, S. E., Establishing, Maintaining and Modifying DNA 
Methylation Patterns in Plants and Animals. Nat. Rev. Genet., 2010, 11, 204-220. 
Reference 
195 
 
187. Deaton, A. M.; Bird, A., CpG Islands and the Regulation of Transcription. Genes Dev., 
2011, 25, 1010-1022. 
188. Ramsahoye, B. H.; Biniszkiewicz, D.; Lyko, F.; Clark, V.; Bird, A. P.; Jaenisch, R., 
Non-CpG Methylation is Prevalent in Embryonic Stem Cells and may be Mediated by 
DNA Methyltransferase 3a. Proc. Natl. Acad. Sci. USA, 2000, 97, 5237-5242. 
189. Shirane, K.; Toh, H.; Kobayashi, H.; Miura, F.; Chiba, H.; Ito, T.; Kono, T.; Sasaki, H., 
Mouse Oocyte Methylomes at Base Resolution Reveal Genome-wide Accumulation of 
Non-CpG Methylation and Role of DNA Methyltransferases. PLoS Genet., 2013, 9, 
e1003439. 
190. Lister, R.; Mukamel, E. A.; Nery, J. R.; Urich, M.; Puddifoot, C. A.; Johnson, N. D.; 
Lucero, J.; Huang, Y.; Dwork, A. J.; Schultz, M. D.; Yu, M.; Tonti-Filippini, J.; Heyn, 
H.; Hu, S.; Wu, J. C.; Rao, A.; Esteller, M.; He, C.; Haghighi, F. G.; Sejnowski, T. J.; 
Behrens, M. M.; Ecker, J. R., Global Epigenomic Reconfiguration During Mammalian 
Brain Development. Science, 2013, 341, 629. 
191. Xie, W.; Barr, Cathy L.; Kim, A.; Yue, F.; Lee, Ah Y.; Eubanks, J.; Dempster, Emma L.; 
Ren, B., Base-resolution Analyses of Sequence and Parent-of-origin Dependent DNA 
Methylation in the Mouse Genome. Cell, 2011, 148, 816-831. 
192. Ehrlich, M.; Wang, R., 5-Methylcytosine in Eukaryotic DNA. Science, 1981, 212, 
1350-1357. 
193. Feinberg, A. P.; Ohlsson, R.; Henikoff, S., The Epigenetic Progenitor Origin of Human 
Cancer. Nat. Rev. Genet., 2006, 7, 21-33. 
194. Razin, A.; Riggs, A., DNA Methylation and Gene Function. Science, 1980, 210, 
604-610. 
195. Lister, R.; Pelizzola, M.; Dowen, R. H.; Hawkins, R. D.; Hon, G.; Tonti-Filippini, J.; 
Nery, J. R.; Lee, L.; Ye, Z.; Ngo, Q.-M.; Edsall, L.; Antosiewicz-Bourget, J.; Stewart, 
R.; Ruotti, V.; Millar, A. H.; Thomson, J. A.; Ren, B.; Ecker, J. R., Human DNA 
Methylomes at Base Resolution Show Widespread Epigenomic Differences. Nature, 
2009, 462, 315-322. 
196. Rauch, T. A.; Wu, X.; Zhong, X.; Riggs, A. D.; Pfeifer, G. P., A Human B Cell 
Methylome at 100-Base Pair Resolution. Proc. Natl. Acad. Sci. USA, 2009, 106, 
671-678. 
197. Laurent, L.; Wong, E.; Li, G.; Huynh, T.; Tsirigos, A.; Ong, C. T.; Low, H. M.; Kin 
Sung, K. W.; Rigoutsos, I.; Loring, J.; Wei, C.-L., Dynamic Changes in the Human 
Methylome during Differentiation. Genome Res., 2010, 20, 320-331. 
198. Chen, T.; Ueda, Y.; Dodge, J. E.; Wang, Z.; Li, E., Establishment and Maintenance of 
Genomic Methylation Patterns in Mouse Embryonic Stem Cells by Dnmt3a and 
Dnmt3b. Mol. Cell  Bio., 2003, 23, 5594-5605. 
199. Wu, S. C.; Zhang, Y., Active DNA Demethylation: Many Roads Lead to Rome. Nat. 
Rev. Mol. Cell Biol., 2010, 11, 607-620. 
200. Bhutani, N.; Burns, David M.; Blau, Helen M., DNA Demethylation Dynamics. Cell, 
2011, 146, 866-872. 
201. Zhu, J.-K., Active DNA Demethylation Mediated by DNA Glycosylases. Ann. Rev. 
Reference   
196 
   
Genet., 2009, 43, 143-166. 
202. Bhattacharya, S. K.; Ramchandani, S.; Cervoni, N.; Szyf, M., A Mammalian Protein 
with Specific Demethylase Activity for mCpG DNA. Nature, 1999, 397, 579-583. 
203. Zhu, B.; Zheng, Y.; Hess, D.; Angliker, H.; Schwarz, S.; Siegmann, M.; Thiry, S.; Jost, 
J.-P., 5-Methylcytosine-DNA Glycosylase Activity is Present in a Cloned G/T 
Mismatch DNA Glycosylase Associated with the Chicken Embryo DNA 
Demethylation Complex. Proc. Natl. Acad. Sci. USA, 2000, 97, 5135-5139. 
204. Barreto, G.; Schafer, A.; Marhold, J.; Stach, D.; Swaminathan, S. K.; Handa, V.; 
Doderlein, G.; Maltry, N.; Wu, W.; Lyko, F.; Niehrs, C., Gadd45a Promotes Epigenetic 
Gene Activation by Repair-mediated DNA Demethylation. Nature, 2007, 445, 671-675. 
205. Nabel, C. S.; Jia, H.; Ye, Y.; Shen, L.; Goldschmidt, H. L.; Stivers, J. T.; Zhang, Y.; 
Kohli, R. M., AID/APOBEC deaminases disfavor modified cytosines implicated in 
DNA demethylation. Nat Chem Biol, 2012, 8, 751-758. 
206. Popp, C.; Dean, W.; Feng, S.; Cokus, S. J.; Andrews, S.; Pellegrini, M.; Jacobsen, S. E.; 
Reik, W., Genome-wide Erasure of DNA Methylation in Mouse Primordial Germ Cells 
is Affected by AID Deficiency. Nature, 2010, 463, 1101-1105. 
207. Kumar, R.; DiMenna, L.; Schrode, N.; Liu, T.-C.; Franck, P.; Munoz-Descalzo, S.; 
Hadjantonakis, A.-K.; Zarrin, A. A.; Chaudhuri, J.; Elemento, O.; Evans, T., AID 
Stabilizes Stem-cell Phenotype by Removing Epigenetic Memory of Pluripotency 
Genes. Nature, 2013, 500, 89-92. 
208. Metivier, R.; Gallais, R.; Tiffoche, C.; Le Peron, C.; Jurkowska, R. Z.; Carmouche, R. 
P.; Ibberson, D.; Barath, P.; Demay, F.; Reid, G.; Benes, V.; Jeltsch, A.; Gannon, F.; 
Salbert, G., Cyclical DNA Methylation of a Transcriptionally Active Promoter. Nature, 
2008, 452, 45-50. 
209. Wyatt, G. R.; Cohen, S. S., A New Pyrimidine Base from Bacteriophage Nucleic Acids. 
Nature, 1952, 170, 1072-1073. 
210. Penn, N. W.; Suwalski, R.; O'Riley, C.; Bojanowski, K.; Yura, R., The Presence of 
5-Hydroxymethylcytosine in Animal Deoxyribonucleic Acid. Biochem. J., 1972, 126, 
781-790. 
211. Kriaucionis, S.; Heintz, N., The Nuclear DNA Base 5-Hydroxymethylcytosine is 
Present in Purkinje Neurons and the Brain. Science, 2009, 324, 929-930. 
212. Tahiliani, M.; Koh, K. P.; Shen, Y.; Pastor, W. A.; Bandukwala, H.; Brudno, Y.; 
Agarwal, S.; Iyer, L. M.; Liu, D. R.; Aravind, L.; Rao, A., Conversion of 
5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner 
TET1. Science, 2009, 324, 930-935. 
213. Yu, M.; Hon, Gary C.; Szulwach, Keith E.; Song, C.-X.; Zhang, L.; Kim, A.; Li, X.; 
Dai, Q.; Shen, Y.; Park, B.; Min, J.-H.; Jin, P.; Ren, B.; He, C., Base-resolution 
Analysis of 5-Hydroxymethylcytosine in the Mammalian Genome. Cell, 2012, 149, 
1368-1380. 
214. Booth, M. J.; Branco, M. R.; Ficz, G.; Oxley, D.; Krueger, F.; Reik, W.; 
Balasubramanian, S., Quantitative Sequencing of 5-Methylcytosine and 
5-Hydroxymethylcytosine at Single-Base Resolution. Science, 2012, 336, 934-937. 
Reference 
197 
 
215. Szulwach, K. E.; Li, X.; Li, Y.; Song, C.-X.; Han, J. W.; Kim, S.; Namburi, S.; Hermetz, 
K.; Kim, J. J.; Rudd, M. K.; Yoon, Y.-S.; Ren, B.; He, C.; Jin, P., Integrating 
5-Hydroxymethylcytosine into the Epigenomic Landscape of Human Embryonic Stem 
Cells. PLoS Genet., 2011, 7, e1002154. 
216. Xu, Y.; Wu, F.; Tan, L.; Kong, L.; Xiong, L.; Deng, J.; Barbera, A. J.; Zheng, L.; Zhang, 
H.; Huang, S.; Min, J.; Nicholson, T.; Chen, T.; Xu, G.; Shi, Y.; Zhang, K.; Shi, 
Yujiang G., Genome-wide Regulation of hmdC, mdC, and Gene Expression by Tet1 
Hydroxylase in Mouse Embryonic Stem Cells. Mol. Cell, 2011, 42, 451-464. 
217. Stroud, H.; Feng, S.; Morey Kinney, S.; Pradhan, S.; Jacobsen, S. E., 5-Hydroxy- 
methylcytosine is Associated with Enhancers and Gene Bodies in Human Embryonic 
Stem Cells. Genome Biol., 2011, 12, R54. 
218. Shen, Y.; Yue, F.; McCleary, D. F.; Ye, Z.; Edsall, L.; Kuan, S.; Wagner, U.; Dixon, J.; 
Lee, L.; Lobanenkov, V. V.; Ren, B., A Map of the cis-Regulatory Sequences in the 
Mouse Genome. Nature, 2012, 488, 116-120. 
219. Münzel, M.; Globisch, D.; Brückl, T.; Wagner, M.; Welzmiller, V.; Michalakis, S.; 
Müller, M.; Biel, M.; Carell, T., Quantification of the Sixth DNA Base 
Hydroxymethylcytosine in the Brain. Angew. Chem., Int. Ed., 2010, 49, 5375-5377. 
220. Globisch, D.; Münzel, M.; Müller, M.; Michalakis, S.; Wagner, M.; Koch, S.; Brückl, 
T.; Biel, M.; Carell, T., Tissue Distribution of 5-Hydroxymethylcytosine and Search for 
Active Demethylation Intermediates. PLoS ONE, 2010, 5, e15367. 
221. Li, W.; Liu, M., Distribution of 5-Hydroxymethylcytosine in Different Human Tissues. 
J. Nucleic Acids, 2011, 2011, 870726. 
222. Wu, H.; Zhang, Y., Reversing DNA Methylation: Mechanisms, Genomics, and 
Biological Functions. Cell, 2014, 156, 45-68. 
223. Pastor, W. A.; Pape, U. J.; Huang, Y.; Henderson, H. R.; Lister, R.; Ko, M.; 
McLoughlin, E. M.; Brudno, Y.; Mahapatra, S.; Kapranov, P.; Tahiliani, M.; Daley, G. 
Q.; Liu, X. S.; Ecker, J. R.; Milos, P. M.; Agarwal, S.; Rao, A., Genome-wide Mapping 
of 5-Hydroxymethylcytosine in Embryonic Stem Cells. Nature, 2011, 473, 394-397. 
224. Mellén, M.; Ayata, P.; Dewell, S.; Kriaucionis, S.; Heintz, N., MeCP2 Binds to hmdC 
Enriched within Active Genes and Accessible Chromatin in the Nervous System. Cell, 
2012, 151, 1417-1430. 
225. Guo, Junjie U.; Su, Y.; Zhong, C.; Ming, G.-l.; Song, H., Hydroxylation of 
5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain. 
Cell, 2011, 145, 423-434. 
226. Chen, C.-C.; Wang, K.-Y.; Shen, C.-K. J., The Mammalian de Novo DNA 
Methyltransferases DNMT3A and DNMT3B are also DNA 5-Hydroxymethylcytosine 
Dehydroxymethylases. J. Biol. Chem., 2012, 287, 33116-33121. 
227. Ito, S.; Shen, L.; Dai, Q.; Wu, S. C.; Collins, L. B.; Swenberg, J. A.; He, C.; Zhang, Y., 
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxyl- 
cytosine. Science, 2011, 333, 1300-1303. 
228. He, Y.-F.; Li, B.-Z.; Li, Z.; Liu, P.; Wang, Y.; Tang, Q.; Ding, J.; Jia, Y.; Chen, Z.; Li, L.; 
Sun, Y.; Li, X.; Dai, Q.; Song, C.-X.; Zhang, K.; He, C.; Xu, G.-L., Tet-mediated 
Reference   
198 
   
Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA. 
Science, 2011, 333, 1303-1307. 
229. Pfaffeneder, T.; Hackner, B.; Truss, M.; Munzel, M.; Muller, M.; Deiml, C.; Hagemeier, 
C.; Carell, T., The Discovery of 5-Formylcytosine in Embryonic Stem Cell DNA. 
Angew. Chem., Int. Ed., 2011, 50, 7008 - 7012. 
230. Liu, S.; Wang, J.; Su, Y.; Guerrero, C.; Zeng, Y.; Mitra, D.; Brooks, P. J.; Fisher, D. E.; 
Song, H.; Wang, Y., Quantitative Assessment of Tet-induced Oxidation Products of 
5-Methylcytosine in Cellular and Tissue DNA. Nucleic Acids Res., 2013, 41, 
6421-6429. 
231. Sun, Z.; Dai, N.; Borgaro, Janine G.; Quimby, A.; Sun, D.; Corrêa, Ivan R., Jr.; Zheng, 
Y.; Zhu, Z.; Guan, S., A Sensitive Approach to Map Genome-wide 5-Hydroxy 
methylcytosine and 5-Formylcytosine at Single-base Resolution. Mol. Cell, 2015, 57, 
750-761. 
232. Shen, L.; Wu, H.; Diep, D.; Yamaguchi, S.; D’Alessio, Ana C.; Fung, H.-L.; Zhang, K.; 
Zhang, Y., Genome-wide Analysis Reveals TET- and TDG-dependent 5-Methyl- 
cytosine Oxidation Dynamics. Cell, 2013, 153, 692-706. 
233. Song, C.-X.; Szulwach, Keith E.; Dai, Q.; Fu, Y.; Mao, S.-Q.; Lin, L.; Street, C.; Li, Y.; 
Poidevin, M.; Wu, H.; Gao, J.; Liu, P.; Li, L.; Xu, G.-L.; Jin, P.; He, C., Genome-wide 
Profiling of 5-Formylcytosine Reveals Its Roles in Epigenetic Priming. Cell, 2013, 153, 
678-691. 
234. Bachman, M.; Uribe-Lewis, S.; Yang, X.; Burgess, H. E.; Iurlaro, M.; Reik, W.; 
Murrell, A.; Balasubramanian, S., 5-Formylcytosine can be a Stable DNA Modification 
in Mammals. Nat. Chem. Biol., 2015, 11, 555-557. 
235. Maiti, A.; Drohat, A. C., Thymine DNA Glycosylase can Rapidly Excise 5-Formyl- 
cytosine and 5-Carboxylcytosine. J. Biol. Chem., 2011, 286, 35334-35338. 
236. Cortazar, D.; Kunz, C.; Selfridge, J.; Lettieri, T.; Saito, Y.; MacDougall, E.; Wirz, A.; 
Schuermann, D.; Jacobs, A. L.; Siegrist, F.; Steinacher, R.; Jiricny, J.; Bird, A.; Schar, 
P., Embryonic Lethal Phenotype Reveals a Function of TDG in Maintaining Epigenetic 
Stability. Nature, 2011, 470, 419-423. 
237. Nabel, C. S.; Jia, H.; Ye, Y.; Shen, L.; Goldschmidt, H. L.; Stivers, J. T.; Zhang, Y.; 
Kohli, R. M., AID/APOBEC Deaminases Disfavor Modified Cytosines Implicated in 
DNA Demethylation. Nat. Chem. Biol., 2012, 8, 751-758. 
238. Schiesser, S.; Hackner, B.; Pfaffeneder, T.; Müller, M.; Hagemeier, C.; Truss, M.; 
Carell, T., Mechanism and Stem-cell Activity of 5-Carboxycytosine Decarboxylation 
Determined by Isotope Tracing. Angew. Chem., Int. Ed., 2012, 51, 6516-6520. 
239. Schiesser, S.; Pfaffeneder, T.; Sadeghian, K.; Hackner, B.; Steigenberger, B.; Schröder, 
A. S.; Steinbacher, J.; Kashiwazaki, G.; Höfner, G.; Wanner, K. T.; Ochsenfeld, C.; 
Carell, T., Deamination, Oxidation, and C-C Bond Cleavage Reactivity of 
5-Hydroxymethylcytosine, 5-Formylcytosine, and 5-Carboxycytosine. J. Am. Chem. 
Soc., 2013, 135, 14593-14599. 
240. Tanzi, R.; Watkins, P. C.; Ottina, K.; Wallace, M. R.; Sakaguchi, A.; Young, A. B.; 
Shoulson, I.; Bonilla, E.; Martin, J., A Polymorphic DNA Marker Genetically Linked 
Reference 
199 
 
to Huntingtons Disease. Nature, 1983, 306, 234-238. 
241. Venter, J. C.; Smith, H. O.; Hood, L., A New Strategy for Genome Sequencing. Nature, 
1996, 381, 364-366. 
242. Maxam, A. M.; Gilbert, W., A New Method for Sequencing DNA. Proc. Natl. Acad. Sci. 
USA, 1977, 74, 560-564. 
243. Lawley, P. D.; Brookes, P., Further Studies on the Alkylation of Nucleic Acids and their 
Consitituent Nucleotides. Biochem. J., 1963, 89, 127-138. 
244. Temperli, A.; Türler, H.; Rüst, P.; Danon, A.; Chargaff, E., Studies on the Nucleotide 
Arrangement in Deoxyribonucleic Acids IX. Selective Degradation of Pyrimidine 
Deoxyribonucleotides. Biochim. Biophys. Acta, 1964, 91, 462-476. 
245. Sanger, F.; Coulson, A. R., A Rapid Method for Determining Sequences in DNA by 
Primed Synthesis with DNA Polymerase. J. Mol. Biol., 1975, 94, 441-448. 
246. Sanger, F.; Nicklen, S.; Coulson, A. R., DNA Sequencing with Chain-terminating 
Inhibitors. Proc. Natl. Acad. Sci. USA, 1977, 74, 5463-5467. 
247. Smith, L. M.; Fung, S.; Hunkapiller, M. W.; Hunkapiller, T. J.; Hood, L. E., The 
Synthesis of Oligonucleotides Containing an Aliphatic Amino Group at the 5′ Terminus: 
Synthesis of Fluorescent DNA Primers for Use in DNA Sequence Analysis. Nucleic 
Acids Res., 1985, 13, 2399-2412. 
248. Smith, L. M.; Sanders, J. Z.; Kaiser, R. J.; Hughes, P.; Dodd, C.; Connell, C. R.; Heiner, 
C.; Kent, S. B. H.; Hood, L. E., Fluorescence Detection in Automated DNA Sequence 
Analysis. Nature, 1986, 321, 674-679. 
249. Craig Chinault, A.; Carbon, J., Overlap Hybridization Screening: Isolation and 
Characterization of Overlapping DNA Fragments Surrounding the Leu2 Gene on Yeast 
Chromosome III. Gene, 1979, 5, 111-126. 
250. Staden, R., A Strategy of DNA Sequencing Employing Computer Programs. Nucleic 
Acids Res., 1979, 6, 2601-2610. 
251. Anderson, S., Shotgun DNA Sequencing using Cloned DNase I-generated Fragments. 
Nucleic Acids Res., 1981, 9, 3015-3027. 
252. Consortium, I. H. G. S., Initial Sequencing and Analysis of the Human Genome. 
Nature, 2001, 409, 860-921. 
253. Consortium, M. G. S., Initial Sequencing and Comparative Analysis of the Mouse 
Genome. Nature, 2002, 420, 520-562. 
254. Wang, T.; Hong, T.; Tang, T.; Zhai, Q.; Xing, X.; Mao, W.; Zheng, X.; Xu, L.; Wu, J.; 
Weng, X.; Wang, S.; Tian, T.; Yuan, B.; Huang, B.; Zhuang, L.; Zhou, X., Application 
of N-Halogeno-N-sodiobenzenesulfonamide Reagents to the Selective Detection of 
5-Methylcytosine in DNA Sequences. J. Am. Chem. Soc., 2013, 135, 1240-1243. 
255. Münzel, M.; Lercher, L.; Müller, M.; Carell, T., Chemical Discrimination between dC 
and 5MedC via their Hydroxylamine Adducts. Nucleic Acids Res., 2010, 38, e192. 
256. Huang, R.; Wang, J.; Mao, W.; Fu, B.; Xing, X.; Guo, G.; Zhou, X., A Novel Combined 
Bisulfite UDG Assay for Selective 5-Methylcytosine Detection. Talanta, 2013, 117, 
445-448. 
257. Tian, T.; Zhang, X.; Fu, B.; Long, Y.; Peng, S.; Wang, S.; Zhou, X.; Zhou, X., 
Reference   
200 
   
Systematic Investigation of DNAs with Modified Cytosines under Hot Alkali 
Treatment. Chem. Commun., 2013, 49, 9968-9970. 
258. Ko, M.; Huang, Y.; Jankowska, A. M.; Pape, U. J.; Tahiliani, M.; Bandukwala, H. S.; 
An, J.; Lamperti, E. D.; Koh, K. P.; Ganetzky, R.; Liu, X. S.; Aravind, L.; Agarwal, S.; 
Maciejewski, J. P.; Rao, A., Impaired Hydroxylation of 5-Methylcytosine in Myeloid 
Cancers with Mutant TET2. Nature, 2010, 468, 839-843. 
259. Szwagierczak, A.; Bultmann, S.; Schmidt, C. S.; Spada, F.; Leonhardt, H., Sensitive 
Enzymatic Quantification of 5-Hydroxymethylcytosine in Genomic DNA. Nucleic 
Acids Res., 2010, 38, e181-e181. 
260. Ficz, G.; Branco, M. R.; Seisenberger, S.; Santos, F.; Krueger, F.; Hore, T. A.; Marques, 
C. J.; Andrews, S.; Reik, W., Dynamic Regulation of 5-Hydroxymethylcytosine in 
Mouse ES Cells and during Differentiation. Nature, 2011, 473, 398-402. 
261. Kinney, S. M.; Chin, H. G.; Vaisvila, R.; Bitinaite, J.; Zheng, Y.; Estève, P.-O.; Feng, S.; 
Stroud, H.; Jacobsen, S. E.; Pradhan, S., Tissue-specific Distribution and Dynamic 
Changes of 5-Hydroxymethylcytosine in Mammalian Genomes. J. Biol. Chem., 2011, 
286, 24685-24693. 
262. Song, C.-X.; Szulwach, K. E.; Fu, Y.; Dai, Q.; Yi, C.; Li, X.; Li, Y.; Chen, C.-H.; Zhang, 
W.; Jian, X.; Wang, J.; Zhang, L.; Looney, T. J.; Zhang, B.; Godley, L. A.; Hicks, L. M.; 
Lahn, B. T.; Jin, P.; He, C., Selective Chemical Labeling Reveals the Genome-wide 
Distribution of 5-Hydroxymethylcytosine. Nat. Biotech., 2011, 29, 68-72. 
263. Raiber, E.-A.; Beraldi, D.; Ficz, G.; Burgess, H.; Branco, M.; Murat, P.; Oxley, D.; 
Booth, M.; Reik, W.; Balasubramanian, S., Genome-wide Distribution of 
5-Formylcytosine in Embryonic Stem Cells is Associated with Transcription and 
Depends on Thymine DNA Glycosylase. Genome Biol., 2012, 13, R69. 
264. Dai, Q.; He, C., Syntheses of 5-Formyl- and 5-Carboxyl-dC Containing DNA Oligos as 
Potential Oxidation Products of 5-Hydroxymethylcytosine in DNA. Org. Lett., 2011, 
13, 3446-3449. 
265. Xia, B.; Han, D.; Lu, X.; Sun, Z.; Zhou, A.; Yin, Q.; Zeng, H.; Liu, M.; Jiang, X.; Xie, 
W.; He, C.; Yi, C., Bisulfite-free, Base-resolution Analysis of 5-Formylcytosine at the 
Genome Scale. Nat. Meth., 2015, 12, 1047-1050. 
266. Shapiro, R.; Servis, R. E.; Welcher, M., Reactions of Uracil and Cytosine Derivatives 
with Sodium Bisulfite. J. Am. Chem. Soc., 1970, 92, 422-424. 
267. Shapiro, R.; Braverman, B.; Louis, J. B.; Servis, R. E., Nucleic Acid Reactivity and 
Conformation: II. Reaction of Cytosine and Uracil with Sodium Bisulfite. J. Biol. 
Chem., 1973, 248, 4060-4064. 
268. Booth, M. J.; Marsico, G.; Bachman, M.; Beraldi, D.; Balasubramanian, S., 
Quantitative Sequencing of 5-Formylcytosine in DNA at Single-Base Resolution. Nat. 
Chem., 2014, 6, 435-440. 
269. Meissner, A.; Gnirke, A.; Bell, G. W.; Ramsahoye, B.; Lander, E. S.; Jaenisch, R., 
Reduced Representation Bisulfite Sequencing for Comparative High-resolution DNA 
Methylation Analysis. Nucleic Acids Res., 2005, 33, 5868-5877. 
270. Meissner, A.; Mikkelsen, T. S.; Gu, H.; Wernig, M.; Hanna, J.; Sivachenko, A.; Zhang, 
Reference 
201 
 
X.; Bernstein, B. E.; Nusbaum, C.; Jaffe, D. B.; Gnirke, A.; Jaenisch, R.; Lander, E. S., 
Genome-scale DNA Methylation Maps of Pluripotent and Differentiated Cells. Nature, 
2008, 454, 766-770. 
271. Lu, X.; Song, C.-X.; Szulwach, K.; Wang, Z.; Weidenbacher, P.; Jin, P.; He, C., 
Chemical Modification-Assisted Bisulfite Sequencing (CAB-Seq) for 5-Carboxyl- 
cytosine Detection in DNA. J. Am. Chem. Soc., 2013, 135, 9315-9317. 
272. Wang, R. Y.-H.; Gehrke, C. W.; Ehrlich, M., Comparison of Bisulfite Modification of 
5-Methyldeoxycytidine and Deoxycytidine Residues. Nucleic Acids Res., 1980, 8, 
4777-4790. 
273. Grunau, C.; Clark, S. J.; Rosenthal, A., Bisulfite Genomic Sequencing: Systematic 
Investigation of Critical Experimental Parameters. Nucleic Acids Res., 2001, 29, e65. 
274. Tanaka, K.; Okamoto, A., Degradation of DNA by Bisulfite Treatment. Bioorg. Med. 
Chem. Lett., 2007, 17, 1912-1915. 
275. Rivera, Chloe M.; Ren, B., Mapping Human Epigenomes. Cell, 2013, 155, 39-55. 
276. Nomura, A.; Sugizaki, K.; Yanagisawa, H.; Okamoto, A., Discrimination Between 
5-Hydroxymethylcytosine and 5-Methylcytosine by a Chemically Designed Peptide. 
Chem. Commun., 2011, 47, 8277-8279. 
277. Duprey, J.-L. H. A.; Bullen, G. A.; Zhao, Z.-y.; Bassani, D. M.; Peacock, A. F. A.; 
Wilkie, J.; Tucker, J. H. R., Single Site Discrimination of Cytosine, 5-Methylcytosine, 
and 5-Hydroxymethylcytosine in Target DNA Using Anthracene-tagged Fluorescent 
Probes. ACS Chem. Bio., 2015. 
278. Flusberg, B. A.; Webster, D. R.; Lee, J. H.; Travers, K. J.; Olivares, E. C.; Clark, T. A.; 
Korlach, J.; Turner, S. W., Direct Detection of DNA Methylation during Single- 
molecule, Real-time Sequencing. Nat. Methods, 2010, 7, 461-465. 
279. Clark, T.; Lu, X.; Luong, K.; Dai, Q.; Boitano, M.; Turner, S.; He, C.; Korlach, J., 
Enhanced 5-Methylcytosine Detection in Single-molecule, Real-time Sequencing via 
Tet1 Oxidation. BMC Biol., 2013, 11, 4. 
280. Deamer, D. W.; Branton, D., Characterization of Nucleic Acids by Nanopore Analysis. 
Acc. Chem. Res., 2002, 35, 817-825. 
281. Kasianowicz, J. J.; Brandin, E.; Branton, D.; Deamer, D. W., Characterization of 
Individual Polynucleotide Molecules using a Membrane Channel. Proc. Natl. Acad. Sci. 
USA, 1996, 93, 13770-13773. 
282. Cherf, G. M.; Lieberman, K. R.; Rashid, H.; Lam, C. E.; Karplus, K.; Akeson, M., 
Automated Forward and Reverse Ratcheting of DNA in a Nanopore at 5-A Precision. 
Nat. Biotech., 2012, 30, 344-348. 
283. Manrao, E. A.; Derrington, I. M.; Laszlo, A. H.; Langford, K. W.; Hopper, M. K.; 
Gillgren, N.; Pavlenok, M.; Niederweis, M.; Gundlach, J. H., Reading DNA at 
Single-nucleotide Resolution with a Mutant MspA Nanopore and Φ29 DNA 
Polymerase. Nat. Biotech., 2012, 30, 349-353. 
284. Lieberman, K. R.; Cherf, G. M.; Doody, M. J.; Olasagasti, F.; Kolodji, Y.; Akeson, M., 
Processive Replication of Single DNA Molecules in a Nanopore Catalyzed by Φ29 
DNA Polymerase. J. Am. Chem. Soc., 2010, 132, 17961-17972. 
Reference   
202 
   
285. Wallace, E. V. B.; Stoddart, D.; Heron, A. J.; Mikhailova, E.; Maglia, G.; Donohoe, T. 
J.; Bayley, H., Identification of Epigenetic DNA Modifications with a Protein 
Nanopore. Chem. Commun., 2010, 46, 8195-8197. 
286. Laszlo, A. H.; Derrington, I. M.; Brinkerhoff, H.; Langford, K. W.; Nova, I. C.; 
Samson, J. M.; Bartlett, J. J.; Pavlenok, M.; Gundlach, J. H., Detection and Mapping of 
5-Methylcytosine and 5-Hydroxymethylcytosine with Nanopore MspA. Proc. Natl. 
Acad. Sci. USA, 2013, 110, 18904-18909. 
287. Schreiber, J.; Wescoe, Z. L.; Abu-Shumays, R.; Vivian, J. T.; Baatar, B.; Karplus, K.; 
Akeson, M., Error Rates for Nanopore Discrimination among Cytosine, 
Methylcytosine, and Hydroxymethylcytosine along Individual DNA Strands. Proc. 
Natl. Acad. Sci. USA, 2013, 110, 18910-18915. 
288. Wescoe, Z. L.; Schreiber, J.; Akeson, M., Nanopores Discriminate among Five 
C5-Cytosine Variants in DNA. J. Am. Chem. Soc., 2014, 136, 16582-16587. 
289. Venkatesan, B. M.; Bashir, R., Nanopore Sensors for Nucleic Acid Analysis. Nat. Nano, 
2011, 6, 615-624. 
290. Feng, J.; Liu, K.; Bulushev, R. D.; Khlybov, S.; Dumcenco, D.; Kis, A.; Radenovic, A., 
Identification of Single Nucleotides in MoS2 Nanopores. Nat. Nano, 2015, 10, 
1070-1076. 
291. Eid, J.; Fehr, A.; Gray, J.; Luong, K.; Lyle, J.; Otto, G.; Peluso, P.; Rank, D.; Baybayan, 
P.; Bettman, B.; Bibillo, A.; Bjornson, K.; Chaudhuri, B.; Christians, F.; Cicero, R.; 
Clark, S.; Dalal, R.; deWinter, A.; Dixon, J.; Foquet, M.; Gaertner, A.; Hardenbol, P.; 
Heiner, C.; Hester, K.; Holden, D.; Kearns, G.; Kong, X.; Kuse, R.; Lacroix, Y.; Lin, S.; 
Lundquist, P.; Ma, C.; Marks, P.; Maxham, M.; Murphy, D.; Park, I.; Pham, T.; Phillips, 
M.; Roy, J.; Sebra, R.; Shen, G.; Sorenson, J.; Tomaney, A.; Travers, K.; Trulson, M.; 
Vieceli, J.; Wegener, J.; Wu, D.; Yang, A.; Zaccarin, D.; Zhao, P.; Zhong, F.; Korlach, J.; 
Turner, S., Real-time DNA Sequencing from Single Polymerase Molecules. Science, 
2009, 323, 133-138. 
292. Liu, X.; Li, J.; Dong, J.; Hu, C.; Gong, W.; Wang, J., Genetic Incorporation of a 
Metal-chelating Amino Acid as a Probe for Protein Electron Transfer. Angew. Chem., 
Int. Ed., 2012, 51, 10261-10265. 
293. Hoffer, M., α-Thymidin. Chem. Ber., 1960, 93, 2777-2781. 
294. Gu, W.; Wang, S., Synthesis and Antimicrobial Activities of Novel 1H-dibenzo[a,c] 
carbazoles from Dehydroabietic Acid. Eur. J. Med. Chem., 2010, 45, 4692-4696. 
295. de Brito, A. F.; Martins, J. L. R.; Fajemiroye, J. O.; Galdino, P. M.; De Lima, T. C. M.; 
Menegatti, R.; Costa, E. A., Central Pharmacological Activity of a New Piperazine 
Derivative: 4-(1-Phenyl-1H-pyrazol-4-ylmethyl)-piperazine-1-carboxylic Acid Ethyl 
ester. Life Sci., 2012, 90, 910-916. 
296. Sousa, C.; Silva, P. J., BBr3-Assisted Cleavage of Most Ethers Does Not Follow the 
Commonly Assumed Mechanism. Eur. J. Org. Chem., 2013, 2013, 5195-5199. 
297. Batchu, H.; Bhattacharyya, S.; Kant, R.; Batra, S., Palladium-catalyzed 
Chelation-assisted Regioselective Oxidative Dehydrogenative Homocoupling/ Ortho- 
Hydroxylation in N-Phenylpyrazoles. J. Org. Chem., 2015, 80, 7360-7374. 
Reference 
203 
 
298. Corey, E. J.; Posner, G. H., Selective Formation of Carbon-carbon Bonds between 
Unlike Groups using Organocopper Reagents. J. Am. Chem. Soc., 1967, 89, 3911-3912. 
299. House, H. O.; Respess, W. L.; Whitesides, G. M., The Chemistry of Carbanions. XII. 
The Role of Copper in the Conjugate Addition of Organometallic Reagents1. J. Org. 
Chem., 1966, 31, 3128-3141. 
300. Gilman, H.; Jones, R. G.; Woods, L. A., The Preparation of Methylcopper and some 
Observations on the Decomposition of Organocopper Compounds. J. Org. Chem., 
1952, 17, 1630-1634. 
301. Lorenzen, N. P.; Weiss, E., Synthesis and Structure of a Dimeric Lithium 
Diphenylcuprate: [{Li(OEt)2}(CuPh2)]2. Angew. Chem., Int. Ed., 1990, 29, 300-302. 
302. Reddy, M. P.; Farooqui, F.; Hanna, N. B., Methylamine Deprotection Provides 
Increased Yield of Oligoribonucleotides. Tetrahedron Lett., 1995, 36, 8929-8932. 
303. Larrow, J. F.; Jacobsen, E. N.; Gao, Y.; Hong, Y.; Nie, X.; Zepp, C. M., A Practical 
Method for the Large-scale Preparation of [N,N'-Bis(3,5-di-tertbutylsalicylidene)- 
1,2-cyclohexanediaminato(2-)]manganese(III) chloride, a Highly Enantioselective 
Epoxi- dation Catalyst. J. Org. Chem., 1994, 59, 1939-1942. 
304. Betz, K.; Malyshev, D. A.; Lavergne, T.; Welte, W.; Diederichs, K.; Romesberg, F. E.; 
Marx, A., Structural Insights into DNA Replication without Hydrogen Bonds. J. Am. 
Chem. Soc., 2013, 135, 18637-18643. 
305. Agarwal, K.; Sharma, A.; Talukder, G., Effects of Copper on Mammalian Cell 
Components. Chem. Biol. Interact., 1989, 69, 1-16. 
306. Valko, M.; Rhodes, C. J.; Moncol, J.; Izakovic, M.; Mazur, M., Free Radicals, Metals 
and Antioxidants in Oxidative Stress-induced Cancer. Chem. Biol. Interact., 2006, 160, 
1-40. 
307. Hureau, C.; Faller, P., Aβ-mediated ROS Production by Cu Ions: Structural Insights, 
Mechanisms and Relevance to Alzheimer's Disease. Biochimie, 2009, 91, 1212-1217. 
308. Caton-Williams, J.; Smith, M.; Carrasco, N.; Huang, Z., Protection-free One-pot 
Synthesis of 2′-Deoxynucleoside 5′-Triphosphates and DNA Polymerization. Org. Lett., 
2011, 13, 4156-4159. 
309. Burgess, K.; Cook, D., Syntheses of Nucleoside Triphosphates. Chem. Rev., 2000, 100, 
2047-2060. 
310. Gardner, A. F.; Jack, W. E., Determinants of Nucleotide Sugar Recognition in an 
Archaeon DNA Polymerase. Nucleic Acids Res., 1999, 27, 2545-2553. 
311. Gardner, A. F.; Jack, W. E., Acyclic and Dideoxy Terminator Preferences Denote 
Divergent Sugar Recognition by Archaeon and Taq DNA Polymerases. Nucleic Acids 
Res., 2002, 30, 605-613. 
312. Horhota, A.; Zou, K.; Ichida, J. K.; Yu, B.; McLaughlin, L. W.; Szostak, J. W.; Chaput, 
J. C., Kinetic Analysis of an Efficient DNA-dependent TNA Polymerase. J. Am. Chem. 
Soc., 2005, 127, 7427-7434. 
313. Ichida, J. K.; Zou, K.; Horhota, A.; Yu, B.; McLaughlin, L. W.; Szostak, J. W., An in 
vitro Selection System for TNA. J. Am. Chem. Soc., 2005, 127, 2802-2803. 
314. Roelfes, G.; Feringa, B. L., DNA-based Asymmetric Catalysis. Angew. Chem., Int. Ed., 
Reference   
204 
   
2005, 44, 3230-3232. 
315. Park, S.; Ikehata, K.; Watabe, R.; Hidaka, Y.; Rajendran, A.; Sugiyama, H., 
Deciphering DNA-based Asymmetric Catalysis Through Intramolecular Friedel-Crafts 
Alkylations. Chem. Commun., 2012, 48, 10398-10400. 
316. Park, S.; Zheng, L.; Kumakiri, S.; Sakashita, S.; Otomo, H.; Ikehata, K.; Sugiyama, H., 
Development of DNA-Based Hybrid Catalysts through Direct Ligand Incorporation: 
Toward Understanding of DNA-Based Asymmetric Catalysis. ACS Catal., 2014, 4, 
4070-4073. 
317. Wang, C.; Jia, G.; Zhou, J.; Li, Y.; Liu, Y.; Lu, S.; Li, C., Enantioselective Diels-Alder 
Reactions with G-Quadruplex DNA-based Catalysts. Angew. Chem., Int. Ed., 2012, 51, 
9352-9355. 
318. Otto, S.; Bertoncin, F.; Engberts, J. B. F. N., Lewis Acid Catalysis of a Diels−Alder 
Reaction in Water. J. Am. Chem. Soc., 1996, 118, 7702-7707. 
319. Kim, S.; Misra, A., SNP Genotyping: Technologies and Biomedical Applications. Annu. 
Rev. Biomed. Eng., 2007, 9, 289-320. 
320. Li, P.; He, H.; Wang, Z.; Feng, M.; Jin, H.; Wu, Y.; Zhang, L.; Zhang, L.; Tang, X., 
Sensitive Detection of Single-nucleotide Mutation in the BRAF Mutation Site (V600E) 
of Human Melanoma Using Phosphate-pyrene-labeled DNA Probes. Anal. Chem., 
2016, 88, 883-889. 
321. Banér, J.; Isaksson, A.; Waldenström, E.; Jarvius, J.; Landegren, U.; Nilsson, M., 
Parallel Gene Analysis with Allele-specific Padlock Probes and Tag Microarrays. 
Nucleic Acids Res., 2003, 31, e103. 
322. Felsenfeld, G.; Groudine, M., Controlling the Double Helix. Nature, 2003, 421, 
448-453. 
323. Guo, P.; Yan, S.; Hu, J.; Xing, X.; Wang, C.; Xu, X.; Qiu, X.; Ma, W.; Lu, C.; Weng, X.; 
Zhou, X., Selective Detection of 5-Formyl-2′-deoxycytidine in DNA Using a 
Fluorogenic Hydroxylamine Reagent. Org. Lett., 2013, 15, 3266-3269. 
324. Xu, L.; Chen, Y.-C.; Nakajima, S.; Chong, J.; Wang, L.; Lan, L.; Zhang, C.; Wang, D., 
A Chemical Probe Targets DNA 5-Formylcytosine Sites and Inhibits TDG Excision, 
Polymerases Bypass, and Gene Expression. Chem. Sci., 2014, 5, 567-574. 
325. Hu, J.; Xing, X.; Xu, X.; Wu, F.; Guo, P.; Yan, S.; Xu, Z.; Xu, J.; Weng, X.; Zhou, X., 
Selective Chemical Labelling of 5-Formylcytosine in DNA by Fluorescent Dyes. Chem. 
Eur. J., 2013, 19, 5836-5840. 
326. Zhang, Z.; Smith, B. A. C.; Wang, L.; Brock, A.; Cho, C.; Schultz, P. G., A New 
Strategy for the Site-Specific Modification of Proteins in vivo. Biochemistry, 2003, 42, 
6735-6746. 
327. Wang, L.; Zhang, Z.; Brock, A.; Schultz, P. G., Addition of the Keto Functional Group 
to the Genetic Code of Escherichia coli. Proc. Natl. Acad. Sci. USA, 2003, 100, 56-61. 
328. Chen, I.; Howarth, M.; Lin, W.; Ting, A. Y., Site-specific Labeling of Cell Surface 
Proteins with Biophysical Probes using Biotin Ligase. Nat. Methods, 2005, 2, 99-104. 
329. Taylor, M. T.; Blackman, M. L.; Dmitrenko, O.; Fox, J. M., Design and Synthesis of 
Highly Reactive Dienophiles for the Tetrazine-trans-cyclooctene Ligation. J. Am. Chem. 
Reference 
205 
 
Soc., 2011, 133, 9646-9649. 
330. Patterson, D. M.; Nazarova, L. A.; Xie, B.; Kamber, D. N.; Prescher, J. A., 
Functionalized Cyclopropenes As Bioorthogonal Chemical Reporters. J. Am. Chem. 
Soc., 2012, 134, 18638-18643. 
331. Liang, Y.; Mackey, J. L.; Lopez, S. A.; Liu, F.; Houk, K. N., Control and Design of 
Mutual Orthogonality in Bioorthogonal Cycloadditions. J. Am. Chem. Soc., 2012, 134, 
17904-17907. 
332. Noda, H.; Erős, G.; Bode, J. W., Rapid Ligations with Equimolar Reactants in Water 
with the Potassium Acyltrifluoroborate (KAT) Amide Formation. J. Am. Chem. Soc., 
2014, 136, 5611-5614. 
333. Saito, F.; Noda, H.; Bode, J. W., Critical Evaluation and Rate Constants of 
Chemoselective Ligation Reactions for Stoichiometric Conjugations in Water. ACS 
Chem. Bio., 2015, 10, 1026-1033. 
334. Dirksen, A.; Hackeng, T. M.; Dawson, P. E., Nucleophilic Catalysis of Oxime Ligation. 
Angew. Chem., Int. Ed., 2006, 45, 7581-7584. 
335. Duprey, J.-L. H. A.; Takezawa, Y.; Shionoya, M., Metal-locked DNA Three-way 
Junction. Angew. Chem., Int. Ed., 2013, 52, 1212-1216. 
336. Guan, L.; van der Heijden, G. W.; Bortvin, A.; Greenberg, M. M., Intracellular 
Detection of Cytosine Incorporation in Genomic DNA by Using 
5-Ethynyl-2′-deoxycytidine. ChemBioChem, 2011, 12, 2184-2190. 
337. Obeid, S.; Bußkamp, H.; Welte, W.; Diederichs, K.; Marx, A., Interactions of 
Non-polar and "Clickable" Nucleotides in the Confines of a DNA Polymerase Active 
Site. Chem. Commun., 2012, 48, 8320-8322. 
338. Griffith, J. A.; Withers, J. M.; Martin, D. J.; Rowlands, G. J.; Filichev, V. V., Ligand 
Assembly and Chirality Transfer Guided by DNA Modified with Enantiomerically 
Pure [2.2]Paracyclophanes. RSC Adv., 2013, 3, 9373-9380. 
339. Wenge, U.; Ehrenschwender, T.; Wagenknecht, H.-A., Synthesis of 2′-O-Propargyl 
Nucleoside Triphosphates for Enzymatic Oligonucleotide Preparation and “Click” 
Modification of DNA with Nile Red as Fluorescent Probe. Bioconjugate Chem., 2013, 
24, 301-304. 
340. Wendeler, M.; Grinberg, L.; Wang, X.; Dawson, P. E.; Baca, M., Enhanced Catalysis of 
Oxime-based Bioconjugations by Substituted Anilines. Bioconjugate Chem., 2014, 25, 
93-101. 
341. Camiener, G. W., Studies of the Enzymatic Deamination of Ara-cytidine-V: Inhibition 
in vitro and in vivo by Tetrahydrouridine and Other Reduced Pyrimidine Nucleosides. 
Biochem. Pharmacol., 1968, 17, 1981-1991. 
342. Green, N. M., Avidin. 3. The Nature of the Biotin-binding Site. Biochem. J., 1963, 89, 
599-609. 
343. Green, N. M., Avidin. 1. The Use of 14C Biotin for Kinetic Studies and for Assay. 
Biochem. J., 1963, 89, 585-591. 
344. Nilsson, M.; Malmgren, H.; Samiotaki, M.; Kwiatkowski, M.; Chowdhary, B.; 
Landegren, U., Padlock Probes: Circularizing Oligonucleotides for Localized DNA 
Reference   
206 
   
Detection. Science, 1994, 265, 2085-2088. 
345. Liu, S.; Wang, C.; Zhang, C.; Wang, Y.; Tang, B., Label-free and Ultrasensitive 
Electrochemical Detection of Nucleic Acids Based on Autocatalytic and Exonuclease 
III-assisted Target Recycling Strategy. Anal. Chem., 2013, 85, 2282-2288. 
346. Untergasser, A.; Nijveen, H.; Rao, X.; Bisseling, T.; Geurts, R.; Leunissen, J. A. M., 
Primer3Plus, An Enhanced Web Interface to Primer3. Nucleic Acids Res., 2007, 35, 
W71-W74. 
347. van Eijk, M. J. T.; Broekhof, J. L. N.; van der Poel, H. J. A.; Hogers, R. C. J.; 
Schneiders, H.; Kamerbeek, J.; Verstege, E.; van Aart, J. W.; Geerlings, H.; Buntjer, J. 
B.; van Oeveren, A. J.; Vos, P., SNPWaveTM: A Flexible Multiplexed SNP Genotyping 
Technology. Nucleic Acids Res., 2004, 32, e47. 
348. Hindson, B. J.; Ness, K. D.; Masquelier, D. A.; Belgrader, P.; Heredia, N. J.; 
Makarewicz, A. J.; Bright, I. J.; Lucero, M. Y.; Hiddessen, A. L.; Legler, T. C.; Kitano, 
T. K.; Hodel, M. R.; Petersen, J. F.; Wyatt, P. W.; Steenblock, E. R.; Shah, P. H.; 
Bousse, L. J.; Troup, C. B.; Mellen, J. C.; Wittmann, D. K.; Erndt, N. G.; Cauley, T. H.; 
Koehler, R. T.; So, A. P.; Dube, S.; Rose, K. A.; Montesclaros, L.; Wang, S.; Stumbo, D. 
P.; Hodges, S. P.; Romine, S.; Milanovich, F. P.; White, H. E.; Regan, J. F.; 
Karlin-Neumann, G. A.; Hindson, C. M.; Saxonov, S.; Colston, B. W., High-throughput 
Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number. Anal. 
Chem., 2011, 83, 8604-8610. 
349. Han, H.-S.; Cantalupo, P. G.; Rotem, A.; Cockrell, S. K.; Carbonnaux, M.; Pipas, J. M.; 
Weitz, D. A., Whole-genome Sequencing of a Single Viral Species from a Highly 
Heterogeneous Sample. Angew. Chem., Int. Ed., 2015, 54, 13985-13988. 
350. Lubin, F. D.; Roth, T. L.; Sweatt, J. D., Epigenetic Regulation of bdnf Gene 
Transcription in the Consolidation of Fear Memory. J. Neurosci., 2008, 28, 
10576-10586. 
351. Hardenbol, P.; Baner, J.; Jain, M.; Nilsson, M.; Namsaraev, E. A.; Karlin-Neumann, G. 
A.; Fakhrai-Rad, H.; Ronaghi, M.; Willis, T. D.; Landegren, U.; Davis, R. W., 
Multiplexed Genotyping with Sequence-tagged Molecular Inversion Probes. Nat. 
Biotech., 2003, 21, 673-678. 
352. Schröder, A. S.; Steinbacher, J.; Steigenberger, B.; Gnerlich, F. A.; Schiesser, S.; 
Pfaffeneder, T.; Carell, T., Synthesis of a DNA Promoter Segment Containing All Four 
Epigenetic Nucleosides: 5-Methyl-, 5-Hydroxymethyl-, 5-Formyl-, and 5-Carboxy- 
2′-Deoxycytidine. Angew. Chem., Int. Ed., 2014, 53, 315-318. 
 
 
207 
 
Postscript 
Frank Herbert, an American writer, said “There is no real ending. It’s just the place 
where you stop the story.” So, here is the best place to close this thesis. 
Four years ago, it was the first time for the author, a little boy, to go abroad. He was 
alone, with two pieces of baggage. Facing a new and fantastic world, he did not know 
what would be the future. He had imagined the most difficult scenarios. There is no 
way back. 
Since then, he learned to manage everything himself in this strange land. He tried to 
rent a flat. He took the ankle surgery in the hospital. He was a Marathon runner more 
than a football player in the lab. He drew up the itinerary and traveled alone to see the 
world. He talked to himself to drive away loneliness. He went through the days when 
his friend slid off the mountain and passed away. He met his girlfriend from Kyoto in 
Munich by coincidence. He strived hard to find out where should be his next stop, and 
what the future will be. He followed his heart in making decisions because he knew 
that this is his own life. He tries to live his life to the fullest. 
Little by little, he learned to be brave, to be independent, to be grateful. He thanks all 
the person he encountered, kind or severe. He thanks all the things happened to him, 
good or bad. He learned to be himself. He learned to love the world, a world of 
laughter and tears, a world of prosperity and poverty, a world of light and darkness. 
He learned that there is no definite answer for the future because the future itself 
means infinite possibilities.  
He thanks himself sincerely, for the unparalleled courage, for the curiosity, for the 
enthusiasm and persistent in chasing his dreams.  
Every story has an end, and every ending is just a new beginning. Now, the young 
man is eager for a larger world, for the future, even more than ever, as the boy four 
years ago, but with less fear. 
 
